{"source": "Human", "value": 0.0, "ngenes": 25384, "max_val": 8.705585111092352, "rank": 2075.0, "id": "38f2ce24-8e05-11ea-88ba-5cf37097309a", "children": [{"source": "Signal Transduction", "value": 0.4419035080884291, "ngenes": 3731, "max_val": 8.706, "rank": 1336.0, "id": "38f2ce25-8e05-11ea-ab27-5cf37097309a", "children": [{"source": "Signaling by Hedgehog", "value": 0.3186832326709682, "ngenes": 267, "max_val": 8.706, "rank": 1924.0, "id": "38f2ce26-8e05-11ea-8fbc-5cf37097309a", "children": [{"source": "Hedgehog 'on' state", "value": 0.5026538838841291, "ngenes": 125, "max_val": 8.706, "rank": 1087.0, "id": "38f2ce27-8e05-11ea-b66e-5cf37097309a", "children": [{"source": "Activation of SMO", "value": 5.212872163562974, "ngenes": 26, "max_val": 8.706, "rank": 3.0, "id": "38f2ce28-8e05-11ea-88a3-5cf37097309a"}, {"source": "Ligand-receptor interactions", "value": 3.7482115603111694, "ngenes": 12, "max_val": 8.706, "rank": 15.0, "id": "38f2ce29-8e05-11ea-acd4-5cf37097309a"}, {"source": "GLI proteins bind promoters of Hh responsive genes to promote transcription", "value": 3.5908796581964135, "ngenes": 7, "max_val": 8.706, "rank": 19.0, "id": "38f2ce2a-8e05-11ea-825f-5cf37097309a"}]}, {"source": "Hedgehog ligand biogenesis", "value": 0.5129675413459008, "ngenes": 88, "max_val": 8.706, "rank": 1057.0, "id": "38f2f518-8e05-11ea-8ae1-5cf37097309a", "children": [{"source": "Release of Hh-Np from the secreting cell", "value": 0.9661300639587429, "ngenes": 12, "max_val": 8.706, "rank": 562.0, "id": "38f2f519-8e05-11ea-a57c-5cf37097309a"}]}, {"source": "Hedgehog 'off' state", "value": 0.8180223841458668, "ngenes": 212, "max_val": 8.706, "rank": 651.0, "id": "38f2f51a-8e05-11ea-8bde-5cf37097309a", "children": [{"source": "GLI3 is processed to GLI3R by the proteasome", "value": 0.9062602594897696, "ngenes": 78, "max_val": 8.706, "rank": 592.0, "id": "38f2f51b-8e05-11ea-bd3c-5cf37097309a"}, {"source": "Degradation of GLI1 by the proteasome", "value": 0.6937103871398255, "ngenes": 80, "max_val": 8.706, "rank": 766.0, "id": "38f2f51c-8e05-11ea-a874-5cf37097309a"}, {"source": "Degradation of GLI2 by the proteasome", "value": 0.5539472432420487, "ngenes": 78, "max_val": 8.706, "rank": 986.0, "id": "38f2f51d-8e05-11ea-91c0-5cf37097309a"}]}]}, {"source": "Signaling by NOTCH", "value": 1.168118768538981, "ngenes": 324, "max_val": 8.706, "rank": 455.0, "id": "38f2f51e-8e05-11ea-adfa-5cf37097309a", "children": [{"source": "Signaling by NOTCH1", "value": 0.4411522306478651, "ngenes": 97, "max_val": 8.706, "rank": 1342.0, "id": "38f2f51f-8e05-11ea-8419-5cf37097309a", "children": [{"source": "Activated NOTCH1 Transmits Signal to the Nucleus", "value": 3.7636234745699113, "ngenes": 42, "max_val": 8.706, "rank": 12.0, "id": "38f2f520-8e05-11ea-8003-5cf37097309a"}, {"source": "NOTCH1 Intracellular Domain Regulates Transcription", "value": 0.5261868648768158, "ngenes": 61, "max_val": 8.706, "rank": 1037.0, "id": "38f2f521-8e05-11ea-94ae-5cf37097309a"}]}, {"source": "Signaling by NOTCH2", "value": 1.5411445750463468, "ngenes": 44, "max_val": 8.706, "rank": 299.0, "id": "38f2f522-8e05-11ea-b664-5cf37097309a", "children": [{"source": "NOTCH2 Activation and Transmission of Signal to the Nucleus", "value": 2.877529328454117, "ngenes": 25, "max_val": 8.706, "rank": 47.0, "id": "38f2f523-8e05-11ea-9913-5cf37097309a"}, {"source": "NOTCH2 intracellular domain regulates transcription", "value": 0.3984289558542966, "ngenes": 21, "max_val": 8.706, "rank": 1510.0, "id": "38f2f524-8e05-11ea-aec8-5cf37097309a"}]}, {"source": "Pre-NOTCH Expression and Processing", "value": 2.1267895101999463, "ngenes": 150, "max_val": 8.706, "rank": 117.0, "id": "38f2f525-8e05-11ea-9f9b-5cf37097309a", "children": [{"source": "Pre-NOTCH Processing in Golgi", "value": 2.2992180940805307, "ngenes": 28, "max_val": 8.706, "rank": 98.0, "id": "38f2f526-8e05-11ea-b09f-5cf37097309a"}, {"source": "Pre-NOTCH Transcription and Translation", "value": 1.9876163820754629, "ngenes": 128, "max_val": 8.706, "rank": 141.0, "id": "38f2f527-8e05-11ea-8e15-5cf37097309a"}, {"source": "Pre-NOTCH Processing in the Endoplasmic Reticulum", "value": 1.9421060230542748, "ngenes": 9, "max_val": 8.706, "rank": 161.0, "id": "38f2f528-8e05-11ea-b446-5cf37097309a"}]}, {"source": "Signaling by NOTCH4", "value": 0.40594021400370056, "ngenes": 116, "max_val": 8.706, "rank": 1480.0, "id": "38f2f529-8e05-11ea-854f-5cf37097309a", "children": [{"source": "NOTCH4 Activation and Transmission of Signal to the Nucleus", "value": 1.9223814449351928, "ngenes": 18, "max_val": 8.706, "rank": 167.0, "id": "38f2f52a-8e05-11ea-86af-5cf37097309a"}, {"source": "NOTCH4 Intracellular Domain Regulates Transcription", "value": 1.8558811401682511, "ngenes": 35, "max_val": 8.706, "rank": 184.0, "id": "38f2f52b-8e05-11ea-bd14-5cf37097309a"}, {"source": "Negative regulation of NOTCH4 signaling", "value": 0.3040711199823073, "ngenes": 79, "max_val": 8.706, "rank": 2047.0, "id": "38f2f52c-8e05-11ea-a807-5cf37097309a"}]}, {"source": "Signaling by NOTCH3", "value": 2.4731510426684333, "ngenes": 77, "max_val": 8.706, "rank": 80.0, "id": "38f2f52d-8e05-11ea-966d-5cf37097309a", "children": [{"source": "NOTCH3 Intracellular Domain Regulates Transcription", "value": 0.3846942455040212, "ngenes": 43, "max_val": 8.706, "rank": 1566.0, "id": "38f2f52e-8e05-11ea-8519-5cf37097309a"}, {"source": "NOTCH3 Activation and Transmission of Signal to the Nucleus", "value": 2.627832216398577, "ngenes": 36, "max_val": 8.706, "rank": 70.0, "id": "38f2f52f-8e05-11ea-8fc7-5cf37097309a", "children": [{"source": "Noncanonical activation of NOTCH3", "value": 0.3663505507769889, "ngenes": 8, "max_val": 8.706, "rank": 1635.0, "id": "38f2f530-8e05-11ea-b6fd-5cf37097309a"}]}]}]}, {"source": "Signaling by Rho GTPases", "value": 1.2070420459358313, "ngenes": 534, "max_val": 8.706, "rank": 423.0, "id": "38f2f531-8e05-11ea-a77c-5cf37097309a", "children": [{"source": "Rho GTPase cycle", "value": 3.5527756477987986, "ngenes": 152, "max_val": 8.706, "rank": 20.0, "id": "38f2f532-8e05-11ea-bd92-5cf37097309a"}, {"source": "RHO GTPase Effectors", "value": 1.1339374873055101, "ngenes": 392, "max_val": 8.706, "rank": 473.0, "id": "38f2f533-8e05-11ea-b969-5cf37097309a", "children": [{"source": "RHO GTPases Activate Rhotekin and Rhophilins", "value": 2.8914757315633093, "ngenes": 13, "max_val": 8.706, "rank": 45.0, "id": "38f2f534-8e05-11ea-a303-5cf37097309a"}, {"source": "RHO GTPases activate PAKs", "value": 2.351020923608807, "ngenes": 38, "max_val": 8.706, "rank": 92.0, "id": "38f2f535-8e05-11ea-8a3a-5cf37097309a"}, {"source": "RHO GTPases Activate ROCKs", "value": 1.7965421170412093, "ngenes": 25, "max_val": 8.706, "rank": 191.0, "id": "38f2f536-8e05-11ea-9714-5cf37097309a"}, {"source": "RHO GTPases activate CIT", "value": 1.7283747075076081, "ngenes": 25, "max_val": 8.706, "rank": 208.0, "id": "38f2f537-8e05-11ea-9307-5cf37097309a"}, {"source": "RHO GTPases activate PKNs", "value": 1.8998969722370689, "ngenes": 100, "max_val": 8.706, "rank": 174.0, "id": "38f2f538-8e05-11ea-a9cd-5cf37097309a", "children": [{"source": "Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3", "value": 1.5805022417093255, "ngenes": 68, "max_val": 8.706, "rank": 275.0, "id": "38f2f539-8e05-11ea-bdfd-5cf37097309a"}]}, {"source": "RHO GTPases Activate NADPH Oxidases", "value": 1.018967659190454, "ngenes": 24, "max_val": 8.706, "rank": 542.0, "id": "38f2f53a-8e05-11ea-aac1-5cf37097309a"}, {"source": "RHO GTPases Activate Formins", "value": 0.9954651226027226, "ngenes": 152, "max_val": 8.706, "rank": 548.0, "id": "38f2f53b-8e05-11ea-b2af-5cf37097309a"}, {"source": "RHO GTPases regulate CFTR trafficking", "value": 0.6647834081114088, "ngenes": 3, "max_val": 8.706, "rank": 795.0, "id": "38f2f53c-8e05-11ea-a10a-5cf37097309a"}, {"source": "RHO GTPases activate IQGAPs", "value": 0.6313164779578079, "ngenes": 32, "max_val": 8.706, "rank": 867.0, "id": "38f2f53d-8e05-11ea-a896-5cf37097309a"}, {"source": "RHO GTPases activate KTN1", "value": 0.6304775359935061, "ngenes": 11, "max_val": 8.706, "rank": 869.0, "id": "38f2f53e-8e05-11ea-905d-5cf37097309a"}, {"source": "RHO GTPases Activate WASPs and WAVEs", "value": 0.3027701496941226, "ngenes": 67, "max_val": 8.706, "rank": 2054.0, "id": "38f2f53f-8e05-11ea-9984-5cf37097309a"}]}]}, {"source": "Signaling by WNT", "value": 1.0631417537005037, "ngenes": 510, "max_val": 8.706, "rank": 497.0, "id": "38f2f540-8e05-11ea-8fc5-5cf37097309a", "children": [{"source": "Degradation of beta-catenin by the destruction complex", "value": 0.7390898562975314, "ngenes": 114, "max_val": 8.706, "rank": 714.0, "id": "38f2f541-8e05-11ea-8765-5cf37097309a", "children": [{"source": "Repression of WNT target genes", "value": 3.5527756477987986, "ngenes": 25, "max_val": 8.706, "rank": 21.0, "id": "38f2f542-8e05-11ea-9e94-5cf37097309a"}, {"source": "Beta-catenin phosphorylation cascade", "value": 0.3568317471571929, "ngenes": 17, "max_val": 8.706, "rank": 1697.0, "id": "38f2f543-8e05-11ea-84c1-5cf37097309a"}]}, {"source": "TCF dependent signaling in response to WNT", "value": 1.5719900845285188, "ngenes": 355, "max_val": 8.706, "rank": 280.0, "id": "38f2f544-8e05-11ea-95f1-5cf37097309a", "children": [{"source": "Formation of the beta-catenin:TCF transactivating complex", "value": 1.9486203325139888, "ngenes": 152, "max_val": 8.706, "rank": 157.0, "id": "38f2f545-8e05-11ea-af83-5cf37097309a", "children": [{"source": "Binding of TCF/LEF:CTNNB1 to target gene promoters", "value": 3.1403756106262635, "ngenes": 8, "max_val": 8.706, "rank": 32.0, "id": "38f2f546-8e05-11ea-8ee8-5cf37097309a"}]}, {"source": "Deactivation of the beta-catenin transactivating complex", "value": 0.8668183151952871, "ngenes": 43, "max_val": 8.706, "rank": 623.0, "id": "38f2f547-8e05-11ea-b22b-5cf37097309a"}, {"source": "Degradation of AXIN", "value": 0.6980377036561468, "ngenes": 73, "max_val": 8.706, "rank": 761.0, "id": "38f2f548-8e05-11ea-8eef-5cf37097309a"}, {"source": "Degradation of DVL", "value": 0.6274259760992917, "ngenes": 75, "max_val": 8.706, "rank": 878.0, "id": "38f2f549-8e05-11ea-b353-5cf37097309a"}, {"source": "Disassembly of the destruction complex and recruitment of AXIN to the membrane", "value": 0.5104201517191181, "ngenes": 59, "max_val": 8.706, "rank": 1064.0, "id": "38f2f54a-8e05-11ea-ac13-5cf37097309a"}, {"source": "Negative regulation of TCF-dependent signaling by WNT ligand antagonists", "value": 0.4689265375340588, "ngenes": 16, "max_val": 8.706, "rank": 1216.0, "id": "38f2f54b-8e05-11ea-bc22-5cf37097309a"}, {"source": "Negative regulation of TCF-dependent signaling by DVL-interacting proteins", "value": 0.4165866033279961, "ngenes": 5, "max_val": 8.706, "rank": 1425.0, "id": "38f2f54c-8e05-11ea-b189-5cf37097309a"}, {"source": "WNT mediated activation of DVL", "value": 0.406467316447748, "ngenes": 14, "max_val": 8.706, "rank": 1465.0, "id": "38f2f54d-8e05-11ea-b0da-5cf37097309a"}, {"source": "Regulation of FZD by ubiquitination", "value": 0.3543975045465841, "ngenes": 22, "max_val": 8.706, "rank": 1724.0, "id": "38f2f54e-8e05-11ea-90cb-5cf37097309a"}]}, {"source": "WNT ligand biogenesis and trafficking", "value": 0.6287478209031482, "ngenes": 51, "max_val": 8.706, "rank": 872.0, "id": "38f2f54f-8e05-11ea-93cb-5cf37097309a"}, {"source": "Beta-catenin independent WNT signaling", "value": 0.3965414113650864, "ngenes": 206, "max_val": 8.706, "rank": 1523.0, "id": "38f2f550-8e05-11ea-847e-5cf37097309a", "children": [{"source": "Ca2+ pathway", "value": 0.4447700765254375, "ngenes": 93, "max_val": 8.706, "rank": 1281.0, "id": "38f2f551-8e05-11ea-abd9-5cf37097309a"}, {"source": "PCP/CE pathway", "value": 0.5896819346331361, "ngenes": 124, "max_val": 8.706, "rank": 932.0, "id": "38f2f552-8e05-11ea-88a5-5cf37097309a", "children": [{"source": "WNT5A-dependent internalization of FZD4", "value": 0.4428091026226384, "ngenes": 15, "max_val": 8.706, "rank": 1287.0, "id": "38f2f553-8e05-11ea-8bad-5cf37097309a"}, {"source": "Asymmetric localization of PCP proteins", "value": 0.40594021400370056, "ngenes": 84, "max_val": 8.706, "rank": 1484.0, "id": "38f2f554-8e05-11ea-bad0-5cf37097309a"}, {"source": "WNT5A-dependent internalization of FZD2, FZD5 and ROR2", "value": 0.3288714815669623, "ngenes": 13, "max_val": 8.706, "rank": 1862.0, "id": "38f2f555-8e05-11ea-ab24-5cf37097309a"}]}]}]}, {"source": "Signaling by Nuclear Receptors", "value": 0.4214001462265449, "ngenes": 322, "max_val": 8.706, "rank": 1406.0, "id": "38f2f556-8e05-11ea-9f7b-5cf37097309a", "children": [{"source": "ESR-mediated signaling", "value": 2.779524099447062, "ngenes": 231, "max_val": 8.706, "rank": 50.0, "id": "38f2f557-8e05-11ea-b70b-5cf37097309a", "children": [{"source": "Extra-nuclear estrogen signaling", "value": 1.6914416068663722, "ngenes": 83, "max_val": 8.706, "rank": 223.0, "id": "38f2f558-8e05-11ea-a04c-5cf37097309a", "children": [{"source": "Estrogen-dependent nuclear events downstream of ESR-membrane signaling", "value": 2.627832216398577, "ngenes": 28, "max_val": 8.706, "rank": 68.0, "id": "38f2f559-8e05-11ea-9bab-5cf37097309a"}, {"source": "Estrogen-stimulated signaling through PRKCZ", "value": 0.5471840327551817, "ngenes": 9, "max_val": 8.706, "rank": 1005.0, "id": "38f2f55a-8e05-11ea-a547-5cf37097309a"}]}, {"source": "Estrogen-dependent gene expression", "value": 2.351020923608807, "ngenes": 151, "max_val": 8.706, "rank": 93.0, "id": "38f2f55b-8e05-11ea-afa1-5cf37097309a"}]}, {"source": "NR1H2 and NR1H3-mediated signaling", "value": 0.5026538838841291, "ngenes": 52, "max_val": 8.706, "rank": 1088.0, "id": "38f2f55c-8e05-11ea-b045-5cf37097309a", "children": [{"source": "NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux", "value": 0.922370045790835, "ngenes": 42, "max_val": 8.706, "rank": 583.0, "id": "38f2f55d-8e05-11ea-b913-5cf37097309a"}, {"source": "NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose", "value": 0.7381700715305367, "ngenes": 10, "max_val": 8.706, "rank": 717.0, "id": "38f2f55e-8e05-11ea-9d97-5cf37097309a"}, {"source": "NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ", "value": 0.7223072136687092, "ngenes": 10, "max_val": 8.706, "rank": 735.0, "id": "38f2f55f-8e05-11ea-bb8c-5cf37097309a"}, {"source": "NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis", "value": 0.5312777291823695, "ngenes": 14, "max_val": 8.706, "rank": 1035.0, "id": "38f2f560-8e05-11ea-af2f-5cf37097309a"}, {"source": "NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis ", "value": 0.4725982743749842, "ngenes": 10, "max_val": 8.706, "rank": 1193.0, "id": "38f2f561-8e05-11ea-b47d-5cf37097309a"}, {"source": "NR1H2 & NR1H3 regulate gene expression linked to lipogenesis", "value": 0.4534794988036097, "ngenes": 14, "max_val": 8.706, "rank": 1268.0, "id": "38f2f562-8e05-11ea-bb61-5cf37097309a"}]}, {"source": "Signaling by Retinoic Acid", "value": 0.5919767843582068, "ngenes": 58, "max_val": 8.706, "rank": 930.0, "id": "38f2f563-8e05-11ea-b8c9-5cf37097309a", "children": [{"source": "RA biosynthesis pathway", "value": 0.4788365094295219, "ngenes": 32, "max_val": 8.706, "rank": 1158.0, "id": "38f2f564-8e05-11ea-a194-5cf37097309a"}]}]}, {"source": "Death Receptor Signalling", "value": 1.4117033129971952, "ngenes": 162, "max_val": 8.706, "rank": 350.0, "id": "38f2f565-8e05-11ea-be68-5cf37097309a", "children": [{"source": "p75 NTR receptor-mediated signalling", "value": 0.6580731317637653, "ngenes": 110, "max_val": 8.706, "rank": 812.0, "id": "38f2f566-8e05-11ea-956c-5cf37097309a", "children": [{"source": "Cell death signalling via NRAGE, NRIF and NADE", "value": 2.4819607064808347, "ngenes": 87, "max_val": 8.706, "rank": 79.0, "id": "38f2f567-8e05-11ea-b9c9-5cf37097309a", "children": [{"source": "NRAGE signals death through JNK", "value": 2.59146225548435, "ngenes": 65, "max_val": 8.706, "rank": 75.0, "id": "38f2f568-8e05-11ea-9ea0-5cf37097309a"}, {"source": "NADE modulates death signalling", "value": 0.5109176790362152, "ngenes": 7, "max_val": 8.706, "rank": 1062.0, "id": "38f2f569-8e05-11ea-b0af-5cf37097309a"}, {"source": "NRIF signals cell death from the nucleus", "value": 0.4165866033279961, "ngenes": 20, "max_val": 8.706, "rank": 1430.0, "id": "38f2f56a-8e05-11ea-af60-5cf37097309a"}]}, {"source": "NFG and proNGF binds to p75NTR", "value": 0.928472844982223, "ngenes": 2, "max_val": 8.706, "rank": 580.0, "id": "38f2f56b-8e05-11ea-b1e5-5cf37097309a"}, {"source": "p75NTR negatively regulates cell cycle via SC1", "value": 0.7589777862287116, "ngenes": 6, "max_val": 8.706, "rank": 696.0, "id": "38f2f56c-8e05-11ea-8f4e-5cf37097309a"}, {"source": "Ceramide signalling", "value": 0.5138735430859052, "ngenes": 3, "max_val": 8.706, "rank": 1056.0, "id": "38f2f56d-8e05-11ea-aa85-5cf37097309a"}, {"source": "Regulated proteolysis of p75NTR", "value": 0.4548693718089983, "ngenes": 11, "max_val": 8.706, "rank": 1262.0, "id": "38f2f56e-8e05-11ea-925a-5cf37097309a"}, {"source": "p75NTR regulates axonogenesis", "value": 0.721392241826102, "ngenes": 10, "max_val": 8.706, "rank": 739.0, "id": "38f2f56f-8e05-11ea-a071-5cf37097309a", "children": [{"source": "Axonal growth inhibition (RHOA activation)", "value": 0.3991319142702046, "ngenes": 9, "max_val": 8.706, "rank": 1497.0, "id": "38f2f570-8e05-11ea-93d4-5cf37097309a"}, {"source": "Axonal growth stimulation", "value": 0.3592004814595621, "ngenes": 4, "max_val": 8.706, "rank": 1679.0, "id": "38f2f571-8e05-11ea-bab0-5cf37097309a"}]}, {"source": "p75NTR signals via NF-kB", "value": 0.6647834081114088, "ngenes": 20, "max_val": 8.706, "rank": 800.0, "id": "38f2f572-8e05-11ea-b04f-5cf37097309a", "children": [{"source": "NF-kB is activated and signals survival", "value": 0.3026960685114295, "ngenes": 13, "max_val": 8.706, "rank": 2056.0, "id": "38f2f573-8e05-11ea-8ede-5cf37097309a"}, {"source": "p75NTR recruits signalling complexes", "value": 0.30251216144429616, "ngenes": 17, "max_val": 8.706, "rank": 2063.0, "id": "38f2f574-8e05-11ea-ac05-5cf37097309a"}]}]}, {"source": "TRAIL  signaling", "value": 1.419244399543124, "ngenes": 8, "max_val": 8.706, "rank": 348.0, "id": "38f2f575-8e05-11ea-a4ee-5cf37097309a"}, {"source": "FasL/ CD95L signaling", "value": 0.6890717402395967, "ngenes": 5, "max_val": 8.706, "rank": 770.0, "id": "38f2f576-8e05-11ea-b87f-5cf37097309a"}, {"source": "TNF signaling", "value": 0.4225585510124096, "ngenes": 50, "max_val": 8.706, "rank": 1399.0, "id": "38f2f577-8e05-11ea-b0f6-5cf37097309a", "children": [{"source": "TNFR1-mediated ceramide production", "value": 0.40594021400370056, "ngenes": 12, "max_val": 8.706, "rank": 1473.0, "id": "38f2f578-8e05-11ea-b202-5cf37097309a"}, {"source": "TNFR1-induced NFkappaB signaling pathway", "value": 0.3984289558542966, "ngenes": 37, "max_val": 8.706, "rank": 1507.0, "id": "38f2f579-8e05-11ea-9a60-5cf37097309a"}, {"source": "Regulation of TNFR1 signaling", "value": 0.3608306486501528, "ngenes": 40, "max_val": 8.706, "rank": 1661.0, "id": "38f2f57a-8e05-11ea-b250-5cf37097309a"}, {"source": "TNFR1-induced proapoptotic signaling", "value": 0.33680443321456344, "ngenes": 19, "max_val": 8.706, "rank": 1816.0, "id": "38f2f57b-8e05-11ea-b102-5cf37097309a"}]}]}, {"source": "Signaling by Receptor Tyrosine Kinases", "value": 0.40594021400370056, "ngenes": 580, "max_val": 8.706, "rank": 1479.0, "id": "38f2f57c-8e05-11ea-85ff-5cf37097309a", "children": [{"source": "Signaling by SCF-KIT", "value": 1.0944708510595589, "ngenes": 51, "max_val": 8.706, "rank": 485.0, "id": "38f2f57d-8e05-11ea-a52d-5cf37097309a", "children": [{"source": "Regulation of KIT signaling", "value": 2.2824800952381548, "ngenes": 18, "max_val": 8.706, "rank": 100.0, "id": "38f2f57e-8e05-11ea-bd81-5cf37097309a"}]}, {"source": "Signaling by NTRKs", "value": 0.3988171647970603, "ngenes": 150, "max_val": 8.706, "rank": 1499.0, "id": "38f2f57f-8e05-11ea-9fa4-5cf37097309a", "children": [{"source": "Expression and Processing of Neurotrophins", "value": 1.9421060230542748, "ngenes": 5, "max_val": 8.706, "rank": 160.0, "id": "38f2f580-8e05-11ea-9f2a-5cf37097309a", "children": [{"source": "NGF processing", "value": 1.9421060230542748, "ngenes": 5, "max_val": 8.706, "rank": 162.0, "id": "38f2f581-8e05-11ea-9108-5cf37097309a"}]}, {"source": "Signaling by NTRK2 (TRKB)", "value": 0.4844203014957389, "ngenes": 36, "max_val": 8.706, "rank": 1142.0, "id": "38f2f582-8e05-11ea-8fc6-5cf37097309a", "children": [{"source": "Activated NTRK2 signals through CDK5", "value": 1.5452964802223617, "ngenes": 6, "max_val": 8.706, "rank": 297.0, "id": "38f2f583-8e05-11ea-b7a4-5cf37097309a"}, {"source": "Activated NTRK2 signals through PI3K", "value": 0.928472844982223, "ngenes": 7, "max_val": 8.706, "rank": 577.0, "id": "38f2f584-8e05-11ea-bbb2-5cf37097309a"}, {"source": "NTF3 activates NTRK2 (TRKB) signaling", "value": 0.4544000457004255, "ngenes": 2, "max_val": 8.706, "rank": 1265.0, "id": "38f2f585-8e05-11ea-961b-5cf37097309a"}, {"source": "Activated NTRK2 signals through PLCG1", "value": 0.3854169023983268, "ngenes": 8, "max_val": 8.706, "rank": 1555.0, "id": "38f2f586-8e05-11ea-ad82-5cf37097309a"}, {"source": "NTF4 activates NTRK2 (TRKB) signaling", "value": 0.3750724859188269, "ngenes": 2, "max_val": 8.706, "rank": 1603.0, "id": "38f2f587-8e05-11ea-9899-5cf37097309a"}, {"source": "Activated NTRK2 signals through RAS", "value": 0.3416738873259401, "ngenes": 10, "max_val": 8.706, "rank": 1784.0, "id": "38f2f588-8e05-11ea-807e-5cf37097309a"}, {"source": "BDNF activates NTRK2 (TRKB) signaling", "value": 0.3242524696726087, "ngenes": 2, "max_val": 8.706, "rank": 1895.0, "id": "38f2f589-8e05-11ea-89e1-5cf37097309a"}, {"source": "Activated NTRK2 signals through FYN", "value": 0.44227409954858976, "ngenes": 11, "max_val": 8.706, "rank": 1319.0, "id": "38f2f58a-8e05-11ea-a9af-5cf37097309a", "children": [{"source": "NTRK2 activates RAC1", "value": 0.32315917780373304, "ngenes": 9, "max_val": 8.706, "rank": 1899.0, "id": "38f2f58b-8e05-11ea-81c9-5cf37097309a"}]}, {"source": "Activated NTRK2 signals through FRS2 and FRS3", "value": 0.3084182102447057, "ngenes": 18, "max_val": 8.706, "rank": 2010.0, "id": "38f2f58c-8e05-11ea-be45-5cf37097309a"}]}, {"source": "Signaling by NTRK1 (TRKA)", "value": 0.7920174338778856, "ngenes": 117, "max_val": 8.706, "rank": 669.0, "id": "38f2f58d-8e05-11ea-ae5f-5cf37097309a", "children": [{"source": "Signalling to ERKs", "value": 0.6397032919655772, "ngenes": 57, "max_val": 8.706, "rank": 850.0, "id": "38f2f58e-8e05-11ea-87c5-5cf37097309a", "children": [{"source": "Prolonged ERK activation events", "value": 1.3288922091967077, "ngenes": 24, "max_val": 8.706, "rank": 375.0, "id": "38f2f58f-8e05-11ea-922d-5cf37097309a", "children": [{"source": "ARMS-mediated activation", "value": 1.2803136533037491, "ngenes": 12, "max_val": 8.706, "rank": 395.0, "id": "38f2f590-8e05-11ea-a8eb-5cf37097309a"}, {"source": "Frs2-mediated activation", "value": 1.1798413414031954, "ngenes": 20, "max_val": 8.706, "rank": 450.0, "id": "38f2f591-8e05-11ea-b33d-5cf37097309a"}]}, {"source": "Signalling to RAS", "value": 0.7699143358175191, "ngenes": 33, "max_val": 8.706, "rank": 686.0, "id": "38f2f592-8e05-11ea-b56f-5cf37097309a", "children": [{"source": "p38MAPK events", "value": 0.7073571356562612, "ngenes": 21, "max_val": 8.706, "rank": 755.0, "id": "38f2f593-8e05-11ea-90c4-5cf37097309a"}]}, {"source": "Signalling to p38 via RIT and RIN", "value": 0.3145197366001602, "ngenes": 5, "max_val": 8.706, "rank": 1950.0, "id": "38f2f594-8e05-11ea-9b40-5cf37097309a"}]}, {"source": "Retrograde neurotrophin signalling", "value": 0.7478709676371822, "ngenes": 24, "max_val": 8.706, "rank": 708.0, "id": "38f2f595-8e05-11ea-9b7e-5cf37097309a"}, {"source": "Activation of TRKA receptors", "value": 0.3925893017325684, "ngenes": 8, "max_val": 8.706, "rank": 1530.0, "id": "38f2f596-8e05-11ea-af39-5cf37097309a", "children": [{"source": "NGF-independant TRKA activation", "value": 0.7223072136687092, "ngenes": 5, "max_val": 8.706, "rank": 737.0, "id": "38f2f597-8e05-11ea-83bc-5cf37097309a"}, {"source": "TRKA activation by NGF", "value": 0.3272772875640805, "ngenes": 4, "max_val": 8.706, "rank": 1879.0, "id": "38f2f598-8e05-11ea-9904-5cf37097309a"}]}, {"source": "PI3K/AKT activation", "value": 0.6937103871398255, "ngenes": 13, "max_val": 8.706, "rank": 765.0, "id": "38f2f599-8e05-11ea-8e29-5cf37097309a"}, {"source": "Signalling to ERK5", "value": 0.5565507266078732, "ngenes": 3, "max_val": 8.706, "rank": 966.0, "id": "38f2f59a-8e05-11ea-a47d-5cf37097309a"}, {"source": "Nuclear Events (kinase and transcription factor activation)", "value": 0.3229052919360341, "ngenes": 29, "max_val": 8.706, "rank": 1903.0, "id": "38f2f59b-8e05-11ea-bcd0-5cf37097309a", "children": [{"source": "ERK/MAPK targets", "value": 0.5471840327551817, "ngenes": 26, "max_val": 8.706, "rank": 1002.0, "id": "38f2f59c-8e05-11ea-875b-5cf37097309a", "children": [{"source": "ERKs are inactivated", "value": 0.3849420497242914, "ngenes": 13, "max_val": 8.706, "rank": 1559.0, "id": "38f2f59d-8e05-11ea-ad9d-5cf37097309a"}]}, {"source": "CREB phosphorylation", "value": 0.3050811988978337, "ngenes": 8, "max_val": 8.706, "rank": 2033.0, "id": "38f2f59e-8e05-11ea-8786-5cf37097309a"}]}, {"source": "PLC-gamma1 signalling", "value": 0.3678618516057002, "ngenes": 3, "max_val": 8.706, "rank": 1628.0, "id": "38f2f59f-8e05-11ea-8ece-5cf37097309a"}, {"source": "Signalling to STAT3", "value": 0.3071128122122555, "ngenes": 3, "max_val": 8.706, "rank": 2019.0, "id": "38f2f5a0-8e05-11ea-892d-5cf37097309a"}]}, {"source": "Signaling by NTRK3 (TRKC)", "value": 0.4526489555267599, "ngenes": 22, "max_val": 8.706, "rank": 1269.0, "id": "38f2f5a1-8e05-11ea-8c97-5cf37097309a", "children": [{"source": "Activated NTRK3 signals through PI3K", "value": 0.3620996197243039, "ngenes": 9, "max_val": 8.706, "rank": 1650.0, "id": "38f31c0c-8e05-11ea-ae73-5cf37097309a"}, {"source": "Activated NTRK3 signals through PLCG1", "value": 0.3608306486501528, "ngenes": 6, "max_val": 8.706, "rank": 1660.0, "id": "38f31c0d-8e05-11ea-b94d-5cf37097309a"}, {"source": "NTF3 activates NTRK3 signaling", "value": 0.3288714815669623, "ngenes": 4, "max_val": 8.706, "rank": 1863.0, "id": "38f31c0e-8e05-11ea-bb8c-5cf37097309a"}, {"source": "NTRK3 as a dependence receptor", "value": 0.3272772875640805, "ngenes": 3, "max_val": 8.706, "rank": 1888.0, "id": "38f31c0f-8e05-11ea-91c7-5cf37097309a"}, {"source": "Activated NTRK3 signals through RAS", "value": 0.3088724561369422, "ngenes": 9, "max_val": 8.706, "rank": 2006.0, "id": "38f31c10-8e05-11ea-bbcb-5cf37097309a"}]}]}, {"source": "Signaling by ERBB4", "value": 1.5997680848295852, "ngenes": 70, "max_val": 8.706, "rank": 273.0, "id": "38f31c11-8e05-11ea-93d1-5cf37097309a", "children": [{"source": "Nuclear signaling by ERBB4", "value": 1.7819400448321585, "ngenes": 36, "max_val": 8.706, "rank": 201.0, "id": "38f31c12-8e05-11ea-b388-5cf37097309a"}, {"source": "Downregulation of ERBB4 signaling", "value": 0.5827222432250884, "ngenes": 9, "max_val": 8.706, "rank": 942.0, "id": "38f31c13-8e05-11ea-8162-5cf37097309a"}, {"source": "PI3K events in ERBB4 signaling", "value": 0.4650140905731859, "ngenes": 10, "max_val": 8.706, "rank": 1224.0, "id": "38f31c14-8e05-11ea-99ee-5cf37097309a"}, {"source": "SHC1 events in ERBB4 signaling", "value": 0.4571687716241703, "ngenes": 15, "max_val": 8.706, "rank": 1258.0, "id": "38f31c15-8e05-11ea-b675-5cf37097309a"}]}, {"source": "Signaling by FGFR", "value": 0.4568509509375958, "ngenes": 90, "max_val": 8.706, "rank": 1260.0, "id": "38f31c16-8e05-11ea-af8b-5cf37097309a", "children": [{"source": "Signaling by FGFR1", "value": 0.3483210271800589, "ngenes": 51, "max_val": 8.706, "rank": 1742.0, "id": "38f31c17-8e05-11ea-9900-5cf37097309a", "children": [{"source": "Negative regulation of FGFR1 signaling", "value": 0.4282645668527017, "ngenes": 33, "max_val": 8.706, "rank": 1371.0, "id": "38f31c18-8e05-11ea-b67b-5cf37097309a", "children": [{"source": "Spry regulation of FGF signaling", "value": 1.5805022417093255, "ngenes": 16, "max_val": 8.706, "rank": 276.0, "id": "38f31c19-8e05-11ea-bf5b-5cf37097309a"}]}, {"source": "Downstream signaling of activated FGFR1", "value": 0.475327333922659, "ngenes": 32, "max_val": 8.706, "rank": 1184.0, "id": "38f31c1a-8e05-11ea-a08f-5cf37097309a", "children": [{"source": "FRS-mediated FGFR1 signaling", "value": 0.7223072136687092, "ngenes": 24, "max_val": 8.706, "rank": 733.0, "id": "38f31c1b-8e05-11ea-8d10-5cf37097309a"}, {"source": "SHC-mediated cascade:FGFR1", "value": 0.5471840327551817, "ngenes": 22, "max_val": 8.706, "rank": 1022.0, "id": "38f31c1c-8e05-11ea-b468-5cf37097309a"}, {"source": "PI-3K cascade:FGFR1", "value": 0.4646123127797776, "ngenes": 21, "max_val": 8.706, "rank": 1237.0, "id": "38f31c1d-8e05-11ea-9473-5cf37097309a"}, {"source": "Phospholipase C-mediated cascade: FGFR1", "value": 0.3247276212270443, "ngenes": 16, "max_val": 8.706, "rank": 1894.0, "id": "38f31c1e-8e05-11ea-9c37-5cf37097309a"}]}, {"source": "FGFRL1 modulation of FGFR1 signaling", "value": 0.5797636634000874, "ngenes": 13, "max_val": 8.706, "rank": 946.0, "id": "38f31c1f-8e05-11ea-bdca-5cf37097309a"}, {"source": "FGFR1 ligand binding and activation", "value": 0.3984289558542966, "ngenes": 16, "max_val": 8.706, "rank": 1501.0, "id": "38f31c20-8e05-11ea-876e-5cf37097309a", "children": [{"source": "FGFR1b ligand binding and activation", "value": 0.4647304025875293, "ngenes": 6, "max_val": 8.706, "rank": 1234.0, "id": "38f31c21-8e05-11ea-8e79-5cf37097309a"}, {"source": "FGFR1c and Klotho ligand binding and activation", "value": 0.35648548265312524, "ngenes": 3, "max_val": 8.706, "rank": 1698.0, "id": "38f31c22-8e05-11ea-8b04-5cf37097309a"}, {"source": "FGFR1c ligand binding and activation", "value": 0.3288714815669623, "ngenes": 12, "max_val": 8.706, "rank": 1857.0, "id": "38f31c23-8e05-11ea-aece-5cf37097309a"}]}]}, {"source": "Signaling by FGFR2", "value": 0.3135746486533741, "ngenes": 76, "max_val": 8.706, "rank": 1955.0, "id": "38f31c24-8e05-11ea-be08-5cf37097309a", "children": [{"source": "Negative regulation of FGFR2 signaling", "value": 0.4198701987286446, "ngenes": 34, "max_val": 8.706, "rank": 1410.0, "id": "38f31c25-8e05-11ea-99ba-5cf37097309a", "children": [{"source": "Spry regulation of FGF signaling", "value": 1.5805022417093255, "ngenes": 16, "max_val": 8.706, "rank": 276.0, "id": "38f31c26-8e05-11ea-a1f3-5cf37097309a"}]}, {"source": "FGFR2 ligand binding and activation", "value": 0.5119210300222867, "ngenes": 20, "max_val": 8.706, "rank": 1058.0, "id": "38f31c27-8e05-11ea-b457-5cf37097309a", "children": [{"source": "FGFR2b ligand binding and activation", "value": 1.0361987859326167, "ngenes": 10, "max_val": 8.706, "rank": 522.0, "id": "38f31c28-8e05-11ea-8daf-5cf37097309a"}, {"source": "FGFR2c ligand binding and activation", "value": 0.3272772875640805, "ngenes": 13, "max_val": 8.706, "rank": 1887.0, "id": "38f31c29-8e05-11ea-a81f-5cf37097309a"}]}, {"source": "FGFR2 alternative splicing", "value": 0.7369642021678243, "ngenes": 29, "max_val": 8.706, "rank": 719.0, "id": "38f31c2a-8e05-11ea-81d0-5cf37097309a"}, {"source": "Downstream signaling of activated FGFR2", "value": 0.5565507266078732, "ngenes": 31, "max_val": 8.706, "rank": 967.0, "id": "38f31c2b-8e05-11ea-a0c7-5cf37097309a", "children": [{"source": "FRS-mediated FGFR2 signaling", "value": 0.6699356337262833, "ngenes": 26, "max_val": 8.706, "rank": 786.0, "id": "38f31c2c-8e05-11ea-8c5f-5cf37097309a"}, {"source": "SHC-mediated cascade:FGFR2", "value": 0.5155641844328289, "ngenes": 24, "max_val": 8.706, "rank": 1054.0, "id": "38f31c2d-8e05-11ea-9513-5cf37097309a"}, {"source": "Phospholipase C-mediated cascade; FGFR2", "value": 0.3592004814595621, "ngenes": 18, "max_val": 8.706, "rank": 1676.0, "id": "38f31c2e-8e05-11ea-9c29-5cf37097309a"}, {"source": "PI-3K cascade:FGFR2", "value": 0.33492726480858154, "ngenes": 23, "max_val": 8.706, "rank": 1829.0, "id": "38f31c2f-8e05-11ea-99e1-5cf37097309a"}]}]}, {"source": "Signaling by FGFR3", "value": 0.4707526078558774, "ngenes": 41, "max_val": 8.706, "rank": 1198.0, "id": "38f31c30-8e05-11ea-976e-5cf37097309a", "children": [{"source": "Negative regulation of FGFR3 signaling", "value": 1.1254348791648023, "ngenes": 29, "max_val": 8.706, "rank": 478.0, "id": "38f31c31-8e05-11ea-a2f4-5cf37097309a", "children": [{"source": "Spry regulation of FGF signaling", "value": 1.5805022417093255, "ngenes": 16, "max_val": 8.706, "rank": 276.0, "id": "38f31c32-8e05-11ea-8e27-5cf37097309a"}]}, {"source": "Downstream signaling of activated FGFR3", "value": 0.4689358402626867, "ngenes": 26, "max_val": 8.706, "rank": 1213.0, "id": "38f31c33-8e05-11ea-a030-5cf37097309a", "children": [{"source": "SHC-mediated cascade:FGFR3", "value": 0.5031720375069153, "ngenes": 19, "max_val": 8.706, "rank": 1086.0, "id": "38f31c34-8e05-11ea-acd2-5cf37097309a"}, {"source": "FRS-mediated FGFR3 signaling", "value": 0.44227409954858976, "ngenes": 21, "max_val": 8.706, "rank": 1306.0, "id": "38f31c35-8e05-11ea-af91-5cf37097309a"}, {"source": "PI-3K cascade:FGFR3", "value": 0.4230965454928581, "ngenes": 18, "max_val": 8.706, "rank": 1398.0, "id": "38f31c36-8e05-11ea-9876-5cf37097309a"}, {"source": "Phospholipase C-mediated cascade; FGFR3", "value": 0.3984289558542966, "ngenes": 13, "max_val": 8.706, "rank": 1505.0, "id": "38f31c37-8e05-11ea-bca0-5cf37097309a"}]}, {"source": "FGFR3 ligand binding and activation", "value": 0.44204625017042704, "ngenes": 13, "max_val": 8.706, "rank": 1334.0, "id": "38f31c38-8e05-11ea-af90-5cf37097309a", "children": [{"source": "FGFR3c ligand binding and activation", "value": 0.4418086319153677, "ngenes": 13, "max_val": 8.706, "rank": 1339.0, "id": "38f31c39-8e05-11ea-9b70-5cf37097309a"}, {"source": "FGFR3b ligand binding and activation", "value": 0.3355089561462777, "ngenes": 7, "max_val": 8.706, "rank": 1826.0, "id": "38f31c3a-8e05-11ea-bece-5cf37097309a"}]}]}, {"source": "Signaling by FGFR4", "value": 0.3869074952818845, "ngenes": 42, "max_val": 8.706, "rank": 1554.0, "id": "38f31c3b-8e05-11ea-97ed-5cf37097309a", "children": [{"source": "Negative regulation of FGFR4 signaling", "value": 0.33680443321456344, "ngenes": 31, "max_val": 8.706, "rank": 1818.0, "id": "38f31c3c-8e05-11ea-948f-5cf37097309a", "children": [{"source": "Spry regulation of FGF signaling", "value": 1.5805022417093255, "ngenes": 16, "max_val": 8.706, "rank": 276.0, "id": "38f31c3d-8e05-11ea-9a85-5cf37097309a"}]}, {"source": "Downstream signaling of activated FGFR4", "value": 0.5741963469893907, "ngenes": 28, "max_val": 8.706, "rank": 951.0, "id": "38f31c3e-8e05-11ea-90f0-5cf37097309a", "children": [{"source": "SHC-mediated cascade:FGFR4", "value": 0.6610639114869609, "ngenes": 21, "max_val": 8.706, "rank": 806.0, "id": "38f31c3f-8e05-11ea-a8f2-5cf37097309a"}, {"source": "FRS-mediated FGFR4 signaling", "value": 0.4804303494846882, "ngenes": 23, "max_val": 8.706, "rank": 1150.0, "id": "38f31c40-8e05-11ea-a6e5-5cf37097309a"}, {"source": "PI-3K cascade:FGFR4", "value": 0.3483210271800589, "ngenes": 20, "max_val": 8.706, "rank": 1747.0, "id": "38f31c41-8e05-11ea-961e-5cf37097309a"}, {"source": "Phospholipase C-mediated cascade; FGFR4", "value": 0.34410454098523524, "ngenes": 15, "max_val": 8.706, "rank": 1775.0, "id": "38f31c42-8e05-11ea-83b9-5cf37097309a"}]}, {"source": "FGFR4 ligand binding and activation", "value": 0.3483210271800589, "ngenes": 14, "max_val": 8.706, "rank": 1745.0, "id": "38f31c43-8e05-11ea-9592-5cf37097309a", "children": [{"source": "betaKlotho-mediated ligand binding", "value": 0.4956021610862506, "ngenes": 3, "max_val": 8.706, "rank": 1105.0, "id": "38f31c44-8e05-11ea-9a56-5cf37097309a"}]}]}]}, {"source": "Signaling by ERBB2", "value": 1.4117033129971952, "ngenes": 72, "max_val": 8.706, "rank": 353.0, "id": "38f31c45-8e05-11ea-847f-5cf37097309a", "children": [{"source": "PI3K events in ERBB2 signaling", "value": 1.474917373322508, "ngenes": 16, "max_val": 8.706, "rank": 324.0, "id": "38f31c46-8e05-11ea-a9f9-5cf37097309a"}, {"source": "ERBB2 Activates PTK6 Signaling", "value": 1.3039497372625592, "ngenes": 13, "max_val": 8.706, "rank": 390.0, "id": "38f31c47-8e05-11ea-9d6e-5cf37097309a"}, {"source": "Downregulation of ERBB2 signaling", "value": 2.4731510426684333, "ngenes": 30, "max_val": 8.706, "rank": 83.0, "id": "38f31c48-8e05-11ea-9518-5cf37097309a", "children": [{"source": "Downregulation of ERBB2:ERBB3 signaling", "value": 1.1206375737965482, "ngenes": 14, "max_val": 8.706, "rank": 481.0, "id": "38f31c49-8e05-11ea-9841-5cf37097309a"}]}, {"source": "GRB7 events in ERBB2 signaling", "value": 0.6156480966272587, "ngenes": 5, "max_val": 8.706, "rank": 896.0, "id": "38f31c4a-8e05-11ea-bd82-5cf37097309a"}, {"source": "SHC1 events in ERBB2 signaling", "value": 0.6008310757219172, "ngenes": 37, "max_val": 8.706, "rank": 918.0, "id": "38f31c4b-8e05-11ea-8d52-5cf37097309a"}, {"source": "GRB2 events in ERBB2 signaling", "value": 0.5482687043601833, "ngenes": 24, "max_val": 8.706, "rank": 995.0, "id": "38f31c4c-8e05-11ea-93d0-5cf37097309a"}, {"source": "Drug-mediated inhibition of ERBB2 signaling", "value": 0.4428091026226384, "ngenes": 4, "max_val": 8.706, "rank": 1290.0, "id": "38f31c4d-8e05-11ea-bbef-5cf37097309a"}, {"source": "ERBB2 Regulates Cell Motility", "value": 0.3148506673604588, "ngenes": 15, "max_val": 8.706, "rank": 1947.0, "id": "38f31c4e-8e05-11ea-ad3e-5cf37097309a"}, {"source": "PLCG1 events in ERBB2 signaling", "value": 0.3071128122122555, "ngenes": 4, "max_val": 8.706, "rank": 2020.0, "id": "38f31c4f-8e05-11ea-8861-5cf37097309a"}]}, {"source": "Signaling by Insulin receptor", "value": 1.8824923819415817, "ngenes": 93, "max_val": 8.706, "rank": 181.0, "id": "38f31c50-8e05-11ea-b78a-5cf37097309a", "children": [{"source": "Insulin receptor recycling", "value": 1.3587138740441582, "ngenes": 33, "max_val": 8.706, "rank": 365.0, "id": "38f31c51-8e05-11ea-a851-5cf37097309a"}, {"source": "Insulin receptor signalling cascade", "value": 0.4796886717786976, "ngenes": 62, "max_val": 8.706, "rank": 1154.0, "id": "38f31c52-8e05-11ea-a73b-5cf37097309a", "children": [{"source": "Signal attenuation", "value": 0.9079693592037908, "ngenes": 10, "max_val": 8.706, "rank": 589.0, "id": "38f31c53-8e05-11ea-b0f7-5cf37097309a"}, {"source": "IRS-mediated signalling", "value": 0.4237924916712859, "ngenes": 55, "max_val": 8.706, "rank": 1392.0, "id": "38f31c54-8e05-11ea-8a80-5cf37097309a", "children": [{"source": "PI3K Cascade", "value": 0.4166701851996452, "ngenes": 46, "max_val": 8.706, "rank": 1420.0, "id": "38f31c55-8e05-11ea-b8f6-5cf37097309a", "children": [{"source": "PKB-mediated events", "value": 0.6008310757219172, "ngenes": 3, "max_val": 8.706, "rank": 917.0, "id": "38f31c56-8e05-11ea-a00b-5cf37097309a", "children": [{"source": "PDE3B signalling", "value": 0.5968341665741489, "ngenes": 3, "max_val": 8.706, "rank": 922.0, "id": "38f31c57-8e05-11ea-b5c7-5cf37097309a"}]}, {"source": "Activation of AKT2", "value": 0.3229052919360341, "ngenes": 4, "max_val": 8.706, "rank": 1906.0, "id": "38f31c58-8e05-11ea-96ee-5cf37097309a"}]}, {"source": "SOS-mediated signalling", "value": 0.3251976715160381, "ngenes": 12, "max_val": 8.706, "rank": 1893.0, "id": "38f31c59-8e05-11ea-aded-5cf37097309a"}]}, {"source": "IRS activation", "value": 0.3135746486533741, "ngenes": 5, "max_val": 8.706, "rank": 1967.0, "id": "38f31c5a-8e05-11ea-ac2d-5cf37097309a"}]}]}, {"source": "Signaling by MET", "value": 0.7233203609307247, "ngenes": 89, "max_val": 8.706, "rank": 731.0, "id": "38f31c5b-8e05-11ea-b332-5cf37097309a", "children": [{"source": "Negative regulation of MET activity", "value": 1.3288922091967077, "ngenes": 22, "max_val": 8.706, "rank": 376.0, "id": "38f31c5c-8e05-11ea-b12a-5cf37097309a"}, {"source": "MET promotes cell motility", "value": 0.4817190664327616, "ngenes": 45, "max_val": 8.706, "rank": 1147.0, "id": "38f31c5d-8e05-11ea-a8ef-5cf37097309a", "children": [{"source": "MET interacts with TNS proteins", "value": 1.2135544825273883, "ngenes": 5, "max_val": 8.706, "rank": 419.0, "id": "38f31c5e-8e05-11ea-89f2-5cf37097309a"}, {"source": "MET activates RAP1 and RAC1", "value": 0.9478742831410916, "ngenes": 11, "max_val": 8.706, "rank": 572.0, "id": "38f31c5f-8e05-11ea-97d0-5cf37097309a"}, {"source": "MET activates PTK2 signaling", "value": 0.4165866033279961, "ngenes": 34, "max_val": 8.706, "rank": 1426.0, "id": "38f31c60-8e05-11ea-a716-5cf37097309a"}]}, {"source": "MET activates PTPN11", "value": 1.039776227036387, "ngenes": 5, "max_val": 8.706, "rank": 517.0, "id": "38f31c61-8e05-11ea-bcbd-5cf37097309a"}, {"source": "MET activates PI3K/AKT signaling", "value": 0.7801496658197862, "ngenes": 6, "max_val": 8.706, "rank": 679.0, "id": "38f31c62-8e05-11ea-9c26-5cf37097309a"}, {"source": "MET activates RAS signaling", "value": 0.39678070566741774, "ngenes": 15, "max_val": 8.706, "rank": 1521.0, "id": "38f31c63-8e05-11ea-b9ee-5cf37097309a"}, {"source": "MET activates STAT3", "value": 0.35886240309060063, "ngenes": 4, "max_val": 8.706, "rank": 1680.0, "id": "38f31c64-8e05-11ea-b19e-5cf37097309a"}, {"source": "MET receptor recycling", "value": 0.3457193675228732, "ngenes": 10, "max_val": 8.706, "rank": 1771.0, "id": "38f31c65-8e05-11ea-87fb-5cf37097309a"}, {"source": "MET Receptor Activation", "value": 0.3333488691934495, "ngenes": 6, "max_val": 8.706, "rank": 1840.0, "id": "38f31c66-8e05-11ea-83db-5cf37097309a"}]}, {"source": "Signaling by EGFR", "value": 0.5098760850672088, "ngenes": 53, "max_val": 8.706, "rank": 1073.0, "id": "38f31c67-8e05-11ea-b381-5cf37097309a", "children": [{"source": "GAB1 signalosome", "value": 1.0652967967935014, "ngenes": 17, "max_val": 8.706, "rank": 494.0, "id": "38f31c68-8e05-11ea-b53c-5cf37097309a"}, {"source": "EGFR downregulation", "value": 0.8912405809203218, "ngenes": 32, "max_val": 8.706, "rank": 606.0, "id": "38f31c69-8e05-11ea-b0ba-5cf37097309a"}, {"source": "EGFR interacts with phospholipase C-gamma", "value": 0.6168382454016268, "ngenes": 9, "max_val": 8.706, "rank": 890.0, "id": "38f31c6a-8e05-11ea-8eee-5cf37097309a"}, {"source": "GRB2 events in EGFR signaling", "value": 0.3135746486533741, "ngenes": 14, "max_val": 8.706, "rank": 1957.0, "id": "38f31c6b-8e05-11ea-a664-5cf37097309a"}, {"source": "SHC1 events in EGFR signaling", "value": 0.31211243572932124, "ngenes": 15, "max_val": 8.706, "rank": 1989.0, "id": "38f31c6c-8e05-11ea-87dd-5cf37097309a"}]}, {"source": "Signaling by VEGF", "value": 0.7785104767935921, "ngenes": 123, "max_val": 8.706, "rank": 680.0, "id": "38f31c6d-8e05-11ea-9ee4-5cf37097309a", "children": [{"source": "VEGF ligand-receptor interactions", "value": 1.058758545290299, "ngenes": 8, "max_val": 8.706, "rank": 503.0, "id": "38f31c6e-8e05-11ea-9b54-5cf37097309a", "children": [{"source": "VEGF binds to VEGFR leading to receptor dimerization", "value": 1.058758545290299, "ngenes": 8, "max_val": 8.706, "rank": 504.0, "id": "38f31c6f-8e05-11ea-939a-5cf37097309a"}]}, {"source": "Neurophilin interactions with VEGF and VEGFR", "value": 0.7621118503838891, "ngenes": 4, "max_val": 8.706, "rank": 693.0, "id": "38f31c70-8e05-11ea-aee9-5cf37097309a"}, {"source": "VEGFA-VEGFR2 Pathway", "value": 0.404962670869091, "ngenes": 115, "max_val": 8.706, "rank": 1487.0, "id": "38f31c71-8e05-11ea-806e-5cf37097309a", "children": [{"source": "VEGFR2 mediated vascular permeability", "value": 0.6473789529752569, "ngenes": 28, "max_val": 8.706, "rank": 836.0, "id": "38f31c72-8e05-11ea-af23-5cf37097309a"}, {"source": "VEGFR2 mediated cell proliferation", "value": 0.3333488691934495, "ngenes": 21, "max_val": 8.706, "rank": 1845.0, "id": "38f31c73-8e05-11ea-a49b-5cf37097309a"}]}]}, {"source": "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)", "value": 0.37629990676095454, "ngenes": 62, "max_val": 8.706, "rank": 1598.0, "id": "38f31c74-8e05-11ea-8498-5cf37097309a", "children": [{"source": "IGF1R signaling cascade", "value": 0.6617484213056293, "ngenes": 61, "max_val": 8.706, "rank": 805.0, "id": "38f31c75-8e05-11ea-b881-5cf37097309a", "children": [{"source": "IRS-related events triggered by IGF1R", "value": 0.6647834081114088, "ngenes": 59, "max_val": 8.706, "rank": 794.0, "id": "38f31c76-8e05-11ea-8f56-5cf37097309a", "children": [{"source": "IRS-mediated signalling", "value": 0.4237924916712859, "ngenes": 55, "max_val": 8.706, "rank": 1392.0, "id": "38f31c77-8e05-11ea-b0de-5cf37097309a", "children": [{"source": "PI3K Cascade", "value": 0.4166701851996452, "ngenes": 46, "max_val": 8.706, "rank": 1420.0, "id": "38f31c78-8e05-11ea-9dc3-5cf37097309a", "children": [{"source": "PKB-mediated events", "value": 0.6008310757219172, "ngenes": 3, "max_val": 8.706, "rank": 917.0, "id": "38f31c79-8e05-11ea-bf24-5cf37097309a", "children": [{"source": "PDE3B signalling", "value": 0.5968341665741489, "ngenes": 3, "max_val": 8.706, "rank": 922.0, "id": "38f31c7a-8e05-11ea-a544-5cf37097309a"}]}, {"source": "Activation of AKT2", "value": 0.3229052919360341, "ngenes": 4, "max_val": 8.706, "rank": 1906.0, "id": "38f31c7b-8e05-11ea-943d-5cf37097309a"}]}, {"source": "SOS-mediated signalling", "value": 0.3251976715160381, "ngenes": 12, "max_val": 8.706, "rank": 1893.0, "id": "38f31c7c-8e05-11ea-afe5-5cf37097309a"}]}]}, {"source": "SHC-related events triggered by IGF1R", "value": 0.40594021400370056, "ngenes": 13, "max_val": 8.706, "rank": 1474.0, "id": "38f31c7d-8e05-11ea-ba10-5cf37097309a"}]}]}, {"source": "Signaling by PDGF", "value": 1.0252185178108288, "ngenes": 59, "max_val": 8.706, "rank": 527.0, "id": "38f31c7e-8e05-11ea-8e82-5cf37097309a", "children": [{"source": "Downstream signal transduction", "value": 0.5487223466543258, "ngenes": 30, "max_val": 8.706, "rank": 992.0, "id": "38f31c7f-8e05-11ea-89b1-5cf37097309a"}]}, {"source": "Signaling by MST1", "value": 0.3845554833325704, "ngenes": 5, "max_val": 8.706, "rank": 1575.0, "id": "38f31c80-8e05-11ea-be24-5cf37097309a"}]}, {"source": "Signaling by GPCR", "value": 0.7026145083602306, "ngenes": 1461, "max_val": 8.706, "rank": 758.0, "id": "38f31c81-8e05-11ea-9860-5cf37097309a", "children": [{"source": "GPCR downstream signalling", "value": 0.6602488744735772, "ngenes": 1378, "max_val": 8.706, "rank": 807.0, "id": "38f31c82-8e05-11ea-95a4-5cf37097309a", "children": [{"source": "G alpha (i) signalling events", "value": 0.8672814804812231, "ngenes": 527, "max_val": 8.706, "rank": 622.0, "id": "38f31c83-8e05-11ea-9850-5cf37097309a", "children": [{"source": "Opioid Signalling", "value": 0.6511705749423734, "ngenes": 122, "max_val": 8.706, "rank": 830.0, "id": "38f31c84-8e05-11ea-bb9e-5cf37097309a", "children": [{"source": "G-protein mediated events", "value": 2.6778860366876533, "ngenes": 84, "max_val": 8.706, "rank": 63.0, "id": "38f31c85-8e05-11ea-ab96-5cf37097309a", "children": [{"source": "PLC beta mediated events", "value": 2.5804067914832407, "ngenes": 73, "max_val": 8.706, "rank": 77.0, "id": "38f31c86-8e05-11ea-a114-5cf37097309a", "children": [{"source": "Ca-dependent events", "value": 2.1815197575248915, "ngenes": 45, "max_val": 8.706, "rank": 114.0, "id": "38f31c87-8e05-11ea-b0f3-5cf37097309a", "children": [{"source": "CaM pathway", "value": 2.3588323809305414, "ngenes": 43, "max_val": 8.706, "rank": 91.0, "id": "38f31c88-8e05-11ea-9bc2-5cf37097309a", "children": [{"source": "Calmodulin induced events", "value": 2.3588323809305414, "ngenes": 43, "max_val": 8.706, "rank": 90.0, "id": "38f31c89-8e05-11ea-89ff-5cf37097309a", "children": [{"source": "PKA-mediated phosphorylation of CREB", "value": 1.6274809485325372, "ngenes": 24, "max_val": 8.706, "rank": 253.0, "id": "38f31c8a-8e05-11ea-8270-5cf37097309a", "children": [{"source": "PKA activation", "value": 2.080152587903454, "ngenes": 19, "max_val": 8.706, "rank": 121.0, "id": "38f31c8b-8e05-11ea-aedd-5cf37097309a"}]}, {"source": "Cam-PDE 1 activation", "value": 0.6937103871398255, "ngenes": 4, "max_val": 8.706, "rank": 768.0, "id": "38f31c8c-8e05-11ea-b7fb-5cf37097309a"}, {"source": "CaMK IV-mediated phosphorylation of CREB", "value": 0.31843317641013524, "ngenes": 14, "max_val": 8.706, "rank": 1929.0, "id": "38f31c8d-8e05-11ea-aecd-5cf37097309a"}]}]}, {"source": "phospho-PLA2 pathway", "value": 0.8217754390035673, "ngenes": 2, "max_val": 8.706, "rank": 645.0, "id": "38f31c8e-8e05-11ea-8a58-5cf37097309a"}]}]}, {"source": "Adenylate cyclase inhibitory pathway", "value": 1.6234368602203797, "ngenes": 29, "max_val": 8.706, "rank": 260.0, "id": "38f31c8f-8e05-11ea-86f2-5cf37097309a"}, {"source": "Adenylate cyclase activating pathway", "value": 1.5495138599497604, "ngenes": 11, "max_val": 8.706, "rank": 291.0, "id": "38f31c90-8e05-11ea-9218-5cf37097309a"}]}, {"source": "G-protein activation", "value": 0.4627309951511139, "ngenes": 29, "max_val": 8.706, "rank": 1250.0, "id": "38f31c91-8e05-11ea-84ae-5cf37097309a"}, {"source": "DARPP-32 events", "value": 0.4382316572142021, "ngenes": 26, "max_val": 8.706, "rank": 1345.0, "id": "38f31c92-8e05-11ea-ad40-5cf37097309a"}]}, {"source": "Visual phototransduction", "value": 0.31211243572932124, "ngenes": 132, "max_val": 8.706, "rank": 1990.0, "id": "38f31c93-8e05-11ea-b614-5cf37097309a", "children": [{"source": "The retinoid cycle in cones (daylight vision)", "value": 0.6287478209031482, "ngenes": 8, "max_val": 8.706, "rank": 870.0, "id": "38f31c94-8e05-11ea-83dd-5cf37097309a"}, {"source": "The phototransduction cascade", "value": 0.4225585510124096, "ngenes": 50, "max_val": 8.706, "rank": 1400.0, "id": "38f31c95-8e05-11ea-b13b-5cf37097309a", "children": [{"source": "Activation of the phototransduction cascade", "value": 0.6261273366476987, "ngenes": 19, "max_val": 8.706, "rank": 879.0, "id": "38f31c96-8e05-11ea-b861-5cf37097309a"}, {"source": "Inactivation, recovery and regulation of the phototransduction cascade", "value": 0.5242748343222906, "ngenes": 45, "max_val": 8.706, "rank": 1041.0, "id": "38f31c97-8e05-11ea-aec3-5cf37097309a"}]}, {"source": "The canonical retinoid cycle in rods (twilight vision)", "value": 0.3519169003926209, "ngenes": 25, "max_val": 8.706, "rank": 1728.0, "id": "38f31c98-8e05-11ea-8377-5cf37097309a", "children": [{"source": "Biosynthesis of A2E, implicated in retinal degradation", "value": 0.5434727133266248, "ngenes": 2, "max_val": 8.706, "rank": 1026.0, "id": "38f31c99-8e05-11ea-8e43-5cf37097309a"}]}, {"source": "Retinoid metabolism and transport", "value": 0.34147347350479673, "ngenes": 57, "max_val": 8.706, "rank": 1788.0, "id": "38f31c9a-8e05-11ea-b1c0-5cf37097309a"}]}]}, {"source": "G alpha (z) signalling events", "value": 1.3136451079029379, "ngenes": 63, "max_val": 8.706, "rank": 383.0, "id": "38f34312-8e05-11ea-8b7d-5cf37097309a"}, {"source": "G-protein beta:gamma signalling", "value": 0.44227409954858976, "ngenes": 34, "max_val": 8.706, "rank": 1327.0, "id": "38f34313-8e05-11ea-9ebc-5cf37097309a", "children": [{"source": "G beta:gamma signalling through PLC beta", "value": 0.6057430516997634, "ngenes": 21, "max_val": 8.706, "rank": 909.0, "id": "38f34314-8e05-11ea-8b07-5cf37097309a"}, {"source": "G beta:gamma signalling through BTK", "value": 0.4788365094295219, "ngenes": 19, "max_val": 8.706, "rank": 1173.0, "id": "38f34315-8e05-11ea-bd39-5cf37097309a"}, {"source": "G beta:gamma signalling through CDC42", "value": 0.4059605972690797, "ngenes": 21, "max_val": 8.706, "rank": 1469.0, "id": "38f34316-8e05-11ea-b380-5cf37097309a"}, {"source": "G beta:gamma signalling through PI3Kgamma", "value": 0.3942103998739486, "ngenes": 27, "max_val": 8.706, "rank": 1527.0, "id": "38f34317-8e05-11ea-be2a-5cf37097309a"}]}, {"source": "G alpha (q) signalling events", "value": 0.9735679675666878, "ngenes": 233, "max_val": 8.706, "rank": 559.0, "id": "38f34318-8e05-11ea-8d6f-5cf37097309a", "children": [{"source": "Gastrin-CREB signalling pathway via PKC and MAPK", "value": 0.8508743873704651, "ngenes": 22, "max_val": 8.706, "rank": 634.0, "id": "38f34319-8e05-11ea-a39e-5cf37097309a", "children": [{"source": "EGFR Transactivation by Gastrin", "value": 0.5896819346331361, "ngenes": 12, "max_val": 8.706, "rank": 934.0, "id": "38f3431a-8e05-11ea-be48-5cf37097309a"}]}, {"source": "Effects of PIP2 hydrolysis", "value": 0.4865631200748303, "ngenes": 28, "max_val": 8.706, "rank": 1129.0, "id": "38f3431b-8e05-11ea-acfd-5cf37097309a", "children": [{"source": "Arachidonate production from DAG", "value": 0.5024478391730836, "ngenes": 5, "max_val": 8.706, "rank": 1089.0, "id": "38f3431c-8e05-11ea-9efe-5cf37097309a"}]}]}, {"source": "G alpha (12/13) signalling events", "value": 0.4225251742038882, "ngenes": 85, "max_val": 8.706, "rank": 1404.0, "id": "38f3431d-8e05-11ea-94e4-5cf37097309a"}, {"source": "G alpha (s) signalling events", "value": 0.4266462015709692, "ngenes": 667, "max_val": 8.706, "rank": 1375.0, "id": "38f3431e-8e05-11ea-b1bb-5cf37097309a", "children": [{"source": "Olfactory Signaling Pathway", "value": 0.3288714815669623, "ngenes": 509, "max_val": 8.706, "rank": 1868.0, "id": "38f3431f-8e05-11ea-a7c1-5cf37097309a"}]}]}, {"source": "GPCR ligand binding", "value": 1.0082686705314727, "ngenes": 513, "max_val": 8.706, "rank": 546.0, "id": "38f34320-8e05-11ea-b3a5-5cf37097309a", "children": [{"source": "Class A/1 (Rhodopsin-like receptors)", "value": 1.171055552302725, "ngenes": 347, "max_val": 8.706, "rank": 454.0, "id": "38f34321-8e05-11ea-9401-5cf37097309a", "children": [{"source": "Eicosanoid ligand-binding receptors", "value": 0.35647002589378085, "ngenes": 17, "max_val": 8.706, "rank": 1703.0, "id": "38f34322-8e05-11ea-8f1b-5cf37097309a", "children": [{"source": "Prostanoid ligand receptors", "value": 1.5463851489188494, "ngenes": 9, "max_val": 8.706, "rank": 294.0, "id": "38f34323-8e05-11ea-89a4-5cf37097309a"}, {"source": "Leukotriene receptors", "value": 0.35591495968525594, "ngenes": 7, "max_val": 8.706, "rank": 1712.0, "id": "38f34324-8e05-11ea-b050-5cf37097309a"}]}, {"source": "Lysosphingolipid and LPA receptors", "value": 1.4388572572093514, "ngenes": 15, "max_val": 8.706, "rank": 341.0, "id": "38f34325-8e05-11ea-b9a5-5cf37097309a"}, {"source": "Peptide ligand-binding receptors", "value": 0.9674422348542536, "ngenes": 210, "max_val": 8.706, "rank": 561.0, "id": "38f34326-8e05-11ea-9ecd-5cf37097309a", "children": [{"source": "Formyl peptide receptors bind formyl peptides and many other ligands", "value": 1.139581425785069, "ngenes": 9, "max_val": 8.706, "rank": 468.0, "id": "38f34327-8e05-11ea-a764-5cf37097309a"}, {"source": "Vasopressin-like receptors", "value": 0.7478709676371822, "ngenes": 6, "max_val": 8.706, "rank": 705.0, "id": "38f34328-8e05-11ea-8574-5cf37097309a"}, {"source": "Orexin and neuropeptides FF and QRFP bind to their respective receptors", "value": 0.5826614062625122, "ngenes": 8, "max_val": 8.706, "rank": 943.0, "id": "38f34329-8e05-11ea-a397-5cf37097309a"}, {"source": "Chemokine receptors bind chemokines", "value": 0.4956021610862506, "ngenes": 66, "max_val": 8.706, "rank": 1107.0, "id": "38f3432a-8e05-11ea-b62a-5cf37097309a"}, {"source": "Tachykinin receptors bind tachykinins", "value": 0.31736890900082704, "ngenes": 5, "max_val": 8.706, "rank": 1932.0, "id": "38f3432b-8e05-11ea-813f-5cf37097309a"}, {"source": "Relaxin receptors", "value": 0.3169714205734984, "ngenes": 9, "max_val": 8.706, "rank": 1936.0, "id": "38f3432c-8e05-11ea-afdd-5cf37097309a"}]}, {"source": "Hydroxycarboxylic acid-binding receptors", "value": 1.1328009409945634, "ngenes": 3, "max_val": 8.706, "rank": 475.0, "id": "38f3432d-8e05-11ea-a5c6-5cf37097309a"}, {"source": "Amine ligand-binding receptors", "value": 0.31634804399455485, "ngenes": 43, "max_val": 8.706, "rank": 1941.0, "id": "38f3432e-8e05-11ea-917f-5cf37097309a", "children": [{"source": "Dopamine receptors", "value": 0.8844612820472848, "ngenes": 6, "max_val": 8.706, "rank": 615.0, "id": "38f3432f-8e05-11ea-be1f-5cf37097309a"}, {"source": "Adrenoceptors", "value": 0.8177354171284293, "ngenes": 9, "max_val": 8.706, "rank": 656.0, "id": "38f34330-8e05-11ea-843f-5cf37097309a"}, {"source": "Muscarinic acetylcholine receptors", "value": 0.4788365094295219, "ngenes": 5, "max_val": 8.706, "rank": 1168.0, "id": "38f34331-8e05-11ea-a549-5cf37097309a"}, {"source": "Serotonin receptors", "value": 0.3939690018783587, "ngenes": 12, "max_val": 8.706, "rank": 1529.0, "id": "38f34332-8e05-11ea-8eb2-5cf37097309a"}, {"source": "Histamine receptors", "value": 0.3088724561369422, "ngenes": 4, "max_val": 8.706, "rank": 2005.0, "id": "38f34333-8e05-11ea-b1ff-5cf37097309a"}]}, {"source": "Nucleotide-like (purinergic) receptors", "value": 0.30251216144429616, "ngenes": 16, "max_val": 8.706, "rank": 2066.0, "id": "38f34334-8e05-11ea-9ace-5cf37097309a", "children": [{"source": "P2Y receptors", "value": 0.7309316306346447, "ngenes": 12, "max_val": 8.706, "rank": 724.0, "id": "38f34335-8e05-11ea-8422-5cf37097309a"}, {"source": "Adenosine P1 receptors", "value": 0.5281761226660511, "ngenes": 4, "max_val": 8.706, "rank": 1036.0, "id": "38f34336-8e05-11ea-a20a-5cf37097309a"}]}, {"source": "Hormone ligand-binding receptors", "value": 0.6569571172567668, "ngenes": 12, "max_val": 8.706, "rank": 815.0, "id": "38f34337-8e05-11ea-95ff-5cf37097309a"}, {"source": "Opsins", "value": 0.4882101249560168, "ngenes": 9, "max_val": 8.706, "rank": 1119.0, "id": "38f34338-8e05-11ea-9400-5cf37097309a"}, {"source": "Free fatty acid receptors", "value": 0.3582908682862535, "ngenes": 5, "max_val": 8.706, "rank": 1688.0, "id": "38f34339-8e05-11ea-b533-5cf37097309a"}]}, {"source": "Class C/3 (Metabotropic glutamate/pheromone receptors)", "value": 0.4865631200748303, "ngenes": 67, "max_val": 8.706, "rank": 1130.0, "id": "38f3433a-8e05-11ea-bbb9-5cf37097309a"}, {"source": "Class B/2 (Secretin family receptors)", "value": 0.8325911246241103, "ngenes": 100, "max_val": 8.706, "rank": 641.0, "id": "38f3433b-8e05-11ea-8ef0-5cf37097309a", "children": [{"source": "Glucagon-type ligand receptors", "value": 0.3845554833325704, "ngenes": 35, "max_val": 8.706, "rank": 1574.0, "id": "38f3433c-8e05-11ea-8918-5cf37097309a"}, {"source": "Calcitonin-like ligand receptors", "value": 0.3607722029989453, "ngenes": 10, "max_val": 8.706, "rank": 1667.0, "id": "38f3433d-8e05-11ea-b691-5cf37097309a"}]}]}]}, {"source": "Intracellular signaling by second messengers", "value": 0.3333488691934495, "ngenes": 402, "max_val": 8.706, "rank": 1833.0, "id": "38f3433e-8e05-11ea-9778-5cf37097309a", "children": [{"source": "DAG and IP3 signaling", "value": 0.9062602594897696, "ngenes": 49, "max_val": 8.706, "rank": 590.0, "id": "38f3433f-8e05-11ea-93d1-5cf37097309a", "children": [{"source": "CaM pathway", "value": 2.3588323809305414, "ngenes": 43, "max_val": 8.706, "rank": 91.0, "id": "38f34340-8e05-11ea-ba0c-5cf37097309a", "children": [{"source": "Calmodulin induced events", "value": 2.3588323809305414, "ngenes": 43, "max_val": 8.706, "rank": 90.0, "id": "38f34341-8e05-11ea-89a8-5cf37097309a", "children": [{"source": "PKA-mediated phosphorylation of CREB", "value": 1.6274809485325372, "ngenes": 24, "max_val": 8.706, "rank": 253.0, "id": "38f34342-8e05-11ea-962d-5cf37097309a", "children": [{"source": "PKA activation", "value": 2.080152587903454, "ngenes": 19, "max_val": 8.706, "rank": 121.0, "id": "38f34343-8e05-11ea-b2b4-5cf37097309a"}]}, {"source": "Cam-PDE 1 activation", "value": 0.6937103871398255, "ngenes": 4, "max_val": 8.706, "rank": 768.0, "id": "38f34344-8e05-11ea-ab58-5cf37097309a"}, {"source": "CaMK IV-mediated phosphorylation of CREB", "value": 0.31843317641013524, "ngenes": 14, "max_val": 8.706, "rank": 1929.0, "id": "38f34345-8e05-11ea-96a3-5cf37097309a"}]}]}]}, {"source": "PIP3 activates AKT signaling", "value": 0.4420577665440262, "ngenes": 353, "max_val": 8.706, "rank": 1331.0, "id": "38f34346-8e05-11ea-9753-5cf37097309a", "children": [{"source": "Negative regulation of the PI3K/AKT network", "value": 1.434200512371639, "ngenes": 117, "max_val": 8.706, "rank": 343.0, "id": "38f34347-8e05-11ea-b425-5cf37097309a", "children": [{"source": "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling", "value": 1.382270482432535, "ngenes": 109, "max_val": 8.706, "rank": 358.0, "id": "38f34348-8e05-11ea-b24f-5cf37097309a"}]}, {"source": "AKT phosphorylates targets in the nucleus", "value": 0.7949731088105921, "ngenes": 11, "max_val": 8.706, "rank": 667.0, "id": "38f34349-8e05-11ea-b5b4-5cf37097309a"}, {"source": "PTEN Regulation", "value": 0.3135746486533741, "ngenes": 218, "max_val": 8.706, "rank": 1964.0, "id": "38f3434a-8e05-11ea-8458-5cf37097309a", "children": [{"source": "Regulation of PTEN stability and activity", "value": 0.5070556504709329, "ngenes": 98, "max_val": 8.706, "rank": 1083.0, "id": "38f3434b-8e05-11ea-98d7-5cf37097309a"}, {"source": "Regulation of PTEN gene transcription", "value": 0.4437546620665331, "ngenes": 110, "max_val": 8.706, "rank": 1284.0, "id": "38f3434c-8e05-11ea-87a0-5cf37097309a"}, {"source": "Regulation of PTEN localization", "value": 0.4180679562165688, "ngenes": 9, "max_val": 8.706, "rank": 1413.0, "id": "38f3434d-8e05-11ea-8e32-5cf37097309a"}, {"source": "Regulation of PTEN mRNA translation", "value": 0.35647002589378085, "ngenes": 10, "max_val": 8.706, "rank": 1706.0, "id": "38f3434e-8e05-11ea-a221-5cf37097309a", "children": [{"source": "Competing endogenous RNAs (ceRNAs) regulate PTEN translation", "value": 0.3697835599897704, "ngenes": 8, "max_val": 8.706, "rank": 1622.0, "id": "38f3434f-8e05-11ea-a82c-5cf37097309a"}]}]}, {"source": "AKT phosphorylates targets in the cytosol", "value": 0.4165866033279961, "ngenes": 19, "max_val": 8.706, "rank": 1427.0, "id": "38f34350-8e05-11ea-b67f-5cf37097309a"}]}]}, {"source": "Signaling by Erythropoietin", "value": 1.5463851489188494, "ngenes": 42, "max_val": 8.706, "rank": 293.0, "id": "38f34351-8e05-11ea-a35f-5cf37097309a", "children": [{"source": "Erythropoietin activates STAT5", "value": 1.8826193423712003, "ngenes": 7, "max_val": 8.706, "rank": 180.0, "id": "38f34352-8e05-11ea-87d9-5cf37097309a"}, {"source": "Erythropoietin activates Phospholipase C gamma (PLCG)", "value": 1.6341505816288515, "ngenes": 7, "max_val": 8.706, "rank": 249.0, "id": "38f34353-8e05-11ea-8a7b-5cf37097309a"}, {"source": "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)", "value": 1.3632463316604375, "ngenes": 23, "max_val": 8.706, "rank": 361.0, "id": "38f34354-8e05-11ea-ba22-5cf37097309a"}, {"source": "Erythropoietin activates RAS", "value": 0.6286195179544306, "ngenes": 25, "max_val": 8.706, "rank": 877.0, "id": "38f34355-8e05-11ea-bcd3-5cf37097309a"}]}, {"source": "Signaling by Non-Receptor Tyrosine Kinases", "value": 0.5202675432027881, "ngenes": 56, "max_val": 8.706, "rank": 1050.0, "id": "38f34356-8e05-11ea-b948-5cf37097309a", "children": [{"source": "Signaling by PTK6", "value": 0.5202675432027881, "ngenes": 56, "max_val": 8.706, "rank": 1047.0, "id": "38f34357-8e05-11ea-bd61-5cf37097309a", "children": [{"source": "PTK6 Down-Regulation", "value": 1.359821413270241, "ngenes": 3, "max_val": 8.706, "rank": 364.0, "id": "38f34358-8e05-11ea-b5cb-5cf37097309a"}, {"source": "ERBB2 Activates PTK6 Signaling", "value": 1.3039497372625592, "ngenes": 13, "max_val": 8.706, "rank": 390.0, "id": "38f34359-8e05-11ea-9c58-5cf37097309a"}, {"source": "PTK6 Expression", "value": 1.0781114833954044, "ngenes": 5, "max_val": 8.706, "rank": 487.0, "id": "38f3435a-8e05-11ea-a0c2-5cf37097309a"}, {"source": "PTK6 promotes HIF1A stabilization", "value": 0.7755857772952262, "ngenes": 6, "max_val": 8.706, "rank": 684.0, "id": "38f3435b-8e05-11ea-9a2a-5cf37097309a"}, {"source": "PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1", "value": 0.5059675539726222, "ngenes": 9, "max_val": 8.706, "rank": 1085.0, "id": "38f3435c-8e05-11ea-9fe8-5cf37097309a"}, {"source": "PTK6 Regulates Cell Cycle", "value": 0.4878030683316549, "ngenes": 6, "max_val": 8.706, "rank": 1120.0, "id": "38f3435d-8e05-11ea-8df6-5cf37097309a"}, {"source": "PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases", "value": 0.3543975045465841, "ngenes": 15, "max_val": 8.706, "rank": 1718.0, "id": "38f3435e-8e05-11ea-9df1-5cf37097309a"}, {"source": "PTK6 Activates STAT3", "value": 0.3084182102447057, "ngenes": 5, "max_val": 8.706, "rank": 2008.0, "id": "38f3435f-8e05-11ea-9621-5cf37097309a"}, {"source": "PTK6 Regulates Proteins Involved in RNA Processing", "value": 0.30251216144429616, "ngenes": 5, "max_val": 8.706, "rank": 2060.0, "id": "38f34360-8e05-11ea-9b34-5cf37097309a"}]}]}, {"source": "Signaling by TGF-beta family members", "value": 0.4214001462265449, "ngenes": 139, "max_val": 8.706, "rank": 1407.0, "id": "38f34361-8e05-11ea-b1c6-5cf37097309a", "children": [{"source": "Signaling by Activin", "value": 0.5565507266078732, "ngenes": 18, "max_val": 8.706, "rank": 971.0, "id": "38f34362-8e05-11ea-a409-5cf37097309a", "children": [{"source": "Antagonism of Activin by Follistatin", "value": 1.235370081966744, "ngenes": 4, "max_val": 8.706, "rank": 410.0, "id": "38f34363-8e05-11ea-a73f-5cf37097309a"}]}, {"source": "Signaling by TGF-beta Receptor Complex", "value": 0.3914299493155223, "ngenes": 105, "max_val": 8.706, "rank": 1533.0, "id": "38f34364-8e05-11ea-93e3-5cf37097309a", "children": [{"source": "Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer", "value": 0.4627309951511139, "ngenes": 58, "max_val": 8.706, "rank": 1245.0, "id": "38f34365-8e05-11ea-8fc3-5cf37097309a", "children": [{"source": "Downregulation of SMAD2/3:SMAD4 transcriptional activity", "value": 0.86492840468403, "ngenes": 35, "max_val": 8.706, "rank": 631.0, "id": "38f34366-8e05-11ea-88fb-5cf37097309a"}, {"source": "SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription", "value": 0.6647834081114088, "ngenes": 38, "max_val": 8.706, "rank": 797.0, "id": "38f34367-8e05-11ea-9042-5cf37097309a"}]}, {"source": "TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)", "value": 0.3413293980204016, "ngenes": 27, "max_val": 8.706, "rank": 1791.0, "id": "38f34368-8e05-11ea-bcff-5cf37097309a"}, {"source": "TGF-beta receptor signaling activates SMADs", "value": 0.33791596117958894, "ngenes": 45, "max_val": 8.706, "rank": 1808.0, "id": "38f34369-8e05-11ea-8686-5cf37097309a", "children": [{"source": "Downregulation of TGF-beta receptor signaling", "value": 0.3040711199823073, "ngenes": 37, "max_val": 8.706, "rank": 2049.0, "id": "38f3436a-8e05-11ea-9518-5cf37097309a"}]}]}, {"source": "Signaling by BMP", "value": 0.4165866033279961, "ngenes": 29, "max_val": 8.706, "rank": 1435.0, "id": "38f3436b-8e05-11ea-952e-5cf37097309a"}]}, {"source": "Signaling by Leptin", "value": 0.9580043355188876, "ngenes": 13, "max_val": 8.706, "rank": 565.0, "id": "38f3436c-8e05-11ea-82dc-5cf37097309a"}, {"source": "MAPK family signaling cascades", "value": 0.3040711199823073, "ngenes": 323, "max_val": 8.706, "rank": 2046.0, "id": "38f3436d-8e05-11ea-8057-5cf37097309a", "children": [{"source": "MAPK1/MAPK3 signaling", "value": 0.3849420497242914, "ngenes": 277, "max_val": 8.706, "rank": 1560.0, "id": "38f3436e-8e05-11ea-93f9-5cf37097309a", "children": [{"source": "RAF/MAP kinase cascade", "value": 0.4717863154195249, "ngenes": 271, "max_val": 8.706, "rank": 1196.0, "id": "38f3436f-8e05-11ea-9be3-5cf37097309a", "children": [{"source": "Regulation of RAS by GAPs", "value": 0.6445692907358854, "ngenes": 89, "max_val": 8.706, "rank": 840.0, "id": "38f34370-8e05-11ea-ad4b-5cf37097309a"}, {"source": "MAP2K and MAPK activation", "value": 0.3663505507769889, "ngenes": 41, "max_val": 8.706, "rank": 1632.0, "id": "38f34371-8e05-11ea-9bd8-5cf37097309a"}, {"source": "RAF activation", "value": 0.3363680139764464, "ngenes": 31, "max_val": 8.706, "rank": 1823.0, "id": "38f34372-8e05-11ea-a627-5cf37097309a"}, {"source": "Negative regulation of MAPK pathway", "value": 0.44227409954858976, "ngenes": 44, "max_val": 8.706, "rank": 1298.0, "id": "38f34373-8e05-11ea-907d-5cf37097309a", "children": [{"source": "Negative feedback regulation of MAPK pathway", "value": 0.3272772875640805, "ngenes": 6, "max_val": 8.706, "rank": 1882.0, "id": "38f34374-8e05-11ea-9871-5cf37097309a"}]}]}, {"source": "RAF-independent MAPK1/3 activation", "value": 0.3750724859188269, "ngenes": 26, "max_val": 8.706, "rank": 1601.0, "id": "38f34375-8e05-11ea-abcd-5cf37097309a", "children": [{"source": "MAPK1 (ERK2) activation", "value": 0.40594021400370056, "ngenes": 9, "max_val": 8.706, "rank": 1481.0, "id": "38f34376-8e05-11ea-b613-5cf37097309a"}, {"source": "MAPK3 (ERK1) activation", "value": 0.3416738873259401, "ngenes": 10, "max_val": 8.706, "rank": 1785.0, "id": "38f34377-8e05-11ea-aafa-5cf37097309a"}]}]}, {"source": "MAPK6/MAPK4 signaling", "value": 0.3111226958039473, "ngenes": 114, "max_val": 8.706, "rank": 1995.0, "id": "38f34378-8e05-11ea-bfdf-5cf37097309a"}]}, {"source": "mTOR signalling", "value": 0.33791596117958894, "ngenes": 40, "max_val": 8.706, "rank": 1806.0, "id": "38f34379-8e05-11ea-9e5b-5cf37097309a", "children": [{"source": "Energy dependent regulation of mTOR by LKB1-AMPK", "value": 0.6385615301399149, "ngenes": 29, "max_val": 8.706, "rank": 853.0, "id": "38f3437a-8e05-11ea-82d3-5cf37097309a"}, {"source": "Inhibition of TSC complex formation by PKB", "value": 0.44227409954858976, "ngenes": 3, "max_val": 8.706, "rank": 1325.0, "id": "38f3437b-8e05-11ea-b0dd-5cf37097309a"}, {"source": "mTORC1-mediated signalling", "value": 0.3967816616170723, "ngenes": 23, "max_val": 8.706, "rank": 1516.0, "id": "38f3437c-8e05-11ea-8b37-5cf37097309a"}]}, {"source": "Integrin signaling", "value": 1.4914632628555191, "ngenes": 27, "max_val": 8.706, "rank": 318.0, "id": "38f3437d-8e05-11ea-ab8e-5cf37097309a", "children": [{"source": "p130Cas linkage to MAPK signaling for integrins", "value": 0.5471840327551817, "ngenes": 15, "max_val": 8.706, "rank": 1008.0, "id": "38f3437e-8e05-11ea-861b-5cf37097309a"}, {"source": "GRB2:SOS provides linkage to MAPK signaling for Integrins ", "value": 0.3028939955380687, "ngenes": 15, "max_val": 8.706, "rank": 2053.0, "id": "38f3437f-8e05-11ea-b416-5cf37097309a"}]}, {"source": "Signaling by Hippo", "value": 0.40594021400370056, "ngenes": 22, "max_val": 8.706, "rank": 1482.0, "id": "38f34380-8e05-11ea-88e4-5cf37097309a"}]}, {"source": "Cell-Cell communication", "value": 8.705585111092352, "ngenes": 142, "max_val": 8.706, "rank": 1.0, "id": "38f34381-8e05-11ea-95ac-5cf37097309a", "children": [{"source": "Cell junction organization", "value": 8.705585111092352, "ngenes": 97, "max_val": 8.706, "rank": 2.0, "id": "38f34382-8e05-11ea-8cf3-5cf37097309a", "children": [{"source": "Type I hemidesmosome assembly", "value": 4.977256822310271, "ngenes": 11, "max_val": 8.706, "rank": 4.0, "id": "38f34383-8e05-11ea-800d-5cf37097309a"}, {"source": "Cell-cell junction organization", "value": 2.627832216398577, "ngenes": 70, "max_val": 8.706, "rank": 69.0, "id": "38f34384-8e05-11ea-8e6f-5cf37097309a", "children": [{"source": "Tight junction interactions", "value": 3.445707479629962, "ngenes": 31, "max_val": 8.706, "rank": 23.0, "id": "38f34385-8e05-11ea-bead-5cf37097309a"}, {"source": "Adherens junctions interactions", "value": 0.3592004814595621, "ngenes": 37, "max_val": 8.706, "rank": 1678.0, "id": "38f34386-8e05-11ea-a80a-5cf37097309a", "children": [{"source": "Nectin/Necl  trans heterodimerization", "value": 3.4374885248837974, "ngenes": 7, "max_val": 8.706, "rank": 24.0, "id": "38f34387-8e05-11ea-b3d4-5cf37097309a"}]}, {"source": "SDK interactions", "value": 0.44227409954858976, "ngenes": 2, "max_val": 8.706, "rank": 1302.0, "id": "38f34388-8e05-11ea-ac1f-5cf37097309a"}]}, {"source": "Cell-extracellular matrix interactions", "value": 3.679933165339415, "ngenes": 18, "max_val": 8.706, "rank": 16.0, "id": "38f34389-8e05-11ea-9237-5cf37097309a", "children": [{"source": "Regulation of cytoskeletal remodeling and cell spreading by IPP complex components", "value": 1.6383002223565075, "ngenes": 8, "max_val": 8.706, "rank": 246.0, "id": "38f3438a-8e05-11ea-9c2b-5cf37097309a"}, {"source": "Localization of the PINCH-ILK-PARVIN complex to focal adhesions", "value": 0.40594021400370056, "ngenes": 4, "max_val": 8.706, "rank": 1478.0, "id": "38f3438b-8e05-11ea-8ce0-5cf37097309a"}]}]}, {"source": "Nephrin family interactions", "value": 1.3587138740441582, "ngenes": 27, "max_val": 8.706, "rank": 366.0, "id": "38f3438c-8e05-11ea-a156-5cf37097309a"}, {"source": "Signal regulatory protein family interactions", "value": 0.714245852972956, "ngenes": 18, "max_val": 8.706, "rank": 747.0, "id": "38f3438d-8e05-11ea-9d13-5cf37097309a"}]}, {"source": "Metabolism", "value": 0.3543975045465841, "ngenes": 2445, "max_val": 8.706, "rank": 1722.0, "id": "38f3438e-8e05-11ea-9e28-5cf37097309a", "children": [{"source": "Inositol phosphate metabolism", "value": 4.7096769179282045, "ngenes": 51, "max_val": 8.706, "rank": 5.0, "id": "38f3438f-8e05-11ea-803e-5cf37097309a", "children": [{"source": "Synthesis of IP3 and IP4 in the cytosol", "value": 3.9430760699501217, "ngenes": 29, "max_val": 8.706, "rank": 8.0, "id": "38f34390-8e05-11ea-9d6e-5cf37097309a"}, {"source": "Synthesis of pyrophosphates in the cytosol", "value": 2.1742345165122767, "ngenes": 11, "max_val": 8.706, "rank": 115.0, "id": "38f34391-8e05-11ea-8c61-5cf37097309a"}, {"source": "Synthesis of IP2, IP, and Ins in the cytosol", "value": 0.4731128235942158, "ngenes": 14, "max_val": 8.706, "rank": 1187.0, "id": "38f34392-8e05-11ea-a74e-5cf37097309a"}, {"source": "Synthesis of IPs in the nucleus", "value": 0.34410454098523524, "ngenes": 4, "max_val": 8.706, "rank": 1774.0, "id": "38f34393-8e05-11ea-aeb3-5cf37097309a"}]}, {"source": "Metabolism of lipids", "value": 0.5167286546642752, "ngenes": 867, "max_val": 8.706, "rank": 1053.0, "id": "38f34394-8e05-11ea-80f1-5cf37097309a", "children": [{"source": "Phospholipid metabolism", "value": 1.6261673024063232, "ngenes": 259, "max_val": 8.706, "rank": 255.0, "id": "38f34395-8e05-11ea-ba9a-5cf37097309a", "children": [{"source": "Glycerophospholipid biosynthesis", "value": 1.5247081939801168, "ngenes": 166, "max_val": 8.706, "rank": 305.0, "id": "38f34396-8e05-11ea-8d6b-5cf37097309a", "children": [{"source": "Synthesis of PG", "value": 3.6356032699687737, "ngenes": 9, "max_val": 8.706, "rank": 18.0, "id": "38f369f6-8e05-11ea-b01d-5cf37097309a"}, {"source": "Acyl chain remodelling of PC", "value": 1.6129733081434927, "ngenes": 28, "max_val": 8.706, "rank": 261.0, "id": "38f369f7-8e05-11ea-8bb0-5cf37097309a"}, {"source": "Acyl chain remodelling of PG", "value": 1.3587138740441582, "ngenes": 19, "max_val": 8.706, "rank": 369.0, "id": "38f369f8-8e05-11ea-8e16-5cf37097309a"}, {"source": "Acyl chain remodelling of PE", "value": 1.267585854303222, "ngenes": 30, "max_val": 8.706, "rank": 402.0, "id": "38f369f9-8e05-11ea-aa18-5cf37097309a"}, {"source": "Synthesis of PI", "value": 1.0087469802896305, "ngenes": 5, "max_val": 8.706, "rank": 545.0, "id": "38f369fa-8e05-11ea-8230-5cf37097309a"}, {"source": "Acyl chain remodelling of PS", "value": 0.8937906069613646, "ngenes": 23, "max_val": 8.706, "rank": 605.0, "id": "38f369fb-8e05-11ea-8810-5cf37097309a"}, {"source": "Acyl chain remodelling of PI", "value": 0.8507317999043241, "ngenes": 27, "max_val": 8.706, "rank": 635.0, "id": "38f369fc-8e05-11ea-b593-5cf37097309a"}, {"source": "Synthesis of PA", "value": 0.8215683371641818, "ngenes": 47, "max_val": 8.706, "rank": 648.0, "id": "38f369fd-8e05-11ea-b8a5-5cf37097309a"}, {"source": "Synthesis of PC", "value": 0.7431049667999374, "ngenes": 41, "max_val": 8.706, "rank": 712.0, "id": "38f369fe-8e05-11ea-9033-5cf37097309a"}, {"source": "Acyl chain remodeling of CL", "value": 0.5907663399306763, "ngenes": 6, "max_val": 8.706, "rank": 931.0, "id": "38f369ff-8e05-11ea-bf6b-5cf37097309a"}, {"source": "Acyl chain remodeling of DAG and TAG", "value": 0.4166701851996452, "ngenes": 8, "max_val": 8.706, "rank": 1418.0, "id": "38f36a00-8e05-11ea-bf17-5cf37097309a"}, {"source": "Synthesis of PS", "value": 0.3833531257989761, "ngenes": 2, "max_val": 8.706, "rank": 1577.0, "id": "38f36a01-8e05-11ea-8862-5cf37097309a"}, {"source": "Hydrolysis of LPE", "value": 0.35591495968525594, "ngenes": 2, "max_val": 8.706, "rank": 1713.0, "id": "38f36a02-8e05-11ea-b82b-5cf37097309a"}, {"source": "Hydrolysis of LPC", "value": 0.3446291910156124, "ngenes": 9, "max_val": 8.706, "rank": 1773.0, "id": "38f36a03-8e05-11ea-add2-5cf37097309a"}, {"source": "Synthesis of PE", "value": 0.33680443321456344, "ngenes": 13, "max_val": 8.706, "rank": 1815.0, "id": "38f36a04-8e05-11ea-ae88-5cf37097309a"}]}, {"source": "PI Metabolism", "value": 2.248959385177685, "ngenes": 94, "max_val": 8.706, "rank": 104.0, "id": "38f36a05-8e05-11ea-bfe2-5cf37097309a", "children": [{"source": "Synthesis of PIPs at the plasma membrane", "value": 2.7773370220486857, "ngenes": 56, "max_val": 8.706, "rank": 52.0, "id": "38f36a06-8e05-11ea-bb6a-5cf37097309a"}, {"source": "Synthesis of PIPs at the Golgi membrane", "value": 1.0230929066990757, "ngenes": 21, "max_val": 8.706, "rank": 534.0, "id": "38f36a07-8e05-11ea-ae40-5cf37097309a"}, {"source": "Synthesis of PIPs at the early endosome membrane", "value": 0.8028965885639533, "ngenes": 21, "max_val": 8.706, "rank": 666.0, "id": "38f36a08-8e05-11ea-8c58-5cf37097309a"}, {"source": "Synthesis of PIPs at the ER membrane", "value": 0.7850477614605029, "ngenes": 5, "max_val": 8.706, "rank": 675.0, "id": "38f36a09-8e05-11ea-81c8-5cf37097309a"}, {"source": "Synthesis of PIPs in the nucleus", "value": 0.6971911352598542, "ngenes": 5, "max_val": 8.706, "rank": 762.0, "id": "38f36a0a-8e05-11ea-ac4b-5cf37097309a"}, {"source": "Synthesis of PIPs at the late endosome membrane", "value": 0.4129204759764161, "ngenes": 15, "max_val": 8.706, "rank": 1448.0, "id": "38f36a0b-8e05-11ea-80bc-5cf37097309a"}, {"source": "Glycerophospholipid catabolism", "value": 0.3483210271800589, "ngenes": 7, "max_val": 8.706, "rank": 1755.0, "id": "38f36a0c-8e05-11ea-809e-5cf37097309a"}]}]}, {"source": "Fatty acid metabolism", "value": 2.1267895101999463, "ngenes": 202, "max_val": 8.706, "rank": 119.0, "id": "38f36a0d-8e05-11ea-a13d-5cf37097309a", "children": [{"source": "Arachidonic acid metabolism", "value": 1.661575951901214, "ngenes": 66, "max_val": 8.706, "rank": 230.0, "id": "38f36a0e-8e05-11ea-9c45-5cf37097309a", "children": [{"source": "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)", "value": 2.232500285816241, "ngenes": 15, "max_val": 8.706, "rank": 108.0, "id": "38f36a0f-8e05-11ea-a1a4-5cf37097309a"}, {"source": "Synthesis of Leukotrienes (LT) and Eoxins (EX)", "value": 0.93870511485396, "ngenes": 25, "max_val": 8.706, "rank": 573.0, "id": "38f36a10-8e05-11ea-8585-5cf37097309a"}, {"source": "Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)", "value": 0.7478709676371822, "ngenes": 9, "max_val": 8.706, "rank": 706.0, "id": "38f36a11-8e05-11ea-9713-5cf37097309a"}, {"source": "Synthesis of 5-eicosatetraenoic acids", "value": 0.4704952658544049, "ngenes": 11, "max_val": 8.706, "rank": 1206.0, "id": "38f36a12-8e05-11ea-b978-5cf37097309a"}, {"source": "Synthesis of 12-eicosatetraenoic acid derivatives", "value": 0.4364096796909963, "ngenes": 7, "max_val": 8.706, "rank": 1354.0, "id": "38f36a13-8e05-11ea-8447-5cf37097309a"}, {"source": "Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)", "value": 0.3886713294759547, "ngenes": 8, "max_val": 8.706, "rank": 1549.0, "id": "38f36a14-8e05-11ea-80c6-5cf37097309a"}, {"source": "Synthesis of 15-eicosatetraenoic acid derivatives", "value": 0.31843317641013524, "ngenes": 6, "max_val": 8.706, "rank": 1930.0, "id": "38f36a15-8e05-11ea-a08b-5cf37097309a"}]}, {"source": "Fatty acyl-CoA biosynthesis", "value": 0.40594021400370056, "ngenes": 53, "max_val": 8.706, "rank": 1471.0, "id": "38f36a16-8e05-11ea-8192-5cf37097309a", "children": [{"source": "Synthesis of very long-chain fatty acyl-CoAs", "value": 1.5642138230806937, "ngenes": 26, "max_val": 8.706, "rank": 284.0, "id": "38f36a17-8e05-11ea-98b5-5cf37097309a"}]}, {"source": "Peroxisomal lipid metabolism", "value": 0.7771640831272257, "ngenes": 30, "max_val": 8.706, "rank": 682.0, "id": "38f36a18-8e05-11ea-aa98-5cf37097309a", "children": [{"source": "Alpha-oxidation of phytanate", "value": 1.4652019089103367, "ngenes": 6, "max_val": 8.706, "rank": 329.0, "id": "38f36a19-8e05-11ea-b454-5cf37097309a"}, {"source": "Beta-oxidation of pristanoyl-CoA", "value": 0.7594169863466287, "ngenes": 9, "max_val": 8.706, "rank": 695.0, "id": "38f36a1a-8e05-11ea-b525-5cf37097309a"}, {"source": "Beta-oxidation of very long chain fatty acids", "value": 0.6771791518304687, "ngenes": 12, "max_val": 8.706, "rank": 777.0, "id": "38f36a1b-8e05-11ea-9fe0-5cf37097309a"}]}, {"source": "Mitochondrial Fatty Acid Beta-Oxidation", "value": 0.6433207399987266, "ngenes": 37, "max_val": 8.706, "rank": 842.0, "id": "38f36a1c-8e05-11ea-babd-5cf37097309a", "children": [{"source": "mitochondrial fatty acid beta-oxidation of saturated fatty acids", "value": 0.3050811988978337, "ngenes": 11, "max_val": 8.706, "rank": 2040.0, "id": "38f36a1d-8e05-11ea-abce-5cf37097309a", "children": [{"source": "Beta oxidation of palmitoyl-CoA to myristoyl-CoA", "value": 1.2204039526638528, "ngenes": 3, "max_val": 8.706, "rank": 415.0, "id": "38f36a1e-8e05-11ea-be80-5cf37097309a"}, {"source": "Beta oxidation of butanoyl-CoA to acetyl-CoA", "value": 0.6540597655456246, "ngenes": 5, "max_val": 8.706, "rank": 824.0, "id": "38f36a1f-8e05-11ea-909b-5cf37097309a"}, {"source": "Beta oxidation of octanoyl-CoA to hexanoyl-CoA", "value": 0.4704952658544049, "ngenes": 5, "max_val": 8.706, "rank": 1207.0, "id": "38f36a20-8e05-11ea-ad94-5cf37097309a"}, {"source": "Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA", "value": 0.44227409954858976, "ngenes": 6, "max_val": 8.706, "rank": 1318.0, "id": "38f36a21-8e05-11ea-b941-5cf37097309a"}, {"source": "Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA", "value": 0.4225585510124096, "ngenes": 5, "max_val": 8.706, "rank": 1401.0, "id": "38f36a22-8e05-11ea-8747-5cf37097309a"}, {"source": "Beta oxidation of hexanoyl-CoA to butanoyl-CoA", "value": 0.3128507621405376, "ngenes": 5, "max_val": 8.706, "rank": 1982.0, "id": "38f36a23-8e05-11ea-8fd5-5cf37097309a"}, {"source": "Beta oxidation of myristoyl-CoA to lauroyl-CoA", "value": 0.30251216144429616, "ngenes": 3, "max_val": 8.706, "rank": 2062.0, "id": "38f36a24-8e05-11ea-9405-5cf37097309a"}]}, {"source": "mitochondrial fatty acid beta-oxidation of unsaturated fatty acids", "value": 0.86492840468403, "ngenes": 6, "max_val": 8.706, "rank": 629.0, "id": "38f36a25-8e05-11ea-96b3-5cf37097309a"}, {"source": "Propionyl-CoA catabolism", "value": 0.4865631200748303, "ngenes": 5, "max_val": 8.706, "rank": 1126.0, "id": "38f36a26-8e05-11ea-aa0b-5cf37097309a"}]}, {"source": "alpha-linolenic (omega3) and linoleic (omega6) acid metabolism", "value": 0.3582908682862535, "ngenes": 14, "max_val": 8.706, "rank": 1687.0, "id": "38f36a27-8e05-11ea-a7f4-5cf37097309a", "children": [{"source": "alpha-linolenic acid (ALA) metabolism", "value": 0.3586028553859912, "ngenes": 14, "max_val": 8.706, "rank": 1682.0, "id": "38f36a28-8e05-11ea-90b7-5cf37097309a"}, {"source": "Linoleic acid (LA) metabolism", "value": 0.3060879909830721, "ngenes": 8, "max_val": 8.706, "rank": 2024.0, "id": "38f36a29-8e05-11ea-9fce-5cf37097309a"}]}, {"source": "Carnitine metabolism", "value": 0.3483210271800589, "ngenes": 15, "max_val": 8.706, "rank": 1758.0, "id": "38f36a2a-8e05-11ea-b1db-5cf37097309a"}]}, {"source": "Metabolism of steroids", "value": 0.39678070566741774, "ngenes": 169, "max_val": 8.706, "rank": 1522.0, "id": "38f36a2b-8e05-11ea-8ef0-5cf37097309a", "children": [{"source": "Metabolism of steroid hormones", "value": 0.3721247903393208, "ngenes": 41, "max_val": 8.706, "rank": 1615.0, "id": "38f36a2c-8e05-11ea-9018-5cf37097309a", "children": [{"source": "Estrogen biosynthesis", "value": 1.6963277822546186, "ngenes": 6, "max_val": 8.706, "rank": 221.0, "id": "38f36a2d-8e05-11ea-81db-5cf37097309a"}, {"source": "Glucocorticoid biosynthesis", "value": 0.6445692907358854, "ngenes": 16, "max_val": 8.706, "rank": 838.0, "id": "38f36a2e-8e05-11ea-920f-5cf37097309a"}, {"source": "Androgen biosynthesis", "value": 0.5471840327551817, "ngenes": 11, "max_val": 8.706, "rank": 1009.0, "id": "38f36a2f-8e05-11ea-9856-5cf37097309a"}, {"source": "Mineralocorticoid biosynthesis", "value": 0.3871848753228034, "ngenes": 11, "max_val": 8.706, "rank": 1550.0, "id": "38f36a30-8e05-11ea-8d8d-5cf37097309a"}, {"source": "Pregnenolone biosynthesis", "value": 0.3139794302814273, "ngenes": 12, "max_val": 8.706, "rank": 1951.0, "id": "38f36a31-8e05-11ea-a31c-5cf37097309a"}]}, {"source": "Bile acid and bile salt metabolism", "value": 2.0252923967732435, "ngenes": 44, "max_val": 8.706, "rank": 129.0, "id": "38f36a32-8e05-11ea-9a48-5cf37097309a", "children": [{"source": "Synthesis of bile acids and bile salts", "value": 2.0363088110652465, "ngenes": 35, "max_val": 8.706, "rank": 126.0, "id": "38f36a33-8e05-11ea-bcc3-5cf37097309a", "children": [{"source": "Synthesis of bile acids and bile salts via 24-hydroxycholesterol", "value": 1.64313516823229, "ngenes": 14, "max_val": 8.706, "rank": 240.0, "id": "38f36a34-8e05-11ea-b9bd-5cf37097309a"}, {"source": "Synthesis of bile acids and bile salts via 27-hydroxycholesterol", "value": 1.3632463316604375, "ngenes": 15, "max_val": 8.706, "rank": 362.0, "id": "38f36a35-8e05-11ea-be7e-5cf37097309a"}, {"source": "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol", "value": 1.1957209721612054, "ngenes": 25, "max_val": 8.706, "rank": 438.0, "id": "38f36a36-8e05-11ea-bd22-5cf37097309a"}]}, {"source": "Recycling of bile acids and salts", "value": 0.6377133922155797, "ngenes": 17, "max_val": 8.706, "rank": 855.0, "id": "38f36a37-8e05-11ea-b197-5cf37097309a"}]}, {"source": "Regulation of cholesterol biosynthesis by SREBP (SREBF)", "value": 1.3172744012649678, "ngenes": 66, "max_val": 8.706, "rank": 382.0, "id": "38f36a38-8e05-11ea-8fc5-5cf37097309a", "children": [{"source": "Activation of gene expression by SREBF (SREBP)", "value": 0.5104201517191181, "ngenes": 52, "max_val": 8.706, "rank": 1068.0, "id": "38f36a39-8e05-11ea-a12c-5cf37097309a"}]}, {"source": "Vitamin D (calciferol) metabolism", "value": 0.40594021400370056, "ngenes": 11, "max_val": 8.706, "rank": 1475.0, "id": "38f36a3a-8e05-11ea-af23-5cf37097309a"}, {"source": "Cholesterol biosynthesis", "value": 0.3189312555743547, "ngenes": 26, "max_val": 8.706, "rank": 1922.0, "id": "38f36a3b-8e05-11ea-97e5-5cf37097309a", "children": [{"source": "Cholesterol biosynthesis via lathosterol", "value": 0.3734982504423127, "ngenes": 4, "max_val": 8.706, "rank": 1607.0, "id": "38f36a3c-8e05-11ea-91fb-5cf37097309a"}, {"source": "Cholesterol biosynthesis via desmosterol", "value": 0.37331638253090615, "ngenes": 4, "max_val": 8.706, "rank": 1610.0, "id": "38f36a3d-8e05-11ea-b67d-5cf37097309a"}]}]}, {"source": "Triglyceride metabolism", "value": 0.68890446669966, "ngenes": 40, "max_val": 8.706, "rank": 771.0, "id": "38f36a3e-8e05-11ea-a108-5cf37097309a", "children": [{"source": "Triglyceride biosynthesis", "value": 1.3266782214154982, "ngenes": 15, "max_val": 8.706, "rank": 378.0, "id": "38f36a3f-8e05-11ea-a5ba-5cf37097309a"}, {"source": "Triglyceride catabolism", "value": 0.4788365094295219, "ngenes": 25, "max_val": 8.706, "rank": 1163.0, "id": "38f36a40-8e05-11ea-a41b-5cf37097309a"}]}, {"source": "Sphingolipid metabolism", "value": 1.3269997505123603, "ngenes": 98, "max_val": 8.706, "rank": 377.0, "id": "38f36a41-8e05-11ea-910b-5cf37097309a", "children": [{"source": "Sphingolipid de novo biosynthesis", "value": 1.3103188900005018, "ngenes": 45, "max_val": 8.706, "rank": 388.0, "id": "38f36a42-8e05-11ea-9d11-5cf37097309a"}, {"source": "Glycosphingolipid metabolism", "value": 0.7478709676371822, "ngenes": 53, "max_val": 8.706, "rank": 707.0, "id": "38f36a43-8e05-11ea-9469-5cf37097309a"}]}, {"source": "Biosynthesis of specialized proresolving mediators (SPMs)", "value": 0.7135917989205224, "ngenes": 22, "max_val": 8.706, "rank": 750.0, "id": "38f36a44-8e05-11ea-bebf-5cf37097309a", "children": [{"source": "Biosynthesis of DHA-derived SPMs", "value": 1.0729001168503527, "ngenes": 20, "max_val": 8.706, "rank": 490.0, "id": "38f36a45-8e05-11ea-9d5f-5cf37097309a", "children": [{"source": "Biosynthesis of D-series resolvins", "value": 1.0361987859326167, "ngenes": 5, "max_val": 8.706, "rank": 523.0, "id": "38f36a46-8e05-11ea-b7ab-5cf37097309a"}, {"source": "Biosynthesis of aspirin-triggered D-series resolvins", "value": 0.9780469208975756, "ngenes": 4, "max_val": 8.706, "rank": 554.0, "id": "38f36a47-8e05-11ea-841b-5cf37097309a"}, {"source": "Biosynthesis of protectins", "value": 0.4416225578705676, "ngenes": 4, "max_val": 8.706, "rank": 1341.0, "id": "38f36a48-8e05-11ea-ade5-5cf37097309a"}, {"source": "Biosynthesis of maresins", "value": 0.5471840327551817, "ngenes": 10, "max_val": 8.706, "rank": 1013.0, "id": "38f36a49-8e05-11ea-a1ca-5cf37097309a", "children": [{"source": "Biosynthesis of maresin-like SPMs", "value": 0.3333488691934495, "ngenes": 7, "max_val": 8.706, "rank": 1834.0, "id": "38f36a4a-8e05-11ea-a5e1-5cf37097309a"}]}, {"source": "Biosynthesis of DHA-derived sulfido conjugates", "value": 0.3288714815669623, "ngenes": 3, "max_val": 8.706, "rank": 1872.0, "id": "38f36a4b-8e05-11ea-92fb-5cf37097309a", "children": [{"source": "Biosynthesis of maresin conjugates in tissue regeneration (MCTR)", "value": 0.3288714815669623, "ngenes": 3, "max_val": 8.706, "rank": 1871.0, "id": "38f36a4c-8e05-11ea-9917-5cf37097309a"}, {"source": "Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR)", "value": 0.3148506673604588, "ngenes": 2, "max_val": 8.706, "rank": 1946.0, "id": "38f36a4d-8e05-11ea-864c-5cf37097309a"}]}]}, {"source": "Biosynthesis of EPA-derived SPMs", "value": 1.1927360947461465, "ngenes": 7, "max_val": 8.706, "rank": 442.0, "id": "38f36a4e-8e05-11ea-9a3b-5cf37097309a", "children": [{"source": "Biosynthesis of E-series 18(S)-resolvins", "value": 1.020293720900078, "ngenes": 6, "max_val": 8.706, "rank": 541.0, "id": "38f36a4f-8e05-11ea-ab10-5cf37097309a"}, {"source": "Biosynthesis of E-series 18(R)-resolvins", "value": 0.9582225135119388, "ngenes": 5, "max_val": 8.706, "rank": 563.0, "id": "38f36a50-8e05-11ea-bdd2-5cf37097309a"}]}, {"source": "Biosynthesis of DPA-derived SPMs", "value": 1.0470122881596666, "ngenes": 5, "max_val": 8.706, "rank": 511.0, "id": "38f36a51-8e05-11ea-ae38-5cf37097309a", "children": [{"source": "Biosynthesis of DPAn-3 SPMs", "value": 1.0470122881596666, "ngenes": 5, "max_val": 8.706, "rank": 510.0, "id": "38f36a52-8e05-11ea-8942-5cf37097309a", "children": [{"source": "Biosynthesis of DPAn-3-derived maresins", "value": 0.9249610941518668, "ngenes": 3, "max_val": 8.706, "rank": 582.0, "id": "38f36a53-8e05-11ea-a815-5cf37097309a"}, {"source": "Biosynthesis of DPAn-3-derived 13-series resolvins", "value": 0.9146572636402835, "ngenes": 2, "max_val": 8.706, "rank": 584.0, "id": "38f36a54-8e05-11ea-b8a3-5cf37097309a"}, {"source": "Biosynthesis of DPAn-3-derived protectins and resolvins", "value": 0.9062602594897696, "ngenes": 3, "max_val": 8.706, "rank": 591.0, "id": "38f36a55-8e05-11ea-bd78-5cf37097309a"}]}, {"source": "Biosynthesis of DPAn-6 SPMs", "value": 0.3071128122122555, "ngenes": 2, "max_val": 8.706, "rank": 2023.0, "id": "38f36a56-8e05-11ea-b3aa-5cf37097309a"}]}, {"source": "Synthesis of Lipoxins (LX)", "value": 0.5731573050831115, "ngenes": 8, "max_val": 8.706, "rank": 953.0, "id": "38f36a57-8e05-11ea-bb62-5cf37097309a"}]}, {"source": "Wax and plasmalogen biosynthesis", "value": 0.31979698022717656, "ngenes": 7, "max_val": 8.706, "rank": 1917.0, "id": "38f36a58-8e05-11ea-a159-5cf37097309a", "children": [{"source": "Plasmalogen biosynthesis", "value": 0.383122548138848, "ngenes": 3, "max_val": 8.706, "rank": 1579.0, "id": "38f36a59-8e05-11ea-bbcf-5cf37097309a"}, {"source": "Wax biosynthesis", "value": 0.3787761940540222, "ngenes": 4, "max_val": 8.706, "rank": 1586.0, "id": "38f36a5a-8e05-11ea-be8d-5cf37097309a"}]}, {"source": "Ketone body metabolism", "value": 0.3135746486533741, "ngenes": 11, "max_val": 8.706, "rank": 1971.0, "id": "38f36a5b-8e05-11ea-ba34-5cf37097309a", "children": [{"source": "Synthesis of Ketone Bodies", "value": 0.3592004814595621, "ngenes": 9, "max_val": 8.706, "rank": 1673.0, "id": "38f36a5c-8e05-11ea-b7c9-5cf37097309a"}, {"source": "Utilization of Ketone Bodies", "value": 0.3543975045465841, "ngenes": 5, "max_val": 8.706, "rank": 1720.0, "id": "38f36a5d-8e05-11ea-8cfe-5cf37097309a"}]}, {"source": "Lipid particle organization", "value": 0.33680443321456344, "ngenes": 7, "max_val": 8.706, "rank": 1817.0, "id": "38f36a5e-8e05-11ea-bbaa-5cf37097309a"}, {"source": "Regulation of lipid metabolism by PPARalpha", "value": 0.3272772875640805, "ngenes": 143, "max_val": 8.706, "rank": 1877.0, "id": "38f36a5f-8e05-11ea-859f-5cf37097309a", "children": [{"source": "PPARA activates gene expression", "value": 0.3229052919360341, "ngenes": 141, "max_val": 8.706, "rank": 1902.0, "id": "38f36a60-8e05-11ea-b36b-5cf37097309a"}]}]}, {"source": "Metabolism of amino acids and derivatives", "value": 0.37006877479975736, "ngenes": 422, "max_val": 8.706, "rank": 1620.0, "id": "38f36a61-8e05-11ea-83a6-5cf37097309a", "children": [{"source": "Glutamate and glutamine metabolism", "value": 2.8914757315633093, "ngenes": 15, "max_val": 8.706, "rank": 44.0, "id": "38f36a62-8e05-11ea-97b5-5cf37097309a"}, {"source": "Sulfur amino acid metabolism", "value": 0.4428091026226384, "ngenes": 30, "max_val": 8.706, "rank": 1289.0, "id": "38f36a63-8e05-11ea-b785-5cf37097309a", "children": [{"source": "Methionine salvage pathway", "value": 2.2449288700508485, "ngenes": 6, "max_val": 8.706, "rank": 106.0, "id": "38f36a64-8e05-11ea-a89b-5cf37097309a"}, {"source": "Degradation of cysteine and homocysteine", "value": 0.4129012734621538, "ngenes": 16, "max_val": 8.706, "rank": 1452.0, "id": "38f36a65-8e05-11ea-9435-5cf37097309a", "children": [{"source": "Sulfide oxidation to sulfate", "value": 0.4838070809976256, "ngenes": 7, "max_val": 8.706, "rank": 1144.0, "id": "38f36a66-8e05-11ea-a036-5cf37097309a"}]}, {"source": "Cysteine formation from homocysteine", "value": 0.3193822760013298, "ngenes": 3, "max_val": 8.706, "rank": 1920.0, "id": "38f36a67-8e05-11ea-9ebc-5cf37097309a"}]}, {"source": "Serine biosynthesis", "value": 1.7935735216480264, "ngenes": 9, "max_val": 8.706, "rank": 192.0, "id": "38f36a68-8e05-11ea-9790-5cf37097309a"}, {"source": "Metabolism of polyamines", "value": 0.721392241826102, "ngenes": 77, "max_val": 8.706, "rank": 741.0, "id": "38f36a69-8e05-11ea-afa5-5cf37097309a", "children": [{"source": "Interconversion of polyamines", "value": 1.2558574266990867, "ngenes": 3, "max_val": 8.706, "rank": 404.0, "id": "38f36a6a-8e05-11ea-9e7b-5cf37097309a"}, {"source": "Regulation of ornithine decarboxylase (ODC)", "value": 0.7476930723929579, "ngenes": 69, "max_val": 8.706, "rank": 709.0, "id": "38f36a6b-8e05-11ea-9d02-5cf37097309a"}, {"source": "Agmatine biosynthesis", "value": 0.4799169825852786, "ngenes": 2, "max_val": 8.706, "rank": 1152.0, "id": "38f36a6c-8e05-11ea-84ad-5cf37097309a"}]}, {"source": "Phenylalanine and tyrosine metabolism", "value": 0.36519026429481855, "ngenes": 11, "max_val": 8.706, "rank": 1643.0, "id": "38f36a6d-8e05-11ea-99e5-5cf37097309a", "children": [{"source": "Tyrosine catabolism", "value": 0.7625117359403885, "ngenes": 5, "max_val": 8.706, "rank": 691.0, "id": "38f36a6e-8e05-11ea-9bbb-5cf37097309a"}, {"source": "Phenylalanine metabolism", "value": 0.31470332622564146, "ngenes": 6, "max_val": 8.706, "rank": 1949.0, "id": "38f36a6f-8e05-11ea-9261-5cf37097309a"}]}, {"source": "Metabolism of amine-derived hormones", "value": 0.6445692907358854, "ngenes": 18, "max_val": 8.706, "rank": 837.0, "id": "38f36a70-8e05-11ea-87a0-5cf37097309a", "children": [{"source": "Thyroxine biosynthesis", "value": 1.6839357628617688, "ngenes": 10, "max_val": 8.706, "rank": 226.0, "id": "38f36a71-8e05-11ea-bb0f-5cf37097309a", "children": [{"source": "Regulation of thyroid hormone activity", "value": 0.6647834081114088, "ngenes": 3, "max_val": 8.706, "rank": 801.0, "id": "38f36a72-8e05-11ea-94bf-5cf37097309a"}]}, {"source": "Serotonin and melatonin biosynthesis", "value": 0.44227409954858976, "ngenes": 5, "max_val": 8.706, "rank": 1314.0, "id": "38f36a73-8e05-11ea-9c41-5cf37097309a"}, {"source": "Catecholamine biosynthesis", "value": 0.3692901478169492, "ngenes": 4, "max_val": 8.706, "rank": 1626.0, "id": "38f36a74-8e05-11ea-881f-5cf37097309a"}]}, {"source": "Alanine metabolism", "value": 0.5826614062625122, "ngenes": 2, "max_val": 8.706, "rank": 944.0, "id": "38f36a75-8e05-11ea-843d-5cf37097309a"}, {"source": "Urea cycle", "value": 0.5433031131756395, "ngenes": 11, "max_val": 8.706, "rank": 1028.0, "id": "38f36a76-8e05-11ea-9e29-5cf37097309a"}, {"source": "Glyoxylate metabolism and glycine degradation", "value": 0.8940666968669725, "ngenes": 31, "max_val": 8.706, "rank": 604.0, "id": "38f36a77-8e05-11ea-8d2a-5cf37097309a", "children": [{"source": "Glycine degradation", "value": 0.4865631200748303, "ngenes": 4, "max_val": 8.706, "rank": 1122.0, "id": "38f36a78-8e05-11ea-bae4-5cf37097309a"}]}, {"source": "Creatine metabolism", "value": 0.4237924916712859, "ngenes": 11, "max_val": 8.706, "rank": 1387.0, "id": "38f36a79-8e05-11ea-9665-5cf37097309a"}, {"source": "Choline catabolism", "value": 0.4201400939234678, "ngenes": 6, "max_val": 8.706, "rank": 1409.0, "id": "38f36a7a-8e05-11ea-941c-5cf37097309a"}, {"source": "Carnitine synthesis", "value": 0.4141343503713849, "ngenes": 4, "max_val": 8.706, "rank": 1443.0, "id": "38f36a7b-8e05-11ea-91c2-5cf37097309a"}, {"source": "Tryptophan catabolism", "value": 0.3967816616170723, "ngenes": 15, "max_val": 8.706, "rank": 1519.0, "id": "38f36a7c-8e05-11ea-b544-5cf37097309a"}, {"source": "Branched-chain amino acid catabolism", "value": 0.3925207713611613, "ngenes": 19, "max_val": 8.706, "rank": 1531.0, "id": "38f36a7d-8e05-11ea-ad8e-5cf37097309a"}, {"source": "Proline catabolism", "value": 0.3757183321003118, "ngenes": 3, "max_val": 8.706, "rank": 1599.0, "id": "38f36a7e-8e05-11ea-a17a-5cf37097309a"}, {"source": "Aspartate and asparagine metabolism", "value": 0.3646071303559334, "ngenes": 12, "max_val": 8.706, "rank": 1644.0, "id": "38f36a7f-8e05-11ea-b6bd-5cf37097309a"}, {"source": "Lysine catabolism", "value": 0.35647002589378085, "ngenes": 13, "max_val": 8.706, "rank": 1702.0, "id": "38f36a80-8e05-11ea-8b1a-5cf37097309a"}, {"source": "Melanin biosynthesis", "value": 0.33791596117958894, "ngenes": 5, "max_val": 8.706, "rank": 1807.0, "id": "38f36a81-8e05-11ea-8273-5cf37097309a"}, {"source": "Threonine catabolism", "value": 0.3363680139764464, "ngenes": 4, "max_val": 8.706, "rank": 1824.0, "id": "38f36a82-8e05-11ea-a348-5cf37097309a"}, {"source": "Selenoamino acid metabolism", "value": 0.3288714815669623, "ngenes": 136, "max_val": 8.706, "rank": 1873.0, "id": "38f36a83-8e05-11ea-b06a-5cf37097309a", "children": [{"source": "Metabolism of ingested SeMet, Sec, MeSec into H2Se", "value": 0.3226933204850961, "ngenes": 8, "max_val": 8.706, "rank": 1908.0, "id": "38f36a84-8e05-11ea-8722-5cf37097309a"}, {"source": "Selenocysteine synthesis", "value": 0.3128507621405376, "ngenes": 111, "max_val": 8.706, "rank": 1976.0, "id": "38f36a85-8e05-11ea-9fce-5cf37097309a"}, {"source": "Metabolism of ingested H2SeO4 and H2SeO3 into H2Se", "value": 0.3028939955380687, "ngenes": 4, "max_val": 8.706, "rank": 2052.0, "id": "38f36a86-8e05-11ea-8d9e-5cf37097309a"}]}, {"source": "Histidine catabolism", "value": 0.3135746486533741, "ngenes": 8, "max_val": 8.706, "rank": 1961.0, "id": "38f390e8-8e05-11ea-aa51-5cf37097309a"}]}, {"source": "Integration of energy metabolism", "value": 0.4851187072567963, "ngenes": 177, "max_val": 8.706, "rank": 1137.0, "id": "38f390e9-8e05-11ea-b6c0-5cf37097309a", "children": [{"source": "Glucagon signaling in metabolic regulation", "value": 0.33492726480858154, "ngenes": 36, "max_val": 8.706, "rank": 1830.0, "id": "38f390ea-8e05-11ea-afc2-5cf37097309a", "children": [{"source": "PKA activation in glucagon signalling", "value": 2.0619725442400907, "ngenes": 19, "max_val": 8.706, "rank": 123.0, "id": "38f390eb-8e05-11ea-abb3-5cf37097309a"}]}, {"source": "Regulation of insulin secretion", "value": 0.3574248285523114, "ngenes": 123, "max_val": 8.706, "rank": 1692.0, "id": "38f390ec-8e05-11ea-b9b8-5cf37097309a", "children": [{"source": "Acetylcholine regulates insulin secretion", "value": 1.9301960130704008, "ngenes": 17, "max_val": 8.706, "rank": 165.0, "id": "38f390ed-8e05-11ea-9bd4-5cf37097309a"}, {"source": "Free fatty acids regulate insulin secretion", "value": 0.6635767503826286, "ngenes": 18, "max_val": 8.706, "rank": 803.0, "id": "38f390ee-8e05-11ea-a3c1-5cf37097309a", "children": [{"source": "Intracellular metabolism of fatty acids regulates insulin secretion", "value": 0.7771640831272257, "ngenes": 3, "max_val": 8.706, "rank": 683.0, "id": "38f390ef-8e05-11ea-8628-5cf37097309a"}, {"source": "Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion", "value": 0.522429238388565, "ngenes": 15, "max_val": 8.706, "rank": 1043.0, "id": "38f390f0-8e05-11ea-9262-5cf37097309a"}]}, {"source": "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion", "value": 0.7499322965575571, "ngenes": 68, "max_val": 8.706, "rank": 704.0, "id": "38f390f1-8e05-11ea-9502-5cf37097309a"}, {"source": "Adrenaline,noradrenaline inhibits insulin secretion", "value": 0.3169714205734984, "ngenes": 50, "max_val": 8.706, "rank": 1935.0, "id": "38f390f2-8e05-11ea-a5fd-5cf37097309a"}]}, {"source": "AMPK inhibits chREBP transcriptional activation activity", "value": 1.657615261891164, "ngenes": 16, "max_val": 8.706, "rank": 237.0, "id": "38f390f3-8e05-11ea-98d4-5cf37097309a"}, {"source": "ChREBP activates metabolic gene expression", "value": 0.4647304025875293, "ngenes": 18, "max_val": 8.706, "rank": 1231.0, "id": "38f390f4-8e05-11ea-9084-5cf37097309a"}, {"source": "PKA-mediated phosphorylation of key metabolic factors", "value": 0.4416225578705676, "ngenes": 6, "max_val": 8.706, "rank": 1340.0, "id": "38f390f5-8e05-11ea-9806-5cf37097309a"}, {"source": "Insulin effects increased synthesis of Xylulose-5-Phosphate", "value": 0.4237924916712859, "ngenes": 2, "max_val": 8.706, "rank": 1394.0, "id": "38f390f6-8e05-11ea-8420-5cf37097309a"}, {"source": "PP2A-mediated dephosphorylation of key metabolic factors", "value": 0.4143568490855231, "ngenes": 7, "max_val": 8.706, "rank": 1442.0, "id": "38f390f7-8e05-11ea-a767-5cf37097309a"}]}, {"source": "Reversible hydration of carbon dioxide", "value": 1.8914017356331347, "ngenes": 12, "max_val": 8.706, "rank": 178.0, "id": "38f390f8-8e05-11ea-b01b-5cf37097309a"}, {"source": "Metabolism of carbohydrates", "value": 0.3105368164831691, "ngenes": 323, "max_val": 8.706, "rank": 2000.0, "id": "38f390f9-8e05-11ea-9703-5cf37097309a", "children": [{"source": "Glycosaminoglycan metabolism", "value": 0.3058941684179461, "ngenes": 139, "max_val": 8.706, "rank": 2026.0, "id": "38f390fa-8e05-11ea-a877-5cf37097309a", "children": [{"source": "Hyaluronan metabolism", "value": 1.1348126759327422, "ngenes": 17, "max_val": 8.706, "rank": 471.0, "id": "38f390fb-8e05-11ea-86df-5cf37097309a", "children": [{"source": "Hyaluronan uptake and degradation", "value": 1.8602783625439252, "ngenes": 12, "max_val": 8.706, "rank": 183.0, "id": "38f390fc-8e05-11ea-8b1d-5cf37097309a"}, {"source": "Hyaluronan biosynthesis and export", "value": 0.4237924916712859, "ngenes": 5, "max_val": 8.706, "rank": 1393.0, "id": "38f390fd-8e05-11ea-96ec-5cf37097309a"}]}, {"source": "Chondroitin sulfate/dermatan sulfate metabolism", "value": 0.7135917989205224, "ngenes": 52, "max_val": 8.706, "rank": 752.0, "id": "38f390fe-8e05-11ea-9db3-5cf37097309a", "children": [{"source": "Chondroitin sulfate biosynthesis", "value": 1.3587138740441582, "ngenes": 20, "max_val": 8.706, "rank": 368.0, "id": "38f390ff-8e05-11ea-a454-5cf37097309a"}, {"source": "Dermatan sulfate biosynthesis", "value": 1.187463899996147, "ngenes": 12, "max_val": 8.706, "rank": 446.0, "id": "38f39100-8e05-11ea-8701-5cf37097309a"}, {"source": "A tetrasaccharide linker sequence is required for GAG synthesis", "value": 0.6783032359193764, "ngenes": 27, "max_val": 8.706, "rank": 776.0, "id": "38f39101-8e05-11ea-8d07-5cf37097309a"}, {"source": "CS/DS degradation", "value": 0.4627309951511139, "ngenes": 14, "max_val": 8.706, "rank": 1248.0, "id": "38f39102-8e05-11ea-8309-5cf37097309a"}]}, {"source": "Heparan sulfate/heparin (HS-GAG) metabolism", "value": 0.3483210271800589, "ngenes": 69, "max_val": 8.706, "rank": 1763.0, "id": "38f39103-8e05-11ea-9cb2-5cf37097309a", "children": [{"source": "A tetrasaccharide linker sequence is required for GAG synthesis", "value": 0.6783032359193764, "ngenes": 27, "max_val": 8.706, "rank": 776.0, "id": "38f39104-8e05-11ea-bc37-5cf37097309a"}, {"source": "HS-GAG biosynthesis", "value": 0.5208914706784245, "ngenes": 44, "max_val": 8.706, "rank": 1045.0, "id": "38f39105-8e05-11ea-9040-5cf37097309a"}, {"source": "HS-GAG degradation", "value": 0.4689265375340588, "ngenes": 22, "max_val": 8.706, "rank": 1218.0, "id": "38f39106-8e05-11ea-ae77-5cf37097309a"}]}, {"source": "Keratan sulfate/keratin metabolism", "value": 0.44227409954858976, "ngenes": 34, "max_val": 8.706, "rank": 1291.0, "id": "38f39107-8e05-11ea-ba31-5cf37097309a", "children": [{"source": "Keratan sulfate biosynthesis", "value": 0.5677987949361472, "ngenes": 28, "max_val": 8.706, "rank": 959.0, "id": "38f39108-8e05-11ea-a445-5cf37097309a"}, {"source": "Keratan sulfate degradation", "value": 0.3478031390103817, "ngenes": 13, "max_val": 8.706, "rank": 1765.0, "id": "38f39109-8e05-11ea-91b3-5cf37097309a"}]}, {"source": "Transport and synthesis of PAPS", "value": 0.4166701851996452, "ngenes": 6, "max_val": 8.706, "rank": 1422.0, "id": "38f3910a-8e05-11ea-9c66-5cf37097309a"}]}, {"source": "Fructose metabolism", "value": 1.063803245003592, "ngenes": 7, "max_val": 8.706, "rank": 496.0, "id": "38f3910b-8e05-11ea-985e-5cf37097309a", "children": [{"source": "Fructose biosynthesis", "value": 1.3931404119354651, "ngenes": 2, "max_val": 8.706, "rank": 355.0, "id": "38f3910c-8e05-11ea-8ce9-5cf37097309a"}, {"source": "Fructose catabolism", "value": 0.3169714205734984, "ngenes": 5, "max_val": 8.706, "rank": 1937.0, "id": "38f3910d-8e05-11ea-8d09-5cf37097309a"}]}, {"source": "Formation of xylulose-5-phosphate", "value": 1.0230929066990757, "ngenes": 5, "max_val": 8.706, "rank": 539.0, "id": "38f3910e-8e05-11ea-bea1-5cf37097309a"}, {"source": "Glycogen metabolism", "value": 0.5889912856481021, "ngenes": 33, "max_val": 8.706, "rank": 936.0, "id": "38f3910f-8e05-11ea-80b3-5cf37097309a", "children": [{"source": "Glycogen synthesis", "value": 0.6348430454009657, "ngenes": 16, "max_val": 8.706, "rank": 858.0, "id": "38f39110-8e05-11ea-a3d0-5cf37097309a"}, {"source": "Glycogen breakdown (glycogenolysis)", "value": 0.5519775888320267, "ngenes": 21, "max_val": 8.706, "rank": 989.0, "id": "38f39111-8e05-11ea-a558-5cf37097309a"}]}, {"source": "Lactose synthesis", "value": 0.6252084740540722, "ngenes": 3, "max_val": 8.706, "rank": 880.0, "id": "38f39112-8e05-11ea-bfd2-5cf37097309a"}, {"source": "Glucose metabolism", "value": 0.34370110533546, "ngenes": 97, "max_val": 8.706, "rank": 1776.0, "id": "38f39113-8e05-11ea-840c-5cf37097309a", "children": [{"source": "Gluconeogenesis", "value": 0.4773766239854317, "ngenes": 36, "max_val": 8.706, "rank": 1178.0, "id": "38f39114-8e05-11ea-a53c-5cf37097309a"}, {"source": "Glycolysis", "value": 0.42910731206928376, "ngenes": 75, "max_val": 8.706, "rank": 1367.0, "id": "38f39115-8e05-11ea-aa85-5cf37097309a", "children": [{"source": "Regulation of glycolysis by fructose 2,6-bisphosphate metabolism", "value": 0.44227409954858976, "ngenes": 13, "max_val": 8.706, "rank": 1305.0, "id": "38f39116-8e05-11ea-baf6-5cf37097309a"}, {"source": "Regulation of Glucokinase by Glucokinase Regulatory Protein", "value": 0.30831601652699897, "ngenes": 33, "max_val": 8.706, "rank": 2012.0, "id": "38f39117-8e05-11ea-a01e-5cf37097309a"}]}]}, {"source": "Galactose catabolism", "value": 0.4364096796909963, "ngenes": 5, "max_val": 8.706, "rank": 1355.0, "id": "38f39118-8e05-11ea-a985-5cf37097309a"}, {"source": "Pentose phosphate pathway", "value": 0.44227409954858976, "ngenes": 15, "max_val": 8.706, "rank": 1312.0, "id": "38f39119-8e05-11ea-b112-5cf37097309a", "children": [{"source": "5-Phosphoribose 1-diphosphate biosynthesis", "value": 0.40296808805944107, "ngenes": 3, "max_val": 8.706, "rank": 1489.0, "id": "38f3911a-8e05-11ea-a7e3-5cf37097309a"}]}, {"source": "Blood group systems biosynthesis", "value": 0.32392824775404444, "ngenes": 25, "max_val": 8.706, "rank": 1897.0, "id": "38f3911b-8e05-11ea-829a-5cf37097309a", "children": [{"source": "Rhesus blood group biosynthesis", "value": 0.3473777131540049, "ngenes": 2, "max_val": 8.706, "rank": 1768.0, "id": "38f3911c-8e05-11ea-a0c6-5cf37097309a"}, {"source": "ABO blood group biosynthesis", "value": 0.3416738873259401, "ngenes": 2, "max_val": 8.706, "rank": 1782.0, "id": "38f3911d-8e05-11ea-8417-5cf37097309a"}, {"source": "Lewis blood group biosynthesis", "value": 0.3147920311767596, "ngenes": 22, "max_val": 8.706, "rank": 1948.0, "id": "38f3911e-8e05-11ea-91bb-5cf37097309a"}]}, {"source": "Lysosomal oligosaccharide catabolism", "value": 0.3272772875640805, "ngenes": 4, "max_val": 8.706, "rank": 1889.0, "id": "38f3911f-8e05-11ea-be98-5cf37097309a"}]}, {"source": "Metabolism of nucleotides", "value": 0.6110274058194686, "ngenes": 102, "max_val": 8.706, "rank": 903.0, "id": "38f39120-8e05-11ea-add6-5cf37097309a", "children": [{"source": "Interconversion of nucleotide di- and triphosphates", "value": 1.7839265397441235, "ngenes": 30, "max_val": 8.706, "rank": 199.0, "id": "38f39121-8e05-11ea-9ad9-5cf37097309a"}, {"source": "Nucleobase catabolism", "value": 0.3033556517187352, "ngenes": 36, "max_val": 8.706, "rank": 2051.0, "id": "38f39122-8e05-11ea-96e3-5cf37097309a", "children": [{"source": "Pyrimidine catabolism", "value": 1.187463899996147, "ngenes": 12, "max_val": 8.706, "rank": 445.0, "id": "38f39123-8e05-11ea-8afa-5cf37097309a"}, {"source": "Purine catabolism", "value": 0.3128507621405376, "ngenes": 18, "max_val": 8.706, "rank": 1975.0, "id": "38f39124-8e05-11ea-bc38-5cf37097309a", "children": [{"source": "Phosphate bond hydrolysis by NUDT proteins", "value": 0.3810678621512812, "ngenes": 7, "max_val": 8.706, "rank": 1582.0, "id": "38f39125-8e05-11ea-abcf-5cf37097309a"}]}, {"source": "Phosphate bond hydrolysis by NTPDase proteins", "value": 0.3513971844420395, "ngenes": 8, "max_val": 8.706, "rank": 1729.0, "id": "38f39126-8e05-11ea-9a4d-5cf37097309a"}]}, {"source": "Nucleobase biosynthesis", "value": 0.4788365094295219, "ngenes": 16, "max_val": 8.706, "rank": 1160.0, "id": "38f39127-8e05-11ea-b147-5cf37097309a", "children": [{"source": "Purine ribonucleoside monophosphate biosynthesis", "value": 0.5084880631396131, "ngenes": 13, "max_val": 8.706, "rank": 1075.0, "id": "38f39128-8e05-11ea-9ce7-5cf37097309a"}, {"source": "Pyrimidine biosynthesis", "value": 0.3272772875640805, "ngenes": 3, "max_val": 8.706, "rank": 1886.0, "id": "38f39129-8e05-11ea-b8f2-5cf37097309a"}]}, {"source": "Nucleotide salvage", "value": 0.3967816616170723, "ngenes": 24, "max_val": 8.706, "rank": 1520.0, "id": "38f3912a-8e05-11ea-9c19-5cf37097309a", "children": [{"source": "Pyrimidine salvage", "value": 0.4249767972057781, "ngenes": 11, "max_val": 8.706, "rank": 1382.0, "id": "38f3912b-8e05-11ea-bfbc-5cf37097309a"}, {"source": "Purine salvage", "value": 0.3483210271800589, "ngenes": 14, "max_val": 8.706, "rank": 1749.0, "id": "38f3912c-8e05-11ea-9676-5cf37097309a"}]}]}, {"source": "The citric acid (TCA) cycle and respiratory electron transport", "value": 1.3704942770307549, "ngenes": 189, "max_val": 8.706, "rank": 360.0, "id": "38f3912d-8e05-11ea-9f87-5cf37097309a", "children": [{"source": "Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.", "value": 1.5115534898118657, "ngenes": 133, "max_val": 8.706, "rank": 315.0, "id": "38f3912e-8e05-11ea-8233-5cf37097309a", "children": [{"source": "Respiratory electron transport", "value": 1.6383002223565075, "ngenes": 110, "max_val": 8.706, "rank": 244.0, "id": "38f3912f-8e05-11ea-9f5a-5cf37097309a", "children": [{"source": "Complex I biogenesis", "value": 1.7253941578024832, "ngenes": 63, "max_val": 8.706, "rank": 210.0, "id": "38f39130-8e05-11ea-a40c-5cf37097309a"}]}, {"source": "Formation of ATP by chemiosmotic coupling", "value": 1.1836221177273651, "ngenes": 18, "max_val": 8.706, "rank": 447.0, "id": "38f39131-8e05-11ea-a408-5cf37097309a"}, {"source": "Mitochondrial Uncoupling Proteins", "value": 0.4990868904375801, "ngenes": 5, "max_val": 8.706, "rank": 1099.0, "id": "38f39132-8e05-11ea-b0f0-5cf37097309a", "children": [{"source": "The proton buffering model", "value": 0.4990868904375801, "ngenes": 5, "max_val": 8.706, "rank": 1098.0, "id": "38f39133-8e05-11ea-8f44-5cf37097309a"}, {"source": "The fatty acid cycling model", "value": 0.4970792093307619, "ngenes": 5, "max_val": 8.706, "rank": 1101.0, "id": "38f39134-8e05-11ea-82e3-5cf37097309a"}]}]}, {"source": "Pyruvate metabolism and Citric Acid (TCA) cycle", "value": 0.4704952658544049, "ngenes": 56, "max_val": 8.706, "rank": 1204.0, "id": "38f39135-8e05-11ea-aa27-5cf37097309a", "children": [{"source": "Pyruvate metabolism", "value": 0.4704952658544049, "ngenes": 32, "max_val": 8.706, "rank": 1201.0, "id": "38f39136-8e05-11ea-942b-5cf37097309a", "children": [{"source": "Regulation of pyruvate dehydrogenase (PDH) complex", "value": 0.5691521675585234, "ngenes": 16, "max_val": 8.706, "rank": 958.0, "id": "38f39137-8e05-11ea-be8f-5cf37097309a"}]}, {"source": "Interconversion of 2-oxoglutarate and 2-hydroxyglutarate", "value": 0.4249767972057781, "ngenes": 3, "max_val": 8.706, "rank": 1383.0, "id": "38f39138-8e05-11ea-9674-5cf37097309a"}, {"source": "Citric acid cycle (TCA cycle)", "value": 0.3272772875640805, "ngenes": 22, "max_val": 8.706, "rank": 1881.0, "id": "38f39139-8e05-11ea-a2de-5cf37097309a"}]}]}, {"source": "Metabolism of vitamins and cofactors", "value": 1.462901731367718, "ngenes": 211, "max_val": 8.706, "rank": 331.0, "id": "38f3913a-8e05-11ea-b460-5cf37097309a", "children": [{"source": "Metabolism of water-soluble vitamins and cofactors", "value": 1.0660199883512147, "ngenes": 131, "max_val": 8.706, "rank": 491.0, "id": "38f3913b-8e05-11ea-a9db-5cf37097309a", "children": [{"source": "Vitamin C (ascorbate) metabolism", "value": 1.5252073611613504, "ngenes": 8, "max_val": 8.706, "rank": 303.0, "id": "38f3913c-8e05-11ea-9754-5cf37097309a"}, {"source": "Nicotinate metabolism", "value": 0.9914712729302528, "ngenes": 33, "max_val": 8.706, "rank": 550.0, "id": "38f3913d-8e05-11ea-8ee0-5cf37097309a", "children": [{"source": "Nicotinamide salvaging", "value": 1.1267411192284258, "ngenes": 21, "max_val": 8.706, "rank": 477.0, "id": "38f3913e-8e05-11ea-8c92-5cf37097309a"}]}, {"source": "Vitamin B1 (thiamin) metabolism", "value": 1.1193635366216188, "ngenes": 6, "max_val": 8.706, "rank": 482.0, "id": "38f3913f-8e05-11ea-8c6e-5cf37097309a"}, {"source": "Biotin transport and metabolism", "value": 0.6304775359935061, "ngenes": 12, "max_val": 8.706, "rank": 868.0, "id": "38f39140-8e05-11ea-8558-5cf37097309a"}, {"source": "Molybdenum cofactor biosynthesis", "value": 0.5888563173343263, "ngenes": 6, "max_val": 8.706, "rank": 937.0, "id": "38f39141-8e05-11ea-960a-5cf37097309a"}, {"source": "Vitamin B2 (riboflavin) metabolism", "value": 0.4865631200748303, "ngenes": 8, "max_val": 8.706, "rank": 1135.0, "id": "38f39142-8e05-11ea-b6cf-5cf37097309a"}, {"source": "Metabolism of folate and pterines", "value": 0.4850737434907887, "ngenes": 17, "max_val": 8.706, "rank": 1140.0, "id": "38f39143-8e05-11ea-9184-5cf37097309a"}, {"source": "Cobalamin (Cbl, vitamin B12) transport and metabolism", "value": 0.4086960495026968, "ngenes": 23, "max_val": 8.706, "rank": 1460.0, "id": "38f39144-8e05-11ea-863d-5cf37097309a"}, {"source": "Vitamins B6 activation to pyridoxal phosphate", "value": 0.3984289558542966, "ngenes": 3, "max_val": 8.706, "rank": 1508.0, "id": "38f39145-8e05-11ea-be01-5cf37097309a"}, {"source": "Vitamin B5 (pantothenate) metabolism", "value": 0.5471840327551817, "ngenes": 18, "max_val": 8.706, "rank": 1001.0, "id": "38f39146-8e05-11ea-befc-5cf37097309a", "children": [{"source": "Coenzyme A biosynthesis", "value": 0.3333488691934495, "ngenes": 9, "max_val": 8.706, "rank": 1839.0, "id": "38f39147-8e05-11ea-b4c8-5cf37097309a"}]}]}, {"source": "Metabolism of cofactors", "value": 0.6125658117352507, "ngenes": 19, "max_val": 8.706, "rank": 900.0, "id": "38f39148-8e05-11ea-9219-5cf37097309a", "children": [{"source": "Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation", "value": 1.0810802943177429, "ngenes": 10, "max_val": 8.706, "rank": 486.0, "id": "38f39149-8e05-11ea-8ac7-5cf37097309a"}, {"source": "Ubiquinol biosynthesis", "value": 0.3911487587762643, "ngenes": 8, "max_val": 8.706, "rank": 1535.0, "id": "38f3914a-8e05-11ea-8621-5cf37097309a"}]}, {"source": "Metabolism of fat-soluble vitamins", "value": 0.3483210271800589, "ngenes": 61, "max_val": 8.706, "rank": 1754.0, "id": "38f3914b-8e05-11ea-89d1-5cf37097309a", "children": [{"source": "Metabolism of vitamin K", "value": 0.4477729164886938, "ngenes": 3, "max_val": 8.706, "rank": 1279.0, "id": "38f3914c-8e05-11ea-a98b-5cf37097309a"}, {"source": "Retinoid metabolism and transport", "value": 0.34147347350479673, "ngenes": 57, "max_val": 8.706, "rank": 1788.0, "id": "38f3914d-8e05-11ea-91d0-5cf37097309a"}]}]}, {"source": "Abacavir transport and metabolism", "value": 0.4129012734621538, "ngenes": 10, "max_val": 8.706, "rank": 1454.0, "id": "38f3914e-8e05-11ea-b5ff-5cf37097309a", "children": [{"source": "Abacavir transmembrane transport", "value": 1.4426566730786436, "ngenes": 5, "max_val": 8.706, "rank": 336.0, "id": "38f3914f-8e05-11ea-b6a1-5cf37097309a"}, {"source": "Abacavir metabolism", "value": 0.3483210271800589, "ngenes": 5, "max_val": 8.706, "rank": 1761.0, "id": "38f39150-8e05-11ea-8efa-5cf37097309a"}]}, {"source": "Biological oxidations", "value": 0.38526349105618296, "ngenes": 233, "max_val": 8.706, "rank": 1556.0, "id": "38f39151-8e05-11ea-b097-5cf37097309a", "children": [{"source": "Phase I - Functionalization of compounds", "value": 0.7351803864773258, "ngenes": 112, "max_val": 8.706, "rank": 721.0, "id": "38f39152-8e05-11ea-a5f6-5cf37097309a", "children": [{"source": "Cytochrome P450 - arranged by substrate type", "value": 0.44227409954858976, "ngenes": 71, "max_val": 8.706, "rank": 1307.0, "id": "38f39153-8e05-11ea-92a0-5cf37097309a", "children": [{"source": "Vitamins", "value": 1.2809833691874195, "ngenes": 6, "max_val": 8.706, "rank": 394.0, "id": "38f39154-8e05-11ea-b54f-5cf37097309a"}, {"source": "Endogenous sterols", "value": 0.37629990676095454, "ngenes": 32, "max_val": 8.706, "rank": 1596.0, "id": "38f39155-8e05-11ea-b285-5cf37097309a", "children": [{"source": "Sterols are 12-hydroxylated by CYP8B1", "value": 0.8763111881572679, "ngenes": 2, "max_val": 8.706, "rank": 618.0, "id": "38f39156-8e05-11ea-a361-5cf37097309a"}]}, {"source": "Fatty acids", "value": 0.3942103998739486, "ngenes": 16, "max_val": 8.706, "rank": 1528.0, "id": "38f39157-8e05-11ea-91e0-5cf37097309a"}, {"source": "Eicosanoids", "value": 0.3849420497242914, "ngenes": 12, "max_val": 8.706, "rank": 1562.0, "id": "38f39158-8e05-11ea-914d-5cf37097309a"}, {"source": "Xenobiotics", "value": 0.4646123127797776, "ngenes": 25, "max_val": 8.706, "rank": 1240.0, "id": "38f39159-8e05-11ea-8289-5cf37097309a", "children": [{"source": "CYP2E1 reactions", "value": 0.3543975045465841, "ngenes": 12, "max_val": 8.706, "rank": 1723.0, "id": "38f3915a-8e05-11ea-bb5e-5cf37097309a"}]}, {"source": "Miscellaneous substrates", "value": 0.3272772875640805, "ngenes": 13, "max_val": 8.706, "rank": 1883.0, "id": "38f3915b-8e05-11ea-afff-5cf37097309a"}]}, {"source": "Ethanol oxidation", "value": 1.2169560989631576, "ngenes": 12, "max_val": 8.706, "rank": 417.0, "id": "38f3915c-8e05-11ea-8f7a-5cf37097309a"}, {"source": "Amine Oxidase reactions", "value": 0.5060922776015859, "ngenes": 4, "max_val": 8.706, "rank": 1084.0, "id": "38f3915d-8e05-11ea-ade9-5cf37097309a", "children": [{"source": "PAOs oxidise polyamines to amines", "value": 0.9040451189857748, "ngenes": 2, "max_val": 8.706, "rank": 601.0, "id": "38f3915e-8e05-11ea-b0c9-5cf37097309a"}, {"source": "Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB", "value": 0.5111620186862319, "ngenes": 2, "max_val": 8.706, "rank": 1059.0, "id": "38f3915f-8e05-11ea-8a7f-5cf37097309a"}]}, {"source": "FMO oxidises nucleophiles", "value": 0.86492840468403, "ngenes": 3, "max_val": 8.706, "rank": 628.0, "id": "38f39160-8e05-11ea-8254-5cf37097309a"}, {"source": "Aryl hydrocarbon receptor signalling", "value": 0.406467316447748, "ngenes": 7, "max_val": 8.706, "rank": 1464.0, "id": "38f39161-8e05-11ea-9287-5cf37097309a"}]}, {"source": "Aflatoxin activation and detoxification", "value": 1.0596970515135842, "ngenes": 20, "max_val": 8.706, "rank": 502.0, "id": "38f39162-8e05-11ea-b857-5cf37097309a"}, {"source": "Phase II - Conjugation of compounds", "value": 0.4165866033279961, "ngenes": 114, "max_val": 8.706, "rank": 1433.0, "id": "38f39163-8e05-11ea-aff1-5cf37097309a", "children": [{"source": "Amino Acid conjugation", "value": 0.31736890900082704, "ngenes": 9, "max_val": 8.706, "rank": 1931.0, "id": "38f39164-8e05-11ea-88ca-5cf37097309a", "children": [{"source": "Conjugation of carboxylic acids", "value": 0.31843317641013524, "ngenes": 9, "max_val": 8.706, "rank": 1928.0, "id": "38f39165-8e05-11ea-916c-5cf37097309a", "children": [{"source": "Conjugation of phenylacetate with glutamine", "value": 0.44592139269503495, "ngenes": 2, "max_val": 8.706, "rank": 1280.0, "id": "38f39166-8e05-11ea-923c-5cf37097309a"}, {"source": "Conjugation of salicylate with glycine", "value": 0.3789602593706693, "ngenes": 8, "max_val": 8.706, "rank": 1583.0, "id": "38f39167-8e05-11ea-95b7-5cf37097309a"}, {"source": "Conjugation of benzoate with glycine", "value": 0.3663505507769889, "ngenes": 6, "max_val": 8.706, "rank": 1630.0, "id": "38f39168-8e05-11ea-9830-5cf37097309a"}]}]}, {"source": "Cytosolic sulfonation of small molecules", "value": 0.3054119582193906, "ngenes": 24, "max_val": 8.706, "rank": 2031.0, "id": "38f39169-8e05-11ea-802c-5cf37097309a", "children": [{"source": "Transport and synthesis of PAPS", "value": 0.4166701851996452, "ngenes": 6, "max_val": 8.706, "rank": 1422.0, "id": "38f3916a-8e05-11ea-8419-5cf37097309a"}]}, {"source": "Methylation", "value": 0.3608306486501528, "ngenes": 14, "max_val": 8.706, "rank": 1663.0, "id": "38f3916b-8e05-11ea-89b8-5cf37097309a"}, {"source": "Glucuronidation", "value": 0.4808199864692593, "ngenes": 27, "max_val": 8.706, "rank": 1148.0, "id": "38f3916c-8e05-11ea-8930-5cf37097309a", "children": [{"source": "Formation of the active cofactor, UDP-glucuronate", "value": 0.33680443321456344, "ngenes": 3, "max_val": 8.706, "rank": 1819.0, "id": "38f3916d-8e05-11ea-951d-5cf37097309a"}]}, {"source": "Acetylation", "value": 0.32392824775404444, "ngenes": 2, "max_val": 8.706, "rank": 1896.0, "id": "38f3916e-8e05-11ea-a00f-5cf37097309a"}, {"source": "Glutathione conjugation", "value": 0.3984289558542966, "ngenes": 39, "max_val": 8.706, "rank": 1504.0, "id": "38f3916f-8e05-11ea-aeb4-5cf37097309a", "children": [{"source": "Glutathione synthesis and recycling", "value": 0.3050811988978337, "ngenes": 13, "max_val": 8.706, "rank": 2034.0, "id": "38f39170-8e05-11ea-a1c9-5cf37097309a"}]}]}]}, {"source": "Metabolism of nitric oxide: eNOS activation and regulation", "value": 0.33871289172223634, "ngenes": 21, "max_val": 8.706, "rank": 1801.0, "id": "38f39171-8e05-11ea-9a47-5cf37097309a", "children": [{"source": "NOSIP mediated eNOS trafficking", "value": 1.1927360947461465, "ngenes": 2, "max_val": 8.706, "rank": 441.0, "id": "38f39172-8e05-11ea-8152-5cf37097309a"}, {"source": "eNOS activation", "value": 0.3586028553859912, "ngenes": 17, "max_val": 8.706, "rank": 1681.0, "id": "38f39173-8e05-11ea-8476-5cf37097309a"}, {"source": "NOSTRIN mediated eNOS trafficking", "value": 0.33832512665576203, "ngenes": 5, "max_val": 8.706, "rank": 1805.0, "id": "38f39174-8e05-11ea-b5bb-5cf37097309a"}]}, {"source": "Cytosolic iron-sulfur cluster assembly", "value": 0.5565507266078732, "ngenes": 13, "max_val": 8.706, "rank": 977.0, "id": "38f39175-8e05-11ea-a02d-5cf37097309a"}, {"source": "Metabolism of porphyrins", "value": 0.8217754390035673, "ngenes": 29, "max_val": 8.706, "rank": 646.0, "id": "38f39176-8e05-11ea-8fe5-5cf37097309a", "children": [{"source": "Heme degradation", "value": 0.4477729164886938, "ngenes": 16, "max_val": 8.706, "rank": 1278.0, "id": "38f39177-8e05-11ea-9da6-5cf37097309a"}, {"source": "Heme biosynthesis", "value": 0.4381517822180467, "ngenes": 15, "max_val": 8.706, "rank": 1346.0, "id": "38f3b7e4-8e05-11ea-ab5a-5cf37097309a"}]}, {"source": "Pyrophosphate hydrolysis", "value": 0.35647002589378085, "ngenes": 2, "max_val": 8.706, "rank": 1700.0, "id": "38f3b7e5-8e05-11ea-adf7-5cf37097309a"}, {"source": "Mitochondrial iron-sulfur cluster biogenesis", "value": 0.7476791996962816, "ngenes": 13, "max_val": 8.706, "rank": 710.0, "id": "38f3b7e6-8e05-11ea-a17f-5cf37097309a", "children": [{"source": "Electron transport from NADPH to Ferredoxin", "value": 0.3483210271800589, "ngenes": 3, "max_val": 8.706, "rank": 1744.0, "id": "38f3b7e7-8e05-11ea-8b9d-5cf37097309a"}]}]}, {"source": "Neuronal System", "value": 1.0729001168503527, "ngenes": 530, "max_val": 8.706, "rank": 489.0, "id": "38f3b7e8-8e05-11ea-8c6d-5cf37097309a", "children": [{"source": "Potassium Channels", "value": 0.3543975045465841, "ngenes": 108, "max_val": 8.706, "rank": 1725.0, "id": "38f3b7e9-8e05-11ea-971d-5cf37097309a", "children": [{"source": "Ca2+ activated K+ channels", "value": 3.887370245076865, "ngenes": 9, "max_val": 8.706, "rank": 9.0, "id": "38f3b7ea-8e05-11ea-80d2-5cf37097309a"}, {"source": "Inwardly rectifying K+ channels", "value": 0.4070349062071831, "ngenes": 38, "max_val": 8.706, "rank": 1462.0, "id": "38f3b7eb-8e05-11ea-9377-5cf37097309a", "children": [{"source": "ATP sensitive Potassium channels", "value": 0.7625117359403885, "ngenes": 4, "max_val": 8.706, "rank": 690.0, "id": "38f3b7ec-8e05-11ea-bfe6-5cf37097309a"}, {"source": "Classical Kir channels", "value": 0.6546837086397028, "ngenes": 4, "max_val": 8.706, "rank": 819.0, "id": "38f3b7ed-8e05-11ea-a8e7-5cf37097309a"}, {"source": "G protein gated Potassium channels", "value": 0.5202675432027881, "ngenes": 32, "max_val": 8.706, "rank": 1048.0, "id": "38f3b7ee-8e05-11ea-b8f0-5cf37097309a", "children": [{"source": "Activation of G protein gated Potassium channels", "value": 0.522429238388565, "ngenes": 32, "max_val": 8.706, "rank": 1044.0, "id": "38f3b7ef-8e05-11ea-94a9-5cf37097309a"}]}, {"source": "Potassium transport channels", "value": 0.4151266266704886, "ngenes": 3, "max_val": 8.706, "rank": 1438.0, "id": "38f3b7f0-8e05-11ea-8ae8-5cf37097309a"}]}, {"source": "Tandem pore domain potassium channels", "value": 0.3135746486533741, "ngenes": 12, "max_val": 8.706, "rank": 1966.0, "id": "38f3b7f1-8e05-11ea-b79f-5cf37097309a", "children": [{"source": "Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)", "value": 0.6578857562816522, "ngenes": 3, "max_val": 8.706, "rank": 814.0, "id": "38f3b7f2-8e05-11ea-a32d-5cf37097309a"}, {"source": "TWIK-releated acid-sensitive K+ channel (TASK)", "value": 0.5482687043601833, "ngenes": 2, "max_val": 8.706, "rank": 994.0, "id": "38f3b7f3-8e05-11ea-bcb0-5cf37097309a"}, {"source": "TWIK-related alkaline pH activated K+ channel (TALK)", "value": 0.4393366400540071, "ngenes": 2, "max_val": 8.706, "rank": 1343.0, "id": "38f3b7f4-8e05-11ea-aea1-5cf37097309a"}, {"source": "TWIK related potassium channel (TREK)", "value": 0.32630520522342715, "ngenes": 3, "max_val": 8.706, "rank": 1892.0, "id": "38f3b7f5-8e05-11ea-9241-5cf37097309a"}]}, {"source": "HCN channels", "value": 0.4129012734621538, "ngenes": 5, "max_val": 8.706, "rank": 1450.0, "id": "38f3b7f6-8e05-11ea-991d-5cf37097309a"}, {"source": "Voltage gated Potassium channels", "value": 0.36097557694506893, "ngenes": 44, "max_val": 8.706, "rank": 1655.0, "id": "38f3b7f7-8e05-11ea-a7f5-5cf37097309a"}]}, {"source": "Protein-protein interactions at synapses", "value": 1.3587138740441582, "ngenes": 125, "max_val": 8.706, "rank": 370.0, "id": "38f3b7f8-8e05-11ea-aab3-5cf37097309a", "children": [{"source": "Neurexins and neuroligins", "value": 2.004174553739853, "ngenes": 84, "max_val": 8.706, "rank": 134.0, "id": "38f3b7f9-8e05-11ea-9539-5cf37097309a"}, {"source": "Synaptic adhesion-like molecules", "value": 0.7657798574682171, "ngenes": 26, "max_val": 8.706, "rank": 688.0, "id": "38f3b7fa-8e05-11ea-aaca-5cf37097309a"}, {"source": "Receptor-type tyrosine-protein phosphatases", "value": 0.33680443321456344, "ngenes": 21, "max_val": 8.706, "rank": 1820.0, "id": "38f3b7fb-8e05-11ea-bb76-5cf37097309a"}]}, {"source": "Transmission across Chemical Synapses", "value": 0.6569571172567668, "ngenes": 355, "max_val": 8.706, "rank": 816.0, "id": "38f3b7fc-8e05-11ea-8556-5cf37097309a", "children": [{"source": "Neurotransmitter receptors and postsynaptic signal transmission", "value": 0.4704087176438319, "ngenes": 283, "max_val": 8.706, "rank": 1210.0, "id": "38f3b7fd-8e05-11ea-b211-5cf37097309a", "children": [{"source": "Glutamate binding, activation of AMPA receptors and synaptic plasticity", "value": 1.2746557905721092, "ngenes": 33, "max_val": 8.706, "rank": 397.0, "id": "38f3b7fe-8e05-11ea-a292-5cf37097309a", "children": [{"source": "Trafficking of AMPA receptors", "value": 1.2746557905721092, "ngenes": 33, "max_val": 8.706, "rank": 398.0, "id": "38f3b7ff-8e05-11ea-8c8e-5cf37097309a", "children": [{"source": "Trafficking of GluR2-containing AMPA receptors", "value": 1.6274809485325372, "ngenes": 19, "max_val": 8.706, "rank": 254.0, "id": "38f3b800-8e05-11ea-90e6-5cf37097309a"}]}, {"source": "Activation of AMPA receptors", "value": 0.6473789529752569, "ngenes": 4, "max_val": 8.706, "rank": 835.0, "id": "38f3b801-8e05-11ea-b74b-5cf37097309a"}]}, {"source": "GABA receptor activation", "value": 0.4207392430371242, "ngenes": 91, "max_val": 8.706, "rank": 1408.0, "id": "38f3b802-8e05-11ea-876f-5cf37097309a", "children": [{"source": "GABA B receptor activation", "value": 0.44227409954858976, "ngenes": 61, "max_val": 8.706, "rank": 1329.0, "id": "38f3b803-8e05-11ea-a061-5cf37097309a", "children": [{"source": "Activation of GABAB receptors", "value": 0.44227409954858976, "ngenes": 61, "max_val": 8.706, "rank": 1316.0, "id": "38f3b804-8e05-11ea-a44a-5cf37097309a", "children": [{"source": "Adenylate cyclase inhibitory pathway", "value": 1.6234368602203797, "ngenes": 29, "max_val": 8.706, "rank": 260.0, "id": "38f3b805-8e05-11ea-ad9b-5cf37097309a"}, {"source": "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits", "value": 0.5242748343222906, "ngenes": 32, "max_val": 8.706, "rank": 1040.0, "id": "38f3b806-8e05-11ea-b286-5cf37097309a"}]}]}]}, {"source": "Activation of kainate receptors upon glutamate binding", "value": 0.3111226958039473, "ngenes": 31, "max_val": 8.706, "rank": 1994.0, "id": "38f3b807-8e05-11ea-8e18-5cf37097309a", "children": [{"source": "Presynaptic function of Kainate receptors", "value": 0.86492840468403, "ngenes": 22, "max_val": 8.706, "rank": 630.0, "id": "38f3b808-8e05-11ea-b348-5cf37097309a"}, {"source": "Ionotropic activity of kainate receptors", "value": 0.5565507266078732, "ngenes": 10, "max_val": 8.706, "rank": 978.0, "id": "38f3b809-8e05-11ea-a4d6-5cf37097309a", "children": [{"source": "Activation of Na-permeable kainate receptors", "value": 0.6495994913559057, "ngenes": 2, "max_val": 8.706, "rank": 832.0, "id": "38f3b80a-8e05-11ea-b81a-5cf37097309a"}, {"source": "Activation of Ca-permeable Kainate Receptor", "value": 0.5565507266078732, "ngenes": 10, "max_val": 8.706, "rank": 982.0, "id": "38f3b80b-8e05-11ea-b0b9-5cf37097309a"}]}]}, {"source": "Activation of NMDA receptors and postsynaptic events", "value": 0.3349092986662009, "ngenes": 134, "max_val": 8.706, "rank": 1832.0, "id": "38f3b80c-8e05-11ea-89b5-5cf37097309a", "children": [{"source": "Post NMDA receptor activation events", "value": 0.33680443321456344, "ngenes": 101, "max_val": 8.706, "rank": 1821.0, "id": "38f3b80d-8e05-11ea-b57e-5cf37097309a", "children": [{"source": "CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling", "value": 0.4722213486251765, "ngenes": 35, "max_val": 8.706, "rank": 1194.0, "id": "38f3b80e-8e05-11ea-b1ec-5cf37097309a", "children": [{"source": "Ras activation upon Ca2+ influx through NMDA receptor", "value": 0.7931726846877779, "ngenes": 21, "max_val": 8.706, "rank": 668.0, "id": "38f3b80f-8e05-11ea-b1a5-5cf37097309a"}, {"source": "RSK activation", "value": 0.4597474868933949, "ngenes": 13, "max_val": 8.706, "rank": 1254.0, "id": "38f3b810-8e05-11ea-8500-5cf37097309a"}]}, {"source": "CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde", "value": 0.5471840327551817, "ngenes": 12, "max_val": 8.706, "rank": 1010.0, "id": "38f3b811-8e05-11ea-ab13-5cf37097309a"}, {"source": "Long-term potentiation", "value": 0.4865631200748303, "ngenes": 25, "max_val": 8.706, "rank": 1123.0, "id": "38f3b812-8e05-11ea-af2c-5cf37097309a"}, {"source": "Activation of AMPK downstream of NMDARs", "value": 0.4788365094295219, "ngenes": 31, "max_val": 8.706, "rank": 1169.0, "id": "38f3b813-8e05-11ea-aef2-5cf37097309a"}, {"source": "CREB1 phosphorylation through the activation of Adenylate Cyclase", "value": 0.44227409954858976, "ngenes": 16, "max_val": 8.706, "rank": 1295.0, "id": "38f3b814-8e05-11ea-b69c-5cf37097309a"}, {"source": "Activation of RAC1 downstream of NMDARs", "value": 0.3135746486533741, "ngenes": 11, "max_val": 8.706, "rank": 1962.0, "id": "38f3b815-8e05-11ea-936d-5cf37097309a"}]}, {"source": "Negative regulation of NMDA receptor-mediated neuronal transmission", "value": 0.4889791746852051, "ngenes": 21, "max_val": 8.706, "rank": 1117.0, "id": "38f3b816-8e05-11ea-9b1c-5cf37097309a"}, {"source": "Unblocking of NMDA receptors, glutamate binding and activation", "value": 0.3639215042559732, "ngenes": 41, "max_val": 8.706, "rank": 1646.0, "id": "38f3b817-8e05-11ea-837e-5cf37097309a"}, {"source": "Assembly and cell surface presentation of NMDA receptors", "value": 0.3483210271800589, "ngenes": 49, "max_val": 8.706, "rank": 1757.0, "id": "38f3b818-8e05-11ea-82cd-5cf37097309a"}]}, {"source": "Acetylcholine binding and downstream events", "value": 0.5565507266078732, "ngenes": 14, "max_val": 8.706, "rank": 969.0, "id": "38f3b819-8e05-11ea-825f-5cf37097309a", "children": [{"source": "Postsynaptic nicotinic acetylcholine receptors", "value": 0.5565507266078732, "ngenes": 14, "max_val": 8.706, "rank": 983.0, "id": "38f3b81a-8e05-11ea-8693-5cf37097309a", "children": [{"source": "Highly calcium permeable postsynaptic nicotinic acetylcholine receptors", "value": 0.4788365094295219, "ngenes": 11, "max_val": 8.706, "rank": 1174.0, "id": "38f3b81b-8e05-11ea-92a3-5cf37097309a"}, {"source": "Highly sodium permeable acetylcholine nicotinic receptors", "value": 0.3721247903393208, "ngenes": 7, "max_val": 8.706, "rank": 1616.0, "id": "38f3b81c-8e05-11ea-8216-5cf37097309a"}]}, {"source": "Presynaptic nicotinic acetylcholine receptors", "value": 0.36278270997328815, "ngenes": 12, "max_val": 8.706, "rank": 1648.0, "id": "38f3b81d-8e05-11ea-ab1e-5cf37097309a", "children": [{"source": "Highly sodium permeable acetylcholine nicotinic receptors", "value": 0.3721247903393208, "ngenes": 7, "max_val": 8.706, "rank": 1616.0, "id": "38f3b81e-8e05-11ea-ac9e-5cf37097309a"}, {"source": "Highly calcium permeable nicotinic acetylcholine receptors", "value": 0.31524626085366114, "ngenes": 9, "max_val": 8.706, "rank": 1942.0, "id": "38f3b81f-8e05-11ea-b894-5cf37097309a"}]}]}]}, {"source": "Neurotransmitter release cycle", "value": 1.2767059380921544, "ngenes": 51, "max_val": 8.706, "rank": 396.0, "id": "38f3b820-8e05-11ea-966e-5cf37097309a", "children": [{"source": "GABA synthesis, release, reuptake and degradation", "value": 0.3886713294759547, "ngenes": 19, "max_val": 8.706, "rank": 1548.0, "id": "38f3b821-8e05-11ea-b329-5cf37097309a", "children": [{"source": "Degradation of GABA", "value": 1.1350276433488258, "ngenes": 2, "max_val": 8.706, "rank": 470.0, "id": "38f3b822-8e05-11ea-8117-5cf37097309a"}, {"source": "Reuptake of GABA", "value": 0.6388865419450723, "ngenes": 4, "max_val": 8.706, "rank": 851.0, "id": "38f3b823-8e05-11ea-8946-5cf37097309a"}, {"source": "GABA synthesis", "value": 0.3483210271800589, "ngenes": 2, "max_val": 8.706, "rank": 1753.0, "id": "38f3b824-8e05-11ea-9ed0-5cf37097309a"}]}, {"source": "Glutamate Neurotransmitter Release Cycle", "value": 0.9837117406301448, "ngenes": 24, "max_val": 8.706, "rank": 552.0, "id": "38f3b825-8e05-11ea-b5a0-5cf37097309a"}, {"source": "Dopamine Neurotransmitter Release Cycle", "value": 0.7390898562975314, "ngenes": 23, "max_val": 8.706, "rank": 713.0, "id": "38f3b826-8e05-11ea-b43f-5cf37097309a"}, {"source": "Serotonin Neurotransmitter Release Cycle", "value": 0.5519775888320267, "ngenes": 18, "max_val": 8.706, "rank": 990.0, "id": "38f3b827-8e05-11ea-be8c-5cf37097309a"}, {"source": "Acetylcholine Neurotransmitter Release Cycle", "value": 0.5439304681170083, "ngenes": 17, "max_val": 8.706, "rank": 1025.0, "id": "38f3b828-8e05-11ea-a074-5cf37097309a"}, {"source": "Norepinephrine Neurotransmitter Release Cycle", "value": 0.453816823018859, "ngenes": 18, "max_val": 8.706, "rank": 1267.0, "id": "38f3b829-8e05-11ea-a1c5-5cf37097309a"}]}, {"source": "Presynaptic depolarization and calcium channel opening", "value": 1.0230929066990757, "ngenes": 13, "max_val": 8.706, "rank": 535.0, "id": "38f3b82a-8e05-11ea-aa32-5cf37097309a"}, {"source": "Neurotransmitter clearance", "value": 0.3333488691934495, "ngenes": 11, "max_val": 8.706, "rank": 1843.0, "id": "38f3b82b-8e05-11ea-b28a-5cf37097309a", "children": [{"source": "Dopamine clearance from the synaptic cleft", "value": 0.36613200722070544, "ngenes": 5, "max_val": 8.706, "rank": 1641.0, "id": "38f3b82c-8e05-11ea-ac24-5cf37097309a", "children": [{"source": "Enzymatic degradation of Dopamine by monoamine oxidase", "value": 0.7904315269009606, "ngenes": 2, "max_val": 8.706, "rank": 670.0, "id": "38f3b82d-8e05-11ea-b755-5cf37097309a"}, {"source": "Enzymatic degradation of dopamine by COMT", "value": 0.3663379689942575, "ngenes": 3, "max_val": 8.706, "rank": 1640.0, "id": "38f3b82e-8e05-11ea-96a4-5cf37097309a"}]}, {"source": "Serotonin clearance from the synaptic cleft", "value": 0.44227409954858976, "ngenes": 3, "max_val": 8.706, "rank": 1300.0, "id": "38f3b82f-8e05-11ea-938b-5cf37097309a", "children": [{"source": "Metabolism of serotonin", "value": 0.3483210271800589, "ngenes": 2, "max_val": 8.706, "rank": 1750.0, "id": "38f3b830-8e05-11ea-bb93-5cf37097309a"}]}]}, {"source": "Neurotransmitter uptake and metabolism In glial cells", "value": 0.5892204298327643, "ngenes": 4, "max_val": 8.706, "rank": 935.0, "id": "38f3b831-8e05-11ea-a6e7-5cf37097309a", "children": [{"source": "Astrocytic Glutamate-Glutamine Uptake And Metabolism", "value": 0.5896819346331361, "ngenes": 4, "max_val": 8.706, "rank": 933.0, "id": "38f3b832-8e05-11ea-8fb6-5cf37097309a"}]}]}, {"source": "Transmission across Electrical Synapses ", "value": 0.5471840327551817, "ngenes": 5, "max_val": 8.706, "rank": 1003.0, "id": "38f3b833-8e05-11ea-9932-5cf37097309a", "children": [{"source": "Electric Transmission Across Gap Junctions", "value": 0.5471840327551817, "ngenes": 5, "max_val": 8.706, "rank": 1020.0, "id": "38f3b834-8e05-11ea-b978-5cf37097309a"}]}]}, {"source": "Developmental Biology", "value": 0.4165866033279961, "ngenes": 1469, "max_val": 8.706, "rank": 1424.0, "id": "38f3b835-8e05-11ea-b538-5cf37097309a", "children": [{"source": "Axon guidance", "value": 0.40594021400370056, "ngenes": 750, "max_val": 8.706, "rank": 1472.0, "id": "38f3b836-8e05-11ea-be2f-5cf37097309a", "children": [{"source": "Signaling by ROBO receptors", "value": 0.5471840327551817, "ngenes": 268, "max_val": 8.706, "rank": 1014.0, "id": "38f3b837-8e05-11ea-b717-5cf37097309a", "children": [{"source": "Regulation of commissural axon pathfinding by SLIT and ROBO", "value": 3.7636234745699113, "ngenes": 12, "max_val": 8.706, "rank": 10.0, "id": "38f3b838-8e05-11ea-8c1a-5cf37097309a"}, {"source": "ROBO receptors bind AKAP5", "value": 3.0845486535014746, "ngenes": 11, "max_val": 8.706, "rank": 38.0, "id": "38f3b839-8e05-11ea-9c39-5cf37097309a"}, {"source": "SLIT2:ROBO1 increases RHOA activity", "value": 3.0845486535014746, "ngenes": 4, "max_val": 8.706, "rank": 40.0, "id": "38f3b83a-8e05-11ea-ab00-5cf37097309a"}, {"source": "Role of ABL in ROBO-SLIT signaling", "value": 2.9760698561077104, "ngenes": 12, "max_val": 8.706, "rank": 42.0, "id": "38f3b83b-8e05-11ea-b660-5cf37097309a"}, {"source": "Regulation of cortical dendrite branching", "value": 0.721392241826102, "ngenes": 4, "max_val": 8.706, "rank": 743.0, "id": "38f3b83c-8e05-11ea-b5c0-5cf37097309a"}, {"source": "Regulation of expression of SLITs and ROBOs", "value": 0.6180023629967516, "ngenes": 212, "max_val": 8.706, "rank": 887.0, "id": "38f3b83d-8e05-11ea-a76a-5cf37097309a"}, {"source": "Activation of RAC1", "value": 0.5471840327551817, "ngenes": 13, "max_val": 8.706, "rank": 1011.0, "id": "38f3b83e-8e05-11ea-9d12-5cf37097309a"}, {"source": "Inactivation of CDC42 and RAC1", "value": 0.3846844748472291, "ngenes": 8, "max_val": 8.706, "rank": 1571.0, "id": "38f3b83f-8e05-11ea-a0d4-5cf37097309a"}]}, {"source": "RET signaling", "value": 3.379892228770036, "ngenes": 41, "max_val": 8.706, "rank": 26.0, "id": "38f3b840-8e05-11ea-be95-5cf37097309a"}, {"source": "Semaphorin interactions", "value": 1.0448064621071822, "ngenes": 87, "max_val": 8.706, "rank": 513.0, "id": "38f3b841-8e05-11ea-bf26-5cf37097309a", "children": [{"source": "CRMPs in Sema3A signaling", "value": 2.627832216398577, "ngenes": 25, "max_val": 8.706, "rank": 67.0, "id": "38f3b842-8e05-11ea-99ae-5cf37097309a"}, {"source": "SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion", "value": 2.4625761311928502, "ngenes": 22, "max_val": 8.706, "rank": 85.0, "id": "38f3b843-8e05-11ea-9b7b-5cf37097309a"}, {"source": "Sema3A PAK dependent Axon repulsion", "value": 2.1388886456952534, "ngenes": 17, "max_val": 8.706, "rank": 116.0, "id": "38f3b844-8e05-11ea-aaa7-5cf37097309a"}, {"source": "Sema4D in semaphorin signaling", "value": 1.9876163820754629, "ngenes": 30, "max_val": 8.706, "rank": 140.0, "id": "38f3b845-8e05-11ea-87ec-5cf37097309a", "children": [{"source": "Sema4D induced cell migration and growth-cone collapse", "value": 1.645291063554907, "ngenes": 26, "max_val": 8.706, "rank": 239.0, "id": "38f3b846-8e05-11ea-a843-5cf37097309a"}, {"source": "Sema4D mediated inhibition of cell attachment and migration", "value": 0.4571687716241703, "ngenes": 8, "max_val": 8.706, "rank": 1259.0, "id": "38f3b847-8e05-11ea-b477-5cf37097309a"}]}, {"source": "Other semaphorin interactions", "value": 0.3608306486501528, "ngenes": 21, "max_val": 8.706, "rank": 1664.0, "id": "38f3b848-8e05-11ea-905b-5cf37097309a"}]}, {"source": "EPH-Ephrin signaling", "value": 0.3411564189282697, "ngenes": 134, "max_val": 8.706, "rank": 1794.0, "id": "38f3b849-8e05-11ea-94e6-5cf37097309a", "children": [{"source": "Ephrin signaling", "value": 2.348129991681356, "ngenes": 30, "max_val": 8.706, "rank": 95.0, "id": "38f3b84a-8e05-11ea-bd18-5cf37097309a"}, {"source": "EPHA-mediated growth cone collapse", "value": 1.0450114955474672, "ngenes": 52, "max_val": 8.706, "rank": 512.0, "id": "38f3b84b-8e05-11ea-8d1a-5cf37097309a"}, {"source": "EPHB-mediated forward signaling", "value": 0.5867347796208139, "ngenes": 65, "max_val": 8.706, "rank": 938.0, "id": "38f3b84c-8e05-11ea-bcca-5cf37097309a"}, {"source": "EPH-ephrin mediated repulsion of cells", "value": 0.3071128122122555, "ngenes": 67, "max_val": 8.706, "rank": 2022.0, "id": "38f3b84d-8e05-11ea-b132-5cf37097309a"}]}, {"source": "Reelin signalling pathway", "value": 2.036896701647701, "ngenes": 5, "max_val": 8.706, "rank": 124.0, "id": "38f3b84e-8e05-11ea-9938-5cf37097309a"}, {"source": "NCAM signaling for neurite out-growth", "value": 1.474917373322508, "ngenes": 76, "max_val": 8.706, "rank": 322.0, "id": "38f3b84f-8e05-11ea-a569-5cf37097309a", "children": [{"source": "NCAM1 interactions", "value": 1.2713790571457095, "ngenes": 44, "max_val": 8.706, "rank": 401.0, "id": "38f3b850-8e05-11ea-9167-5cf37097309a"}]}, {"source": "Netrin-1 signaling", "value": 0.3186832326709682, "ngenes": 61, "max_val": 8.706, "rank": 1925.0, "id": "38f3b851-8e05-11ea-974c-5cf37097309a", "children": [{"source": "Netrin mediated repulsion signals", "value": 0.5471840327551817, "ngenes": 8, "max_val": 8.706, "rank": 1007.0, "id": "38f3b852-8e05-11ea-977c-5cf37097309a"}, {"source": "Role of second messengers in netrin-1 signaling", "value": 0.5101304271242245, "ngenes": 10, "max_val": 8.706, "rank": 1069.0, "id": "38f3b853-8e05-11ea-aa0a-5cf37097309a"}, {"source": "DCC mediated attractive signaling", "value": 0.4704952658544049, "ngenes": 23, "max_val": 8.706, "rank": 1200.0, "id": "38f3b854-8e05-11ea-8448-5cf37097309a"}, {"source": "DSCAM interactions", "value": 0.4627309951511139, "ngenes": 12, "max_val": 8.706, "rank": 1247.0, "id": "38f3b855-8e05-11ea-a1ac-5cf37097309a"}]}, {"source": "L1CAM interactions", "value": 0.44227409954858976, "ngenes": 177, "max_val": 8.706, "rank": 1328.0, "id": "38f3b856-8e05-11ea-849c-5cf37097309a", "children": [{"source": "Recycling pathway of L1", "value": 0.4731128235942158, "ngenes": 85, "max_val": 8.706, "rank": 1188.0, "id": "38f3b857-8e05-11ea-bfb5-5cf37097309a"}, {"source": "Neurofascin interactions", "value": 0.4266462015709692, "ngenes": 9, "max_val": 8.706, "rank": 1376.0, "id": "38f3b858-8e05-11ea-9a0e-5cf37097309a"}, {"source": "NrCAM interactions", "value": 0.3911487587762643, "ngenes": 7, "max_val": 8.706, "rank": 1536.0, "id": "38f3b859-8e05-11ea-88a7-5cf37097309a"}, {"source": "CHL1 interactions", "value": 0.35647002589378085, "ngenes": 9, "max_val": 8.706, "rank": 1708.0, "id": "38f3b85a-8e05-11ea-9cd2-5cf37097309a"}, {"source": "Signal transduction by L1", "value": 0.33504506189282457, "ngenes": 27, "max_val": 8.706, "rank": 1828.0, "id": "38f3b85b-8e05-11ea-a424-5cf37097309a"}, {"source": "Interaction between L1 and Ankyrins", "value": 0.3054119582193906, "ngenes": 44, "max_val": 8.706, "rank": 2030.0, "id": "38f3dedc-8e05-11ea-a5fb-5cf37097309a"}]}]}, {"source": "Keratinization", "value": 2.4285574636338136, "ngenes": 262, "max_val": 8.706, "rank": 87.0, "id": "38f3dedd-8e05-11ea-9da3-5cf37097309a", "children": [{"source": "Formation of the cornified envelope", "value": 2.5867388904740847, "ngenes": 144, "max_val": 8.706, "rank": 76.0, "id": "38f3dede-8e05-11ea-bef0-5cf37097309a"}]}, {"source": "Activation of HOX genes during differentiation", "value": 1.9486203325139888, "ngenes": 125, "max_val": 8.706, "rank": 149.0, "id": "38f3dedf-8e05-11ea-8ed0-5cf37097309a", "children": [{"source": "Activation of anterior HOX genes in hindbrain development during early embryogenesis", "value": 1.9486203325139888, "ngenes": 125, "max_val": 8.706, "rank": 158.0, "id": "38f3dee0-8e05-11ea-8d9b-5cf37097309a"}]}, {"source": "Transcriptional regulation of granulopoiesis", "value": 1.6416890358367588, "ngenes": 106, "max_val": 8.706, "rank": 241.0, "id": "38f3dee1-8e05-11ea-b3c2-5cf37097309a"}, {"source": "Regulation of beta-cell development", "value": 2.036896701647701, "ngenes": 50, "max_val": 8.706, "rank": 125.0, "id": "38f3dee2-8e05-11ea-991c-5cf37097309a", "children": [{"source": "Regulation of gene expression in early pancreatic precursor cells", "value": 0.7065233012069697, "ngenes": 9, "max_val": 8.706, "rank": 757.0, "id": "38f3dee3-8e05-11ea-8ef3-5cf37097309a"}, {"source": "Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells", "value": 0.41257686165516577, "ngenes": 5, "max_val": 8.706, "rank": 1455.0, "id": "38f3dee4-8e05-11ea-a45e-5cf37097309a"}, {"source": "Regulation of gene expression in beta cells", "value": 0.3128507621405376, "ngenes": 24, "max_val": 8.706, "rank": 1980.0, "id": "38f3dee5-8e05-11ea-98e6-5cf37097309a", "children": [{"source": "AKT-mediated inactivation of FOXO1A", "value": 0.3750724859188269, "ngenes": 5, "max_val": 8.706, "rank": 1600.0, "id": "38f3dee6-8e05-11ea-9ff4-5cf37097309a"}]}, {"source": "Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells", "value": 0.30251216144429616, "ngenes": 18, "max_val": 8.706, "rank": 2064.0, "id": "38f3dee7-8e05-11ea-ae0c-5cf37097309a"}]}, {"source": "Signaling by NODAL", "value": 0.4184696081607941, "ngenes": 22, "max_val": 8.706, "rank": 1412.0, "id": "38f3dee8-8e05-11ea-a040-5cf37097309a", "children": [{"source": "Regulation of signaling by NODAL", "value": 0.4927591590767967, "ngenes": 11, "max_val": 8.706, "rank": 1110.0, "id": "38f3dee9-8e05-11ea-8462-5cf37097309a"}]}, {"source": "LGI-ADAM interactions", "value": 0.4360038330702255, "ngenes": 14, "max_val": 8.706, "rank": 1356.0, "id": "38f3deea-8e05-11ea-9d29-5cf37097309a"}, {"source": "Transcriptional regulation of pluripotent stem cells", "value": 0.4850737434907887, "ngenes": 38, "max_val": 8.706, "rank": 1139.0, "id": "38f3deeb-8e05-11ea-8bc1-5cf37097309a", "children": [{"source": "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation", "value": 0.3871848753228034, "ngenes": 20, "max_val": 8.706, "rank": 1551.0, "id": "38f3deec-8e05-11ea-9ce0-5cf37097309a"}, {"source": "POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation", "value": 0.3510645151402919, "ngenes": 16, "max_val": 8.706, "rank": 1737.0, "id": "38f3deed-8e05-11ea-889a-5cf37097309a"}]}, {"source": "Myogenesis", "value": 0.35591495968525594, "ngenes": 51, "max_val": 8.706, "rank": 1714.0, "id": "38f3deee-8e05-11ea-95c8-5cf37097309a"}, {"source": "Transcriptional regulation of white adipocyte differentiation", "value": 0.30413790891450376, "ngenes": 145, "max_val": 8.706, "rank": 2042.0, "id": "38f3deef-8e05-11ea-8097-5cf37097309a"}]}, {"source": "Gene expression (Transcription)", "value": 0.301527568478906, "ngenes": 2039, "max_val": 8.706, "rank": 2074.0, "id": "38f3def0-8e05-11ea-8430-5cf37097309a", "children": [{"source": "RNA Polymerase II Transcription", "value": 0.31921159908015423, "ngenes": 1799, "max_val": 8.706, "rank": 1921.0, "id": "38f3def1-8e05-11ea-b5d6-5cf37097309a", "children": [{"source": "Generic Transcription Pathway", "value": 0.3776101236632095, "ngenes": 1586, "max_val": 8.706, "rank": 1589.0, "id": "38f3def2-8e05-11ea-9fd7-5cf37097309a", "children": [{"source": "Transcriptional regulation by RUNX3", "value": 0.44227409954858976, "ngenes": 135, "max_val": 8.706, "rank": 1308.0, "id": "38f3def3-8e05-11ea-b59d-5cf37097309a", "children": [{"source": "RUNX3 regulates WNT signaling", "value": 3.7636234745699113, "ngenes": 8, "max_val": 8.706, "rank": 11.0, "id": "38f3def4-8e05-11ea-8ece-5cf37097309a"}, {"source": "RUNX3 regulates YAP1-mediated transcription", "value": 2.6334936884204705, "ngenes": 8, "max_val": 8.706, "rank": 64.0, "id": "38f3def5-8e05-11ea-a58d-5cf37097309a"}, {"source": "RUNX3 regulates NOTCH signaling", "value": 1.1417105712632436, "ngenes": 28, "max_val": 8.706, "rank": 467.0, "id": "38f3def6-8e05-11ea-a931-5cf37097309a"}, {"source": "RUNX3 Regulates Immune Response and Cell Migration", "value": 0.8138776069432603, "ngenes": 8, "max_val": 8.706, "rank": 659.0, "id": "38f3def7-8e05-11ea-84c8-5cf37097309a"}, {"source": "RUNX3 regulates BCL2L11 (BIM) transcription", "value": 0.6443415160643701, "ngenes": 5, "max_val": 8.706, "rank": 841.0, "id": "38f3def8-8e05-11ea-ac24-5cf37097309a"}, {"source": "RUNX3 regulates CDKN1A transcription", "value": 0.5565507266078732, "ngenes": 7, "max_val": 8.706, "rank": 976.0, "id": "38f3def9-8e05-11ea-be1d-5cf37097309a"}, {"source": "Regulation of RUNX3 expression and activity", "value": 0.5341664341177444, "ngenes": 74, "max_val": 8.706, "rank": 1033.0, "id": "38f3defa-8e05-11ea-b30a-5cf37097309a"}, {"source": "RUNX3 regulates RUNX1-mediated transcription", "value": 0.4646123127797776, "ngenes": 3, "max_val": 8.706, "rank": 1242.0, "id": "38f3defb-8e05-11ea-adb5-5cf37097309a"}, {"source": "RUNX3 regulates p14-ARF", "value": 0.3195511803930253, "ngenes": 14, "max_val": 8.706, "rank": 1919.0, "id": "38f3defc-8e05-11ea-98d2-5cf37097309a"}]}, {"source": "Transcriptional regulation by RUNX1", "value": 0.8177354171284293, "ngenes": 336, "max_val": 8.706, "rank": 655.0, "id": "38f3defd-8e05-11ea-a9dc-5cf37097309a", "children": [{"source": "RUNX1 regulates estrogen receptor mediated transcription", "value": 3.09809796115373, "ngenes": 6, "max_val": 8.706, "rank": 35.0, "id": "38f3defe-8e05-11ea-81d2-5cf37097309a"}, {"source": "Regulation of RUNX1 Expression and Activity", "value": 1.9591814189566623, "ngenes": 18, "max_val": 8.706, "rank": 147.0, "id": "38f3deff-8e05-11ea-ba29-5cf37097309a"}, {"source": "RUNX1 regulates transcription of genes involved in WNT signaling", "value": 1.9486203325139888, "ngenes": 6, "max_val": 8.706, "rank": 159.0, "id": "38f3df00-8e05-11ea-964e-5cf37097309a"}, {"source": "RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function", "value": 1.687148170072536, "ngenes": 99, "max_val": 8.706, "rank": 224.0, "id": "38f3df01-8e05-11ea-8ffe-5cf37097309a"}, {"source": "RUNX1 regulates transcription of genes involved in differentiation of HSCs", "value": 1.430167649559258, "ngenes": 153, "max_val": 8.706, "rank": 346.0, "id": "38f3df02-8e05-11ea-8861-5cf37097309a"}, {"source": "RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known", "value": 0.4757429707706315, "ngenes": 49, "max_val": 8.706, "rank": 1181.0, "id": "38f3df03-8e05-11ea-a83d-5cf37097309a"}, {"source": "RUNX1 regulates transcription of genes involved in interleukin signaling", "value": 0.4420577665440262, "ngenes": 5, "max_val": 8.706, "rank": 1332.0, "id": "38f3df04-8e05-11ea-86ac-5cf37097309a"}, {"source": "RUNX1 regulates transcription of genes involved in BCR signaling", "value": 0.4237924916712859, "ngenes": 6, "max_val": 8.706, "rank": 1395.0, "id": "38f3df05-8e05-11ea-b8bc-5cf37097309a"}, {"source": "RUNX1 regulates expression of components of tight junctions", "value": 0.3510645151402919, "ngenes": 6, "max_val": 8.706, "rank": 1734.0, "id": "38f3df06-8e05-11ea-9e02-5cf37097309a"}, {"source": "RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)", "value": 0.3223161519951602, "ngenes": 10, "max_val": 8.706, "rank": 1914.0, "id": "38f3df07-8e05-11ea-b885-5cf37097309a"}, {"source": "RUNX1 regulates transcription of genes involved in differentiation of myeloid cells", "value": 0.30413790891450376, "ngenes": 7, "max_val": 8.706, "rank": 2044.0, "id": "38f3df08-8e05-11ea-96df-5cf37097309a"}, {"source": "RUNX1 regulates transcription of genes involved in differentiation of keratinocytes", "value": 0.3023022443625997, "ngenes": 10, "max_val": 8.706, "rank": 2070.0, "id": "38f3df09-8e05-11ea-a719-5cf37097309a"}]}, {"source": "FOXO-mediated transcription", "value": 0.4990868904375801, "ngenes": 82, "max_val": 8.706, "rank": 1097.0, "id": "38f3df0a-8e05-11ea-936b-5cf37097309a", "children": [{"source": "Regulation of FOXO transcriptional activity by acetylation", "value": 2.6778860366876533, "ngenes": 14, "max_val": 8.706, "rank": 62.0, "id": "38f3df0b-8e05-11ea-ae97-5cf37097309a"}, {"source": "FOXO-mediated transcription of cell death genes", "value": 0.7658076578168936, "ngenes": 21, "max_val": 8.706, "rank": 687.0, "id": "38f3df0c-8e05-11ea-a33e-5cf37097309a"}, {"source": "FOXO-mediated transcription of cell cycle genes", "value": 0.40211125538565895, "ngenes": 24, "max_val": 8.706, "rank": 1493.0, "id": "38f3df0d-8e05-11ea-9444-5cf37097309a"}, {"source": "Regulation of localization of FOXO transcription factors", "value": 0.3510645151402919, "ngenes": 13, "max_val": 8.706, "rank": 1735.0, "id": "38f3df0e-8e05-11ea-b1c1-5cf37097309a"}, {"source": "FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes", "value": 0.33680443321456344, "ngenes": 35, "max_val": 8.706, "rank": 1814.0, "id": "38f3df0f-8e05-11ea-9817-5cf37097309a"}]}, {"source": "Transcriptional Regulation by TP53", "value": 0.6473789529752569, "ngenes": 422, "max_val": 8.706, "rank": 834.0, "id": "38f3df10-8e05-11ea-8560-5cf37097309a", "children": [{"source": "TP53 Regulates Transcription of Cell Cycle Genes", "value": 0.5565507266078732, "ngenes": 58, "max_val": 8.706, "rank": 975.0, "id": "38f3df11-8e05-11ea-ab4d-5cf37097309a", "children": [{"source": "TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest", "value": 2.2841335969125485, "ngenes": 18, "max_val": 8.706, "rank": 99.0, "id": "38f3df12-8e05-11ea-81a8-5cf37097309a"}, {"source": "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest", "value": 1.0392836614911098, "ngenes": 14, "max_val": 8.706, "rank": 519.0, "id": "38f3df13-8e05-11ea-9acc-5cf37097309a"}, {"source": "TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain", "value": 0.34147347350479673, "ngenes": 30, "max_val": 8.706, "rank": 1790.0, "id": "38f3df14-8e05-11ea-924b-5cf37097309a"}]}, {"source": "TP53 Regulates Metabolic Genes", "value": 2.2300065791100416, "ngenes": 91, "max_val": 8.706, "rank": 109.0, "id": "38f3df15-8e05-11ea-b886-5cf37097309a"}, {"source": "Regulation of TP53 Activity", "value": 0.6180023629967516, "ngenes": 182, "max_val": 8.706, "rank": 886.0, "id": "38f3df16-8e05-11ea-9a9e-5cf37097309a", "children": [{"source": "Regulation of TP53 Activity through Acetylation", "value": 0.3697835599897704, "ngenes": 33, "max_val": 8.706, "rank": 1624.0, "id": "38f3df17-8e05-11ea-98e6-5cf37097309a", "children": [{"source": "PI5P Regulates TP53 Acetylation", "value": 0.9056299952939398, "ngenes": 10, "max_val": 8.706, "rank": 598.0, "id": "38f3df18-8e05-11ea-9937-5cf37097309a"}]}, {"source": "Regulation of TP53 Activity through Phosphorylation", "value": 0.4675020182601284, "ngenes": 102, "max_val": 8.706, "rank": 1220.0, "id": "38f3df19-8e05-11ea-bb91-5cf37097309a"}, {"source": "Regulation of TP53 Activity through Methylation", "value": 0.4237924916712859, "ngenes": 24, "max_val": 8.706, "rank": 1390.0, "id": "38f3df1a-8e05-11ea-b423-5cf37097309a"}, {"source": "Regulation of TP53 Activity through Association with Co-factors", "value": 0.40594021400370056, "ngenes": 15, "max_val": 8.706, "rank": 1476.0, "id": "38f3df1b-8e05-11ea-b1e4-5cf37097309a"}, {"source": "Regulation of TP53 Expression and Degradation", "value": 0.3223732079441458, "ngenes": 42, "max_val": 8.706, "rank": 1910.0, "id": "38f3df1c-8e05-11ea-ab9b-5cf37097309a", "children": [{"source": "Regulation of TP53 Expression", "value": 0.3976413926744781, "ngenes": 2, "max_val": 8.706, "rank": 1511.0, "id": "38f3df1d-8e05-11ea-92a2-5cf37097309a"}, {"source": "Regulation of TP53 Degradation", "value": 0.31109751985435913, "ngenes": 41, "max_val": 8.706, "rank": 1996.0, "id": "38f3df1e-8e05-11ea-95c0-5cf37097309a"}]}]}, {"source": "TP53 Regulates Transcription of Cell Death Genes", "value": 0.37629990676095454, "ngenes": 46, "max_val": 8.706, "rank": 1597.0, "id": "38f3df1f-8e05-11ea-85dd-5cf37097309a", "children": [{"source": "TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain", "value": 0.8717705024357975, "ngenes": 16, "max_val": 8.706, "rank": 620.0, "id": "38f3df20-8e05-11ea-840e-5cf37097309a"}, {"source": "TP53 Regulates Transcription of Death Receptors and Ligands", "value": 0.7539411177876717, "ngenes": 12, "max_val": 8.706, "rank": 701.0, "id": "38f3df21-8e05-11ea-9c8a-5cf37097309a"}, {"source": "TP53 Regulates Transcription of Genes Involved in Cytochrome C Release", "value": 0.6725908606488801, "ngenes": 20, "max_val": 8.706, "rank": 783.0, "id": "38f3df22-8e05-11ea-84a8-5cf37097309a"}, {"source": "TP53 Regulates Transcription of Caspase Activators and Caspases", "value": 0.6693509375785416, "ngenes": 12, "max_val": 8.706, "rank": 788.0, "id": "38f3df23-8e05-11ea-adeb-5cf37097309a"}]}, {"source": "TP53 Regulates Transcription of DNA Repair Genes", "value": 0.4865631200748303, "ngenes": 85, "max_val": 8.706, "rank": 1127.0, "id": "38f3df24-8e05-11ea-a2ff-5cf37097309a"}]}, {"source": "Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors", "value": 0.3911487587762643, "ngenes": 45, "max_val": 8.706, "rank": 1537.0, "id": "38f3df25-8e05-11ea-8d59-5cf37097309a", "children": [{"source": "TFAP2 (AP-2) family regulates transcription of growth factors and their receptors", "value": 2.075663534038489, "ngenes": 15, "max_val": 8.706, "rank": 122.0, "id": "38f3df26-8e05-11ea-8b5e-5cf37097309a"}, {"source": "Activation of the TFAP2 (AP-2) family of transcription factors", "value": 0.5529289822231784, "ngenes": 12, "max_val": 8.706, "rank": 987.0, "id": "38f3df27-8e05-11ea-aa4a-5cf37097309a"}, {"source": "TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation", "value": 0.5084255126755077, "ngenes": 5, "max_val": 8.706, "rank": 1076.0, "id": "38f3df28-8e05-11ea-bd47-5cf37097309a"}, {"source": "TFAP2 (AP-2) family regulates transcription of cell cycle factors", "value": 0.4844203014957389, "ngenes": 5, "max_val": 8.706, "rank": 1141.0, "id": "38f3df29-8e05-11ea-b5d3-5cf37097309a"}, {"source": "Negative regulation of activity of TFAP2 (AP-2) family transcription factors", "value": 0.406467316447748, "ngenes": 17, "max_val": 8.706, "rank": 1463.0, "id": "38f3df2a-8e05-11ea-9075-5cf37097309a"}, {"source": "TFAP2 (AP-2) family regulates transcription of other transcription factors", "value": 0.3135746486533741, "ngenes": 4, "max_val": 8.706, "rank": 1960.0, "id": "38f3df2b-8e05-11ea-b389-5cf37097309a"}]}, {"source": "Transcriptional Regulation by MECP2", "value": 1.3497979851565576, "ngenes": 78, "max_val": 8.706, "rank": 371.0, "id": "38f3df2c-8e05-11ea-baa2-5cf37097309a", "children": [{"source": "MECP2 regulates transcription factors", "value": 1.997705699384292, "ngenes": 5, "max_val": 8.706, "rank": 139.0, "id": "38f3df2d-8e05-11ea-9a92-5cf37097309a"}, {"source": "MECP2 regulates neuronal receptors and channels", "value": 1.9486203325139888, "ngenes": 20, "max_val": 8.706, "rank": 150.0, "id": "38f3df2e-8e05-11ea-8bc3-5cf37097309a"}, {"source": "MECP2 regulates transcription of neuronal ligands", "value": 1.1927360947461465, "ngenes": 9, "max_val": 8.706, "rank": 443.0, "id": "38f3df2f-8e05-11ea-a8f1-5cf37097309a"}, {"source": "MECP2 regulates transcription of genes involved in GABA signaling", "value": 0.3582908682862535, "ngenes": 3, "max_val": 8.706, "rank": 1690.0, "id": "38f3df30-8e05-11ea-8b75-5cf37097309a"}, {"source": "Regulation of MECP2 expression and activity", "value": 0.3333488691934495, "ngenes": 33, "max_val": 8.706, "rank": 1838.0, "id": "38f3df31-8e05-11ea-b16e-5cf37097309a"}]}, {"source": "YAP1- and WWTR1 (TAZ)-stimulated gene expression", "value": 1.5805022417093255, "ngenes": 17, "max_val": 8.706, "rank": 277.0, "id": "38f3df32-8e05-11ea-9c7e-5cf37097309a"}, {"source": "Transcriptional regulation by RUNX2", "value": 0.3288714815669623, "ngenes": 220, "max_val": 8.706, "rank": 1856.0, "id": "38f3df33-8e05-11ea-bc38-5cf37097309a", "children": [{"source": "RUNX2 regulates bone development", "value": 0.9837117406301448, "ngenes": 35, "max_val": 8.706, "rank": 551.0, "id": "38f3df34-8e05-11ea-926b-5cf37097309a", "children": [{"source": "RUNX2 regulates chondrocyte maturation", "value": 1.4954639650827157, "ngenes": 5, "max_val": 8.706, "rank": 316.0, "id": "38f3df35-8e05-11ea-aa3e-5cf37097309a"}, {"source": "RUNX2 regulates osteoblast differentiation", "value": 1.1478325057846503, "ngenes": 28, "max_val": 8.706, "rank": 462.0, "id": "38f3df36-8e05-11ea-b4e8-5cf37097309a"}]}, {"source": "RUNX2 regulates genes involved in differentiation of myeloid cells", "value": 0.6125658117352507, "ngenes": 4, "max_val": 8.706, "rank": 898.0, "id": "38f3df37-8e05-11ea-a62c-5cf37097309a"}, {"source": "Regulation of RUNX2 expression and activity", "value": 0.33791596117958894, "ngenes": 168, "max_val": 8.706, "rank": 1811.0, "id": "38f3df38-8e05-11ea-9e88-5cf37097309a"}, {"source": "RUNX2 regulates genes involved in cell migration", "value": 0.3286625145939125, "ngenes": 11, "max_val": 8.706, "rank": 1875.0, "id": "38f3df39-8e05-11ea-9a95-5cf37097309a"}]}, {"source": "Notch-HLH transcription pathway", "value": 0.9263449050774044, "ngenes": 32, "max_val": 8.706, "rank": 581.0, "id": "38f3df3a-8e05-11ea-986a-5cf37097309a"}, {"source": "Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer", "value": 0.4627309951511139, "ngenes": 58, "max_val": 8.706, "rank": 1245.0, "id": "38f3df3b-8e05-11ea-a74c-5cf37097309a", "children": [{"source": "Downregulation of SMAD2/3:SMAD4 transcriptional activity", "value": 0.86492840468403, "ngenes": 35, "max_val": 8.706, "rank": 631.0, "id": "38f3df3c-8e05-11ea-a8fe-5cf37097309a"}, {"source": "SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription", "value": 0.6647834081114088, "ngenes": 38, "max_val": 8.706, "rank": 797.0, "id": "38f3df3d-8e05-11ea-830d-5cf37097309a"}]}, {"source": "Transcriptional Regulation by E2F6", "value": 0.4834580950657935, "ngenes": 45, "max_val": 8.706, "rank": 1145.0, "id": "38f3df3e-8e05-11ea-898f-5cf37097309a"}, {"source": "Nuclear Receptor transcription pathway", "value": 0.4757429707706315, "ngenes": 58, "max_val": 8.706, "rank": 1180.0, "id": "38f3df3f-8e05-11ea-bb10-5cf37097309a"}, {"source": "Transcriptional Regulation by VENTX", "value": 0.4346351931724346, "ngenes": 45, "max_val": 8.706, "rank": 1358.0, "id": "38f3df40-8e05-11ea-9cde-5cf37097309a"}]}, {"source": "RNA Polymerase II Transcription Pre-Initiation And Promoter Opening", "value": 1.2070420459358313, "ngenes": 57, "max_val": 8.706, "rank": 425.0, "id": "38f3df41-8e05-11ea-8322-5cf37097309a"}, {"source": "RNA Polymerase II Transcription Initiation And Promoter Clearance", "value": 1.2070420459358313, "ngenes": 57, "max_val": 8.706, "rank": 424.0, "id": "38f3df42-8e05-11ea-be78-5cf37097309a", "children": [{"source": "RNA Polymerase II Transcription Initiation", "value": 1.2070420459358313, "ngenes": 57, "max_val": 8.706, "rank": 427.0, "id": "38f3df43-8e05-11ea-b409-5cf37097309a"}, {"source": "RNA Polymerase II Promoter Escape", "value": 1.2070420459358313, "ngenes": 57, "max_val": 8.706, "rank": 428.0, "id": "38f3df44-8e05-11ea-81e6-5cf37097309a"}]}, {"source": "RNA Pol II CTD phosphorylation and interaction with CE", "value": 0.9507977267366129, "ngenes": 35, "max_val": 8.706, "rank": 567.0, "id": "38f3df45-8e05-11ea-be69-5cf37097309a"}, {"source": "RNA Polymerase II Transcription Elongation", "value": 0.3400535953279963, "ngenes": 74, "max_val": 8.706, "rank": 1796.0, "id": "38f3df46-8e05-11ea-9dcb-5cf37097309a", "children": [{"source": "Formation of the Early Elongation Complex", "value": 0.5104201517191181, "ngenes": 46, "max_val": 8.706, "rank": 1065.0, "id": "38f3df47-8e05-11ea-b4c6-5cf37097309a"}, {"source": "Formation of RNA Pol II elongation complex ", "value": 0.34102093398216465, "ngenes": 74, "max_val": 8.706, "rank": 1795.0, "id": "38f3df48-8e05-11ea-b6d7-5cf37097309a"}]}, {"source": "RNA polymerase II transcribes snRNA genes", "value": 0.4870330356788664, "ngenes": 160, "max_val": 8.706, "rank": 1121.0, "id": "38f3df49-8e05-11ea-8269-5cf37097309a"}, {"source": "RNA Polymerase II Pre-transcription Events", "value": 0.4381517822180467, "ngenes": 99, "max_val": 8.706, "rank": 1348.0, "id": "38f3df4a-8e05-11ea-9b2b-5cf37097309a"}, {"source": "RNA Polymerase II Transcription Termination", "value": 0.40363975349578657, "ngenes": 73, "max_val": 8.706, "rank": 1488.0, "id": "38f3df4b-8e05-11ea-9225-5cf37097309a"}]}, {"source": "Epigenetic regulation of gene expression", "value": 1.8541410489774792, "ngenes": 266, "max_val": 8.706, "rank": 185.0, "id": "38f3df4c-8e05-11ea-8ce9-5cf37097309a", "children": [{"source": "Negative epigenetic regulation of rRNA expression", "value": 2.025681326627676, "ngenes": 188, "max_val": 8.706, "rank": 127.0, "id": "38f3df4d-8e05-11ea-9dc3-5cf37097309a", "children": [{"source": "NoRC negatively regulates rRNA expression", "value": 2.0043142849738764, "ngenes": 184, "max_val": 8.706, "rank": 133.0, "id": "38f3df4e-8e05-11ea-be81-5cf37097309a"}, {"source": "SIRT1 negatively regulates rRNA expression", "value": 1.5670519628419153, "ngenes": 70, "max_val": 8.706, "rank": 283.0, "id": "38f3df4f-8e05-11ea-97da-5cf37097309a"}]}, {"source": "Positive epigenetic regulation of rRNA expression", "value": 1.7662553138583998, "ngenes": 182, "max_val": 8.706, "rank": 202.0, "id": "38f3df50-8e05-11ea-a673-5cf37097309a", "children": [{"source": "B-WICH complex positively regulates rRNA expression", "value": 1.7192109142232588, "ngenes": 99, "max_val": 8.706, "rank": 214.0, "id": "38f3df51-8e05-11ea-a9f0-5cf37097309a"}, {"source": "ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression", "value": 1.6082192522057692, "ngenes": 83, "max_val": 8.706, "rank": 270.0, "id": "38f3df52-8e05-11ea-82f0-5cf37097309a"}]}, {"source": "PRC2 methylates histones and DNA", "value": 1.6082192522057692, "ngenes": 75, "max_val": 8.706, "rank": 268.0, "id": "38f3df53-8e05-11ea-99cd-5cf37097309a"}, {"source": "DNA methylation", "value": 1.5792591853966214, "ngenes": 66, "max_val": 8.706, "rank": 278.0, "id": "38f3df54-8e05-11ea-bf92-5cf37097309a"}, {"source": "TET1,2,3 and TDG demethylate DNA", "value": 0.3556122394795288, "ngenes": 4, "max_val": 8.706, "rank": 1715.0, "id": "38f3df55-8e05-11ea-8dc4-5cf37097309a"}]}, {"source": "RNA Polymerase I Transcription", "value": 2.1267895101999463, "ngenes": 160, "max_val": 8.706, "rank": 118.0, "id": "38f3df56-8e05-11ea-b00b-5cf37097309a", "children": [{"source": "RNA Polymerase I Promoter Clearance", "value": 2.025681326627676, "ngenes": 158, "max_val": 8.706, "rank": 128.0, "id": "38f3df57-8e05-11ea-9fef-5cf37097309a", "children": [{"source": "RNA Polymerase I Promoter Escape", "value": 2.0011542766180703, "ngenes": 108, "max_val": 8.706, "rank": 138.0, "id": "38f3df58-8e05-11ea-9ad9-5cf37097309a"}, {"source": "RNA Polymerase I Promoter Opening", "value": 1.5495138599497604, "ngenes": 64, "max_val": 8.706, "rank": 290.0, "id": "38f3df59-8e05-11ea-9235-5cf37097309a"}, {"source": "RNA Polymerase I Transcription Initiation", "value": 0.4956021610862506, "ngenes": 94, "max_val": 8.706, "rank": 1104.0, "id": "38f3df5a-8e05-11ea-a510-5cf37097309a"}]}, {"source": "RNA Polymerase I Transcription Termination", "value": 0.8142751406557339, "ngenes": 47, "max_val": 8.706, "rank": 658.0, "id": "38f3df5b-8e05-11ea-8b75-5cf37097309a"}]}, {"source": "Gene Silencing by RNA", "value": 2.0160142700617008, "ngenes": 153, "max_val": 8.706, "rank": 131.0, "id": "38f3df5c-8e05-11ea-9ebe-5cf37097309a", "children": [{"source": "Transcriptional regulation by small RNAs", "value": 1.8925853850118608, "ngenes": 109, "max_val": 8.706, "rank": 176.0, "id": "38f3df5d-8e05-11ea-a99a-5cf37097309a"}, {"source": "MicroRNA (miRNA) biogenesis", "value": 1.0652967967935014, "ngenes": 25, "max_val": 8.706, "rank": 493.0, "id": "38f3df5e-8e05-11ea-b7bb-5cf37097309a"}, {"source": "Small interfering RNA (siRNA) biogenesis", "value": 0.9062602594897696, "ngenes": 9, "max_val": 8.706, "rank": 593.0, "id": "38f3df5f-8e05-11ea-a877-5cf37097309a"}, {"source": "Post-transcriptional silencing by small RNAs", "value": 0.3543975045465841, "ngenes": 7, "max_val": 8.706, "rank": 1719.0, "id": "38f3df60-8e05-11ea-8093-5cf37097309a"}, {"source": "PIWI-interacting RNA (piRNA) biogenesis", "value": 0.3272772875640805, "ngenes": 30, "max_val": 8.706, "rank": 1884.0, "id": "38f405ca-8e05-11ea-8cb9-5cf37097309a"}]}, {"source": "RNA Polymerase III Transcription", "value": 0.30251216144429616, "ngenes": 81, "max_val": 8.706, "rank": 2059.0, "id": "38f405cb-8e05-11ea-a05a-5cf37097309a", "children": [{"source": "RNA Polymerase III Transcription Initiation", "value": 0.3483210271800589, "ngenes": 76, "max_val": 8.706, "rank": 1756.0, "id": "38f405cc-8e05-11ea-b5b6-5cf37097309a", "children": [{"source": "RNA Polymerase III Transcription Initiation From Type 1 Promoter", "value": 0.714245852972956, "ngenes": 60, "max_val": 8.706, "rank": 749.0, "id": "38f405cd-8e05-11ea-a4a7-5cf37097309a"}, {"source": "RNA Polymerase III Transcription Initiation From Type 2 Promoter", "value": 0.6890717402395967, "ngenes": 58, "max_val": 8.706, "rank": 769.0, "id": "38f405ce-8e05-11ea-923c-5cf37097309a"}, {"source": "RNA Polymerase III Transcription Initiation From Type 3 Promoter", "value": 0.3814224132317699, "ngenes": 60, "max_val": 8.706, "rank": 1581.0, "id": "38f405cf-8e05-11ea-8127-5cf37097309a"}]}, {"source": "RNA Polymerase III Chain Elongation", "value": 0.45052063902871503, "ngenes": 19, "max_val": 8.706, "rank": 1274.0, "id": "38f405d0-8e05-11ea-b6b4-5cf37097309a"}, {"source": "RNA Polymerase III Transcription Termination", "value": 0.3896195653855341, "ngenes": 24, "max_val": 8.706, "rank": 1543.0, "id": "38f405d1-8e05-11ea-848b-5cf37097309a"}, {"source": "RNA Polymerase III Abortive And Retractive Initiation", "value": 0.30251216144429616, "ngenes": 43, "max_val": 8.706, "rank": 2061.0, "id": "38f405d2-8e05-11ea-9338-5cf37097309a"}]}, {"source": "Transcription from mitochondrial promoters", "value": 0.3186832326709682, "ngenes": 4, "max_val": 8.706, "rank": 1923.0, "id": "38f405d3-8e05-11ea-8846-5cf37097309a", "children": [{"source": "Mitochondrial transcription initiation", "value": 0.3050811988978337, "ngenes": 3, "max_val": 8.706, "rank": 2041.0, "id": "38f405d4-8e05-11ea-8c79-5cf37097309a"}]}]}, {"source": "Cell Cycle", "value": 1.22028770479158, "ngenes": 860, "max_val": 8.706, "rank": 416.0, "id": "38f405d5-8e05-11ea-aba6-5cf37097309a", "children": [{"source": "Cell Cycle, Mitotic", "value": 1.1186373727081842, "ngenes": 648, "max_val": 8.706, "rank": 483.0, "id": "38f405d6-8e05-11ea-90a5-5cf37097309a", "children": [{"source": "M Phase", "value": 1.3039497372625592, "ngenes": 458, "max_val": 8.706, "rank": 389.0, "id": "38f405d7-8e05-11ea-8f15-5cf37097309a", "children": [{"source": "Mitotic Prophase", "value": 2.364985768442516, "ngenes": 158, "max_val": 8.706, "rank": 89.0, "id": "38f405d8-8e05-11ea-a1ec-5cf37097309a", "children": [{"source": "MASTL Facilitates Mitotic Progression", "value": 3.7482115603111694, "ngenes": 13, "max_val": 8.706, "rank": 13.0, "id": "38f405d9-8e05-11ea-8cd2-5cf37097309a"}, {"source": "Nuclear Envelope Breakdown", "value": 0.861222434563697, "ngenes": 54, "max_val": 8.706, "rank": 632.0, "id": "38f405da-8e05-11ea-961e-5cf37097309a", "children": [{"source": "Depolymerisation of the Nuclear Lamina", "value": 3.379892228770036, "ngenes": 15, "max_val": 8.706, "rank": 25.0, "id": "38f405db-8e05-11ea-b429-5cf37097309a"}, {"source": "Activation of NIMA Kinases NEK9, NEK6, NEK7", "value": 1.9486203325139888, "ngenes": 7, "max_val": 8.706, "rank": 151.0, "id": "38f405dc-8e05-11ea-9a39-5cf37097309a"}, {"source": "Nuclear Pore Complex (NPC) Disassembly", "value": 0.8053336674550169, "ngenes": 37, "max_val": 8.706, "rank": 665.0, "id": "38f405dd-8e05-11ea-b748-5cf37097309a"}]}, {"source": "Golgi Cisternae Pericentriolar Stack Reorganization", "value": 1.9082842009900065, "ngenes": 19, "max_val": 8.706, "rank": 172.0, "id": "38f405de-8e05-11ea-9c3a-5cf37097309a"}, {"source": "Condensation of Prophase Chromosomes", "value": 1.7662553138583998, "ngenes": 77, "max_val": 8.706, "rank": 204.0, "id": "38f405df-8e05-11ea-a192-5cf37097309a"}]}, {"source": "Mitotic Prometaphase", "value": 0.9056299952939398, "ngenes": 232, "max_val": 8.706, "rank": 594.0, "id": "38f405e0-8e05-11ea-9517-5cf37097309a", "children": [{"source": "Resolution of Sister Chromatid Cohesion", "value": 1.5715994700321363, "ngenes": 131, "max_val": 8.706, "rank": 281.0, "id": "38f405e1-8e05-11ea-b0ea-5cf37097309a"}, {"source": "EML4 and NUDC in mitotic spindle formation", "value": 1.2876022020626001, "ngenes": 122, "max_val": 8.706, "rank": 392.0, "id": "38f405e2-8e05-11ea-a763-5cf37097309a"}, {"source": "Condensation of Prometaphase Chromosomes", "value": 0.3849420497242914, "ngenes": 22, "max_val": 8.706, "rank": 1563.0, "id": "38f405e3-8e05-11ea-99f6-5cf37097309a"}, {"source": "Recruitment of NuMA to mitotic centrosomes", "value": 0.3592004814595621, "ngenes": 106, "max_val": 8.706, "rank": 1670.0, "id": "38f405e4-8e05-11ea-9756-5cf37097309a"}]}, {"source": "Mitotic Telophase/Cytokinesis", "value": 1.474917373322508, "ngenes": 13, "max_val": 8.706, "rank": 325.0, "id": "38f405e5-8e05-11ea-868a-5cf37097309a", "children": [{"source": "Cohesin Loading onto Chromatin", "value": 1.5163013074021197, "ngenes": 10, "max_val": 8.706, "rank": 309.0, "id": "38f405e6-8e05-11ea-af40-5cf37097309a"}]}, {"source": "Mitotic Metaphase and Anaphase", "value": 1.5134688715929976, "ngenes": 225, "max_val": 8.706, "rank": 314.0, "id": "38f405e7-8e05-11ea-a42e-5cf37097309a", "children": [{"source": "Mitotic Anaphase", "value": 1.5193921410162, "ngenes": 224, "max_val": 8.706, "rank": 308.0, "id": "38f405e8-8e05-11ea-bf00-5cf37097309a", "children": [{"source": "Separation of Sister Chromatids", "value": 1.4635686398074523, "ngenes": 213, "max_val": 8.706, "rank": 330.0, "id": "38f405e9-8e05-11ea-a572-5cf37097309a"}, {"source": "Nuclear Envelope Reassembly", "value": 0.7896605942454825, "ngenes": 13, "max_val": 8.706, "rank": 673.0, "id": "38f405ea-8e05-11ea-97cd-5cf37097309a", "children": [{"source": "Initiation of Nuclear Envelope Reformation", "value": 0.7897413854150991, "ngenes": 13, "max_val": 8.706, "rank": 672.0, "id": "38f405eb-8e05-11ea-9645-5cf37097309a"}]}]}, {"source": "Mitotic Metaphase/Anaphase Transition", "value": 0.5001980158333734, "ngenes": 2, "max_val": 8.706, "rank": 1095.0, "id": "38f405ec-8e05-11ea-89f9-5cf37097309a"}]}]}, {"source": "Regulation of mitotic cell cycle", "value": 0.6725908606488801, "ngenes": 104, "max_val": 8.706, "rank": 782.0, "id": "38f405ed-8e05-11ea-a773-5cf37097309a", "children": [{"source": "APC/C-mediated degradation of cell cycle proteins", "value": 0.6735415710397274, "ngenes": 104, "max_val": 8.706, "rank": 781.0, "id": "38f405ee-8e05-11ea-aa15-5cf37097309a", "children": [{"source": "Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins", "value": 0.5567369631043795, "ngenes": 94, "max_val": 8.706, "rank": 965.0, "id": "38f405ef-8e05-11ea-b44a-5cf37097309a", "children": [{"source": "Phosphorylation of the APC/C", "value": 3.5161088039033483, "ngenes": 19, "max_val": 8.706, "rank": 22.0, "id": "38f405f0-8e05-11ea-9187-5cf37097309a"}, {"source": "APC/C:Cdc20 mediated degradation of mitotic proteins", "value": 0.5314003421489712, "ngenes": 93, "max_val": 8.706, "rank": 1034.0, "id": "38f405f1-8e05-11ea-8a06-5cf37097309a", "children": [{"source": "APC/C:Cdc20 mediated degradation of Cyclin B", "value": 3.301370455298916, "ngenes": 23, "max_val": 8.706, "rank": 28.0, "id": "38f405f2-8e05-11ea-9c37-5cf37097309a"}, {"source": "APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint", "value": 0.4225251742038882, "ngenes": 91, "max_val": 8.706, "rank": 1402.0, "id": "38f405f3-8e05-11ea-b550-5cf37097309a", "children": [{"source": "APC-Cdc20 mediated degradation of Nek2A", "value": 3.1403756106262635, "ngenes": 25, "max_val": 8.706, "rank": 33.0, "id": "38f405f4-8e05-11ea-935c-5cf37097309a"}, {"source": "Cdc20:Phospho-APC/C mediated degradation of Cyclin A", "value": 0.3721247903393208, "ngenes": 90, "max_val": 8.706, "rank": 1614.0, "id": "38f405f5-8e05-11ea-a8fe-5cf37097309a"}]}, {"source": "APC/C:Cdc20 mediated degradation of Securin", "value": 0.31843317641013524, "ngenes": 85, "max_val": 8.706, "rank": 1926.0, "id": "38f405f6-8e05-11ea-8aa1-5cf37097309a"}]}]}, {"source": "Regulation of APC/C activators between G1/S and early anaphase", "value": 0.4381517822180467, "ngenes": 98, "max_val": 8.706, "rank": 1349.0, "id": "38f405f7-8e05-11ea-ada5-5cf37097309a", "children": [{"source": "Phosphorylation of Emi1", "value": 1.6082192522057692, "ngenes": 6, "max_val": 8.706, "rank": 272.0, "id": "38f405f8-8e05-11ea-8b21-5cf37097309a"}, {"source": "Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components", "value": 1.1957209721612054, "ngenes": 20, "max_val": 8.706, "rank": 433.0, "id": "38f405f9-8e05-11ea-baa7-5cf37097309a", "children": [{"source": "Inactivation of APC/C via direct inhibition of the APC/C complex", "value": 1.1957209721612054, "ngenes": 20, "max_val": 8.706, "rank": 434.0, "id": "38f405fa-8e05-11ea-9d22-5cf37097309a"}]}, {"source": "SCF-beta-TrCP mediated degradation of Emi1", "value": 0.7566889536504381, "ngenes": 73, "max_val": 8.706, "rank": 697.0, "id": "38f405fb-8e05-11ea-9c50-5cf37097309a"}]}, {"source": "Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase", "value": 0.4165866033279961, "ngenes": 19, "max_val": 8.706, "rank": 1423.0, "id": "38f405fc-8e05-11ea-ab04-5cf37097309a"}, {"source": "Autodegradation of Cdh1 by Cdh1:APC/C", "value": 0.3568317471571929, "ngenes": 81, "max_val": 8.706, "rank": 1696.0, "id": "38f405fd-8e05-11ea-89e4-5cf37097309a"}, {"source": "APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1", "value": 0.3333488691934495, "ngenes": 90, "max_val": 8.706, "rank": 1837.0, "id": "38f405fe-8e05-11ea-bd8e-5cf37097309a"}]}]}, {"source": "Mitotic G2-G2/M phases", "value": 0.6757836629455423, "ngenes": 238, "max_val": 8.706, "rank": 778.0, "id": "38f405ff-8e05-11ea-8257-5cf37097309a", "children": [{"source": "G2/M Transition", "value": 0.8665372242217627, "ngenes": 236, "max_val": 8.706, "rank": 624.0, "id": "38f40600-8e05-11ea-953f-5cf37097309a", "children": [{"source": "Polo-like kinase mediated events", "value": 1.908354321714834, "ngenes": 16, "max_val": 8.706, "rank": 171.0, "id": "38f40601-8e05-11ea-822b-5cf37097309a"}, {"source": "Cyclin A/B1/B2 associated events during G2/M transition", "value": 1.625041882317914, "ngenes": 31, "max_val": 8.706, "rank": 257.0, "id": "38f40602-8e05-11ea-920f-5cf37097309a", "children": [{"source": "Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes", "value": 1.33202224135436, "ngenes": 3, "max_val": 8.706, "rank": 374.0, "id": "38f40603-8e05-11ea-a663-5cf37097309a"}]}, {"source": "FBXL7 down-regulates AURKA during mitotic entry and in early mitosis", "value": 0.6385295459368253, "ngenes": 73, "max_val": 8.706, "rank": 854.0, "id": "38f40604-8e05-11ea-b746-5cf37097309a"}, {"source": "Centrosome maturation", "value": 0.5471840327551817, "ngenes": 92, "max_val": 8.706, "rank": 999.0, "id": "38f40605-8e05-11ea-b085-5cf37097309a", "children": [{"source": "Recruitment of mitotic centrosome proteins and complexes", "value": 0.5471840327551817, "ngenes": 92, "max_val": 8.706, "rank": 997.0, "id": "38f40606-8e05-11ea-bd8f-5cf37097309a"}, {"source": "Loss of proteins required for interphase microtubule organization from the centrosome", "value": 0.30251216144429616, "ngenes": 80, "max_val": 8.706, "rank": 2065.0, "id": "38f40607-8e05-11ea-853b-5cf37097309a", "children": [{"source": "Loss of Nlp from mitotic centrosomes", "value": 0.30251216144429616, "ngenes": 80, "max_val": 8.706, "rank": 2067.0, "id": "38f40608-8e05-11ea-9b3c-5cf37097309a"}]}]}, {"source": "Regulation of PLK1 Activity at G2/M Transition", "value": 0.4788365094295219, "ngenes": 98, "max_val": 8.706, "rank": 1164.0, "id": "38f40609-8e05-11ea-b893-5cf37097309a"}, {"source": "AURKA Activation by TPX2", "value": 0.4649278207945483, "ngenes": 83, "max_val": 8.706, "rank": 1226.0, "id": "38f4060a-8e05-11ea-81e3-5cf37097309a"}, {"source": "Interaction between PHLDA1 and AURKA", "value": 0.3968889352052267, "ngenes": 2, "max_val": 8.706, "rank": 1513.0, "id": "38f4060b-8e05-11ea-a7d2-5cf37097309a"}, {"source": "The role of GTSE1 in G2/M progression after G2 checkpoint", "value": 0.3411564189282697, "ngenes": 100, "max_val": 8.706, "rank": 1793.0, "id": "38f4060c-8e05-11ea-96b7-5cf37097309a"}]}, {"source": "G2 Phase", "value": 0.44227409954858976, "ngenes": 5, "max_val": 8.706, "rank": 1315.0, "id": "38f4060d-8e05-11ea-b247-5cf37097309a"}]}, {"source": "S Phase", "value": 0.8874820603721416, "ngenes": 194, "max_val": 8.706, "rank": 610.0, "id": "38f4060e-8e05-11ea-b2b2-5cf37097309a", "children": [{"source": "Synthesis of DNA", "value": 0.9001944453660256, "ngenes": 148, "max_val": 8.706, "rank": 602.0, "id": "38f4060f-8e05-11ea-b9de-5cf37097309a", "children": [{"source": "DNA replication initiation", "value": 1.6678919263086482, "ngenes": 8, "max_val": 8.706, "rank": 227.0, "id": "38f40610-8e05-11ea-8d43-5cf37097309a"}, {"source": "DNA strand elongation", "value": 1.1346340826365409, "ngenes": 36, "max_val": 8.706, "rank": 472.0, "id": "38f40611-8e05-11ea-8683-5cf37097309a", "children": [{"source": "Lagging Strand Synthesis", "value": 1.2809833691874195, "ngenes": 20, "max_val": 8.706, "rank": 393.0, "id": "38f40612-8e05-11ea-8175-5cf37097309a", "children": [{"source": "Processive synthesis on the lagging strand", "value": 1.2937793685933063, "ngenes": 15, "max_val": 8.706, "rank": 391.0, "id": "38f40613-8e05-11ea-ad3c-5cf37097309a", "children": [{"source": "Removal of the Flap Intermediate", "value": 1.5163013074021197, "ngenes": 14, "max_val": 8.706, "rank": 310.0, "id": "38f40614-8e05-11ea-8e83-5cf37097309a"}]}, {"source": "Polymerase switching", "value": 0.8178691883509146, "ngenes": 14, "max_val": 8.706, "rank": 654.0, "id": "38f40615-8e05-11ea-b19d-5cf37097309a"}]}, {"source": "Unwinding of DNA", "value": 0.9040451189857748, "ngenes": 16, "max_val": 8.706, "rank": 600.0, "id": "38f40616-8e05-11ea-afb0-5cf37097309a"}, {"source": "Leading Strand Synthesis", "value": 0.8178691883509146, "ngenes": 14, "max_val": 8.706, "rank": 653.0, "id": "38f40617-8e05-11ea-a7e6-5cf37097309a", "children": [{"source": "Polymerase switching", "value": 0.8178691883509146, "ngenes": 14, "max_val": 8.706, "rank": 654.0, "id": "38f40618-8e05-11ea-9a41-5cf37097309a"}]}]}, {"source": "Switching of origins to a post-replicative state", "value": 0.383122548138848, "ngenes": 108, "max_val": 8.706, "rank": 1578.0, "id": "38f40619-8e05-11ea-a6e7-5cf37097309a", "children": [{"source": "Orc1 removal from chromatin", "value": 0.3870089130792698, "ngenes": 89, "max_val": 8.706, "rank": 1553.0, "id": "38f4061a-8e05-11ea-a7d5-5cf37097309a"}, {"source": "CDK-mediated phosphorylation and removal of Cdc6", "value": 0.3128507621405376, "ngenes": 90, "max_val": 8.706, "rank": 1979.0, "id": "38f4061b-8e05-11ea-8007-5cf37097309a"}]}]}, {"source": "Establishment of Sister Chromatid Cohesion", "value": 1.5296121809016108, "ngenes": 11, "max_val": 8.706, "rank": 302.0, "id": "38f4061c-8e05-11ea-a139-5cf37097309a"}, {"source": "Ubiquitin-dependent degradation of Cyclin D", "value": 0.6735415710397274, "ngenes": 72, "max_val": 8.706, "rank": 780.0, "id": "38f4061d-8e05-11ea-ad03-5cf37097309a"}, {"source": "Cyclin A:Cdk2-associated events at S phase entry", "value": 0.3169714205734984, "ngenes": 105, "max_val": 8.706, "rank": 1934.0, "id": "38f4061e-8e05-11ea-82fc-5cf37097309a", "children": [{"source": "SCF(Skp2)-mediated degradation of p27/p21", "value": 0.4788365094295219, "ngenes": 78, "max_val": 8.706, "rank": 1171.0, "id": "38f4061f-8e05-11ea-8bc8-5cf37097309a"}]}]}, {"source": "Mitotic G1 phase and G1/S transition", "value": 0.8461089331724394, "ngenes": 194, "max_val": 8.706, "rank": 638.0, "id": "38f40620-8e05-11ea-9d3a-5cf37097309a", "children": [{"source": "G0 and Early G1", "value": 1.7876299106393332, "ngenes": 41, "max_val": 8.706, "rank": 196.0, "id": "38f40621-8e05-11ea-a418-5cf37097309a", "children": [{"source": "Transcription of E2F targets under negative control by DREAM complex", "value": 1.6082192522057692, "ngenes": 31, "max_val": 8.706, "rank": 264.0, "id": "38f40622-8e05-11ea-b5cd-5cf37097309a"}, {"source": "Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1", "value": 1.5566356862971817, "ngenes": 16, "max_val": 8.706, "rank": 286.0, "id": "38f40623-8e05-11ea-96c5-5cf37097309a"}]}, {"source": "G1/S Transition", "value": 0.9914712729302528, "ngenes": 167, "max_val": 8.706, "rank": 549.0, "id": "38f40624-8e05-11ea-97e3-5cf37097309a", "children": [{"source": "E2F mediated regulation of DNA replication", "value": 1.474917373322508, "ngenes": 23, "max_val": 8.706, "rank": 326.0, "id": "38f40625-8e05-11ea-ba0f-5cf37097309a", "children": [{"source": "E2F-enabled inhibition of pre-replication complex formation", "value": 1.4713341519431091, "ngenes": 9, "max_val": 8.706, "rank": 327.0, "id": "38f40626-8e05-11ea-bedc-5cf37097309a"}, {"source": "Inhibition of replication initiation of damaged DNA by RB1/E2F1", "value": 0.5465566780914427, "ngenes": 14, "max_val": 8.706, "rank": 1023.0, "id": "38f40627-8e05-11ea-a170-5cf37097309a"}]}, {"source": "G1/S-Specific Transcription", "value": 1.2427634964099536, "ngenes": 37, "max_val": 8.706, "rank": 408.0, "id": "38f40628-8e05-11ea-acce-5cf37097309a"}, {"source": "Cyclin E associated events during G1/S transition ", "value": 0.3128507621405376, "ngenes": 103, "max_val": 8.706, "rank": 1977.0, "id": "38f40629-8e05-11ea-9132-5cf37097309a", "children": [{"source": "Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes", "value": 1.063803245003592, "ngenes": 4, "max_val": 8.706, "rank": 495.0, "id": "38f4062a-8e05-11ea-a8cb-5cf37097309a"}, {"source": "SCF(Skp2)-mediated degradation of p27/p21", "value": 0.4788365094295219, "ngenes": 78, "max_val": 8.706, "rank": 1171.0, "id": "38f4062b-8e05-11ea-a62a-5cf37097309a"}]}, {"source": "Activation of the pre-replicative complex", "value": 1.009028139243736, "ngenes": 33, "max_val": 8.706, "rank": 544.0, "id": "38f4062c-8e05-11ea-8d50-5cf37097309a"}]}, {"source": "G1 Phase", "value": 0.6200701529762026, "ngenes": 46, "max_val": 8.706, "rank": 885.0, "id": "38f4062d-8e05-11ea-96b8-5cf37097309a", "children": [{"source": "Cyclin D associated events in G1", "value": 0.6219884537178231, "ngenes": 46, "max_val": 8.706, "rank": 884.0, "id": "38f4062e-8e05-11ea-9a97-5cf37097309a"}]}]}]}, {"source": "Cell Cycle Checkpoints", "value": 1.5161237034738917, "ngenes": 328, "max_val": 8.706, "rank": 311.0, "id": "38f4062f-8e05-11ea-9953-5cf37097309a", "children": [{"source": "G2/M Checkpoints", "value": 1.5161237034738917, "ngenes": 200, "max_val": 8.706, "rank": 312.0, "id": "38f40630-8e05-11ea-a388-5cf37097309a", "children": [{"source": "G2/M DNA replication checkpoint", "value": 3.1403756106262635, "ngenes": 5, "max_val": 8.706, "rank": 34.0, "id": "38f40631-8e05-11ea-ba50-5cf37097309a"}, {"source": "G2/M DNA damage checkpoint", "value": 2.877529328454117, "ngenes": 109, "max_val": 8.706, "rank": 49.0, "id": "38f40632-8e05-11ea-93e5-5cf37097309a", "children": [{"source": "Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex", "value": 2.2274976249771457, "ngenes": 15, "max_val": 8.706, "rank": 110.0, "id": "38f40633-8e05-11ea-8316-5cf37097309a"}]}, {"source": "Activation of ATR in response to replication stress", "value": 0.9056299952939398, "ngenes": 38, "max_val": 8.706, "rank": 595.0, "id": "38f40634-8e05-11ea-a16b-5cf37097309a"}]}, {"source": "Mitotic Spindle Checkpoint", "value": 1.5642138230806937, "ngenes": 115, "max_val": 8.706, "rank": 285.0, "id": "38f40635-8e05-11ea-b96f-5cf37097309a", "children": [{"source": "Amplification of signal from the kinetochores", "value": 1.4426566730786436, "ngenes": 99, "max_val": 8.706, "rank": 337.0, "id": "38f40636-8e05-11ea-b84d-5cf37097309a", "children": [{"source": "Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal", "value": 1.4426566730786436, "ngenes": 99, "max_val": 8.706, "rank": 335.0, "id": "38f40637-8e05-11ea-818f-5cf37097309a"}]}, {"source": "Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components", "value": 1.1957209721612054, "ngenes": 20, "max_val": 8.706, "rank": 433.0, "id": "38f40638-8e05-11ea-8e8f-5cf37097309a", "children": [{"source": "Inactivation of APC/C via direct inhibition of the APC/C complex", "value": 1.1957209721612054, "ngenes": 20, "max_val": 8.706, "rank": 434.0, "id": "38f40639-8e05-11ea-b209-5cf37097309a"}]}]}, {"source": "G1/S DNA Damage Checkpoints", "value": 0.4646123127797776, "ngenes": 86, "max_val": 8.706, "rank": 1235.0, "id": "38f4063a-8e05-11ea-bfab-5cf37097309a", "children": [{"source": "p53-Dependent G1/S DNA damage checkpoint", "value": 0.4865631200748303, "ngenes": 84, "max_val": 8.706, "rank": 1131.0, "id": "38f4063b-8e05-11ea-a6c4-5cf37097309a", "children": [{"source": "p53-Dependent G1 DNA Damage Response", "value": 0.4851187072567963, "ngenes": 84, "max_val": 8.706, "rank": 1136.0, "id": "38f4063c-8e05-11ea-ad69-5cf37097309a", "children": [{"source": "Stabilization of p53", "value": 0.6670707125328029, "ngenes": 75, "max_val": 8.706, "rank": 790.0, "id": "38f4063d-8e05-11ea-b0ac-5cf37097309a", "children": [{"source": "Autodegradation of the E3 ubiquitin ligase COP1", "value": 0.6647834081114088, "ngenes": 70, "max_val": 8.706, "rank": 796.0, "id": "38f4063e-8e05-11ea-bf22-5cf37097309a"}]}, {"source": "Transcriptional activation of p53 responsive genes  ", "value": 0.5471840327551817, "ngenes": 4, "max_val": 8.706, "rank": 1016.0, "id": "38f4063f-8e05-11ea-8d7a-5cf37097309a", "children": [{"source": "Transcriptional  activation of  cell cycle inhibitor p21 ", "value": 0.5471840327551817, "ngenes": 4, "max_val": 8.706, "rank": 1012.0, "id": "38f40640-8e05-11ea-b0e6-5cf37097309a"}]}]}]}, {"source": "p53-Independent G1/S DNA damage checkpoint", "value": 0.5630777077609305, "ngenes": 70, "max_val": 8.706, "rank": 963.0, "id": "38f40641-8e05-11ea-9ac0-5cf37097309a", "children": [{"source": "p53-Independent DNA Damage Response", "value": 0.561144325293667, "ngenes": 70, "max_val": 8.706, "rank": 964.0, "id": "38f40642-8e05-11ea-bbe0-5cf37097309a", "children": [{"source": "Ubiquitin Mediated Degradation of Phosphorylated Cdc25A", "value": 0.5677987949361472, "ngenes": 70, "max_val": 8.706, "rank": 960.0, "id": "38f40643-8e05-11ea-bba2-5cf37097309a"}]}]}]}]}, {"source": "Chromosome Maintenance", "value": 3.7482115603111694, "ngenes": 112, "max_val": 8.706, "rank": 14.0, "id": "38f40644-8e05-11ea-b797-5cf37097309a", "children": [{"source": "Nucleosome assembly", "value": 2.767943920292588, "ngenes": 75, "max_val": 8.706, "rank": 53.0, "id": "38f40645-8e05-11ea-b084-5cf37097309a", "children": [{"source": "Deposition of new CENPA-containing nucleosomes at the centromere", "value": 2.767943920292588, "ngenes": 75, "max_val": 8.706, "rank": 54.0, "id": "38f40646-8e05-11ea-8b79-5cf37097309a"}]}, {"source": "Telomere Maintenance", "value": 2.248959385177685, "ngenes": 85, "max_val": 8.706, "rank": 102.0, "id": "38f40647-8e05-11ea-bc20-5cf37097309a", "children": [{"source": "Extension of Telomeres", "value": 1.7819400448321585, "ngenes": 31, "max_val": 8.706, "rank": 200.0, "id": "38f40648-8e05-11ea-b0a6-5cf37097309a", "children": [{"source": "Telomere Extension By Telomerase", "value": 1.7035302808891424, "ngenes": 7, "max_val": 8.706, "rank": 219.0, "id": "38f40649-8e05-11ea-96a3-5cf37097309a"}, {"source": "Telomere C-strand (Lagging Strand) Synthesis", "value": 1.4149636801187944, "ngenes": 24, "max_val": 8.706, "rank": 349.0, "id": "38f4064a-8e05-11ea-977a-5cf37097309a", "children": [{"source": "Telomere C-strand synthesis initiation", "value": 1.6678919263086482, "ngenes": 8, "max_val": 8.706, "rank": 228.0, "id": "38f4064b-8e05-11ea-9290-5cf37097309a"}, {"source": "Processive synthesis on the C-strand of the telomere", "value": 1.0230929066990757, "ngenes": 11, "max_val": 8.706, "rank": 532.0, "id": "38f4064c-8e05-11ea-8f9e-5cf37097309a", "children": [{"source": "Removal of the Flap Intermediate from the C-strand", "value": 1.2135544825273883, "ngenes": 10, "max_val": 8.706, "rank": 418.0, "id": "38f4064d-8e05-11ea-9dc8-5cf37097309a"}]}, {"source": "Polymerase switching on the C-strand of the telomere", "value": 0.8180223841458668, "ngenes": 14, "max_val": 8.706, "rank": 652.0, "id": "38f42bb4-8e05-11ea-98a4-5cf37097309a"}]}]}, {"source": "Packaging Of Telomere Ends", "value": 1.5805022417093255, "ngenes": 54, "max_val": 8.706, "rank": 274.0, "id": "38f42bb5-8e05-11ea-857d-5cf37097309a"}]}]}, {"source": "Meiosis", "value": 1.9486203325139888, "ngenes": 127, "max_val": 8.706, "rank": 153.0, "id": "38f42bb6-8e05-11ea-a533-5cf37097309a", "children": [{"source": "Meiotic recombination", "value": 1.7876299106393332, "ngenes": 94, "max_val": 8.706, "rank": 195.0, "id": "38f42bb7-8e05-11ea-bda5-5cf37097309a"}, {"source": "Meiotic synapsis", "value": 1.724270257946776, "ngenes": 82, "max_val": 8.706, "rank": 211.0, "id": "38f42bb8-8e05-11ea-97d5-5cf37097309a"}]}]}, {"source": "Hemostasis", "value": 1.701124773394432, "ngenes": 808, "max_val": 8.706, "rank": 220.0, "id": "38f42bb9-8e05-11ea-aa43-5cf37097309a", "children": [{"source": "Formation of Fibrin Clot (Clotting Cascade)", "value": 3.33734735977016, "ngenes": 40, "max_val": 8.706, "rank": 27.0, "id": "38f42bba-8e05-11ea-863a-5cf37097309a", "children": [{"source": "Intrinsic Pathway of Fibrin Clot Formation", "value": 3.6356032699687737, "ngenes": 22, "max_val": 8.706, "rank": 17.0, "id": "38f42bbb-8e05-11ea-b800-5cf37097309a"}, {"source": "Extrinsic Pathway of Fibrin Clot Formation", "value": 2.6316837434015983, "ngenes": 5, "max_val": 8.706, "rank": 66.0, "id": "38f42bbc-8e05-11ea-9ad2-5cf37097309a"}, {"source": "Common Pathway of Fibrin Clot Formation", "value": 2.2551113503826032, "ngenes": 23, "max_val": 8.706, "rank": 101.0, "id": "38f42bbd-8e05-11ea-9c96-5cf37097309a"}]}, {"source": "Platelet homeostasis", "value": 0.4704087176438319, "ngenes": 109, "max_val": 8.706, "rank": 1209.0, "id": "38f42bbe-8e05-11ea-a1c9-5cf37097309a", "children": [{"source": "Nitric oxide stimulates guanylate cyclase", "value": 4.000913487160708, "ngenes": 24, "max_val": 8.706, "rank": 7.0, "id": "38f42bbf-8e05-11ea-ad06-5cf37097309a", "children": [{"source": "cGMP effects", "value": 2.4625761311928502, "ngenes": 18, "max_val": 8.706, "rank": 84.0, "id": "38f42bc0-8e05-11ea-8373-5cf37097309a"}]}, {"source": "Platelet calcium homeostasis", "value": 1.120693954178978, "ngenes": 28, "max_val": 8.706, "rank": 479.0, "id": "38f42bc1-8e05-11ea-8dc6-5cf37097309a", "children": [{"source": "Elevation of cytosolic Ca2+ levels", "value": 0.7298336485079014, "ngenes": 16, "max_val": 8.706, "rank": 725.0, "id": "38f42bc2-8e05-11ea-8f74-5cf37097309a"}, {"source": "Reduction of cytosolic Ca++ levels", "value": 0.3967816616170723, "ngenes": 12, "max_val": 8.706, "rank": 1515.0, "id": "38f42bc3-8e05-11ea-b7c1-5cf37097309a"}]}, {"source": "Platelet sensitization by LDL", "value": 0.7223072136687092, "ngenes": 17, "max_val": 8.706, "rank": 736.0, "id": "38f42bc4-8e05-11ea-b3ce-5cf37097309a"}, {"source": "Prostacyclin signalling through prostacyclin receptor", "value": 0.6546837086397028, "ngenes": 40, "max_val": 8.706, "rank": 821.0, "id": "38f42bc5-8e05-11ea-a2b0-5cf37097309a"}]}, {"source": "Platelet activation, signaling and aggregation", "value": 0.9298499352260547, "ngenes": 321, "max_val": 8.706, "rank": 575.0, "id": "38f42bc6-8e05-11ea-a8aa-5cf37097309a", "children": [{"source": "Response to elevated platelet cytosolic Ca2+", "value": 1.8523227696551023, "ngenes": 141, "max_val": 8.706, "rank": 186.0, "id": "38f42bc7-8e05-11ea-8cb2-5cf37097309a", "children": [{"source": "Platelet degranulation ", "value": 1.7894309844534653, "ngenes": 136, "max_val": 8.706, "rank": 193.0, "id": "38f42bc8-8e05-11ea-8938-5cf37097309a"}, {"source": "Disinhibition of SNARE formation", "value": 0.3574248285523114, "ngenes": 5, "max_val": 8.706, "rank": 1691.0, "id": "38f42bc9-8e05-11ea-855e-5cf37097309a"}]}, {"source": "GP1b-IX-V activation signalling", "value": 0.5634689484476202, "ngenes": 12, "max_val": 8.706, "rank": 962.0, "id": "38f42bca-8e05-11ea-970b-5cf37097309a"}, {"source": "Platelet Aggregation (Plug Formation)", "value": 1.4561061147458942, "ngenes": 39, "max_val": 8.706, "rank": 332.0, "id": "38f42bcb-8e05-11ea-9231-5cf37097309a", "children": [{"source": "Integrin signaling", "value": 1.4914632628555191, "ngenes": 27, "max_val": 8.706, "rank": 318.0, "id": "38f42bcc-8e05-11ea-adb9-5cf37097309a", "children": [{"source": "p130Cas linkage to MAPK signaling for integrins", "value": 0.5471840327551817, "ngenes": 15, "max_val": 8.706, "rank": 1008.0, "id": "38f42bcd-8e05-11ea-a8bf-5cf37097309a"}, {"source": "GRB2:SOS provides linkage to MAPK signaling for Integrins ", "value": 0.3028939955380687, "ngenes": 15, "max_val": 8.706, "rank": 2053.0, "id": "38f42bce-8e05-11ea-bb6a-5cf37097309a"}]}, {"source": "Adrenaline signalling through Alpha-2 adrenergic receptor", "value": 0.5070556504709329, "ngenes": 3, "max_val": 8.706, "rank": 1082.0, "id": "38f42bcf-8e05-11ea-8f31-5cf37097309a"}]}, {"source": "Effects of PIP2 hydrolysis", "value": 0.4865631200748303, "ngenes": 28, "max_val": 8.706, "rank": 1129.0, "id": "38f42bd0-8e05-11ea-b893-5cf37097309a", "children": [{"source": "Arachidonate production from DAG", "value": 0.5024478391730836, "ngenes": 5, "max_val": 8.706, "rank": 1089.0, "id": "38f42bd1-8e05-11ea-9b43-5cf37097309a"}]}, {"source": "Thrombin signalling through proteinase activated receptors (PARs)", "value": 0.4865631200748303, "ngenes": 56, "max_val": 8.706, "rank": 1128.0, "id": "38f42bd2-8e05-11ea-8346-5cf37097309a"}, {"source": "Signal amplification", "value": 0.3574097461640464, "ngenes": 56, "max_val": 8.706, "rank": 1695.0, "id": "38f42bd3-8e05-11ea-8cad-5cf37097309a", "children": [{"source": "Thromboxane signalling through TP receptor", "value": 0.4620447057411108, "ngenes": 24, "max_val": 8.706, "rank": 1253.0, "id": "38f42bd4-8e05-11ea-9265-5cf37097309a"}, {"source": "ADP signalling through P2Y purinoceptor 12", "value": 0.4304215594493656, "ngenes": 23, "max_val": 8.706, "rank": 1365.0, "id": "38f42bd5-8e05-11ea-8512-5cf37097309a"}, {"source": "ADP signalling through P2Y purinoceptor 1", "value": 0.3321954797871033, "ngenes": 49, "max_val": 8.706, "rank": 1852.0, "id": "38f42bd6-8e05-11ea-87b4-5cf37097309a"}]}, {"source": "GPVI-mediated activation cascade", "value": 0.3705490884006152, "ngenes": 55, "max_val": 8.706, "rank": 1619.0, "id": "38f42bd7-8e05-11ea-9638-5cf37097309a"}]}, {"source": "Cell surface interactions at the vascular wall", "value": 1.5252073611613504, "ngenes": 240, "max_val": 8.706, "rank": 304.0, "id": "38f42bd8-8e05-11ea-a794-5cf37097309a", "children": [{"source": "PECAM1 interactions", "value": 1.4434837109103942, "ngenes": 13, "max_val": 8.706, "rank": 334.0, "id": "38f42bd9-8e05-11ea-b3a5-5cf37097309a"}, {"source": "Tie2 Signaling", "value": 0.3663505507769889, "ngenes": 21, "max_val": 8.706, "rank": 1638.0, "id": "38f42bda-8e05-11ea-852c-5cf37097309a"}, {"source": "Basigin interactions", "value": 0.3050811988978337, "ngenes": 26, "max_val": 8.706, "rank": 2037.0, "id": "38f42bdb-8e05-11ea-acfc-5cf37097309a"}]}, {"source": "Factors involved in megakaryocyte development and platelet production", "value": 1.0230929066990757, "ngenes": 194, "max_val": 8.706, "rank": 537.0, "id": "38f42bdc-8e05-11ea-8aec-5cf37097309a", "children": [{"source": "Kinesins", "value": 1.4247054828328074, "ngenes": 75, "max_val": 8.706, "rank": 347.0, "id": "38f42bdd-8e05-11ea-b215-5cf37097309a"}]}, {"source": "Dissolution of Fibrin Clot", "value": 1.2070420459358313, "ngenes": 14, "max_val": 8.706, "rank": 421.0, "id": "38f42bde-8e05-11ea-b8ec-5cf37097309a"}, {"source": "Platelet Adhesion to exposed collagen", "value": 0.3223732079441458, "ngenes": 26, "max_val": 8.706, "rank": 1911.0, "id": "38f42bdf-8e05-11ea-9cb6-5cf37097309a"}]}, {"source": "Disease", "value": 0.5070556504709329, "ngenes": 1397, "max_val": 8.706, "rank": 1080.0, "id": "38f42be0-8e05-11ea-b9ac-5cf37097309a", "children": [{"source": "Diseases of signal transduction", "value": 0.4731128235942158, "ngenes": 410, "max_val": 8.706, "rank": 1189.0, "id": "38f42be1-8e05-11ea-9ddf-5cf37097309a", "children": [{"source": "Signaling by NOTCH1 in Cancer", "value": 0.4313636827808811, "ngenes": 61, "max_val": 8.706, "rank": 1363.0, "id": "38f42be2-8e05-11ea-907f-5cf37097309a", "children": [{"source": "Signaling by NOTCH1 HD Domain Mutants in Cancer", "value": 3.2716172437902653, "ngenes": 16, "max_val": 8.706, "rank": 29.0, "id": "38f42be3-8e05-11ea-9c69-5cf37097309a", "children": [{"source": "Constitutive Signaling by NOTCH1 HD Domain Mutants", "value": 3.2716172437902653, "ngenes": 16, "max_val": 8.706, "rank": 30.0, "id": "38f42be4-8e05-11ea-9aad-5cf37097309a"}]}, {"source": "FBXW7 Mutants and NOTCH1 in Cancer", "value": 3.0845486535014746, "ngenes": 5, "max_val": 8.706, "rank": 39.0, "id": "38f42be5-8e05-11ea-96a7-5cf37097309a", "children": [{"source": "Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling", "value": 3.0845486535014746, "ngenes": 5, "max_val": 8.706, "rank": 37.0, "id": "38f42be6-8e05-11ea-8213-5cf37097309a"}]}, {"source": "Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant", "value": 2.7160177327246107, "ngenes": 8, "max_val": 8.706, "rank": 55.0, "id": "38f42be7-8e05-11ea-a6ef-5cf37097309a", "children": [{"source": "Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant", "value": 2.7160177327246107, "ngenes": 8, "max_val": 8.706, "rank": 57.0, "id": "38f42be8-8e05-11ea-87d1-5cf37097309a"}]}, {"source": "Signaling by NOTCH1 PEST Domain Mutants in Cancer", "value": 0.43227162991556456, "ngenes": 61, "max_val": 8.706, "rank": 1362.0, "id": "38f42be9-8e05-11ea-88c9-5cf37097309a", "children": [{"source": "Constitutive Signaling by NOTCH1 PEST Domain Mutants", "value": 0.43316717218059536, "ngenes": 61, "max_val": 8.706, "rank": 1359.0, "id": "38f42bea-8e05-11ea-8026-5cf37097309a"}]}, {"source": "Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer", "value": 0.4325258552861523, "ngenes": 61, "max_val": 8.706, "rank": 1361.0, "id": "38f42beb-8e05-11ea-957b-5cf37097309a", "children": [{"source": "Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants", "value": 0.4325258552861523, "ngenes": 61, "max_val": 8.706, "rank": 1360.0, "id": "38f42bec-8e05-11ea-913d-5cf37097309a"}]}]}, {"source": "Signaling by FGFR in disease", "value": 0.4850737434907887, "ngenes": 67, "max_val": 8.706, "rank": 1138.0, "id": "38f42bed-8e05-11ea-b180-5cf37097309a", "children": [{"source": "Signaling by FGFR1 in disease", "value": 0.3171994012961841, "ngenes": 39, "max_val": 8.706, "rank": 1933.0, "id": "38f42bee-8e05-11ea-b5ed-5cf37097309a", "children": [{"source": "FGFR1 mutant receptor activation", "value": 2.2449288700508485, "ngenes": 31, "max_val": 8.706, "rank": 105.0, "id": "38f42bef-8e05-11ea-8aa2-5cf37097309a", "children": [{"source": "Signaling by cytosolic FGFR1 fusion mutants", "value": 2.3148467674991804, "ngenes": 18, "max_val": 8.706, "rank": 97.0, "id": "38f42bf0-8e05-11ea-9ab3-5cf37097309a"}, {"source": "Signaling by plasma membrane FGFR1 fusions", "value": 0.32943830271672403, "ngenes": 3, "max_val": 8.706, "rank": 1854.0, "id": "38f42bf1-8e05-11ea-a05a-5cf37097309a"}, {"source": "Signaling by activated point mutants of FGFR1", "value": 0.3019999655757002, "ngenes": 11, "max_val": 8.706, "rank": 2072.0, "id": "38f42bf2-8e05-11ea-9962-5cf37097309a"}]}]}, {"source": "Signaling by FGFR3 in disease", "value": 0.4788365094295219, "ngenes": 23, "max_val": 8.706, "rank": 1161.0, "id": "38f42bf3-8e05-11ea-a867-5cf37097309a", "children": [{"source": "Signaling by FGFR3 fusions in cancer", "value": 0.7834513696941174, "ngenes": 11, "max_val": 8.706, "rank": 678.0, "id": "38f42bf4-8e05-11ea-bdab-5cf37097309a"}, {"source": "Signaling by FGFR3 point mutants in cancer", "value": 0.4788365094295219, "ngenes": 23, "max_val": 8.706, "rank": 1157.0, "id": "38f42bf5-8e05-11ea-8abb-5cf37097309a", "children": [{"source": "FGFR3 mutant receptor activation", "value": 0.4418086319153677, "ngenes": 12, "max_val": 8.706, "rank": 1338.0, "id": "38f42bf6-8e05-11ea-a504-5cf37097309a", "children": [{"source": "Signaling by activated point mutants of FGFR3", "value": 0.4419035080884291, "ngenes": 12, "max_val": 8.706, "rank": 1335.0, "id": "38f42bf7-8e05-11ea-98d3-5cf37097309a"}]}]}]}, {"source": "Signaling by FGFR2 in disease", "value": 0.3333488691934495, "ngenes": 47, "max_val": 8.706, "rank": 1842.0, "id": "38f42bf8-8e05-11ea-99c8-5cf37097309a", "children": [{"source": "FGFR2 mutant receptor activation", "value": 0.5471840327551817, "ngenes": 36, "max_val": 8.706, "rank": 1018.0, "id": "38f42bf9-8e05-11ea-b3ee-5cf37097309a", "children": [{"source": "Signaling by FGFR2 IIIa TM", "value": 0.5565507266078732, "ngenes": 19, "max_val": 8.706, "rank": 974.0, "id": "38f42bfa-8e05-11ea-bd6c-5cf37097309a"}, {"source": "Activated point mutants of FGFR2", "value": 0.3734982504423127, "ngenes": 17, "max_val": 8.706, "rank": 1606.0, "id": "38f42bfb-8e05-11ea-b738-5cf37097309a"}]}]}, {"source": "Signaling by FGFR4 in disease", "value": 0.41346520967708095, "ngenes": 12, "max_val": 8.706, "rank": 1444.0, "id": "38f42bfc-8e05-11ea-8e28-5cf37097309a"}]}, {"source": "Signaling by TGF-beta Receptor Complex in Cancer", "value": 0.3333488691934495, "ngenes": 8, "max_val": 8.706, "rank": 1835.0, "id": "38f42bfd-8e05-11ea-9b52-5cf37097309a", "children": [{"source": "Loss of Function of SMAD2/3 in Cancer", "value": 0.4817190664327616, "ngenes": 7, "max_val": 8.706, "rank": 1146.0, "id": "38f42bfe-8e05-11ea-8788-5cf37097309a", "children": [{"source": "SMAD2/3 Phosphorylation Motif Mutants in Cancer", "value": 1.5198387418049517, "ngenes": 6, "max_val": 8.706, "rank": 306.0, "id": "38f42bff-8e05-11ea-a2d7-5cf37097309a"}, {"source": "SMAD2/3 MH2 Domain Mutants in Cancer", "value": 0.4014171287452973, "ngenes": 3, "max_val": 8.706, "rank": 1495.0, "id": "38f42c00-8e05-11ea-85a6-5cf37097309a"}]}, {"source": "Loss of Function of TGFBR1 in Cancer", "value": 0.6662940788862453, "ngenes": 7, "max_val": 8.706, "rank": 793.0, "id": "38f42c01-8e05-11ea-9246-5cf37097309a", "children": [{"source": "TGFBR1 KD Mutants in Cancer", "value": 1.5198387418049517, "ngenes": 6, "max_val": 8.706, "rank": 307.0, "id": "38f42c02-8e05-11ea-adaf-5cf37097309a"}, {"source": "TGFBR1 LBD Mutants in Cancer", "value": 0.3984289558542966, "ngenes": 4, "max_val": 8.706, "rank": 1502.0, "id": "38f42c03-8e05-11ea-acab-5cf37097309a"}]}, {"source": "Loss of Function of TGFBR2 in Cancer", "value": 0.4704952658544049, "ngenes": 3, "max_val": 8.706, "rank": 1203.0, "id": "38f42c04-8e05-11ea-b10f-5cf37097309a", "children": [{"source": "TGFBR2 MSI Frameshift Mutants in Cancer", "value": 0.5023596675057564, "ngenes": 2, "max_val": 8.706, "rank": 1090.0, "id": "38f42c05-8e05-11ea-9747-5cf37097309a"}, {"source": "TGFBR2 Kinase Domain Mutants in Cancer", "value": 0.4704952658544049, "ngenes": 3, "max_val": 8.706, "rank": 1208.0, "id": "38f42c06-8e05-11ea-8f87-5cf37097309a"}]}, {"source": "Loss of Function of SMAD4 in Cancer", "value": 0.4022091594852065, "ngenes": 3, "max_val": 8.706, "rank": 1491.0, "id": "38f42c07-8e05-11ea-bde0-5cf37097309a", "children": [{"source": "SMAD4 MH2 Domain Mutants in Cancer", "value": 0.4008234554238711, "ngenes": 3, "max_val": 8.706, "rank": 1496.0, "id": "38f42c08-8e05-11ea-a863-5cf37097309a"}]}]}, {"source": "PI3K/AKT Signaling in Cancer", "value": 1.6917814984203143, "ngenes": 103, "max_val": 8.706, "rank": 222.0, "id": "38f42c09-8e05-11ea-9376-5cf37097309a", "children": [{"source": "Constitutive Signaling by Aberrant PI3K in Cancer", "value": 1.4088178542982623, "ngenes": 75, "max_val": 8.706, "rank": 354.0, "id": "38f42c0a-8e05-11ea-bf57-5cf37097309a"}, {"source": "Constitutive Signaling by AKT1 E17K in Cancer", "value": 0.4548063126614417, "ngenes": 27, "max_val": 8.706, "rank": 1263.0, "id": "38f42c0b-8e05-11ea-a603-5cf37097309a"}]}, {"source": "Signaling by EGFR in Cancer", "value": 0.3678618516057002, "ngenes": 26, "max_val": 8.706, "rank": 1629.0, "id": "38f42c0c-8e05-11ea-9863-5cf37097309a", "children": [{"source": "Signaling by Overexpressed Wild-Type EGFR in Cancer", "value": 0.928472844982223, "ngenes": 8, "max_val": 8.706, "rank": 578.0, "id": "38f42c0d-8e05-11ea-bbfa-5cf37097309a", "children": [{"source": "Inhibition of Signaling by Overexpressed EGFR", "value": 0.928472844982223, "ngenes": 8, "max_val": 8.706, "rank": 579.0, "id": "38f42c0e-8e05-11ea-a718-5cf37097309a"}]}, {"source": "Signaling by EGFRvIII in Cancer", "value": 0.4167706555651146, "ngenes": 16, "max_val": 8.706, "rank": 1417.0, "id": "38f42c0f-8e05-11ea-9cdb-5cf37097309a", "children": [{"source": "Constitutive Signaling by EGFRvIII", "value": 0.4170254099451946, "ngenes": 16, "max_val": 8.706, "rank": 1416.0, "id": "38f42c10-8e05-11ea-b57f-5cf37097309a"}]}, {"source": "Signaling by Ligand-Responsive EGFR Variants in Cancer", "value": 0.3475211864393831, "ngenes": 20, "max_val": 8.706, "rank": 1766.0, "id": "38f42c11-8e05-11ea-af04-5cf37097309a", "children": [{"source": "Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants", "value": 0.3473777131540049, "ngenes": 20, "max_val": 8.706, "rank": 1767.0, "id": "38f42c12-8e05-11ea-a5c0-5cf37097309a"}]}]}, {"source": "Oncogenic MAPK signaling", "value": 0.44227409954858976, "ngenes": 74, "max_val": 8.706, "rank": 1322.0, "id": "38f42c13-8e05-11ea-95ee-5cf37097309a", "children": [{"source": "Signaling by high-kinase activity BRAF mutants", "value": 0.6511705749423734, "ngenes": 37, "max_val": 8.706, "rank": 828.0, "id": "38f42c14-8e05-11ea-8fc4-5cf37097309a"}, {"source": "Signaling by moderate kinase activity BRAF mutants", "value": 0.3827810609356897, "ngenes": 46, "max_val": 8.706, "rank": 1580.0, "id": "38f42c15-8e05-11ea-82bf-5cf37097309a"}, {"source": "Signaling by RAS mutants", "value": 0.3774121429253873, "ngenes": 46, "max_val": 8.706, "rank": 1590.0, "id": "38f42c16-8e05-11ea-971e-5cf37097309a", "children": [{"source": "Signaling downstream of RAS mutants", "value": 0.3789602593706693, "ngenes": 46, "max_val": 8.706, "rank": 1585.0, "id": "38f42c17-8e05-11ea-8472-5cf37097309a"}, {"source": "RAS GTPase cycle mutants", "value": 0.37229868455505055, "ngenes": 4, "max_val": 8.706, "rank": 1613.0, "id": "38f42c18-8e05-11ea-8081-5cf37097309a"}]}, {"source": "Paradoxical activation of RAF signaling by kinase inactive BRAF", "value": 0.3774121429253873, "ngenes": 46, "max_val": 8.706, "rank": 1591.0, "id": "38f42c19-8e05-11ea-9c0d-5cf37097309a"}, {"source": "RAS signaling downstream of NF1 loss-of-function variants", "value": 0.3369350433320172, "ngenes": 8, "max_val": 8.706, "rank": 1813.0, "id": "38f42c1a-8e05-11ea-a862-5cf37097309a"}, {"source": "Signaling by BRAF and RAF fusions", "value": 0.32029037862335463, "ngenes": 67, "max_val": 8.706, "rank": 1916.0, "id": "38f42c1b-8e05-11ea-9312-5cf37097309a"}]}, {"source": "Signaling by WNT in cancer", "value": 0.603246594200587, "ngenes": 35, "max_val": 8.706, "rank": 914.0, "id": "38f42c1c-8e05-11ea-9e4c-5cf37097309a", "children": [{"source": "Misspliced GSK3beta mutants stabilize beta-catenin", "value": 0.6241412736333948, "ngenes": 15, "max_val": 8.706, "rank": 881.0, "id": "38f42c1d-8e05-11ea-a9e1-5cf37097309a"}, {"source": "phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex", "value": 0.6156480966272587, "ngenes": 15, "max_val": 8.706, "rank": 895.0, "id": "38f42c1e-8e05-11ea-b815-5cf37097309a", "children": [{"source": "S37 mutants of beta-catenin aren't phosphorylated", "value": 0.6180023629967516, "ngenes": 15, "max_val": 8.706, "rank": 888.0, "id": "38f42c1f-8e05-11ea-8a47-5cf37097309a"}, {"source": "T41 mutants of beta-catenin aren't phosphorylated", "value": 0.6180023629967516, "ngenes": 15, "max_val": 8.706, "rank": 889.0, "id": "38f42c20-8e05-11ea-8db6-5cf37097309a"}, {"source": "S45 mutants of beta-catenin aren't phosphorylated", "value": 0.6162197498177749, "ngenes": 15, "max_val": 8.706, "rank": 892.0, "id": "38f42c21-8e05-11ea-84da-5cf37097309a"}, {"source": "S33 mutants of beta-catenin aren't phosphorylated", "value": 0.6156480966272587, "ngenes": 15, "max_val": 8.706, "rank": 894.0, "id": "38f42c22-8e05-11ea-9d8d-5cf37097309a"}]}, {"source": "RNF mutants show enhanced WNT signaling and proliferation", "value": 0.6065267598638269, "ngenes": 9, "max_val": 8.706, "rank": 906.0, "id": "38f42c23-8e05-11ea-a50c-5cf37097309a"}, {"source": "AMER1 mutants destabilize the destruction complex", "value": 0.4287036694369606, "ngenes": 14, "max_val": 8.706, "rank": 1370.0, "id": "38f42c24-8e05-11ea-b3b7-5cf37097309a", "children": [{"source": "Truncations of AMER1 destabilize the destruction complex", "value": 0.4287036694369606, "ngenes": 14, "max_val": 8.706, "rank": 1369.0, "id": "38f42c25-8e05-11ea-b51e-5cf37097309a"}]}, {"source": "AXIN mutants destabilize the destruction complex, activating WNT signaling", "value": 0.4266462015709692, "ngenes": 14, "max_val": 8.706, "rank": 1373.0, "id": "38f42c26-8e05-11ea-9c6c-5cf37097309a", "children": [{"source": "AXIN missense mutants destabilize the destruction complex", "value": 0.4282645668527017, "ngenes": 14, "max_val": 8.706, "rank": 1372.0, "id": "38f42c27-8e05-11ea-9991-5cf37097309a"}]}, {"source": "truncated APC mutants destabilize the destruction complex", "value": 0.4266462015709692, "ngenes": 14, "max_val": 8.706, "rank": 1381.0, "id": "38f42c28-8e05-11ea-b20c-5cf37097309a", "children": [{"source": "APC truncation mutants have impaired AXIN binding", "value": 0.4266462015709692, "ngenes": 14, "max_val": 8.706, "rank": 1374.0, "id": "38f42c29-8e05-11ea-83f0-5cf37097309a"}]}, {"source": "TCF7L2 mutants don't bind CTBP", "value": 0.3984289558542966, "ngenes": 3, "max_val": 8.706, "rank": 1500.0, "id": "38f42c2a-8e05-11ea-84a5-5cf37097309a"}, {"source": "Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling", "value": 0.3416738873259401, "ngenes": 6, "max_val": 8.706, "rank": 1783.0, "id": "38f42c2b-8e05-11ea-a749-5cf37097309a"}]}, {"source": "Signaling by ERBB2 in Cancer", "value": 0.6546837086397028, "ngenes": 27, "max_val": 8.706, "rank": 820.0, "id": "38f42c2c-8e05-11ea-8d2c-5cf37097309a", "children": [{"source": "Constitutive Signaling by Overexpressed ERBB2", "value": 0.6236208770428966, "ngenes": 12, "max_val": 8.706, "rank": 883.0, "id": "38f42c2d-8e05-11ea-a620-5cf37097309a"}, {"source": "Drug resistance in ERBB2 KD mutants", "value": 0.44227409954858976, "ngenes": 4, "max_val": 8.706, "rank": 1321.0, "id": "38f42c2e-8e05-11ea-aa48-5cf37097309a", "children": [{"source": "Resistance of ERBB2 KD mutants to sapitinib", "value": 0.4477733315881959, "ngenes": 4, "max_val": 8.706, "rank": 1277.0, "id": "38f42c2f-8e05-11ea-8beb-5cf37097309a"}, {"source": "Resistance of ERBB2 KD mutants to osimertinib", "value": 0.4444360105185445, "ngenes": 4, "max_val": 8.706, "rank": 1282.0, "id": "38f42c30-8e05-11ea-84c0-5cf37097309a"}, {"source": "Resistance of ERBB2 KD mutants to trastuzumab", "value": 0.4428241493344547, "ngenes": 4, "max_val": 8.706, "rank": 1285.0, "id": "38f42c31-8e05-11ea-909a-5cf37097309a"}, {"source": "Resistance of ERBB2 KD mutants to afatinib", "value": 0.4428241493344547, "ngenes": 4, "max_val": 8.706, "rank": 1286.0, "id": "38f42c32-8e05-11ea-82dd-5cf37097309a"}, {"source": "Resistance of ERBB2 KD mutants to tesevatinib", "value": 0.44227409954858976, "ngenes": 4, "max_val": 8.706, "rank": 1294.0, "id": "38f42c33-8e05-11ea-9206-5cf37097309a"}, {"source": "Resistance of ERBB2 KD mutants to AEE788", "value": 0.44227409954858976, "ngenes": 4, "max_val": 8.706, "rank": 1311.0, "id": "38f42c34-8e05-11ea-85bb-5cf37097309a"}, {"source": "Resistance of ERBB2 KD mutants to neratinib", "value": 0.44227409954858976, "ngenes": 4, "max_val": 8.706, "rank": 1324.0, "id": "38f42c35-8e05-11ea-ba69-5cf37097309a"}, {"source": "Resistance of ERBB2 KD mutants to lapatinib", "value": 0.44227409954858976, "ngenes": 4, "max_val": 8.706, "rank": 1330.0, "id": "38f42c36-8e05-11ea-8b41-5cf37097309a"}]}, {"source": "Signaling by ERBB2 KD Mutants", "value": 0.3054605019195545, "ngenes": 26, "max_val": 8.706, "rank": 2028.0, "id": "38f42c37-8e05-11ea-87c9-5cf37097309a"}]}, {"source": "Hh mutants abrogate ligand secretion", "value": 0.7561293692766552, "ngenes": 78, "max_val": 8.706, "rank": 699.0, "id": "38f42c38-8e05-11ea-a7e1-5cf37097309a", "children": [{"source": "Hh mutants that don't undergo autocatalytic processing are degraded by ERAD", "value": 0.5864478440977111, "ngenes": 74, "max_val": 8.706, "rank": 939.0, "id": "38f42c39-8e05-11ea-91e1-5cf37097309a"}, {"source": "HHAT G278V abrogates palmitoylation of Hh-Np", "value": 0.4266462015709692, "ngenes": 5, "max_val": 8.706, "rank": 1380.0, "id": "38f42c3a-8e05-11ea-9261-5cf37097309a"}]}, {"source": "Diseases associated with visual transduction", "value": 0.3787218054158285, "ngenes": 14, "max_val": 8.706, "rank": 1587.0, "id": "38f42c3b-8e05-11ea-b262-5cf37097309a", "children": [{"source": "Retinoid cycle disease events", "value": 0.3787218054158285, "ngenes": 14, "max_val": 8.706, "rank": 1588.0, "id": "38f42c3c-8e05-11ea-b555-5cf37097309a", "children": [{"source": "Biosynthesis of A2E, implicated in retinal degradation", "value": 0.5434727133266248, "ngenes": 2, "max_val": 8.706, "rank": 1026.0, "id": "38f42c3d-8e05-11ea-84d2-5cf37097309a"}]}]}]}, {"source": "Neurodegenerative Diseases", "value": 2.877529328454117, "ngenes": 31, "max_val": 8.706, "rank": 48.0, "id": "38f45398-8e05-11ea-b164-5cf37097309a", "children": [{"source": "Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models", "value": 2.877529328454117, "ngenes": 31, "max_val": 8.706, "rank": 46.0, "id": "38f45399-8e05-11ea-8a1d-5cf37097309a"}]}, {"source": "Diseases of glycosylation", "value": 1.2070420459358313, "ngenes": 161, "max_val": 8.706, "rank": 422.0, "id": "38f4539a-8e05-11ea-8719-5cf37097309a", "children": [{"source": "Diseases associated with O-glycosylation of proteins", "value": 3.2137200627126665, "ngenes": 79, "max_val": 8.706, "rank": 31.0, "id": "38f4539b-8e05-11ea-a2d7-5cf37097309a", "children": [{"source": "Defective LFNG causes SCDO3", "value": 1.9846503791724424, "ngenes": 8, "max_val": 8.706, "rank": 143.0, "id": "38f4539c-8e05-11ea-b3aa-5cf37097309a"}, {"source": "Defective B3GALTL causes Peters-plus syndrome (PpS)", "value": 1.8263202721526164, "ngenes": 40, "max_val": 8.706, "rank": 188.0, "id": "38f4539d-8e05-11ea-be6b-5cf37097309a"}, {"source": "Defective LARGE causes MDDGA6 and MDDGB6", "value": 0.9146572636402835, "ngenes": 2, "max_val": 8.706, "rank": 585.0, "id": "38f4539e-8e05-11ea-af1f-5cf37097309a"}, {"source": "Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2", "value": 0.7263568752464411, "ngenes": 3, "max_val": 8.706, "rank": 727.0, "id": "38f4539f-8e05-11ea-ad8c-5cf37097309a"}, {"source": "Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1", "value": 0.7234247428597694, "ngenes": 3, "max_val": 8.706, "rank": 730.0, "id": "38f453a0-8e05-11ea-841a-5cf37097309a"}, {"source": "Defective GALNT12 causes colorectal cancer 1 (CRCS1)", "value": 0.4151266266704886, "ngenes": 22, "max_val": 8.706, "rank": 1440.0, "id": "38f453a1-8e05-11ea-99c3-5cf37097309a"}, {"source": "Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3", "value": 0.3849420497242914, "ngenes": 2, "max_val": 8.706, "rank": 1558.0, "id": "38f453a2-8e05-11ea-abb4-5cf37097309a"}, {"source": "Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)", "value": 0.3510645151402919, "ngenes": 22, "max_val": 8.706, "rank": 1736.0, "id": "38f453a3-8e05-11ea-aa32-5cf37097309a"}, {"source": "Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)", "value": 0.3288714815669623, "ngenes": 23, "max_val": 8.706, "rank": 1860.0, "id": "38f453a4-8e05-11ea-ba98-5cf37097309a"}]}, {"source": "Diseases associated with glycosaminoglycan metabolism", "value": 0.7561293692766552, "ngenes": 41, "max_val": 8.706, "rank": 700.0, "id": "38f453a5-8e05-11ea-a04f-5cf37097309a", "children": [{"source": "Defective CHST3 causes SEDCJD", "value": 1.235370081966744, "ngenes": 8, "max_val": 8.706, "rank": 409.0, "id": "38f453a6-8e05-11ea-b14c-5cf37097309a"}, {"source": "Defective CHSY1 causes TPBS", "value": 0.9478742831410916, "ngenes": 8, "max_val": 8.706, "rank": 569.0, "id": "38f453a7-8e05-11ea-956d-5cf37097309a"}, {"source": "Defective B4GALT7 causes EDS, progeroid type", "value": 0.9056299952939398, "ngenes": 20, "max_val": 8.706, "rank": 596.0, "id": "38f453a8-8e05-11ea-bf5c-5cf37097309a"}, {"source": "Defective B3GALT6 causes EDSP2 and SEMDJL1", "value": 0.8863337244260859, "ngenes": 20, "max_val": 8.706, "rank": 613.0, "id": "38f453a9-8e05-11ea-b3f7-5cf37097309a"}, {"source": "Defective B3GAT3 causes JDSSDHD", "value": 0.8493554075691849, "ngenes": 20, "max_val": 8.706, "rank": 637.0, "id": "38f453aa-8e05-11ea-9f76-5cf37097309a"}, {"source": "Defective CHST14 causes EDS, musculocontractural type", "value": 0.7390898562975314, "ngenes": 8, "max_val": 8.706, "rank": 715.0, "id": "38f453ab-8e05-11ea-8f36-5cf37097309a"}, {"source": "Defective EXT1 causes exostoses 1, TRPS2 and CHDS", "value": 0.6533504283858577, "ngenes": 14, "max_val": 8.706, "rank": 825.0, "id": "38f453ac-8e05-11ea-bafd-5cf37097309a"}, {"source": "Defective EXT2 causes exostoses 2", "value": 0.6516618261399026, "ngenes": 14, "max_val": 8.706, "rank": 827.0, "id": "38f453ad-8e05-11ea-8868-5cf37097309a"}, {"source": "Defective ST3GAL3 causes MCT12 and EIEE15", "value": 0.4514326563741269, "ngenes": 8, "max_val": 8.706, "rank": 1273.0, "id": "38f453ae-8e05-11ea-88b1-5cf37097309a"}, {"source": "Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)", "value": 0.4166701851996452, "ngenes": 2, "max_val": 8.706, "rank": 1421.0, "id": "38f453af-8e05-11ea-9424-5cf37097309a"}, {"source": "Defective CHST6 causes MCDC1", "value": 0.3411564189282697, "ngenes": 8, "max_val": 8.706, "rank": 1792.0, "id": "38f453b0-8e05-11ea-9474-5cf37097309a"}]}, {"source": "Diseases associated with glycosylation precursor biosynthesis", "value": 0.698859115893927, "ngenes": 25, "max_val": 8.706, "rank": 760.0, "id": "38f453b1-8e05-11ea-8e68-5cf37097309a", "children": [{"source": "Defective DPM1 causes DPM1-CDG (CDG-1e)", "value": 1.1957209721612054, "ngenes": 3, "max_val": 8.706, "rank": 436.0, "id": "38f453b2-8e05-11ea-9fa7-5cf37097309a"}, {"source": "Defective DPM2 causes DPM2-CDG (CDG-1u)", "value": 1.1957209721612054, "ngenes": 3, "max_val": 8.706, "rank": 437.0, "id": "38f453b3-8e05-11ea-a714-5cf37097309a"}, {"source": "Defective DPM3 causes DPM3-CDG (CDG-1o)", "value": 1.1957209721612054, "ngenes": 3, "max_val": 8.706, "rank": 439.0, "id": "38f453b4-8e05-11ea-9d53-5cf37097309a"}, {"source": "Defective NEU1 causes sialidosis", "value": 0.5471840327551817, "ngenes": 10, "max_val": 8.706, "rank": 1015.0, "id": "38f453b5-8e05-11ea-88ba-5cf37097309a"}, {"source": "Defective DHDDS causes retinitis pigmentosa 59", "value": 0.4780077744234615, "ngenes": 2, "max_val": 8.706, "rank": 1177.0, "id": "38f453b6-8e05-11ea-a25a-5cf37097309a"}]}, {"source": "Diseases associated with N-glycosylation of proteins", "value": 1.0729001168503527, "ngenes": 17, "max_val": 8.706, "rank": 488.0, "id": "38f453b7-8e05-11ea-955f-5cf37097309a", "children": [{"source": "Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)", "value": 1.030292207154635, "ngenes": 2, "max_val": 8.706, "rank": 524.0, "id": "38f453b8-8e05-11ea-ab56-5cf37097309a"}, {"source": "Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)", "value": 0.4166701851996452, "ngenes": 2, "max_val": 8.706, "rank": 1421.0, "id": "38f453b9-8e05-11ea-85ee-5cf37097309a"}]}]}, {"source": "Infectious disease", "value": 0.3271542772980752, "ngenes": 655, "max_val": 8.706, "rank": 1890.0, "id": "38f453ba-8e05-11ea-b9fb-5cf37097309a", "children": [{"source": "HCMV Infection", "value": 1.91522512138709, "ngenes": 171, "max_val": 8.706, "rank": 169.0, "id": "38f453bb-8e05-11ea-b5f4-5cf37097309a", "children": [{"source": "HCMV Late Events", "value": 1.7876299106393332, "ngenes": 121, "max_val": 8.706, "rank": 198.0, "id": "38f453bc-8e05-11ea-8858-5cf37097309a"}, {"source": "HCMV Early Events", "value": 1.735693857640123, "ngenes": 145, "max_val": 8.706, "rank": 206.0, "id": "38f453bd-8e05-11ea-9972-5cf37097309a"}]}, {"source": "Influenza Infection", "value": 0.7073571356562612, "ngenes": 179, "max_val": 8.706, "rank": 753.0, "id": "38f453be-8e05-11ea-a67d-5cf37097309a", "children": [{"source": "Influenza Life Cycle", "value": 0.6286195179544306, "ngenes": 167, "max_val": 8.706, "rank": 875.0, "id": "38f453bf-8e05-11ea-ad71-5cf37097309a", "children": [{"source": "Export of Viral Ribonucleoproteins from Nucleus", "value": 0.421803881582456, "ngenes": 38, "max_val": 8.706, "rank": 1405.0, "id": "38f453c0-8e05-11ea-a43f-5cf37097309a", "children": [{"source": "Viral RNP Complexes in the Host Cell Nucleus", "value": 1.4791261008213858, "ngenes": 5, "max_val": 8.706, "rank": 320.0, "id": "38f453c1-8e05-11ea-bdc1-5cf37097309a"}, {"source": "NEP/NS2 Interacts with the Cellular Export Machinery", "value": 0.3894910406723921, "ngenes": 33, "max_val": 8.706, "rank": 1545.0, "id": "38f453c2-8e05-11ea-b7d3-5cf37097309a"}]}, {"source": "Entry of Influenza Virion into Host Cell via Endocytosis", "value": 0.5956993858052144, "ngenes": 2, "max_val": 8.706, "rank": 927.0, "id": "38f453c3-8e05-11ea-a455-5cf37097309a"}, {"source": "Influenza Viral RNA Transcription and Replication", "value": 0.4707526078558774, "ngenes": 153, "max_val": 8.706, "rank": 1197.0, "id": "38f453c4-8e05-11ea-b876-5cf37097309a", "children": [{"source": "vRNP Assembly", "value": 0.4151266266704886, "ngenes": 2, "max_val": 8.706, "rank": 1441.0, "id": "38f453c5-8e05-11ea-9196-5cf37097309a"}, {"source": "Viral Messenger RNA Synthesis", "value": 0.3845554833325704, "ngenes": 45, "max_val": 8.706, "rank": 1572.0, "id": "38f453c6-8e05-11ea-b194-5cf37097309a"}, {"source": "Viral mRNA Translation", "value": 0.3128507621405376, "ngenes": 106, "max_val": 8.706, "rank": 1985.0, "id": "38f453c7-8e05-11ea-b18c-5cf37097309a"}]}, {"source": "Transport of Ribonucleoproteins into the Host Nucleus", "value": 0.3483210271800589, "ngenes": 33, "max_val": 8.706, "rank": 1751.0, "id": "38f453c8-8e05-11ea-9e28-5cf37097309a"}]}, {"source": "Host Interactions with Influenza Factors", "value": 0.3968889352052267, "ngenes": 45, "max_val": 8.706, "rank": 1514.0, "id": "38f453c9-8e05-11ea-bfe1-5cf37097309a", "children": [{"source": "NS1 Mediated Effects on Host Pathways", "value": 0.3969417908279325, "ngenes": 43, "max_val": 8.706, "rank": 1512.0, "id": "38f453ca-8e05-11ea-8782-5cf37097309a", "children": [{"source": "Inhibition of Host mRNA Processing and RNA Silencing", "value": 0.4026839496616447, "ngenes": 2, "max_val": 8.706, "rank": 1490.0, "id": "38f453cb-8e05-11ea-abe5-5cf37097309a"}]}]}]}, {"source": "Infection with Mycobacterium tuberculosis", "value": 0.3610331014271911, "ngenes": 33, "max_val": 8.706, "rank": 1654.0, "id": "38f453cc-8e05-11ea-b185-5cf37097309a", "children": [{"source": "Response of Mtb to phagocytosis", "value": 0.3333488691934495, "ngenes": 28, "max_val": 8.706, "rank": 1844.0, "id": "38f453cd-8e05-11ea-90e0-5cf37097309a", "children": [{"source": "Suppression of phagosomal maturation", "value": 0.4151266266704886, "ngenes": 13, "max_val": 8.706, "rank": 1439.0, "id": "38f453ce-8e05-11ea-b910-5cf37097309a", "children": [{"source": "Inhibition of nitric oxide production", "value": 1.3103188900005018, "ngenes": 3, "max_val": 8.706, "rank": 387.0, "id": "38f453cf-8e05-11ea-be96-5cf37097309a"}, {"source": "Prevention of phagosomal-lysosomal fusion", "value": 0.3510645151402919, "ngenes": 9, "max_val": 8.706, "rank": 1733.0, "id": "38f453d0-8e05-11ea-b6a9-5cf37097309a"}]}, {"source": "Suppression of apoptosis", "value": 0.5934456702094588, "ngenes": 11, "max_val": 8.706, "rank": 928.0, "id": "38f453d1-8e05-11ea-9756-5cf37097309a"}, {"source": "Manipulation of host energy metabolism", "value": 0.5110429122928255, "ngenes": 2, "max_val": 8.706, "rank": 1061.0, "id": "38f453d2-8e05-11ea-8668-5cf37097309a"}, {"source": "Suppression of autophagy", "value": 0.4165866033279961, "ngenes": 3, "max_val": 8.706, "rank": 1431.0, "id": "38f453d3-8e05-11ea-92fc-5cf37097309a"}]}, {"source": "Modulation by Mtb of host immune system", "value": 0.3054605019195545, "ngenes": 8, "max_val": 8.706, "rank": 2029.0, "id": "38f453d4-8e05-11ea-89aa-5cf37097309a"}]}, {"source": "HIV Infection", "value": 0.4707526078558774, "ngenes": 335, "max_val": 8.706, "rank": 1199.0, "id": "38f453d5-8e05-11ea-99a8-5cf37097309a", "children": [{"source": "HIV Life Cycle", "value": 0.5565507266078732, "ngenes": 198, "max_val": 8.706, "rank": 970.0, "id": "38f453d6-8e05-11ea-84dd-5cf37097309a", "children": [{"source": "Late Phase of HIV Life Cycle", "value": 0.5964891032919118, "ngenes": 185, "max_val": 8.706, "rank": 923.0, "id": "38f453d7-8e05-11ea-b95a-5cf37097309a", "children": [{"source": "Transcription of the HIV genome", "value": 0.31211243572932124, "ngenes": 116, "max_val": 8.706, "rank": 1988.0, "id": "38f453d8-8e05-11ea-8d82-5cf37097309a", "children": [{"source": "HIV Transcription Initiation", "value": 1.2070420459358313, "ngenes": 57, "max_val": 8.706, "rank": 426.0, "id": "38f453d9-8e05-11ea-b41c-5cf37097309a"}, {"source": "RNA Polymerase II HIV Promoter Escape", "value": 1.2070420459358313, "ngenes": 57, "max_val": 8.706, "rank": 429.0, "id": "38f453da-8e05-11ea-8199-5cf37097309a"}, {"source": "RNA Pol II CTD phosphorylation and interaction with CE during HIV infection", "value": 0.9507977267366129, "ngenes": 35, "max_val": 8.706, "rank": 566.0, "id": "38f453db-8e05-11ea-88f9-5cf37097309a"}, {"source": "HIV Transcription Elongation", "value": 0.5722592952759611, "ngenes": 87, "max_val": 8.706, "rank": 955.0, "id": "38f453dc-8e05-11ea-8ba1-5cf37097309a", "children": [{"source": "Abortive elongation of HIV-1 transcript in the absence of Tat", "value": 0.7254329041975404, "ngenes": 28, "max_val": 8.706, "rank": 729.0, "id": "38f453dd-8e05-11ea-bf74-5cf37097309a"}, {"source": "Tat-mediated elongation of the HIV-1 transcript", "value": 0.5753792348651889, "ngenes": 87, "max_val": 8.706, "rank": 950.0, "id": "38f453de-8e05-11ea-86ec-5cf37097309a", "children": [{"source": "Formation of HIV-1 elongation complex containing HIV-1 Tat", "value": 0.5736268881952109, "ngenes": 87, "max_val": 8.706, "rank": 952.0, "id": "38f453df-8e05-11ea-a9fe-5cf37097309a"}]}, {"source": "Formation of the HIV-1 Early Elongation Complex", "value": 0.5104201517191181, "ngenes": 46, "max_val": 8.706, "rank": 1066.0, "id": "38f453e0-8e05-11ea-980d-5cf37097309a"}]}, {"source": "Formation of HIV elongation complex in the absence of HIV Tat", "value": 0.6388865419450723, "ngenes": 61, "max_val": 8.706, "rank": 852.0, "id": "38f453e1-8e05-11ea-a277-5cf37097309a"}, {"source": "Pausing and recovery of Tat-mediated HIV elongation", "value": 0.4237924916712859, "ngenes": 39, "max_val": 8.706, "rank": 1385.0, "id": "38f453e2-8e05-11ea-aec8-5cf37097309a"}, {"source": "Tat-mediated HIV elongation arrest and recovery", "value": 0.4237924916712859, "ngenes": 39, "max_val": 8.706, "rank": 1386.0, "id": "38f453e3-8e05-11ea-a78c-5cf37097309a"}, {"source": "HIV elongation arrest and recovery", "value": 0.3846942455040212, "ngenes": 41, "max_val": 8.706, "rank": 1568.0, "id": "38f453e4-8e05-11ea-a4bc-5cf37097309a"}, {"source": "Pausing and recovery of HIV elongation", "value": 0.3846942455040212, "ngenes": 41, "max_val": 8.706, "rank": 1569.0, "id": "38f453e5-8e05-11ea-bb18-5cf37097309a"}]}, {"source": "Assembly Of The HIV Virion", "value": 0.4627309951511139, "ngenes": 17, "max_val": 8.706, "rank": 1244.0, "id": "38f453e6-8e05-11ea-aeb0-5cf37097309a", "children": [{"source": "Synthesis And Processing Of GAG, GAGPOL Polyproteins", "value": 1.0291225946186895, "ngenes": 15, "max_val": 8.706, "rank": 526.0, "id": "38f453e7-8e05-11ea-9f44-5cf37097309a", "children": [{"source": "Membrane binding and targetting of GAG proteins", "value": 1.0291225946186895, "ngenes": 15, "max_val": 8.706, "rank": 525.0, "id": "38f453e8-8e05-11ea-9692-5cf37097309a"}]}]}, {"source": "Budding and maturation of HIV virion", "value": 1.0252185178108288, "ngenes": 30, "max_val": 8.706, "rank": 528.0, "id": "38f453e9-8e05-11ea-9d9a-5cf37097309a"}, {"source": "Rev-mediated nuclear export of HIV RNA", "value": 0.40594021400370056, "ngenes": 36, "max_val": 8.706, "rank": 1470.0, "id": "38f453ea-8e05-11ea-b85b-5cf37097309a"}]}, {"source": "Early Phase of HIV Life Cycle", "value": 1.9611870398104247, "ngenes": 14, "max_val": 8.706, "rank": 146.0, "id": "38f453eb-8e05-11ea-bce0-5cf37097309a", "children": [{"source": "Integration of provirus", "value": 1.312509161686529, "ngenes": 9, "max_val": 8.706, "rank": 385.0, "id": "38f453ec-8e05-11ea-a9be-5cf37097309a", "children": [{"source": "2-LTR circle formation", "value": 0.714245852972956, "ngenes": 7, "max_val": 8.706, "rank": 748.0, "id": "38f453ed-8e05-11ea-8fb3-5cf37097309a"}, {"source": "Integration of viral DNA into host genomic DNA", "value": 0.4788365094295219, "ngenes": 3, "max_val": 8.706, "rank": 1156.0, "id": "38f453ee-8e05-11ea-8c07-5cf37097309a"}, {"source": "Autointegration results in viral DNA circles", "value": 0.4788365094295219, "ngenes": 3, "max_val": 8.706, "rank": 1159.0, "id": "38f453ef-8e05-11ea-9b91-5cf37097309a"}]}, {"source": "Binding and entry of HIV virion", "value": 0.6719816064619923, "ngenes": 4, "max_val": 8.706, "rank": 784.0, "id": "38f453f0-8e05-11ea-bb2d-5cf37097309a"}]}]}, {"source": "Host Interactions of HIV factors", "value": 0.6568523944177979, "ngenes": 185, "max_val": 8.706, "rank": 818.0, "id": "38f453f1-8e05-11ea-b41c-5cf37097309a", "children": [{"source": "The role of Nef in HIV-1 replication and disease pathogenesis", "value": 0.5471840327551817, "ngenes": 30, "max_val": 8.706, "rank": 1021.0, "id": "38f453f2-8e05-11ea-ada2-5cf37097309a", "children": [{"source": "Nef and signal transduction", "value": 0.8136861371731582, "ngenes": 8, "max_val": 8.706, "rank": 660.0, "id": "38f453f3-8e05-11ea-b4fe-5cf37097309a"}, {"source": "Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters", "value": 0.44227409954858976, "ngenes": 23, "max_val": 8.706, "rank": 1326.0, "id": "38f453f4-8e05-11ea-afef-5cf37097309a", "children": [{"source": "Nef mediated downregulation of CD28 cell surface expression", "value": 0.7260301474412532, "ngenes": 2, "max_val": 8.706, "rank": 728.0, "id": "38f453f5-8e05-11ea-b4bd-5cf37097309a"}, {"source": "Nef Mediated CD8 Down-regulation", "value": 0.6669049491165079, "ngenes": 7, "max_val": 8.706, "rank": 791.0, "id": "38f453f6-8e05-11ea-b215-5cf37097309a"}, {"source": "Nef Mediated CD4 Down-regulation", "value": 0.4059605972690797, "ngenes": 9, "max_val": 8.706, "rank": 1468.0, "id": "38f453f7-8e05-11ea-99cc-5cf37097309a"}, {"source": "Nef mediated downregulation of MHC class I complex cell surface expression", "value": 0.3663505507769889, "ngenes": 12, "max_val": 8.706, "rank": 1637.0, "id": "38f453f8-8e05-11ea-ac6d-5cf37097309a"}]}]}, {"source": "Interactions of Vpr with host cellular proteins", "value": 0.3288714815669623, "ngenes": 38, "max_val": 8.706, "rank": 1861.0, "id": "38f453f9-8e05-11ea-9b0c-5cf37097309a", "children": [{"source": "Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization", "value": 0.5639790633982563, "ngenes": 3, "max_val": 8.706, "rank": 961.0, "id": "38f453fa-8e05-11ea-b510-5cf37097309a"}, {"source": "Vpr-mediated nuclear import of PICs", "value": 0.3135746486533741, "ngenes": 35, "max_val": 8.706, "rank": 1956.0, "id": "38f453fb-8e05-11ea-a98e-5cf37097309a"}]}, {"source": "Vif-mediated degradation of APOBEC3G", "value": 0.5565507266078732, "ngenes": 72, "max_val": 8.706, "rank": 972.0, "id": "38f453fc-8e05-11ea-a908-5cf37097309a"}, {"source": "Vpu mediated degradation of CD4", "value": 0.5366882111971166, "ngenes": 70, "max_val": 8.706, "rank": 1029.0, "id": "38f453fd-8e05-11ea-baec-5cf37097309a"}, {"source": "Interactions of Rev with host cellular proteins", "value": 0.4757429707706315, "ngenes": 71, "max_val": 8.706, "rank": 1182.0, "id": "38f453fe-8e05-11ea-b39c-5cf37097309a", "children": [{"source": "Nuclear import of Rev protein", "value": 0.4804303494846882, "ngenes": 37, "max_val": 8.706, "rank": 1149.0, "id": "38f453ff-8e05-11ea-ad1b-5cf37097309a"}, {"source": "Rev-mediated nuclear export of HIV RNA", "value": 0.40594021400370056, "ngenes": 36, "max_val": 8.706, "rank": 1470.0, "id": "38f45400-8e05-11ea-a44d-5cf37097309a"}]}, {"source": "Interactions of Tat with host cellular proteins", "value": 0.4689265375340588, "ngenes": 2, "max_val": 8.706, "rank": 1215.0, "id": "38f45401-8e05-11ea-82c1-5cf37097309a"}, {"source": "APOBEC3G mediated resistance to HIV-1 infection", "value": 0.3167912402659615, "ngenes": 5, "max_val": 8.706, "rank": 1938.0, "id": "38f45402-8e05-11ea-80fa-5cf37097309a"}]}]}, {"source": "Listeria monocytogenes entry into host cells", "value": 0.4381517822180467, "ngenes": 27, "max_val": 8.706, "rank": 1347.0, "id": "38f45403-8e05-11ea-a363-5cf37097309a", "children": [{"source": "InlA-mediated entry of Listeria monocytogenes into host cells", "value": 0.8863337244260859, "ngenes": 9, "max_val": 8.706, "rank": 612.0, "id": "38f45404-8e05-11ea-913c-5cf37097309a"}, {"source": "InlB-mediated entry of Listeria monocytogenes into host cell", "value": 0.44204625017042704, "ngenes": 22, "max_val": 8.706, "rank": 1333.0, "id": "38f45405-8e05-11ea-8302-5cf37097309a"}]}, {"source": "Uptake and actions of bacterial toxins", "value": 0.34147347350479673, "ngenes": 29, "max_val": 8.706, "rank": 1789.0, "id": "38f45406-8e05-11ea-ba39-5cf37097309a", "children": [{"source": "Neurotoxicity of clostridium toxins", "value": 0.5433031131756395, "ngenes": 10, "max_val": 8.706, "rank": 1027.0, "id": "38f47a9c-8e05-11ea-b43b-5cf37097309a", "children": [{"source": "Toxicity of botulinum toxin type B (BoNT/B)", "value": 0.7888652596954745, "ngenes": 3, "max_val": 8.706, "rank": 674.0, "id": "38f47a9d-8e05-11ea-8948-5cf37097309a"}, {"source": "Toxicity of botulinum toxin type C (BoNT/C)", "value": 0.7625117359403885, "ngenes": 3, "max_val": 8.706, "rank": 692.0, "id": "38f47a9e-8e05-11ea-a5d2-5cf37097309a"}, {"source": "Toxicity of botulinum toxin type F (BoNT/F)", "value": 0.500976461682491, "ngenes": 5, "max_val": 8.706, "rank": 1093.0, "id": "38f47a9f-8e05-11ea-aea5-5cf37097309a"}, {"source": "Toxicity of botulinum toxin type D (BoNT/D)", "value": 0.500976461682491, "ngenes": 5, "max_val": 8.706, "rank": 1094.0, "id": "38f47aa0-8e05-11ea-af92-5cf37097309a"}, {"source": "Toxicity of botulinum toxin type A (BoNT/A)", "value": 0.4428091026226384, "ngenes": 4, "max_val": 8.706, "rank": 1288.0, "id": "38f47aa1-8e05-11ea-9f42-5cf37097309a"}, {"source": "Toxicity of botulinum toxin type E (BoNT/E)", "value": 0.40219039007368224, "ngenes": 3, "max_val": 8.706, "rank": 1492.0, "id": "38f47aa2-8e05-11ea-abf8-5cf37097309a"}, {"source": "Toxicity of botulinum toxin type G (BoNT/G)", "value": 0.3129543214303065, "ngenes": 3, "max_val": 8.706, "rank": 1974.0, "id": "38f47aa3-8e05-11ea-b351-5cf37097309a"}]}, {"source": "Intestinal infectious diseases", "value": 0.4757429707706315, "ngenes": 2, "max_val": 8.706, "rank": 1183.0, "id": "38f47aa4-8e05-11ea-aaa1-5cf37097309a"}, {"source": "Uptake and function of anthrax toxins", "value": 0.44227409954858976, "ngenes": 11, "max_val": 8.706, "rank": 1292.0, "id": "38f47aa5-8e05-11ea-a113-5cf37097309a"}, {"source": "Uptake and function of diphtheria toxin", "value": 0.3457193675228732, "ngenes": 6, "max_val": 8.706, "rank": 1769.0, "id": "38f47aa6-8e05-11ea-8b0e-5cf37097309a"}]}]}, {"source": "Diseases of metabolism", "value": 0.5366882111971166, "ngenes": 112, "max_val": 8.706, "rank": 1030.0, "id": "38f47aa7-8e05-11ea-94ec-5cf37097309a", "children": [{"source": "Metabolic disorders of biological oxidation enzymes", "value": 0.33492726480858154, "ngenes": 42, "max_val": 8.706, "rank": 1831.0, "id": "38f47aa8-8e05-11ea-af50-5cf37097309a", "children": [{"source": "Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)", "value": 1.6249020261081542, "ngenes": 4, "max_val": 8.706, "rank": 259.0, "id": "38f47aa9-8e05-11ea-8f88-5cf37097309a"}, {"source": "Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)", "value": 0.5440753701415803, "ngenes": 2, "max_val": 8.706, "rank": 1024.0, "id": "38f47aaa-8e05-11ea-8571-5cf37097309a"}, {"source": "Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)", "value": 0.4124422229113538, "ngenes": 6, "max_val": 8.706, "rank": 1456.0, "id": "38f47aab-8e05-11ea-b215-5cf37097309a"}, {"source": "Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD)", "value": 0.3543975045465841, "ngenes": 2, "max_val": 8.706, "rank": 1717.0, "id": "38f47aac-8e05-11ea-ac0d-5cf37097309a"}]}, {"source": "Diseases of carbohydrate metabolism", "value": 0.4170913746392284, "ngenes": 35, "max_val": 8.706, "rank": 1415.0, "id": "38f47aad-8e05-11ea-9d76-5cf37097309a", "children": [{"source": "Glycogen storage diseases", "value": 0.4557308667314776, "ngenes": 16, "max_val": 8.706, "rank": 1261.0, "id": "38f47aae-8e05-11ea-a8f4-5cf37097309a", "children": [{"source": "Glycogen storage disease type 0 (muscle GYS1)", "value": 0.6647834081114088, "ngenes": 2, "max_val": 8.706, "rank": 799.0, "id": "38f47aaf-8e05-11ea-b86a-5cf37097309a"}, {"source": "Glycogen storage disease type XV (GYG1)", "value": 0.6635767503826286, "ngenes": 2, "max_val": 8.706, "rank": 802.0, "id": "38f47ab0-8e05-11ea-820c-5cf37097309a"}, {"source": "Glycogen storage disease type 0 (liver GYS2)", "value": 0.6057430516997634, "ngenes": 2, "max_val": 8.706, "rank": 908.0, "id": "38f47ab1-8e05-11ea-94b4-5cf37097309a"}, {"source": "Myoclonic epilepsy of Lafora", "value": 0.4571687716241703, "ngenes": 9, "max_val": 8.706, "rank": 1257.0, "id": "38f47ab2-8e05-11ea-bc61-5cf37097309a"}, {"source": "Glycogen storage disease type IV (GBE1)", "value": 0.3663505507769889, "ngenes": 3, "max_val": 8.706, "rank": 1631.0, "id": "38f47ab3-8e05-11ea-97f3-5cf37097309a"}, {"source": "Glycogen storage disease type II (GAA)", "value": 0.33832512665576203, "ngenes": 2, "max_val": 8.706, "rank": 1803.0, "id": "38f47ab4-8e05-11ea-a111-5cf37097309a"}]}, {"source": "Pentose phosphate pathway disease", "value": 0.6580731317637653, "ngenes": 2, "max_val": 8.706, "rank": 811.0, "id": "38f47ab5-8e05-11ea-819a-5cf37097309a"}, {"source": "Intestinal saccharidase deficiencies", "value": 0.5958405955947986, "ngenes": 3, "max_val": 8.706, "rank": 926.0, "id": "38f47ab6-8e05-11ea-82d6-5cf37097309a"}, {"source": "Mucopolysaccharidoses", "value": 0.31494787026486865, "ngenes": 11, "max_val": 8.706, "rank": 1944.0, "id": "38f47ab7-8e05-11ea-951b-5cf37097309a"}]}, {"source": "Defects in vitamin and cofactor metabolism", "value": 0.44227409954858976, "ngenes": 23, "max_val": 8.706, "rank": 1304.0, "id": "38f47ab8-8e05-11ea-8718-5cf37097309a", "children": [{"source": "Defects in cobalamin (B12) metabolism", "value": 0.6340591051838272, "ngenes": 14, "max_val": 8.706, "rank": 862.0, "id": "38f47ab9-8e05-11ea-9974-5cf37097309a", "children": [{"source": "Defective MTR causes methylmalonic aciduria and homocystinuria type cblG", "value": 0.6040398457343442, "ngenes": 2, "max_val": 8.706, "rank": 911.0, "id": "38f47aba-8e05-11ea-9990-5cf37097309a"}, {"source": "Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE", "value": 0.603246594200587, "ngenes": 2, "max_val": 8.706, "rank": 913.0, "id": "38f47abb-8e05-11ea-ae3d-5cf37097309a"}, {"source": "Defective AMN causes hereditary megaloblastic anemia 1", "value": 0.4677799152961093, "ngenes": 3, "max_val": 8.706, "rank": 1219.0, "id": "38f47abc-8e05-11ea-b115-5cf37097309a"}, {"source": "Defective CUBN causes hereditary megaloblastic anemia 1", "value": 0.4668834851633171, "ngenes": 3, "max_val": 8.706, "rank": 1221.0, "id": "38f47abd-8e05-11ea-a793-5cf37097309a"}, {"source": "Defective CD320 causes methylmalonic aciduria", "value": 0.4649278207945483, "ngenes": 2, "max_val": 8.706, "rank": 1225.0, "id": "38f47abe-8e05-11ea-a23b-5cf37097309a"}, {"source": "Defective MUT causes methylmalonic aciduria mut type", "value": 0.4647304025875293, "ngenes": 2, "max_val": 8.706, "rank": 1232.0, "id": "38f47abf-8e05-11ea-9446-5cf37097309a"}, {"source": "Defective MMAA causes methylmalonic aciduria type cblA", "value": 0.4647304025875293, "ngenes": 2, "max_val": 8.706, "rank": 1233.0, "id": "38f47ac0-8e05-11ea-8bca-5cf37097309a"}, {"source": "Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD", "value": 0.4364096796909963, "ngenes": 2, "max_val": 8.706, "rank": 1352.0, "id": "38f47ac1-8e05-11ea-bb83-5cf37097309a"}]}, {"source": "Defects in biotin (Btn) metabolism", "value": 0.5826614062625122, "ngenes": 9, "max_val": 8.706, "rank": 945.0, "id": "38f47ac2-8e05-11ea-a090-5cf37097309a", "children": [{"source": "Defective HLCS causes multiple carboxylase deficiency", "value": 0.5104201517191181, "ngenes": 8, "max_val": 8.706, "rank": 1063.0, "id": "38f47ac3-8e05-11ea-900d-5cf37097309a"}]}]}, {"source": "Diseases associated with surfactant metabolism", "value": 1.1393611245703057, "ngenes": 10, "max_val": 8.706, "rank": 469.0, "id": "38f47ac4-8e05-11ea-a16a-5cf37097309a", "children": [{"source": "Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)", "value": 0.3288714815669623, "ngenes": 8, "max_val": 8.706, "rank": 1869.0, "id": "38f47ac5-8e05-11ea-9446-5cf37097309a"}, {"source": "Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)", "value": 0.3288714815669623, "ngenes": 8, "max_val": 8.706, "rank": 1870.0, "id": "38f47ac6-8e05-11ea-af9c-5cf37097309a"}]}]}, {"source": "Disorders of transmembrane transporters", "value": 0.3911487587762643, "ngenes": 205, "max_val": 8.706, "rank": 1540.0, "id": "38f47ac7-8e05-11ea-8b96-5cf37097309a", "children": [{"source": "SLC transporter disorders", "value": 0.3128507621405376, "ngenes": 102, "max_val": 8.706, "rank": 1981.0, "id": "38f47ac8-8e05-11ea-a345-5cf37097309a", "children": [{"source": "Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum)", "value": 1.2070420459358313, "ngenes": 2, "max_val": 8.706, "rank": 430.0, "id": "38f47ac9-8e05-11ea-89e1-5cf37097309a"}, {"source": "Defective SLC7A9 causes cystinuria (CSNU)", "value": 0.8260749156745318, "ngenes": 2, "max_val": 8.706, "rank": 643.0, "id": "38f47aca-8e05-11ea-95ec-5cf37097309a"}, {"source": "Defective SLC3A1 causes cystinuria (CSNU)", "value": 0.8255518759052436, "ngenes": 2, "max_val": 8.706, "rank": 644.0, "id": "38f47acb-8e05-11ea-95c2-5cf37097309a"}, {"source": "Defective CP causes aceruloplasminemia (ACERULOP)", "value": 0.613643803421151, "ngenes": 2, "max_val": 8.706, "rank": 897.0, "id": "38f47acc-8e05-11ea-a87c-5cf37097309a"}, {"source": "Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages)", "value": 0.6125658117352507, "ngenes": 2, "max_val": 8.706, "rank": 899.0, "id": "38f47acd-8e05-11ea-89b2-5cf37097309a"}, {"source": "Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)", "value": 0.4364096796909963, "ngenes": 3, "max_val": 8.706, "rank": 1353.0, "id": "38f47ace-8e05-11ea-bf39-5cf37097309a"}, {"source": "Defective SLC7A7 causes lysinuric protein intolerance (LPI)", "value": 0.3911487587762643, "ngenes": 2, "max_val": 8.706, "rank": 1538.0, "id": "38f47acf-8e05-11ea-be0a-5cf37097309a"}, {"source": "Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI)", "value": 0.335679965916088, "ngenes": 2, "max_val": 8.706, "rank": 1825.0, "id": "38f47ad0-8e05-11ea-b5e3-5cf37097309a"}, {"source": "Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)", "value": 0.3082469229805313, "ngenes": 33, "max_val": 8.706, "rank": 2013.0, "id": "38f47ad1-8e05-11ea-a958-5cf37097309a"}, {"source": "Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT)", "value": 0.30251216144429616, "ngenes": 3, "max_val": 8.706, "rank": 2069.0, "id": "38f47ad2-8e05-11ea-a2e9-5cf37097309a"}]}, {"source": "ABC transporter disorders", "value": 0.4313445440462728, "ngenes": 103, "max_val": 8.706, "rank": 1364.0, "id": "38f47ad3-8e05-11ea-8247-5cf37097309a", "children": [{"source": "Defective ABCC9 causes dilated cardiomyopathy 10, familial atrial fibrillation 12 and hypertrichotic osteochondrodysplasia", "value": 0.6397032919655772, "ngenes": 2, "max_val": 8.706, "rank": 849.0, "id": "38f47ad4-8e05-11ea-935a-5cf37097309a"}, {"source": "Defective ABCC8 can cause hypoglycemias and hyperglycemias", "value": 0.6121206829753241, "ngenes": 2, "max_val": 8.706, "rank": 901.0, "id": "38f47ad5-8e05-11ea-b966-5cf37097309a"}, {"source": "Defective ABCC6 causes pseudoxanthoma elasticum (PXE)", "value": 0.44227409954858976, "ngenes": 2, "max_val": 8.706, "rank": 1317.0, "id": "38f47ad6-8e05-11ea-a829-5cf37097309a"}, {"source": "Defective ABCA1 causes Tangier disease", "value": 0.35647002589378085, "ngenes": 2, "max_val": 8.706, "rank": 1704.0, "id": "38f47ad7-8e05-11ea-a126-5cf37097309a"}, {"source": "Defective ABCG8 causes gallbladder disease 4 and sitosterolemia", "value": 0.3457193675228732, "ngenes": 2, "max_val": 8.706, "rank": 1770.0, "id": "38f47ad8-8e05-11ea-ab07-5cf37097309a"}, {"source": "Defective ABCG5 causes sitosterolemia", "value": 0.34493226592596626, "ngenes": 2, "max_val": 8.706, "rank": 1772.0, "id": "38f47ad9-8e05-11ea-8cad-5cf37097309a"}, {"source": "Defective CFTR causes cystic fibrosis", "value": 0.3333488691934495, "ngenes": 86, "max_val": 8.706, "rank": 1849.0, "id": "38f47ada-8e05-11ea-b084-5cf37097309a"}]}]}, {"source": "Diseases of Mismatch Repair (MMR)", "value": 0.8743188457595599, "ngenes": 5, "max_val": 8.706, "rank": 619.0, "id": "38f47adb-8e05-11ea-b677-5cf37097309a", "children": [{"source": "Defective Mismatch Repair Associated With MSH2", "value": 1.018967659190454, "ngenes": 3, "max_val": 8.706, "rank": 543.0, "id": "38f47adc-8e05-11ea-a9b4-5cf37097309a"}, {"source": "Defective Mismatch Repair Associated With MSH3", "value": 0.44227409954858976, "ngenes": 2, "max_val": 8.706, "rank": 1303.0, "id": "38f47add-8e05-11ea-8f38-5cf37097309a"}, {"source": "Defective Mismatch Repair Associated With MLH1", "value": 0.4237924916712859, "ngenes": 2, "max_val": 8.706, "rank": 1391.0, "id": "38f47ade-8e05-11ea-a82e-5cf37097309a"}, {"source": "Defective Mismatch Repair Associated With PMS2", "value": 0.4237924916712859, "ngenes": 2, "max_val": 8.706, "rank": 1397.0, "id": "38f47adf-8e05-11ea-ac4a-5cf37097309a"}, {"source": "Defective Mismatch Repair Associated With MSH6", "value": 0.3967816616170723, "ngenes": 2, "max_val": 8.706, "rank": 1517.0, "id": "38f47ae0-8e05-11ea-911f-5cf37097309a"}]}, {"source": "Diseases of Immune System", "value": 0.5015708041852732, "ngenes": 24, "max_val": 8.706, "rank": 1092.0, "id": "38f47ae1-8e05-11ea-977b-5cf37097309a", "children": [{"source": "Diseases associated with the TLR signaling cascade", "value": 0.5015708041852732, "ngenes": 24, "max_val": 8.706, "rank": 1091.0, "id": "38f47ae2-8e05-11ea-8872-5cf37097309a", "children": [{"source": "IkBA variant leads to EDA-ID", "value": 0.8391977960633554, "ngenes": 7, "max_val": 8.706, "rank": 640.0, "id": "38f47ae3-8e05-11ea-8198-5cf37097309a"}, {"source": "IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)", "value": 0.7152046077294757, "ngenes": 3, "max_val": 8.706, "rank": 745.0, "id": "38f47ae4-8e05-11ea-9e0a-5cf37097309a"}, {"source": "IKBKB deficiency causes SCID", "value": 0.7151991074302457, "ngenes": 3, "max_val": 8.706, "rank": 746.0, "id": "38f47ae5-8e05-11ea-8fbf-5cf37097309a"}, {"source": "UNC93B1 deficiency - HSE", "value": 0.5242748343222906, "ngenes": 2, "max_val": 8.706, "rank": 1042.0, "id": "38f47ae6-8e05-11ea-80e2-5cf37097309a"}, {"source": "TRAF3 deficiency - HSE", "value": 0.41346520967708095, "ngenes": 3, "max_val": 8.706, "rank": 1445.0, "id": "38f47ae7-8e05-11ea-986b-5cf37097309a"}, {"source": "MyD88 deficiency (TLR2/4)", "value": 0.35647002589378085, "ngenes": 10, "max_val": 8.706, "rank": 1701.0, "id": "38f47ae8-8e05-11ea-b8da-5cf37097309a"}, {"source": "IRAK4 deficiency (TLR2/4)", "value": 0.3541168087463224, "ngenes": 11, "max_val": 8.706, "rank": 1726.0, "id": "38f47ae9-8e05-11ea-9fdd-5cf37097309a"}, {"source": "TICAM1 deficiency - HSE", "value": 0.3416738873259401, "ngenes": 2, "max_val": 8.706, "rank": 1781.0, "id": "38f47aea-8e05-11ea-b0a6-5cf37097309a"}, {"source": "MyD88 deficiency (TLR5)", "value": 0.3286625145939125, "ngenes": 2, "max_val": 8.706, "rank": 1874.0, "id": "38f47aeb-8e05-11ea-a96c-5cf37097309a"}, {"source": "IRAK4 deficiency (TLR5)", "value": 0.3135746486533741, "ngenes": 4, "max_val": 8.706, "rank": 1953.0, "id": "38f47aec-8e05-11ea-be8c-5cf37097309a"}]}]}, {"source": "Diseases of Cellular Senescence", "value": 0.6340591051838272, "ngenes": 3, "max_val": 8.706, "rank": 861.0, "id": "38f47aed-8e05-11ea-a9e1-5cf37097309a", "children": [{"source": "Evasion of Oncogene Induced Senescence Due to p16INK4A Defects", "value": 0.6335990380349649, "ngenes": 3, "max_val": 8.706, "rank": 863.0, "id": "38f47aee-8e05-11ea-9943-5cf37097309a", "children": [{"source": "Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6", "value": 0.6319675825835179, "ngenes": 3, "max_val": 8.706, "rank": 865.0, "id": "38f47aef-8e05-11ea-83de-5cf37097309a"}, {"source": "Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4", "value": 0.3639215042559732, "ngenes": 2, "max_val": 8.706, "rank": 1645.0, "id": "38f47af0-8e05-11ea-9ce3-5cf37097309a"}]}, {"source": "Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects", "value": 0.6329087352885052, "ngenes": 3, "max_val": 8.706, "rank": 864.0, "id": "38f47af1-8e05-11ea-a083-5cf37097309a", "children": [{"source": "Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6", "value": 0.6313164779578079, "ngenes": 3, "max_val": 8.706, "rank": 866.0, "id": "38f47af2-8e05-11ea-a180-5cf37097309a"}, {"source": "Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4", "value": 0.3630024758913586, "ngenes": 2, "max_val": 8.706, "rank": 1647.0, "id": "38f47af3-8e05-11ea-b33d-5cf37097309a"}]}]}, {"source": "Diseases of Programmed Cell Death", "value": 0.4517017389266783, "ngenes": 2, "max_val": 8.706, "rank": 1272.0, "id": "38f47af4-8e05-11ea-8698-5cf37097309a", "children": [{"source": "Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function", "value": 0.4525828878860327, "ngenes": 2, "max_val": 8.706, "rank": 1270.0, "id": "38f47af5-8e05-11ea-a1cd-5cf37097309a"}]}, {"source": "Pervasive developmental disorders", "value": 0.5843049052386474, "ngenes": 14, "max_val": 8.706, "rank": 941.0, "id": "38f47af6-8e05-11ea-a4d6-5cf37097309a", "children": [{"source": "Loss of function of MECP2 in Rett syndrome", "value": 0.5843049052386474, "ngenes": 14, "max_val": 8.706, "rank": 940.0, "id": "38f47af7-8e05-11ea-bca3-5cf37097309a", "children": [{"source": "Loss of phosphorylation of MECP2 at T308", "value": 0.4237924916712859, "ngenes": 4, "max_val": 8.706, "rank": 1389.0, "id": "38f47af8-8e05-11ea-bf6d-5cf37097309a"}, {"source": "Loss of MECP2 binding ability to 5mC-DNA", "value": 0.4225251742038882, "ngenes": 4, "max_val": 8.706, "rank": 1403.0, "id": "38f47af9-8e05-11ea-bb48-5cf37097309a"}, {"source": "Loss of MECP2 binding ability to the NCoR/SMRT complex", "value": 0.3135746486533741, "ngenes": 7, "max_val": 8.706, "rank": 1958.0, "id": "38f47afa-8e05-11ea-9d20-5cf37097309a"}]}]}, {"source": "Diseases of Base Excision Repair", "value": 0.350933254566744, "ngenes": 6, "max_val": 8.706, "rank": 1739.0, "id": "38f47afb-8e05-11ea-aad2-5cf37097309a"}]}, {"source": "Muscle contraction", "value": 4.015571393792725, "ngenes": 221, "max_val": 8.706, "rank": 6.0, "id": "38f47afc-8e05-11ea-b576-5cf37097309a", "children": [{"source": "Smooth Muscle Contraction", "value": 3.09809796115373, "ngenes": 43, "max_val": 8.706, "rank": 36.0, "id": "38f47afd-8e05-11ea-9174-5cf37097309a"}, {"source": "Cardiac conduction", "value": 1.7662553138583998, "ngenes": 148, "max_val": 8.706, "rank": 203.0, "id": "38f47afe-8e05-11ea-9256-5cf37097309a", "children": [{"source": "Phase 4 - resting membrane potential", "value": 2.364985768442516, "ngenes": 19, "max_val": 8.706, "rank": 88.0, "id": "38f47aff-8e05-11ea-ad49-5cf37097309a"}, {"source": "Ion homeostasis", "value": 1.1806960134389126, "ngenes": 59, "max_val": 8.706, "rank": 448.0, "id": "38f47b00-8e05-11ea-a93d-5cf37097309a"}, {"source": "Physiological factors", "value": 0.7505610078797723, "ngenes": 13, "max_val": 8.706, "rank": 703.0, "id": "38f47b01-8e05-11ea-be19-5cf37097309a"}, {"source": "Phase 3 - rapid repolarisation", "value": 0.3965414113650864, "ngenes": 8, "max_val": 8.706, "rank": 1524.0, "id": "38f47b02-8e05-11ea-945e-5cf37097309a"}, {"source": "Phase 2 - plateau phase", "value": 0.36097258849275415, "ngenes": 29, "max_val": 8.706, "rank": 1656.0, "id": "38f47b03-8e05-11ea-9810-5cf37097309a"}, {"source": "Phase 1 - inactivation of fast Na+ channels", "value": 0.3333488691934495, "ngenes": 7, "max_val": 8.706, "rank": 1846.0, "id": "38f47b04-8e05-11ea-af07-5cf37097309a"}, {"source": "Phase 0 - rapid depolarisation", "value": 0.3288714815669623, "ngenes": 47, "max_val": 8.706, "rank": 1859.0, "id": "38f47b05-8e05-11ea-a564-5cf37097309a"}]}, {"source": "Striated Muscle Contraction", "value": 0.9287076267065378, "ngenes": 36, "max_val": 8.706, "rank": 576.0, "id": "38f47b06-8e05-11ea-a89c-5cf37097309a"}]}, {"source": "Metabolism of proteins", "value": 0.3088724561369422, "ngenes": 2554, "max_val": 8.706, "rank": 2007.0, "id": "38f47b07-8e05-11ea-8a0f-5cf37097309a", "children": [{"source": "Post-translational protein modification", "value": 0.3620996197243039, "ngenes": 1638, "max_val": 8.706, "rank": 1651.0, "id": "38f47b08-8e05-11ea-892a-5cf37097309a", "children": [{"source": "Gamma carboxylation, hypusine formation and arylsulfatase activation", "value": 0.721392241826102, "ngenes": 42, "max_val": 8.706, "rank": 744.0, "id": "38f47b09-8e05-11ea-9d86-5cf37097309a", "children": [{"source": "Gamma-carboxylation, transport, and amino-terminal cleavage of proteins", "value": 2.707143545868642, "ngenes": 13, "max_val": 8.706, "rank": 58.0, "id": "38f47b0a-8e05-11ea-a0f6-5cf37097309a", "children": [{"source": "Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus", "value": 2.977201610959113, "ngenes": 9, "max_val": 8.706, "rank": 41.0, "id": "38f47b0b-8e05-11ea-bd3e-5cf37097309a"}, {"source": "Gamma-carboxylation of protein precursors", "value": 2.921416886394588, "ngenes": 11, "max_val": 8.706, "rank": 43.0, "id": "38f47b0c-8e05-11ea-97b0-5cf37097309a"}, {"source": "Removal of aminoterminal propeptides from gamma-carboxylated proteins", "value": 2.7160177327246107, "ngenes": 10, "max_val": 8.706, "rank": 56.0, "id": "38f47b0d-8e05-11ea-bef5-5cf37097309a"}]}, {"source": "Synthesis of diphthamide-EEF2", "value": 0.4166701851996452, "ngenes": 9, "max_val": 8.706, "rank": 1419.0, "id": "38f47b0e-8e05-11ea-ab71-5cf37097309a"}, {"source": "The activation of arylsulfatases", "value": 0.35647002589378085, "ngenes": 13, "max_val": 8.706, "rank": 1705.0, "id": "38f47b0f-8e05-11ea-96cd-5cf37097309a"}, {"source": "Hypusine synthesis from eIF5A-lysine", "value": 0.30413790891450376, "ngenes": 4, "max_val": 8.706, "rank": 2043.0, "id": "38f47b10-8e05-11ea-aa17-5cf37097309a"}]}, {"source": "O-linked glycosylation", "value": 1.1748893768529147, "ngenes": 121, "max_val": 8.706, "rank": 451.0, "id": "38f47b11-8e05-11ea-99e6-5cf37097309a", "children": [{"source": "O-glycosylation of TSR domain-containing proteins", "value": 1.9101594894801182, "ngenes": 41, "max_val": 8.706, "rank": 170.0, "id": "38f47b12-8e05-11ea-9c6c-5cf37097309a"}, {"source": "O-linked glycosylation of mucins", "value": 0.30251216144429616, "ngenes": 69, "max_val": 8.706, "rank": 2058.0, "id": "38f47b13-8e05-11ea-b182-5cf37097309a", "children": [{"source": "Termination of O-glycan biosynthesis", "value": 0.4907018464851966, "ngenes": 29, "max_val": 8.706, "rank": 1113.0, "id": "38f47b14-8e05-11ea-8897-5cf37097309a"}]}]}, {"source": "Deubiquitination", "value": 0.4990868904375801, "ngenes": 340, "max_val": 8.706, "rank": 1096.0, "id": "38f47b15-8e05-11ea-b1d0-5cf37097309a", "children": [{"source": "Metalloprotease DUBs", "value": 1.667319292344096, "ngenes": 38, "max_val": 8.706, "rank": 229.0, "id": "38f47b16-8e05-11ea-b697-5cf37097309a"}, {"source": "Ub-specific processing proteases", "value": 0.8089457552972312, "ngenes": 243, "max_val": 8.706, "rank": 663.0, "id": "38f47b17-8e05-11ea-aa9c-5cf37097309a"}, {"source": "UCH proteinases", "value": 0.4625616334894432, "ngenes": 138, "max_val": 8.706, "rank": 1252.0, "id": "38f47b18-8e05-11ea-88c3-5cf37097309a"}, {"source": "Ovarian tumor domain proteases", "value": 0.342723606792187, "ngenes": 39, "max_val": 8.706, "rank": 1779.0, "id": "38f47b19-8e05-11ea-8c4b-5cf37097309a"}, {"source": "Josephin domain DUBs", "value": 0.3135746486533741, "ngenes": 12, "max_val": 8.706, "rank": 1972.0, "id": "38f47b1a-8e05-11ea-aaac-5cf37097309a"}]}, {"source": "Asparagine N-linked glycosylation", "value": 0.6286195179544306, "ngenes": 328, "max_val": 8.706, "rank": 876.0, "id": "38f47b1b-8e05-11ea-9e18-5cf37097309a", "children": [{"source": "Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein", "value": 1.6341505816288515, "ngenes": 88, "max_val": 8.706, "rank": 247.0, "id": "38f47b1c-8e05-11ea-92bf-5cf37097309a", "children": [{"source": "Synthesis of substrates in N-glycan biosythesis", "value": 1.234643919995427, "ngenes": 72, "max_val": 8.706, "rank": 411.0, "id": "38f47b1d-8e05-11ea-b268-5cf37097309a", "children": [{"source": "Synthesis of UDP-N-acetyl-glucosamine", "value": 1.6416890358367588, "ngenes": 8, "max_val": 8.706, "rank": 242.0, "id": "38f47b1e-8e05-11ea-8cd7-5cf37097309a"}, {"source": "Synthesis of dolichyl-phosphate mannose", "value": 1.1957209721612054, "ngenes": 3, "max_val": 8.706, "rank": 435.0, "id": "38f4a18c-8e05-11ea-ad01-5cf37097309a"}, {"source": "Synthesis of Dolichyl-phosphate", "value": 1.0230929066990757, "ngenes": 6, "max_val": 8.706, "rank": 531.0, "id": "38f4a18d-8e05-11ea-9e67-5cf37097309a"}, {"source": "Sialic acid metabolism", "value": 0.6971911352598542, "ngenes": 41, "max_val": 8.706, "rank": 763.0, "id": "38f4a18e-8e05-11ea-9c38-5cf37097309a"}, {"source": "Synthesis of dolichyl-phosphate-glucose", "value": 0.3586028553859912, "ngenes": 2, "max_val": 8.706, "rank": 1685.0, "id": "38f4a18f-8e05-11ea-beb8-5cf37097309a"}, {"source": "Synthesis of GDP-mannose", "value": 0.3545036542872753, "ngenes": 5, "max_val": 8.706, "rank": 1716.0, "id": "38f4a190-8e05-11ea-83ae-5cf37097309a"}, {"source": "GDP-fucose biosynthesis", "value": 0.3107479865717629, "ngenes": 7, "max_val": 8.706, "rank": 1998.0, "id": "38f4a191-8e05-11ea-8ff6-5cf37097309a"}]}]}, {"source": "N-glycan trimming in the ER and Calnexin/Calreticulin cycle", "value": 1.434200512371639, "ngenes": 42, "max_val": 8.706, "rank": 344.0, "id": "38f4a192-8e05-11ea-8dfa-5cf37097309a", "children": [{"source": "Calnexin/calreticulin cycle", "value": 1.2746557905721092, "ngenes": 33, "max_val": 8.706, "rank": 399.0, "id": "38f4a193-8e05-11ea-882d-5cf37097309a", "children": [{"source": "ER Quality Control Compartment (ERQC)", "value": 1.2475232870613495, "ngenes": 27, "max_val": 8.706, "rank": 406.0, "id": "38f4a194-8e05-11ea-bbe5-5cf37097309a"}]}]}, {"source": "Transport to the Golgi and subsequent modification", "value": 0.3288714815669623, "ngenes": 192, "max_val": 8.706, "rank": 1864.0, "id": "38f4a195-8e05-11ea-a042-5cf37097309a", "children": [{"source": "N-glycan antennae elongation in the medial/trans-Golgi", "value": 0.3026960685114295, "ngenes": 29, "max_val": 8.706, "rank": 2055.0, "id": "38f4a196-8e05-11ea-a582-5cf37097309a", "children": [{"source": "Reactions specific to the complex N-glycan synthesis pathway", "value": 1.0629234034971091, "ngenes": 10, "max_val": 8.706, "rank": 499.0, "id": "38f4a197-8e05-11ea-8f2b-5cf37097309a"}, {"source": "N-Glycan antennae elongation", "value": 0.3083646140106745, "ngenes": 18, "max_val": 8.706, "rank": 2011.0, "id": "38f4a198-8e05-11ea-83bf-5cf37097309a"}]}, {"source": "ER to Golgi Anterograde Transport", "value": 0.3135746486533741, "ngenes": 158, "max_val": 8.706, "rank": 1963.0, "id": "38f4a199-8e05-11ea-9f56-5cf37097309a", "children": [{"source": "Cargo concentration in the ER", "value": 0.86492840468403, "ngenes": 33, "max_val": 8.706, "rank": 626.0, "id": "38f4a19a-8e05-11ea-ad1a-5cf37097309a"}, {"source": "COPII-mediated vesicle transport", "value": 0.5479041359653877, "ngenes": 71, "max_val": 8.706, "rank": 996.0, "id": "38f4a19b-8e05-11ea-a526-5cf37097309a"}, {"source": "COPI-mediated anterograde transport", "value": 0.3766009196519696, "ngenes": 104, "max_val": 8.706, "rank": 1595.0, "id": "38f4a19c-8e05-11ea-bad5-5cf37097309a"}]}, {"source": "N-glycan trimming and elongation in the cis-Golgi", "value": 0.4788365094295219, "ngenes": 5, "max_val": 8.706, "rank": 1155.0, "id": "38f4a19d-8e05-11ea-a2d8-5cf37097309a", "children": [{"source": "Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2", "value": 0.5084255126755077, "ngenes": 3, "max_val": 8.706, "rank": 1077.0, "id": "38f4a19e-8e05-11ea-b264-5cf37097309a"}]}]}]}, {"source": "Post-translational modification: synthesis of GPI-anchored proteins", "value": 1.1339374873055101, "ngenes": 111, "max_val": 8.706, "rank": 474.0, "id": "38f4a19f-8e05-11ea-89f3-5cf37097309a", "children": [{"source": "Synthesis of glycosylphosphatidylinositol (GPI)", "value": 1.5326712705333538, "ngenes": 20, "max_val": 8.706, "rank": 301.0, "id": "38f4a1a0-8e05-11ea-a80d-5cf37097309a"}, {"source": "Synthesis of dolichyl-phosphate mannose", "value": 1.1957209721612054, "ngenes": 3, "max_val": 8.706, "rank": 435.0, "id": "38f4a1a1-8e05-11ea-8313-5cf37097309a"}, {"source": "Attachment of GPI anchor to uPAR", "value": 1.1910990786692313, "ngenes": 7, "max_val": 8.706, "rank": 444.0, "id": "38f4a1a2-8e05-11ea-ae9b-5cf37097309a"}]}, {"source": "RAB geranylgeranylation", "value": 1.4388751160820894, "ngenes": 66, "max_val": 8.706, "rank": 338.0, "id": "38f4a1a3-8e05-11ea-bb0b-5cf37097309a"}, {"source": "Protein ubiquitination", "value": 0.9478742831410916, "ngenes": 85, "max_val": 8.706, "rank": 570.0, "id": "38f4a1a4-8e05-11ea-988d-5cf37097309a", "children": [{"source": "E3 ubiquitin ligases ubiquitinate target proteins", "value": 1.3842544305382725, "ngenes": 60, "max_val": 8.706, "rank": 357.0, "id": "38f4a1a5-8e05-11ea-8cbf-5cf37097309a"}, {"source": "Synthesis of active ubiquitin: roles of E1 and E2 enzymes", "value": 0.4646123127797776, "ngenes": 35, "max_val": 8.706, "rank": 1236.0, "id": "38f4a1a6-8e05-11ea-b52b-5cf37097309a"}]}, {"source": "SUMOylation", "value": 0.7223072136687092, "ngenes": 268, "max_val": 8.706, "rank": 738.0, "id": "38f4a1a7-8e05-11ea-9957-5cf37097309a", "children": [{"source": "Processing and activation of SUMO", "value": 1.2627369897587537, "ngenes": 15, "max_val": 8.706, "rank": 403.0, "id": "38f4a1a8-8e05-11ea-b815-5cf37097309a", "children": [{"source": "SUMO is proteolytically processed", "value": 1.234643919995427, "ngenes": 6, "max_val": 8.706, "rank": 412.0, "id": "38f4a1a9-8e05-11ea-be63-5cf37097309a"}, {"source": "SUMO is conjugated to E1 (UBA2:SAE1)", "value": 0.888262295397904, "ngenes": 7, "max_val": 8.706, "rank": 609.0, "id": "38f4a1aa-8e05-11ea-b705-5cf37097309a"}, {"source": "SUMO is transferred from E1 to E2 (UBE2I, UBC9)", "value": 0.86492840468403, "ngenes": 10, "max_val": 8.706, "rank": 627.0, "id": "38f4a1ab-8e05-11ea-ad16-5cf37097309a"}]}, {"source": "SUMO E3 ligases SUMOylate target proteins", "value": 0.6410788406347994, "ngenes": 260, "max_val": 8.706, "rank": 848.0, "id": "38f4a1ac-8e05-11ea-9c73-5cf37097309a", "children": [{"source": "SUMOylation of intracellular receptors", "value": 0.8098107569568984, "ngenes": 37, "max_val": 8.706, "rank": 662.0, "id": "38f4a1ad-8e05-11ea-a6d3-5cf37097309a"}, {"source": "SUMOylation of immune response proteins", "value": 0.7223072136687092, "ngenes": 11, "max_val": 8.706, "rank": 734.0, "id": "38f4a1ae-8e05-11ea-8294-5cf37097309a"}, {"source": "SUMOylation of DNA replication proteins", "value": 0.6445692907358854, "ngenes": 80, "max_val": 8.706, "rank": 839.0, "id": "38f4a1af-8e05-11ea-8d45-5cf37097309a"}, {"source": "SUMOylation of transcription factors", "value": 0.4731128235942158, "ngenes": 22, "max_val": 8.706, "rank": 1186.0, "id": "38f4a1b0-8e05-11ea-aad7-5cf37097309a"}, {"source": "SUMOylation of DNA damage response and repair proteins", "value": 0.4689358402626867, "ngenes": 92, "max_val": 8.706, "rank": 1211.0, "id": "38f4a1b1-8e05-11ea-a9d7-5cf37097309a"}, {"source": "SUMOylation of chromatin organization proteins", "value": 0.4689358402626867, "ngenes": 80, "max_val": 8.706, "rank": 1212.0, "id": "38f4a1b2-8e05-11ea-8189-5cf37097309a"}, {"source": "SUMOylation of SUMOylation proteins", "value": 0.4655495340261421, "ngenes": 36, "max_val": 8.706, "rank": 1223.0, "id": "38f4a1b3-8e05-11ea-b966-5cf37097309a"}, {"source": "SUMOylation of RNA binding proteins", "value": 0.44227409954858976, "ngenes": 54, "max_val": 8.706, "rank": 1293.0, "id": "38f4a1b4-8e05-11ea-ad5c-5cf37097309a"}, {"source": "SUMOylation of DNA methylation proteins", "value": 0.44227409954858976, "ngenes": 24, "max_val": 8.706, "rank": 1309.0, "id": "38f4a1b5-8e05-11ea-94fa-5cf37097309a"}, {"source": "SUMOylation of transcription cofactors", "value": 0.3288714815669623, "ngenes": 55, "max_val": 8.706, "rank": 1867.0, "id": "38f4a1b6-8e05-11ea-8861-5cf37097309a"}, {"source": "SUMOylation of ubiquitinylation proteins", "value": 0.3167912402659615, "ngenes": 44, "max_val": 8.706, "rank": 1939.0, "id": "38f4a1b7-8e05-11ea-bd04-5cf37097309a"}]}]}, {"source": "Post-translational protein phosphorylation", "value": 1.1478325057846503, "ngenes": 110, "max_val": 8.706, "rank": 463.0, "id": "38f4a1b8-8e05-11ea-bec1-5cf37097309a"}, {"source": "Neddylation", "value": 0.4865631200748303, "ngenes": 259, "max_val": 8.706, "rank": 1124.0, "id": "38f4a1b9-8e05-11ea-980b-5cf37097309a"}, {"source": "Carboxyterminal post-translational modifications of tubulin", "value": 0.4865631200748303, "ngenes": 63, "max_val": 8.706, "rank": 1133.0, "id": "38f4a1ba-8e05-11ea-a780-5cf37097309a"}, {"source": "Protein methylation", "value": 0.3223732079441458, "ngenes": 17, "max_val": 8.706, "rank": 1909.0, "id": "38f4a1bb-8e05-11ea-99c8-5cf37097309a"}]}, {"source": "Protein repair", "value": 2.2172797685053527, "ngenes": 7, "max_val": 8.706, "rank": 111.0, "id": "38f4a1bc-8e05-11ea-9c49-5cf37097309a"}, {"source": "Protein folding", "value": 0.5111620186862319, "ngenes": 129, "max_val": 8.706, "rank": 1060.0, "id": "38f4a1bd-8e05-11ea-9dac-5cf37097309a", "children": [{"source": "Post-chaperonin tubulin folding pathway", "value": 2.016203279065112, "ngenes": 25, "max_val": 8.706, "rank": 130.0, "id": "38f4a1be-8e05-11ea-9023-5cf37097309a"}, {"source": "Chaperonin-mediated protein folding", "value": 0.4788365094295219, "ngenes": 121, "max_val": 8.706, "rank": 1162.0, "id": "38f4a1bf-8e05-11ea-940e-5cf37097309a", "children": [{"source": "Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding", "value": 1.9421060230542748, "ngenes": 37, "max_val": 8.706, "rank": 163.0, "id": "38f4a1c0-8e05-11ea-8dea-5cf37097309a", "children": [{"source": "Prefoldin mediated transfer of substrate  to CCT/TriC", "value": 1.6317858092107065, "ngenes": 32, "max_val": 8.706, "rank": 250.0, "id": "38f4a1c1-8e05-11ea-b574-5cf37097309a"}, {"source": "Folding of actin by CCT/TriC", "value": 1.1503079923085315, "ngenes": 10, "max_val": 8.706, "rank": 461.0, "id": "38f4a1c2-8e05-11ea-9503-5cf37097309a"}, {"source": "Formation of tubulin folding intermediates by CCT/TriC", "value": 0.6286195179544306, "ngenes": 26, "max_val": 8.706, "rank": 873.0, "id": "38f4a1c3-8e05-11ea-8cdf-5cf37097309a"}]}, {"source": "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding", "value": 0.6741885157588996, "ngenes": 49, "max_val": 8.706, "rank": 779.0, "id": "38f4a1c4-8e05-11ea-93f5-5cf37097309a"}, {"source": "Association of TriC/CCT with target proteins during biosynthesis", "value": 0.3911487587762643, "ngenes": 53, "max_val": 8.706, "rank": 1539.0, "id": "38f4a1c5-8e05-11ea-8c12-5cf37097309a"}]}]}, {"source": "Translation", "value": 0.7002116702898259, "ngenes": 531, "max_val": 8.706, "rank": 759.0, "id": "38f4a1c6-8e05-11ea-9c9d-5cf37097309a", "children": [{"source": "Mitochondrial translation", "value": 1.93602695036627, "ngenes": 186, "max_val": 8.706, "rank": 164.0, "id": "38f4a1c7-8e05-11ea-886c-5cf37097309a", "children": [{"source": "Mitochondrial translation elongation", "value": 1.9181670415185692, "ngenes": 180, "max_val": 8.706, "rank": 168.0, "id": "38f4a1c8-8e05-11ea-a77f-5cf37097309a"}, {"source": "Mitochondrial translation termination", "value": 1.8914017356331347, "ngenes": 91, "max_val": 8.706, "rank": 177.0, "id": "38f4a1c9-8e05-11ea-878f-5cf37097309a"}, {"source": "Mitochondrial translation initiation", "value": 1.8722218261420536, "ngenes": 91, "max_val": 8.706, "rank": 182.0, "id": "38f4a1ca-8e05-11ea-bb2c-5cf37097309a"}]}, {"source": "Eukaryotic Translation Initiation", "value": 0.3050811988978337, "ngenes": 138, "max_val": 8.706, "rank": 2038.0, "id": "38f4a1cb-8e05-11ea-908d-5cf37097309a", "children": [{"source": "Cap-dependent Translation Initiation", "value": 0.3050811988978337, "ngenes": 138, "max_val": 8.706, "rank": 2035.0, "id": "38f4a1cc-8e05-11ea-b9be-5cf37097309a", "children": [{"source": "Formation of the ternary complex, and subsequently, the 43S complex", "value": 0.6579057484318369, "ngenes": 69, "max_val": 8.706, "rank": 813.0, "id": "38f4a1cd-8e05-11ea-bbb5-5cf37097309a"}, {"source": "Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S", "value": 0.6110274058194686, "ngenes": 77, "max_val": 8.706, "rank": 904.0, "id": "38f4a1ce-8e05-11ea-9718-5cf37097309a", "children": [{"source": "Translation initiation complex formation", "value": 0.6050659324828421, "ngenes": 76, "max_val": 8.706, "rank": 910.0, "id": "38f4a1cf-8e05-11ea-b3a8-5cf37097309a"}]}, {"source": "Ribosomal scanning and start codon recognition", "value": 0.6008310757219172, "ngenes": 76, "max_val": 8.706, "rank": 920.0, "id": "38f4a1d0-8e05-11ea-b151-5cf37097309a"}, {"source": "Recycling of eIF2:GDP", "value": 0.4649278207945483, "ngenes": 8, "max_val": 8.706, "rank": 1228.0, "id": "38f4a1d1-8e05-11ea-9e77-5cf37097309a"}, {"source": "Formation of a pool of free 40S subunits", "value": 0.3135746486533741, "ngenes": 120, "max_val": 8.706, "rank": 1954.0, "id": "38f4a1d2-8e05-11ea-8363-5cf37097309a"}, {"source": "GTP hydrolysis and joining of the 60S ribosomal subunit", "value": 0.3050811988978337, "ngenes": 131, "max_val": 8.706, "rank": 2036.0, "id": "38f4a1d3-8e05-11ea-afb8-5cf37097309a"}]}, {"source": "L13a-mediated translational silencing of Ceruloplasmin expression", "value": 0.3050811988978337, "ngenes": 130, "max_val": 8.706, "rank": 2039.0, "id": "38f4a1d4-8e05-11ea-94e3-5cf37097309a"}]}, {"source": "tRNA Aminoacylation", "value": 0.6348430454009657, "ngenes": 49, "max_val": 8.706, "rank": 859.0, "id": "38f4a1d5-8e05-11ea-898b-5cf37097309a", "children": [{"source": "Mitochondrial tRNA aminoacylation", "value": 0.5560189213165981, "ngenes": 23, "max_val": 8.706, "rank": 984.0, "id": "38f4a1d6-8e05-11ea-91cc-5cf37097309a"}, {"source": "Cytosolic tRNA aminoacylation", "value": 0.4627309951511139, "ngenes": 29, "max_val": 8.706, "rank": 1249.0, "id": "38f4a1d7-8e05-11ea-bc41-5cf37097309a"}]}, {"source": "SRP-dependent cotranslational protein targeting to membrane", "value": 0.4521712080309798, "ngenes": 243, "max_val": 8.706, "rank": 1271.0, "id": "38f4a1d8-8e05-11ea-b228-5cf37097309a"}, {"source": "Eukaryotic Translation Termination", "value": 0.3311527545224607, "ngenes": 113, "max_val": 8.706, "rank": 1853.0, "id": "38f4a1d9-8e05-11ea-9753-5cf37097309a"}, {"source": "Eukaryotic Translation Elongation", "value": 0.3128507621405376, "ngenes": 114, "max_val": 8.706, "rank": 1983.0, "id": "38f4a1da-8e05-11ea-9edb-5cf37097309a", "children": [{"source": "Peptide chain elongation", "value": 0.30974661035986545, "ngenes": 107, "max_val": 8.706, "rank": 2001.0, "id": "38f4a1db-8e05-11ea-a84b-5cf37097309a"}]}]}, {"source": "Amyloid fiber formation", "value": 1.724270257946776, "ngenes": 111, "max_val": 8.706, "rank": 212.0, "id": "38f4a1dc-8e05-11ea-bb5a-5cf37097309a"}, {"source": "Unfolded Protein Response (UPR)", "value": 0.4625616334894432, "ngenes": 106, "max_val": 8.706, "rank": 1251.0, "id": "38f4a1dd-8e05-11ea-b560-5cf37097309a", "children": [{"source": "CREB3 factors activate genes", "value": 1.6341505816288515, "ngenes": 12, "max_val": 8.706, "rank": 248.0, "id": "38f4a1de-8e05-11ea-bc0e-5cf37097309a"}, {"source": "ATF6 (ATF6-alpha) activates chaperones", "value": 0.5482687043601833, "ngenes": 17, "max_val": 8.706, "rank": 993.0, "id": "38f4a1df-8e05-11ea-b262-5cf37097309a", "children": [{"source": "ATF6 (ATF6-alpha) activates chaperone genes", "value": 0.4936817405850117, "ngenes": 15, "max_val": 8.706, "rank": 1108.0, "id": "38f4a1e0-8e05-11ea-a82b-5cf37097309a"}]}, {"source": "PERK regulates gene expression", "value": 0.4646123127797776, "ngenes": 37, "max_val": 8.706, "rank": 1239.0, "id": "38f4a1e1-8e05-11ea-a470-5cf37097309a", "children": [{"source": "ATF4 activates genes in response to endoplasmic reticulum  stress", "value": 0.3229052919360341, "ngenes": 29, "max_val": 8.706, "rank": 1905.0, "id": "38f4a1e2-8e05-11ea-9ae9-5cf37097309a"}]}, {"source": "IRE1alpha activates chaperones", "value": 0.3128507621405376, "ngenes": 52, "max_val": 8.706, "rank": 1978.0, "id": "38f4a1e3-8e05-11ea-98c6-5cf37097309a", "children": [{"source": "XBP1(S) activates chaperone genes", "value": 0.3019084411824866, "ngenes": 49, "max_val": 8.706, "rank": 2073.0, "id": "38f4a1e4-8e05-11ea-a6a3-5cf37097309a"}]}]}, {"source": "Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)", "value": 1.4812531704647378, "ngenes": 127, "max_val": 8.706, "rank": 319.0, "id": "38f4a1e5-8e05-11ea-8bb8-5cf37097309a"}, {"source": "Peptide hormone metabolism", "value": 0.5471840327551817, "ngenes": 102, "max_val": 8.706, "rank": 1006.0, "id": "38f4a1e6-8e05-11ea-8ca0-5cf37097309a", "children": [{"source": "Incretin synthesis, secretion, and inactivation", "value": 0.7785104767935921, "ngenes": 26, "max_val": 8.706, "rank": 681.0, "id": "38f4a1e7-8e05-11ea-b08a-5cf37097309a", "children": [{"source": "Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)", "value": 0.8174724816011347, "ngenes": 21, "max_val": 8.706, "rank": 657.0, "id": "38f4a1e8-8e05-11ea-9295-5cf37097309a"}, {"source": "Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)", "value": 0.6546837086397028, "ngenes": 15, "max_val": 8.706, "rank": 822.0, "id": "38f4a1e9-8e05-11ea-af42-5cf37097309a"}]}, {"source": "Metabolism of Angiotensinogen to Angiotensins", "value": 0.7272808209276187, "ngenes": 20, "max_val": 8.706, "rank": 726.0, "id": "38f4a1ea-8e05-11ea-aecc-5cf37097309a"}, {"source": "Peptide hormone biosynthesis", "value": 0.636980768480068, "ngenes": 14, "max_val": 8.706, "rank": 856.0, "id": "38f4a1eb-8e05-11ea-b781-5cf37097309a", "children": [{"source": "Glycoprotein hormones", "value": 0.7223072136687092, "ngenes": 12, "max_val": 8.706, "rank": 732.0, "id": "38f4a1ec-8e05-11ea-bae2-5cf37097309a"}]}, {"source": "Synthesis, secretion, and deacylation of Ghrelin", "value": 0.6164850109062877, "ngenes": 19, "max_val": 8.706, "rank": 891.0, "id": "38f4a1ed-8e05-11ea-a077-5cf37097309a"}, {"source": "Insulin processing", "value": 0.3697835599897704, "ngenes": 28, "max_val": 8.706, "rank": 1621.0, "id": "38f4a1ee-8e05-11ea-b8da-5cf37097309a"}]}, {"source": "Surfactant metabolism", "value": 0.7135917989205224, "ngenes": 30, "max_val": 8.706, "rank": 751.0, "id": "38f4a1ef-8e05-11ea-9499-5cf37097309a"}]}, {"source": "Transport of small molecules", "value": 0.6669049491165079, "ngenes": 814, "max_val": 8.706, "rank": 792.0, "id": "38f4a1f0-8e05-11ea-bd81-5cf37097309a", "children": [{"source": "Intracellular oxygen transport", "value": 2.69514506382913, "ngenes": 3, "max_val": 8.706, "rank": 59.0, "id": "38f4a1f1-8e05-11ea-82e6-5cf37097309a"}, {"source": "Plasma lipoprotein assembly, remodeling, and clearance", "value": 0.4689265375340588, "ngenes": 79, "max_val": 8.706, "rank": 1214.0, "id": "38f4a1f2-8e05-11ea-9909-5cf37097309a", "children": [{"source": "Plasma lipoprotein assembly", "value": 0.4419035080884291, "ngenes": 19, "max_val": 8.706, "rank": 1337.0, "id": "38f4a1f3-8e05-11ea-8311-5cf37097309a", "children": [{"source": "HDL assembly", "value": 2.6905250378743943, "ngenes": 8, "max_val": 8.706, "rank": 61.0, "id": "38f4a1f4-8e05-11ea-b5f8-5cf37097309a"}, {"source": "Chylomicron assembly", "value": 0.47285193963944605, "ngenes": 10, "max_val": 8.706, "rank": 1190.0, "id": "38f4a1f5-8e05-11ea-afaf-5cf37097309a"}, {"source": "VLDL assembly", "value": 0.3023022443625997, "ngenes": 5, "max_val": 8.706, "rank": 2071.0, "id": "38f4a1f6-8e05-11ea-ab7a-5cf37097309a"}]}, {"source": "Plasma lipoprotein remodeling", "value": 2.1815197575248915, "ngenes": 35, "max_val": 8.706, "rank": 112.0, "id": "38f4a1f7-8e05-11ea-9c3b-5cf37097309a", "children": [{"source": "Assembly of active LPL and LIPC lipase complexes", "value": 1.2043563049899253, "ngenes": 19, "max_val": 8.706, "rank": 431.0, "id": "38f4a1f8-8e05-11ea-bbff-5cf37097309a"}, {"source": "HDL remodeling", "value": 1.161767311553323, "ngenes": 10, "max_val": 8.706, "rank": 457.0, "id": "38f4a1f9-8e05-11ea-a022-5cf37097309a"}, {"source": "Chylomicron remodeling", "value": 0.6814840591522768, "ngenes": 10, "max_val": 8.706, "rank": 772.0, "id": "38f4a1fa-8e05-11ea-a058-5cf37097309a"}, {"source": "LDL remodeling", "value": 0.3333488691934495, "ngenes": 4, "max_val": 8.706, "rank": 1841.0, "id": "38f4a1fb-8e05-11ea-af5f-5cf37097309a"}]}, {"source": "Plasma lipoprotein clearance", "value": 0.33543834605580625, "ngenes": 38, "max_val": 8.706, "rank": 1827.0, "id": "38f4a1fc-8e05-11ea-ba8a-5cf37097309a", "children": [{"source": "VLDLR internalisation and degradation", "value": 0.6120981417357034, "ngenes": 12, "max_val": 8.706, "rank": 902.0, "id": "38f4a1fd-8e05-11ea-9a9b-5cf37097309a"}, {"source": "LDL clearance", "value": 0.4908093789985074, "ngenes": 20, "max_val": 8.706, "rank": 1111.0, "id": "38f4a1fe-8e05-11ea-9ca1-5cf37097309a"}, {"source": "Chylomicron clearance", "value": 0.4129012734621538, "ngenes": 8, "max_val": 8.706, "rank": 1451.0, "id": "38f4a1ff-8e05-11ea-875f-5cf37097309a"}, {"source": "VLDL clearance", "value": 0.4057684758553453, "ngenes": 9, "max_val": 8.706, "rank": 1485.0, "id": "38f4a200-8e05-11ea-ae8e-5cf37097309a"}, {"source": "HDL clearance", "value": 0.3586028553859912, "ngenes": 5, "max_val": 8.706, "rank": 1683.0, "id": "38f4a201-8e05-11ea-9cf5-5cf37097309a"}]}]}, {"source": "ABC-family proteins mediated transport", "value": 0.3678618516057002, "ngenes": 136, "max_val": 8.706, "rank": 1627.0, "id": "38f4a202-8e05-11ea-9665-5cf37097309a", "children": [{"source": "ABC transporters in lipid homeostasis", "value": 2.348129991681356, "ngenes": 18, "max_val": 8.706, "rank": 94.0, "id": "38f4a203-8e05-11ea-ab70-5cf37097309a"}, {"source": "Mitochondrial ABC transporters", "value": 0.3789602593706693, "ngenes": 4, "max_val": 8.706, "rank": 1584.0, "id": "38f4a204-8e05-11ea-aa54-5cf37097309a"}]}, {"source": "SLC-mediated transmembrane transport", "value": 1.3398183743388026, "ngenes": 269, "max_val": 8.706, "rank": 372.0, "id": "38f4a205-8e05-11ea-9356-5cf37097309a", "children": [{"source": "Transport of bile salts and organic acids, metal ions and amine compounds", "value": 1.324383660589583, "ngenes": 100, "max_val": 8.706, "rank": 379.0, "id": "38f4a206-8e05-11ea-8933-5cf37097309a", "children": [{"source": "Metal ion SLC transporters", "value": 0.31843317641013524, "ngenes": 31, "max_val": 8.706, "rank": 1927.0, "id": "38f4a207-8e05-11ea-92ac-5cf37097309a", "children": [{"source": "Zinc transporters", "value": 0.4389680702708547, "ngenes": 22, "max_val": 8.706, "rank": 1344.0, "id": "38f4a208-8e05-11ea-bdcb-5cf37097309a", "children": [{"source": "Zinc efflux and compartmentalization by the SLC30 family", "value": 1.8263202721526164, "ngenes": 7, "max_val": 8.706, "rank": 189.0, "id": "38f4a209-8e05-11ea-b177-5cf37097309a"}, {"source": "Zinc influx into cells by the SLC39 gene family", "value": 0.7840753180362913, "ngenes": 15, "max_val": 8.706, "rank": 677.0, "id": "38f4a20a-8e05-11ea-ae3d-5cf37097309a"}]}]}, {"source": "Organic cation/anion/zwitterion transport", "value": 1.6129733081434927, "ngenes": 15, "max_val": 8.706, "rank": 262.0, "id": "38f4a20b-8e05-11ea-80ac-5cf37097309a", "children": [{"source": "Organic cation transport", "value": 1.6082192522057692, "ngenes": 10, "max_val": 8.706, "rank": 271.0, "id": "38f4a20c-8e05-11ea-8ffd-5cf37097309a"}, {"source": "Organic anion transport", "value": 0.4086960495026968, "ngenes": 5, "max_val": 8.706, "rank": 1459.0, "id": "38f4a20d-8e05-11ea-a99b-5cf37097309a"}]}, {"source": "Rhesus glycoproteins mediate ammonium transport.", "value": 0.6034065875609209, "ngenes": 3, "max_val": 8.706, "rank": 912.0, "id": "38f4a20e-8e05-11ea-824c-5cf37097309a"}, {"source": "Na+/Cl- dependent neurotransmitter transporters", "value": 0.4865631200748303, "ngenes": 20, "max_val": 8.706, "rank": 1125.0, "id": "38f4a20f-8e05-11ea-9161-5cf37097309a"}, {"source": "Sodium-coupled sulphate, di- and tri-carboxylate transporters", "value": 0.4627309951511139, "ngenes": 5, "max_val": 8.706, "rank": 1246.0, "id": "38f4a210-8e05-11ea-ac13-5cf37097309a"}, {"source": "Inositol transporters", "value": 0.3846942455040212, "ngenes": 3, "max_val": 8.706, "rank": 1565.0, "id": "38f4a211-8e05-11ea-830e-5cf37097309a"}, {"source": "Proton-coupled monocarboxylate transport", "value": 0.31494787026486865, "ngenes": 7, "max_val": 8.706, "rank": 1943.0, "id": "38f4a212-8e05-11ea-8ff5-5cf37097309a"}]}, {"source": "Transport of vitamins, nucleosides, and related molecules", "value": 0.5958405955947986, "ngenes": 44, "max_val": 8.706, "rank": 925.0, "id": "38f4a213-8e05-11ea-bcf5-5cf37097309a", "children": [{"source": "Transport of nucleotide sugars", "value": 1.0493715008863531, "ngenes": 9, "max_val": 8.706, "rank": 507.0, "id": "38f4a214-8e05-11ea-a158-5cf37097309a"}, {"source": "Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane", "value": 0.4576107973577838, "ngenes": 12, "max_val": 8.706, "rank": 1255.0, "id": "38f4a215-8e05-11ea-92d5-5cf37097309a"}, {"source": "Transport of organic anions", "value": 0.4437546620665331, "ngenes": 12, "max_val": 8.706, "rank": 1283.0, "id": "38f4a216-8e05-11ea-a7f7-5cf37097309a"}, {"source": "Transport of fatty acids", "value": 0.3654779985375906, "ngenes": 8, "max_val": 8.706, "rank": 1642.0, "id": "38f4a217-8e05-11ea-8eca-5cf37097309a"}]}, {"source": "Transport of inorganic cations/anions and amino acids/oligopeptides", "value": 1.0485791137354077, "ngenes": 109, "max_val": 8.706, "rank": 509.0, "id": "38f4a218-8e05-11ea-98ef-5cf37097309a", "children": [{"source": "Sodium/Calcium exchangers", "value": 0.913589610544886, "ngenes": 11, "max_val": 8.706, "rank": 586.0, "id": "38f4a219-8e05-11ea-8469-5cf37097309a"}, {"source": "Proton/oligopeptide cotransporters", "value": 0.6708116960680702, "ngenes": 4, "max_val": 8.706, "rank": 785.0, "id": "38f4c870-8e05-11ea-9363-5cf37097309a"}, {"source": "Amino acid transport across the plasma membrane", "value": 0.5934456702094588, "ngenes": 34, "max_val": 8.706, "rank": 929.0, "id": "38f4c871-8e05-11ea-9c4d-5cf37097309a"}, {"source": "Sodium-coupled phosphate cotransporters", "value": 0.9134620299838327, "ngenes": 5, "max_val": 8.706, "rank": 588.0, "id": "38f4c872-8e05-11ea-a2cb-5cf37097309a", "children": [{"source": "Type II Na+/Pi cotransporters", "value": 0.5098760850672088, "ngenes": 3, "max_val": 8.706, "rank": 1072.0, "id": "38f4c873-8e05-11ea-9429-5cf37097309a"}]}, {"source": "Multifunctional anion exchangers", "value": 0.4865631200748303, "ngenes": 9, "max_val": 8.706, "rank": 1132.0, "id": "38f4c874-8e05-11ea-8ef8-5cf37097309a"}, {"source": "Cation-coupled Chloride cotransporters", "value": 0.4266462015709692, "ngenes": 7, "max_val": 8.706, "rank": 1377.0, "id": "38f4c875-8e05-11ea-8783-5cf37097309a"}, {"source": "Bicarbonate transporters", "value": 0.3984289558542966, "ngenes": 10, "max_val": 8.706, "rank": 1506.0, "id": "38f4c876-8e05-11ea-a097-5cf37097309a"}, {"source": "Organic anion transporters", "value": 0.3846844748472291, "ngenes": 11, "max_val": 8.706, "rank": 1570.0, "id": "38f4c877-8e05-11ea-b81b-5cf37097309a"}, {"source": "Sodium/Proton exchangers", "value": 0.3483210271800589, "ngenes": 9, "max_val": 8.706, "rank": 1764.0, "id": "38f4c878-8e05-11ea-a077-5cf37097309a"}, {"source": "Proton-coupled neutral amino acid transporters", "value": 0.30251216144429616, "ngenes": 2, "max_val": 8.706, "rank": 2068.0, "id": "38f4c879-8e05-11ea-a33d-5cf37097309a"}]}, {"source": "Cellular hexose transport", "value": 0.9056299952939398, "ngenes": 23, "max_val": 8.706, "rank": 597.0, "id": "38f4c87a-8e05-11ea-8c99-5cf37097309a"}]}, {"source": "Iron uptake and transport", "value": 2.117897320534324, "ngenes": 69, "max_val": 8.706, "rank": 120.0, "id": "38f4c87b-8e05-11ea-9719-5cf37097309a", "children": [{"source": "Transferrin endocytosis and recycling", "value": 1.4388751160820894, "ngenes": 38, "max_val": 8.706, "rank": 339.0, "id": "38f4c87c-8e05-11ea-9b36-5cf37097309a"}]}, {"source": "Ion channel transport", "value": 1.9486203325139888, "ngenes": 197, "max_val": 8.706, "rank": 154.0, "id": "38f4c87d-8e05-11ea-9cdb-5cf37097309a", "children": [{"source": "Ion transport by P-type ATPases", "value": 1.3862603648568932, "ngenes": 55, "max_val": 8.706, "rank": 356.0, "id": "38f4c87e-8e05-11ea-aaec-5cf37097309a"}, {"source": "Stimuli-sensing channels", "value": 0.7463429526481667, "ngenes": 113, "max_val": 8.706, "rank": 711.0, "id": "38f4c87f-8e05-11ea-9b99-5cf37097309a", "children": [{"source": "TRP channels", "value": 0.9478742831410916, "ngenes": 29, "max_val": 8.706, "rank": 571.0, "id": "38f4c880-8e05-11ea-a219-5cf37097309a"}]}]}, {"source": "Aquaporin-mediated transport", "value": 0.5694942523816988, "ngenes": 55, "max_val": 8.706, "rank": 957.0, "id": "38f4c881-8e05-11ea-971c-5cf37097309a", "children": [{"source": "Transport of glycerol from adipocytes to the liver by Aquaporins", "value": 0.6410788406347994, "ngenes": 2, "max_val": 8.706, "rank": 847.0, "id": "38f4c882-8e05-11ea-b6c8-5cf37097309a"}, {"source": "Passive transport by Aquaporins", "value": 0.44958607382897975, "ngenes": 13, "max_val": 8.706, "rank": 1276.0, "id": "38f4c883-8e05-11ea-b1f0-5cf37097309a"}, {"source": "Vasopressin regulates renal water homeostasis via Aquaporins", "value": 0.4155956201894052, "ngenes": 46, "max_val": 8.706, "rank": 1437.0, "id": "38f4c884-8e05-11ea-b077-5cf37097309a"}]}, {"source": "Mitochondrial calcium ion transport", "value": 0.3984289558542966, "ngenes": 26, "max_val": 8.706, "rank": 1509.0, "id": "38f4c885-8e05-11ea-82ab-5cf37097309a", "children": [{"source": "Processing of SMDT1", "value": 0.44227409954858976, "ngenes": 19, "max_val": 8.706, "rank": 1301.0, "id": "38f4c886-8e05-11ea-804d-5cf37097309a"}]}, {"source": "O2/CO2 exchange in erythrocytes", "value": 0.30782438454611044, "ngenes": 13, "max_val": 8.706, "rank": 2014.0, "id": "38f4c887-8e05-11ea-ba11-5cf37097309a", "children": [{"source": "Erythrocytes take up oxygen and release carbon dioxide", "value": 0.3128507621405376, "ngenes": 9, "max_val": 8.706, "rank": 1986.0, "id": "38f4c888-8e05-11ea-a787-5cf37097309a"}, {"source": "Erythrocytes take up carbon dioxide and release oxygen", "value": 0.307809407982239, "ngenes": 13, "max_val": 8.706, "rank": 2016.0, "id": "38f4c889-8e05-11ea-b747-5cf37097309a"}]}, {"source": "Miscellaneous transport and binding events", "value": 0.30750972834915496, "ngenes": 26, "max_val": 8.706, "rank": 2017.0, "id": "38f4c88a-8e05-11ea-9e0e-5cf37097309a"}]}, {"source": "DNA Repair", "value": 1.7262507509034395, "ngenes": 426, "max_val": 8.706, "rank": 209.0, "id": "38f4c88b-8e05-11ea-a978-5cf37097309a", "children": [{"source": "DNA Double-Strand Break Repair", "value": 2.4731510426684333, "ngenes": 177, "max_val": 8.706, "rank": 82.0, "id": "38f4c88c-8e05-11ea-8d89-5cf37097309a", "children": [{"source": "Homology Directed Repair", "value": 2.4995894602182482, "ngenes": 149, "max_val": 8.706, "rank": 78.0, "id": "38f4c88d-8e05-11ea-bfbb-5cf37097309a", "children": [{"source": "HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)", "value": 2.5992734591911946, "ngenes": 143, "max_val": 8.706, "rank": 73.0, "id": "38f4c88e-8e05-11ea-aaed-5cf37097309a", "children": [{"source": "Processing of DNA double-strand break ends", "value": 2.6905250378743943, "ngenes": 109, "max_val": 8.706, "rank": 60.0, "id": "38f4c88f-8e05-11ea-8594-5cf37097309a"}, {"source": "HDR through Homologous Recombination (HRR)", "value": 1.6249020261081542, "ngenes": 69, "max_val": 8.706, "rank": 258.0, "id": "38f4c890-8e05-11ea-aa7a-5cf37097309a", "children": [{"source": "Resolution of D-Loop Structures", "value": 1.8925853850118608, "ngenes": 35, "max_val": 8.706, "rank": 175.0, "id": "38f4c891-8e05-11ea-bb15-5cf37097309a", "children": [{"source": "Resolution of D-loop Structures through Holliday Junction Intermediates", "value": 1.8888641991591488, "ngenes": 34, "max_val": 8.706, "rank": 179.0, "id": "38f4c892-8e05-11ea-a013-5cf37097309a"}, {"source": "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)", "value": 1.714938121786132, "ngenes": 27, "max_val": 8.706, "rank": 216.0, "id": "38f4c893-8e05-11ea-8159-5cf37097309a"}]}, {"source": "Homologous DNA Pairing and Strand Exchange", "value": 1.6082192522057692, "ngenes": 44, "max_val": 8.706, "rank": 265.0, "id": "38f4c894-8e05-11ea-89fb-5cf37097309a", "children": [{"source": "Presynaptic phase of homologous DNA pairing and strand exchange", "value": 1.548127002516829, "ngenes": 41, "max_val": 8.706, "rank": 292.0, "id": "38f4c895-8e05-11ea-9107-5cf37097309a"}]}]}, {"source": "HDR through Single Strand Annealing (SSA)", "value": 1.5566356862971817, "ngenes": 39, "max_val": 8.706, "rank": 287.0, "id": "38f4c896-8e05-11ea-bd68-5cf37097309a"}]}, {"source": "HDR through MMEJ (alt-NHEJ)", "value": 1.6383002223565075, "ngenes": 10, "max_val": 8.706, "rank": 245.0, "id": "38f4c897-8e05-11ea-9adc-5cf37097309a"}]}, {"source": "Nonhomologous End-Joining (NHEJ)", "value": 1.9698897339763397, "ngenes": 78, "max_val": 8.706, "rank": 144.0, "id": "38f4c898-8e05-11ea-9356-5cf37097309a"}, {"source": "DNA Double Strand Break Response", "value": 1.9876163820754629, "ngenes": 86, "max_val": 8.706, "rank": 142.0, "id": "38f4c899-8e05-11ea-84cc-5cf37097309a", "children": [{"source": "Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks", "value": 1.7876299106393332, "ngenes": 85, "max_val": 8.706, "rank": 197.0, "id": "38f4c89a-8e05-11ea-8708-5cf37097309a"}, {"source": "Sensing of DNA Double Strand Breaks", "value": 0.3608306486501528, "ngenes": 6, "max_val": 8.706, "rank": 1659.0, "id": "38f4c89b-8e05-11ea-8022-5cf37097309a"}]}]}, {"source": "DNA Damage Bypass", "value": 2.1815197575248915, "ngenes": 48, "max_val": 8.706, "rank": 113.0, "id": "38f4c89c-8e05-11ea-8bc1-5cf37097309a", "children": [{"source": "Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template", "value": 1.6839357628617688, "ngenes": 39, "max_val": 8.706, "rank": 225.0, "id": "38f4c89d-8e05-11ea-802f-5cf37097309a", "children": [{"source": "Translesion Synthesis by POLH", "value": 1.7162675872266722, "ngenes": 19, "max_val": 8.706, "rank": 215.0, "id": "38f4c89e-8e05-11ea-9d31-5cf37097309a"}, {"source": "Termination of translesion DNA synthesis", "value": 1.645291063554907, "ngenes": 32, "max_val": 8.706, "rank": 238.0, "id": "38f4c89f-8e05-11ea-a4f1-5cf37097309a"}, {"source": "Translesion synthesis by POLI", "value": 0.9055627642191559, "ngenes": 17, "max_val": 8.706, "rank": 599.0, "id": "38f4c8a0-8e05-11ea-a08d-5cf37097309a"}, {"source": "Translesion synthesis by REV1", "value": 0.86492840468403, "ngenes": 16, "max_val": 8.706, "rank": 625.0, "id": "38f4c8a1-8e05-11ea-aa86-5cf37097309a"}, {"source": "Translesion synthesis by POLK", "value": 0.826781739624, "ngenes": 17, "max_val": 8.706, "rank": 642.0, "id": "38f4c8a2-8e05-11ea-8a9a-5cf37097309a"}]}, {"source": "Recognition of DNA damage by PCNA-containing replication complex", "value": 1.6285898565172368, "ngenes": 30, "max_val": 8.706, "rank": 251.0, "id": "38f4c8a3-8e05-11ea-bfa6-5cf37097309a"}]}, {"source": "Base Excision Repair", "value": 2.004174553739853, "ngenes": 148, "max_val": 8.706, "rank": 136.0, "id": "38f4c8a4-8e05-11ea-a513-5cf37097309a", "children": [{"source": "Base-Excision Repair, AP Site Formation", "value": 1.657615261891164, "ngenes": 120, "max_val": 8.706, "rank": 236.0, "id": "38f4c8a5-8e05-11ea-9830-5cf37097309a", "children": [{"source": "Depyrimidination", "value": 1.657615261891164, "ngenes": 63, "max_val": 8.706, "rank": 232.0, "id": "38f4c8a6-8e05-11ea-824a-5cf37097309a", "children": [{"source": "Cleavage of the damaged pyrimidine ", "value": 1.657615261891164, "ngenes": 63, "max_val": 8.706, "rank": 231.0, "id": "38f4c8a7-8e05-11ea-b5c1-5cf37097309a"}, {"source": "Recognition and association of DNA glycosylase with site containing an affected pyrimidine", "value": 1.657615261891164, "ngenes": 63, "max_val": 8.706, "rank": 233.0, "id": "38f4c8a8-8e05-11ea-99d8-5cf37097309a"}]}, {"source": "Depurination", "value": 1.6082192522057692, "ngenes": 113, "max_val": 8.706, "rank": 267.0, "id": "38f4c8a9-8e05-11ea-b4d4-5cf37097309a", "children": [{"source": "Cleavage of the damaged purine", "value": 1.6082192522057692, "ngenes": 113, "max_val": 8.706, "rank": 266.0, "id": "38f4c8aa-8e05-11ea-ab36-5cf37097309a"}, {"source": "Recognition and association of DNA glycosylase with site containing an affected purine", "value": 1.6082192522057692, "ngenes": 113, "max_val": 8.706, "rank": 269.0, "id": "38f4c8ab-8e05-11ea-b668-5cf37097309a"}]}]}, {"source": "Resolution of Abasic Sites (AP sites)", "value": 1.2722484396007954, "ngenes": 38, "max_val": 8.706, "rank": 400.0, "id": "38f4c8ac-8e05-11ea-bd25-5cf37097309a", "children": [{"source": "Resolution of AP sites via the multiple-nucleotide patch replacement pathway", "value": 1.359821413270241, "ngenes": 25, "max_val": 8.706, "rank": 363.0, "id": "38f4c8ad-8e05-11ea-8029-5cf37097309a", "children": [{"source": "POLB-Dependent Long Patch Base Excision Repair", "value": 1.609823036999506, "ngenes": 8, "max_val": 8.706, "rank": 263.0, "id": "38f4c8ae-8e05-11ea-aa27-5cf37097309a"}, {"source": "PCNA-Dependent Long Patch Base Excision Repair", "value": 1.4388572572093514, "ngenes": 21, "max_val": 8.706, "rank": 340.0, "id": "38f4c8af-8e05-11ea-99a9-5cf37097309a"}]}, {"source": "Resolution of AP sites via the single-nucleotide replacement pathway", "value": 0.4788365094295219, "ngenes": 4, "max_val": 8.706, "rank": 1166.0, "id": "38f4c8b0-8e05-11ea-8227-5cf37097309a", "children": [{"source": "Abasic sugar-phosphate removal via the single-nucleotide replacement pathway", "value": 0.6971911352598542, "ngenes": 2, "max_val": 8.706, "rank": 764.0, "id": "38f4c8b1-8e05-11ea-be22-5cf37097309a"}]}, {"source": "Displacement of DNA glycosylase by APEX1", "value": 0.5789998176527524, "ngenes": 9, "max_val": 8.706, "rank": 947.0, "id": "38f4c8b2-8e05-11ea-8e64-5cf37097309a"}, {"source": "APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway", "value": 0.5070556504709329, "ngenes": 7, "max_val": 8.706, "rank": 1081.0, "id": "38f4c8b3-8e05-11ea-bda8-5cf37097309a"}]}]}, {"source": "Nucleotide Excision Repair", "value": 1.120693954178978, "ngenes": 129, "max_val": 8.706, "rank": 480.0, "id": "38f4c8b4-8e05-11ea-a4ca-5cf37097309a", "children": [{"source": "Global Genome Nucleotide Excision Repair (GG-NER)", "value": 1.020998721838789, "ngenes": 103, "max_val": 8.706, "rank": 540.0, "id": "38f4c8b5-8e05-11ea-9d61-5cf37097309a", "children": [{"source": "Formation of Incision Complex in GG-NER", "value": 1.5134688715929976, "ngenes": 51, "max_val": 8.706, "rank": 313.0, "id": "38f4c8b6-8e05-11ea-b091-5cf37097309a"}, {"source": "Gap-filling DNA repair synthesis and ligation in GG-NER", "value": 0.9580043355188876, "ngenes": 25, "max_val": 8.706, "rank": 564.0, "id": "38f4c8b7-8e05-11ea-aaad-5cf37097309a"}, {"source": "Dual Incision in GG-NER", "value": 0.3369350433320172, "ngenes": 48, "max_val": 8.706, "rank": 1812.0, "id": "38f4c8b8-8e05-11ea-b1d5-5cf37097309a"}, {"source": "DNA Damage Recognition in GG-NER", "value": 0.31979698022717656, "ngenes": 49, "max_val": 8.706, "rank": 1918.0, "id": "38f4c8b9-8e05-11ea-ab55-5cf37097309a"}]}, {"source": "Transcription-Coupled Nucleotide Excision Repair (TC-NER)", "value": 0.9692651992257152, "ngenes": 86, "max_val": 8.706, "rank": 560.0, "id": "38f4c8ba-8e05-11ea-a99b-5cf37097309a", "children": [{"source": "Formation of TC-NER Pre-Incision Complex", "value": 1.2470220203600528, "ngenes": 61, "max_val": 8.706, "rank": 407.0, "id": "38f4c8bb-8e05-11ea-abfb-5cf37097309a"}, {"source": "Dual incision in TC-NER", "value": 1.1073058247800949, "ngenes": 73, "max_val": 8.706, "rank": 484.0, "id": "38f4c8bc-8e05-11ea-b725-5cf37097309a"}, {"source": "Gap-filling DNA repair synthesis and ligation in TC-NER", "value": 0.6568523944177979, "ngenes": 72, "max_val": 8.706, "rank": 817.0, "id": "38f4c8bd-8e05-11ea-9d3d-5cf37097309a"}]}]}, {"source": "Fanconi Anemia Pathway", "value": 1.0448064621071822, "ngenes": 40, "max_val": 8.706, "rank": 514.0, "id": "38f4c8be-8e05-11ea-84d4-5cf37097309a"}, {"source": "Mismatch Repair", "value": 0.4129204759764161, "ngenes": 24, "max_val": 8.706, "rank": 1447.0, "id": "38f4c8bf-8e05-11ea-abdf-5cf37097309a", "children": [{"source": "Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)", "value": 0.5077300772956613, "ngenes": 14, "max_val": 8.706, "rank": 1079.0, "id": "38f4c8c0-8e05-11ea-b634-5cf37097309a"}, {"source": "Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)", "value": 0.3026960685114295, "ngenes": 19, "max_val": 8.706, "rank": 2057.0, "id": "38f4c8c1-8e05-11ea-ac3d-5cf37097309a"}]}, {"source": "DNA Damage Reversal", "value": 0.3769883516616439, "ngenes": 8, "max_val": 8.706, "rank": 1592.0, "id": "38f4c8c2-8e05-11ea-bf73-5cf37097309a", "children": [{"source": "Reversal of alkylation damage by DNA dioxygenases", "value": 0.721392241826102, "ngenes": 7, "max_val": 8.706, "rank": 740.0, "id": "38f4c8c3-8e05-11ea-9f85-5cf37097309a", "children": [{"source": "ALKBH3 mediated reversal of alkylation damage", "value": 0.34164437670647896, "ngenes": 4, "max_val": 8.706, "rank": 1787.0, "id": "38f4c8c4-8e05-11ea-b37f-5cf37097309a"}]}]}]}, {"source": "Protein localization", "value": 1.3136451079029379, "ngenes": 282, "max_val": 8.706, "rank": 384.0, "id": "38f4c8c5-8e05-11ea-b48f-5cf37097309a", "children": [{"source": "Mitochondrial protein import", "value": 2.627832216398577, "ngenes": 89, "max_val": 8.706, "rank": 71.0, "id": "38f4c8c6-8e05-11ea-8851-5cf37097309a"}, {"source": "Class I peroxisomal membrane protein import", "value": 2.6268014131872253, "ngenes": 24, "max_val": 8.706, "rank": 72.0, "id": "38f4c8c7-8e05-11ea-a383-5cf37097309a"}, {"source": "Insertion of tail-anchored proteins into the endoplasmic reticulum membrane", "value": 0.6410788406347994, "ngenes": 44, "max_val": 8.706, "rank": 845.0, "id": "38f4c8c8-8e05-11ea-bfa1-5cf37097309a"}, {"source": "Peroxisomal protein import", "value": 0.6013647217066604, "ngenes": 131, "max_val": 8.706, "rank": 916.0, "id": "38f4c8c9-8e05-11ea-a44d-5cf37097309a", "children": [{"source": "TYSND1 cleaves peroxisomal proteins", "value": 0.4839065852617352, "ngenes": 8, "max_val": 8.706, "rank": 1143.0, "id": "38f4c8ca-8e05-11ea-bd5c-5cf37097309a"}]}]}, {"source": "Cellular responses to external stimuli", "value": 0.4907018464851966, "ngenes": 721, "max_val": 8.706, "rank": 1114.0, "id": "38f4c8cb-8e05-11ea-84c8-5cf37097309a", "children": [{"source": "Cellular responses to stress", "value": 0.4649278207945483, "ngenes": 703, "max_val": 8.706, "rank": 1229.0, "id": "38f4c8cc-8e05-11ea-b4bd-5cf37097309a", "children": [{"source": "Cellular response to heat stress", "value": 1.5495138599497604, "ngenes": 117, "max_val": 8.706, "rank": 289.0, "id": "38f4c8cd-8e05-11ea-af9c-5cf37097309a", "children": [{"source": "HSF1 activation", "value": 2.5992734591911946, "ngenes": 45, "max_val": 8.706, "rank": 74.0, "id": "38f4c8ce-8e05-11ea-9c3f-5cf37097309a"}, {"source": "HSF1-dependent transactivation", "value": 2.779524099447062, "ngenes": 52, "max_val": 8.706, "rank": 51.0, "id": "38f4c8cf-8e05-11ea-b998-5cf37097309a", "children": [{"source": "Attenuation phase", "value": 2.4731510426684333, "ngenes": 42, "max_val": 8.706, "rank": 81.0, "id": "38f4c8d0-8e05-11ea-bc4a-5cf37097309a"}]}, {"source": "Regulation of HSF1-mediated heat shock response", "value": 1.7046865309937722, "ngenes": 98, "max_val": 8.706, "rank": 217.0, "id": "38f4c8d1-8e05-11ea-b0d2-5cf37097309a"}]}, {"source": "HSP90 chaperone cycle for steroid hormone receptors (SHR)", "value": 2.433164653480108, "ngenes": 68, "max_val": 8.706, "rank": 86.0, "id": "38f4c8d2-8e05-11ea-a6e9-5cf37097309a"}, {"source": "Amino acids regulate mTORC1", "value": 2.0160142700617008, "ngenes": 63, "max_val": 8.706, "rank": 132.0, "id": "38f4c8d3-8e05-11ea-9cf3-5cf37097309a"}, {"source": "Cellular Senescence", "value": 2.6334936884204705, "ngenes": 221, "max_val": 8.706, "rank": 65.0, "id": "38f4c8d4-8e05-11ea-a3a0-5cf37097309a", "children": [{"source": "Oxidative Stress Induced Senescence", "value": 2.004174553739853, "ngenes": 135, "max_val": 8.706, "rank": 135.0, "id": "38f4c8d5-8e05-11ea-a923-5cf37097309a"}, {"source": "Senescence-Associated Secretory Phenotype (SASP)", "value": 2.0041360120510268, "ngenes": 123, "max_val": 8.706, "rank": 137.0, "id": "38f4c8d6-8e05-11ea-abfc-5cf37097309a"}, {"source": "DNA Damage/Telomere Stress Induced Senescence", "value": 1.8080770714145464, "ngenes": 82, "max_val": 8.706, "rank": 190.0, "id": "38f4c8d7-8e05-11ea-869d-5cf37097309a", "children": [{"source": "Formation of Senescence-Associated Heterochromatin Foci (SAHF)", "value": 0.3436577923483467, "ngenes": 17, "max_val": 8.706, "rank": 1777.0, "id": "38f4c8d8-8e05-11ea-873d-5cf37097309a"}]}, {"source": "Oncogene Induced Senescence", "value": 0.3073451772322425, "ngenes": 39, "max_val": 8.706, "rank": 2018.0, "id": "38f4c8d9-8e05-11ea-b40c-5cf37097309a"}]}, {"source": "Cellular response to hypoxia", "value": 0.4898322962446102, "ngenes": 105, "max_val": 8.706, "rank": 1116.0, "id": "38f4c8da-8e05-11ea-9635-5cf37097309a", "children": [{"source": "Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha", "value": 0.4704952658544049, "ngenes": 96, "max_val": 8.706, "rank": 1202.0, "id": "38f4c8db-8e05-11ea-8d47-5cf37097309a"}, {"source": "Regulation of gene expression by Hypoxia-inducible Factor", "value": 0.3272772875640805, "ngenes": 11, "max_val": 8.706, "rank": 1885.0, "id": "38f4c8dc-8e05-11ea-a2da-5cf37097309a"}]}, {"source": "Detoxification of Reactive Oxygen Species", "value": 0.32315917780373304, "ngenes": 41, "max_val": 8.706, "rank": 1898.0, "id": "38f4c8dd-8e05-11ea-bcfb-5cf37097309a"}, {"source": "Response of EIF2AK4 (GCN2) to amino acid deficiency", "value": 0.3223161519951602, "ngenes": 123, "max_val": 8.706, "rank": 1913.0, "id": "38f4c8de-8e05-11ea-b0d0-5cf37097309a"}, {"source": "Response of EIF2AK1 (HRI) to heme deficiency", "value": 0.30921555957048075, "ngenes": 19, "max_val": 8.706, "rank": 2002.0, "id": "38f4c8df-8e05-11ea-8fc0-5cf37097309a"}]}, {"source": "Response to metal ions", "value": 0.3848477654948391, "ngenes": 18, "max_val": 8.706, "rank": 1564.0, "id": "38f4c8e0-8e05-11ea-ae95-5cf37097309a", "children": [{"source": "MTF1 activates gene expression", "value": 1.468293831901582, "ngenes": 4, "max_val": 8.706, "rank": 328.0, "id": "38f4c8e1-8e05-11ea-b199-5cf37097309a"}, {"source": "Metallothioneins bind metals", "value": 0.3281271091218333, "ngenes": 14, "max_val": 8.706, "rank": 1876.0, "id": "38f4c8e2-8e05-11ea-a685-5cf37097309a"}]}]}, {"source": "Immune System", "value": 0.886097180043873, "ngenes": 3212, "max_val": 8.706, "rank": 614.0, "id": "38f4c8e3-8e05-11ea-903f-5cf37097309a", "children": [{"source": "Cytokine Signaling in Immune system", "value": 0.7566889536504381, "ngenes": 1138, "max_val": 8.706, "rank": 698.0, "id": "38f4c8e4-8e05-11ea-a87a-5cf37097309a", "children": [{"source": "Signaling by Interleukins", "value": 0.8199941346336901, "ngenes": 572, "max_val": 8.706, "rank": 650.0, "id": "38f4c8e5-8e05-11ea-bbc0-5cf37097309a", "children": [{"source": "Interleukin-1 family signaling", "value": 0.5727501737678508, "ngenes": 166, "max_val": 8.706, "rank": 954.0, "id": "38f4c8e6-8e05-11ea-a304-5cf37097309a", "children": [{"source": "Interleukin-1 signaling", "value": 0.3746306286780314, "ngenes": 128, "max_val": 8.706, "rank": 1605.0, "id": "38f4c8e7-8e05-11ea-ba7b-5cf37097309a", "children": [{"source": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "value": 2.317351857242661, "ngenes": 17, "max_val": 8.706, "rank": 96.0, "id": "38f4c8e8-8e05-11ea-a517-5cf37097309a"}, {"source": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "value": 0.38432146764772507, "ngenes": 39, "max_val": 8.706, "rank": 1576.0, "id": "38f4c8e9-8e05-11ea-91c3-5cf37097309a"}]}, {"source": "Interleukin-18 signaling", "value": 1.5787454270640546, "ngenes": 9, "max_val": 8.706, "rank": 279.0, "id": "38f4c8ea-8e05-11ea-abfb-5cf37097309a"}, {"source": "Interleukin-37 signaling", "value": 1.4117033129971952, "ngenes": 21, "max_val": 8.706, "rank": 351.0, "id": "38f4c8eb-8e05-11ea-9460-5cf37097309a"}, {"source": "Interleukin-36 pathway", "value": 0.6937103871398255, "ngenes": 7, "max_val": 8.706, "rank": 767.0, "id": "38f4c8ec-8e05-11ea-b572-5cf37097309a"}, {"source": "Interleukin-38 signaling", "value": 0.44227409954858976, "ngenes": 4, "max_val": 8.706, "rank": 1296.0, "id": "38f4c8ed-8e05-11ea-bc20-5cf37097309a"}, {"source": "Interleukin-1 processing", "value": 0.3870270024082915, "ngenes": 8, "max_val": 8.706, "rank": 1552.0, "id": "38f4c8ee-8e05-11ea-b92a-5cf37097309a"}, {"source": "Interleukin-33 signaling", "value": 0.33871289172223634, "ngenes": 3, "max_val": 8.706, "rank": 1799.0, "id": "38f4c8ef-8e05-11ea-a10b-5cf37097309a"}]}, {"source": "Interleukin-17 signaling", "value": 0.4165866033279961, "ngenes": 77, "max_val": 8.706, "rank": 1432.0, "id": "38f4c8f0-8e05-11ea-afed-5cf37097309a", "children": [{"source": "MAP kinase activation", "value": 0.5180663835710579, "ngenes": 69, "max_val": 8.706, "rank": 1051.0, "id": "38f4c8f1-8e05-11ea-8290-5cf37097309a", "children": [{"source": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "value": 2.317351857242661, "ngenes": 17, "max_val": 8.706, "rank": 96.0, "id": "38f4c8f2-8e05-11ea-80b0-5cf37097309a"}, {"source": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "value": 0.8904984852142677, "ngenes": 22, "max_val": 8.706, "rank": 607.0, "id": "38f4c8f3-8e05-11ea-b1d0-5cf37097309a"}, {"source": "MAPK targets/ Nuclear events mediated by MAP kinases", "value": 0.3908178161262853, "ngenes": 35, "max_val": 8.706, "rank": 1542.0, "id": "38f4c8f4-8e05-11ea-827e-5cf37097309a", "children": [{"source": "Activation of the AP-1 family of transcription factors", "value": 0.406467316447748, "ngenes": 10, "max_val": 8.706, "rank": 1467.0, "id": "38f4c8f5-8e05-11ea-a580-5cf37097309a"}, {"source": "ERK/MAPK targets", "value": 0.5471840327551817, "ngenes": 26, "max_val": 8.706, "rank": 1002.0, "id": "38f4c8f6-8e05-11ea-be3e-5cf37097309a", "children": [{"source": "ERKs are inactivated", "value": 0.3849420497242914, "ngenes": 13, "max_val": 8.706, "rank": 1559.0, "id": "38f4c8f7-8e05-11ea-bf82-5cf37097309a"}]}, {"source": "CREB phosphorylation", "value": 0.3050811988978337, "ngenes": 8, "max_val": 8.706, "rank": 2033.0, "id": "38f4ef90-8e05-11ea-9c7e-5cf37097309a"}]}, {"source": "activated TAK1 mediates p38 MAPK activation", "value": 0.37331638253090615, "ngenes": 23, "max_val": 8.706, "rank": 1608.0, "id": "38f4ef91-8e05-11ea-a2f4-5cf37097309a"}]}]}, {"source": "Other interleukin signaling", "value": 1.9611870398104247, "ngenes": 25, "max_val": 8.706, "rank": 145.0, "id": "38f4ef92-8e05-11ea-9921-5cf37097309a"}, {"source": "Interleukin-4 and Interleukin-13 signaling", "value": 1.8403575974729531, "ngenes": 122, "max_val": 8.706, "rank": 187.0, "id": "38f4ef93-8e05-11ea-826b-5cf37097309a"}, {"source": "Interleukin-12 family signaling", "value": 0.8717705024357975, "ngenes": 74, "max_val": 8.706, "rank": 621.0, "id": "38f4ef94-8e05-11ea-a2b8-5cf37097309a", "children": [{"source": "Interleukin-35 Signalling", "value": 1.6383002223565075, "ngenes": 13, "max_val": 8.706, "rank": 243.0, "id": "38f4ef95-8e05-11ea-ac30-5cf37097309a"}, {"source": "Interleukin-27 signaling", "value": 1.3587138740441582, "ngenes": 18, "max_val": 8.706, "rank": 367.0, "id": "38f4ef96-8e05-11ea-8f86-5cf37097309a"}, {"source": "Interleukin-23 signaling", "value": 1.3346149154582094, "ngenes": 16, "max_val": 8.706, "rank": 373.0, "id": "38f4ef97-8e05-11ea-a9de-5cf37097309a"}, {"source": "Interleukin-12 signaling", "value": 0.3223732079441458, "ngenes": 57, "max_val": 8.706, "rank": 1912.0, "id": "38f4ef98-8e05-11ea-9c1a-5cf37097309a", "children": [{"source": "Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation", "value": 0.5250584137080414, "ngenes": 40, "max_val": 8.706, "rank": 1039.0, "id": "38f4ef99-8e05-11ea-a135-5cf37097309a"}]}]}, {"source": "Interleukin-2 family signaling", "value": 1.1959285221868379, "ngenes": 56, "max_val": 8.706, "rank": 432.0, "id": "38f4ef9a-8e05-11ea-840d-5cf37097309a", "children": [{"source": "Interleukin receptor SHC signaling", "value": 1.474917373322508, "ngenes": 28, "max_val": 8.706, "rank": 323.0, "id": "38f4ef9b-8e05-11ea-8205-5cf37097309a"}, {"source": "Interleukin-2 signaling", "value": 1.0392836614911098, "ngenes": 14, "max_val": 8.706, "rank": 520.0, "id": "38f4ef9c-8e05-11ea-831a-5cf37097309a"}, {"source": "Interleukin-15 signaling", "value": 0.9334510103034738, "ngenes": 22, "max_val": 8.706, "rank": 574.0, "id": "38f4ef9d-8e05-11ea-95a6-5cf37097309a"}, {"source": "Interleukin-21 signaling", "value": 0.8892958081367117, "ngenes": 10, "max_val": 8.706, "rank": 608.0, "id": "38f4ef9e-8e05-11ea-8858-5cf37097309a"}, {"source": "Interleukin-9 signaling", "value": 0.6063782413717023, "ngenes": 9, "max_val": 8.706, "rank": 907.0, "id": "38f4ef9f-8e05-11ea-958c-5cf37097309a"}]}, {"source": "Interleukin-3, Interleukin-5 and GM-CSF signaling", "value": 1.4388572572093514, "ngenes": 67, "max_val": 8.706, "rank": 342.0, "id": "38f4efa0-8e05-11ea-8bef-5cf37097309a", "children": [{"source": "Interleukin receptor SHC signaling", "value": 1.474917373322508, "ngenes": 28, "max_val": 8.706, "rank": 323.0, "id": "38f4efa1-8e05-11ea-ba52-5cf37097309a"}, {"source": "Regulation of signaling by CBL", "value": 1.16005282927545, "ngenes": 35, "max_val": 8.706, "rank": 458.0, "id": "38f4efa2-8e05-11ea-96c6-5cf37097309a"}]}, {"source": "Interleukin-7 signaling", "value": 1.3788214749491916, "ngenes": 63, "max_val": 8.706, "rank": 359.0, "id": "38f4efa3-8e05-11ea-b782-5cf37097309a"}, {"source": "Interleukin-20 family signaling", "value": 1.16005282927545, "ngenes": 26, "max_val": 8.706, "rank": 459.0, "id": "38f4efa4-8e05-11ea-90a5-5cf37097309a"}, {"source": "Interleukin-6 family signaling", "value": 1.1746124312424369, "ngenes": 28, "max_val": 8.706, "rank": 452.0, "id": "38f4efa5-8e05-11ea-91fd-5cf37097309a", "children": [{"source": "Interleukin-6 signaling", "value": 0.7897413854150991, "ngenes": 15, "max_val": 8.706, "rank": 671.0, "id": "38f4efa6-8e05-11ea-90eb-5cf37097309a"}, {"source": "IL-6-type cytokine receptor ligand interactions", "value": 0.3128507621405376, "ngenes": 17, "max_val": 8.706, "rank": 1984.0, "id": "38f4efa7-8e05-11ea-9496-5cf37097309a"}]}, {"source": "Interleukin-10 signaling", "value": 0.3427760220714149, "ngenes": 59, "max_val": 8.706, "rank": 1778.0, "id": "38f4efa8-8e05-11ea-a60b-5cf37097309a"}]}, {"source": "Prolactin receptor signaling", "value": 1.924682443840164, "ngenes": 21, "max_val": 8.706, "rank": 166.0, "id": "38f4efa9-8e05-11ea-9f7b-5cf37097309a"}, {"source": "Interferon Signaling", "value": 0.3288714815669623, "ngenes": 338, "max_val": 8.706, "rank": 1865.0, "id": "38f4efaa-8e05-11ea-82ad-5cf37097309a", "children": [{"source": "Interferon gamma signaling", "value": 0.4266462015709692, "ngenes": 197, "max_val": 8.706, "rank": 1378.0, "id": "38f4efab-8e05-11ea-8e1f-5cf37097309a", "children": [{"source": "Regulation of IFNG signaling", "value": 1.735693857640123, "ngenes": 21, "max_val": 8.706, "rank": 207.0, "id": "38f4efac-8e05-11ea-8eac-5cf37097309a"}]}, {"source": "Interferon alpha/beta signaling", "value": 0.5471840327551817, "ngenes": 131, "max_val": 8.706, "rank": 1004.0, "id": "38f4efad-8e05-11ea-99c0-5cf37097309a", "children": [{"source": "Regulation of IFNA signaling", "value": 0.5958405955947986, "ngenes": 45, "max_val": 8.706, "rank": 924.0, "id": "38f4efae-8e05-11ea-90a3-5cf37097309a"}]}, {"source": "Antiviral mechanism by IFN-stimulated genes", "value": 0.32630520522342715, "ngenes": 84, "max_val": 8.706, "rank": 1891.0, "id": "38f4efaf-8e05-11ea-b8bc-5cf37097309a", "children": [{"source": "ISG15 antiviral mechanism", "value": 0.3483210271800589, "ngenes": 76, "max_val": 8.706, "rank": 1760.0, "id": "38f4efb0-8e05-11ea-bcb3-5cf37097309a"}, {"source": "OAS antiviral response", "value": 0.3272772875640805, "ngenes": 9, "max_val": 8.706, "rank": 1878.0, "id": "38f4efb1-8e05-11ea-9092-5cf37097309a"}]}]}, {"source": "Growth hormone receptor signaling", "value": 1.4117033129971952, "ngenes": 32, "max_val": 8.706, "rank": 352.0, "id": "38f4efb2-8e05-11ea-b6ba-5cf37097309a"}, {"source": "TNFR2 non-canonical NF-kB pathway", "value": 0.4788365094295219, "ngenes": 147, "max_val": 8.706, "rank": 1165.0, "id": "38f4efb3-8e05-11ea-90b3-5cf37097309a", "children": [{"source": "TNFs bind their physiological receptors", "value": 1.0621123301891753, "ngenes": 31, "max_val": 8.706, "rank": 500.0, "id": "38f4efb4-8e05-11ea-90a0-5cf37097309a"}, {"source": "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway", "value": 0.9837117406301448, "ngenes": 39, "max_val": 8.706, "rank": 553.0, "id": "38f4efb5-8e05-11ea-bdf5-5cf37097309a"}, {"source": "NIK-->noncanonical NF-kB signaling", "value": 0.6790841678274517, "ngenes": 77, "max_val": 8.706, "rank": 774.0, "id": "38f4efb6-8e05-11ea-b6c0-5cf37097309a"}]}, {"source": "FLT3 Signaling", "value": 0.5098760850672088, "ngenes": 298, "max_val": 8.706, "rank": 1070.0, "id": "38f4efb7-8e05-11ea-b922-5cf37097309a", "children": [{"source": "STAT5 Activation", "value": 1.0252185178108288, "ngenes": 7, "max_val": 8.706, "rank": 529.0, "id": "38f4efb8-8e05-11ea-a50f-5cf37097309a"}, {"source": "RAF/MAP kinase cascade", "value": 0.4717863154195249, "ngenes": 271, "max_val": 8.706, "rank": 1196.0, "id": "38f4efb9-8e05-11ea-849e-5cf37097309a", "children": [{"source": "Regulation of RAS by GAPs", "value": 0.6445692907358854, "ngenes": 89, "max_val": 8.706, "rank": 840.0, "id": "38f4efba-8e05-11ea-813a-5cf37097309a"}, {"source": "MAP2K and MAPK activation", "value": 0.3663505507769889, "ngenes": 41, "max_val": 8.706, "rank": 1632.0, "id": "38f4efbb-8e05-11ea-a637-5cf37097309a"}, {"source": "RAF activation", "value": 0.3363680139764464, "ngenes": 31, "max_val": 8.706, "rank": 1823.0, "id": "38f4efbc-8e05-11ea-b7ee-5cf37097309a"}, {"source": "Negative regulation of MAPK pathway", "value": 0.44227409954858976, "ngenes": 44, "max_val": 8.706, "rank": 1298.0, "id": "38f4efbd-8e05-11ea-8e76-5cf37097309a", "children": [{"source": "Negative feedback regulation of MAPK pathway", "value": 0.3272772875640805, "ngenes": 6, "max_val": 8.706, "rank": 1882.0, "id": "38f4efbe-8e05-11ea-9570-5cf37097309a"}]}]}, {"source": "PI3K Cascade", "value": 0.4166701851996452, "ngenes": 46, "max_val": 8.706, "rank": 1420.0, "id": "38f4efbf-8e05-11ea-a4b8-5cf37097309a", "children": [{"source": "PKB-mediated events", "value": 0.6008310757219172, "ngenes": 3, "max_val": 8.706, "rank": 917.0, "id": "38f4efc0-8e05-11ea-9e4d-5cf37097309a", "children": [{"source": "PDE3B signalling", "value": 0.5968341665741489, "ngenes": 3, "max_val": 8.706, "rank": 922.0, "id": "38f4efc1-8e05-11ea-8131-5cf37097309a"}]}, {"source": "Activation of AKT2", "value": 0.3229052919360341, "ngenes": 4, "max_val": 8.706, "rank": 1906.0, "id": "38f4efc2-8e05-11ea-9eb3-5cf37097309a"}]}]}]}, {"source": "Innate Immune System", "value": 0.5720588986651673, "ngenes": 1569, "max_val": 8.706, "rank": 956.0, "id": "38f4efc3-8e05-11ea-85ed-5cf37097309a", "children": [{"source": "Toll-like Receptor Cascades", "value": 0.3911487587762643, "ngenes": 168, "max_val": 8.706, "rank": 1534.0, "id": "38f4efc4-8e05-11ea-97de-5cf37097309a", "children": [{"source": "Toll Like Receptor 4 (TLR4) Cascade", "value": 0.598220962941325, "ngenes": 142, "max_val": 8.706, "rank": 921.0, "id": "38f4efc5-8e05-11ea-96b8-5cf37097309a", "children": [{"source": "MyD88:MAL(TIRAP) cascade initiated on plasma membrane", "value": 0.3582908682862535, "ngenes": 107, "max_val": 8.706, "rank": 1686.0, "id": "38f4efc6-8e05-11ea-b412-5cf37097309a", "children": [{"source": "MAP kinase activation", "value": 0.5180663835710579, "ngenes": 69, "max_val": 8.706, "rank": 1051.0, "id": "38f4efc7-8e05-11ea-a5e1-5cf37097309a", "children": [{"source": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "value": 2.317351857242661, "ngenes": 17, "max_val": 8.706, "rank": 96.0, "id": "38f4efc8-8e05-11ea-a710-5cf37097309a"}, {"source": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "value": 0.8904984852142677, "ngenes": 22, "max_val": 8.706, "rank": 607.0, "id": "38f4efc9-8e05-11ea-9dc3-5cf37097309a"}, {"source": "MAPK targets/ Nuclear events mediated by MAP kinases", "value": 0.3908178161262853, "ngenes": 35, "max_val": 8.706, "rank": 1542.0, "id": "38f4efca-8e05-11ea-a2de-5cf37097309a", "children": [{"source": "Activation of the AP-1 family of transcription factors", "value": 0.406467316447748, "ngenes": 10, "max_val": 8.706, "rank": 1467.0, "id": "38f4efcb-8e05-11ea-88ac-5cf37097309a"}, {"source": "ERK/MAPK targets", "value": 0.5471840327551817, "ngenes": 26, "max_val": 8.706, "rank": 1002.0, "id": "38f4efcc-8e05-11ea-9de8-5cf37097309a", "children": [{"source": "ERKs are inactivated", "value": 0.3849420497242914, "ngenes": 13, "max_val": 8.706, "rank": 1559.0, "id": "38f4efcd-8e05-11ea-a7a6-5cf37097309a"}]}, {"source": "CREB phosphorylation", "value": 0.3050811988978337, "ngenes": 8, "max_val": 8.706, "rank": 2033.0, "id": "38f4efce-8e05-11ea-b192-5cf37097309a"}]}, {"source": "activated TAK1 mediates p38 MAPK activation", "value": 0.37331638253090615, "ngenes": 23, "max_val": 8.706, "rank": 1608.0, "id": "38f4efcf-8e05-11ea-8c6b-5cf37097309a"}]}, {"source": "IRAK2 mediated activation of TAK1 complex", "value": 0.3962649391839888, "ngenes": 10, "max_val": 8.706, "rank": 1526.0, "id": "38f4efd0-8e05-11ea-9d3e-5cf37097309a"}, {"source": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "value": 0.38432146764772507, "ngenes": 39, "max_val": 8.706, "rank": 1576.0, "id": "38f4efd1-8e05-11ea-81e3-5cf37097309a"}, {"source": "IRAK1 recruits IKK complex", "value": 0.3483210271800589, "ngenes": 14, "max_val": 8.706, "rank": 1743.0, "id": "38f4efd2-8e05-11ea-a454-5cf37097309a"}]}, {"source": "MyD88-independent TLR4 cascade ", "value": 0.4799169825852786, "ngenes": 112, "max_val": 8.706, "rank": 1151.0, "id": "38f4efd3-8e05-11ea-81f2-5cf37097309a", "children": [{"source": "TRIF(TICAM1)-mediated TLR4 signaling ", "value": 0.4797450541537333, "ngenes": 112, "max_val": 8.706, "rank": 1153.0, "id": "38f4efd4-8e05-11ea-a7eb-5cf37097309a", "children": [{"source": "MAP kinase activation", "value": 0.5180663835710579, "ngenes": 69, "max_val": 8.706, "rank": 1051.0, "id": "38f4efd5-8e05-11ea-bc50-5cf37097309a", "children": [{"source": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "value": 2.317351857242661, "ngenes": 17, "max_val": 8.706, "rank": 96.0, "id": "38f4efd6-8e05-11ea-8485-5cf37097309a"}, {"source": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "value": 0.8904984852142677, "ngenes": 22, "max_val": 8.706, "rank": 607.0, "id": "38f4efd7-8e05-11ea-a705-5cf37097309a"}, {"source": "MAPK targets/ Nuclear events mediated by MAP kinases", "value": 0.3908178161262853, "ngenes": 35, "max_val": 8.706, "rank": 1542.0, "id": "38f4efd8-8e05-11ea-ac6c-5cf37097309a", "children": [{"source": "Activation of the AP-1 family of transcription factors", "value": 0.406467316447748, "ngenes": 10, "max_val": 8.706, "rank": 1467.0, "id": "38f4efd9-8e05-11ea-b16c-5cf37097309a"}, {"source": "ERK/MAPK targets", "value": 0.5471840327551817, "ngenes": 26, "max_val": 8.706, "rank": 1002.0, "id": "38f4efda-8e05-11ea-ad4f-5cf37097309a", "children": [{"source": "ERKs are inactivated", "value": 0.3849420497242914, "ngenes": 13, "max_val": 8.706, "rank": 1559.0, "id": "38f4efdb-8e05-11ea-8432-5cf37097309a"}]}, {"source": "CREB phosphorylation", "value": 0.3050811988978337, "ngenes": 8, "max_val": 8.706, "rank": 2033.0, "id": "38f4efdc-8e05-11ea-9715-5cf37097309a"}]}, {"source": "activated TAK1 mediates p38 MAPK activation", "value": 0.37331638253090615, "ngenes": 23, "max_val": 8.706, "rank": 1608.0, "id": "38f4efdd-8e05-11ea-b7ec-5cf37097309a"}]}, {"source": "TRIF-mediated programmed cell death", "value": 0.4780077744234615, "ngenes": 10, "max_val": 8.706, "rank": 1176.0, "id": "38f4efde-8e05-11ea-82b3-5cf37097309a"}, {"source": "Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon", "value": 0.47285193963944605, "ngenes": 18, "max_val": 8.706, "rank": 1192.0, "id": "38f4efdf-8e05-11ea-9e6d-5cf37097309a"}, {"source": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "value": 0.38432146764772507, "ngenes": 39, "max_val": 8.706, "rank": 1576.0, "id": "38f4efe0-8e05-11ea-a58e-5cf37097309a"}, {"source": "TRAF6-mediated induction of TAK1 complex within TLR4 complex", "value": 0.3769883516616439, "ngenes": 16, "max_val": 8.706, "rank": 1593.0, "id": "38f4efe1-8e05-11ea-a6ef-5cf37097309a"}, {"source": "IKK complex recruitment mediated by RIP1", "value": 0.3663505507769889, "ngenes": 24, "max_val": 8.706, "rank": 1633.0, "id": "38f4efe2-8e05-11ea-8c6e-5cf37097309a"}]}]}, {"source": "Transfer of LPS from LBP carrier to CD14", "value": 0.8217754390035673, "ngenes": 2, "max_val": 8.706, "rank": 647.0, "id": "38f4efe3-8e05-11ea-a811-5cf37097309a"}]}, {"source": "Toll Like Receptor 9 (TLR9) Cascade", "value": 0.7618219869875075, "ngenes": 109, "max_val": 8.706, "rank": 694.0, "id": "38f4efe4-8e05-11ea-8e1e-5cf37097309a", "children": [{"source": "MyD88 dependent cascade initiated on endosome", "value": 0.4165800722910016, "ngenes": 105, "max_val": 8.706, "rank": 1436.0, "id": "38f4efe5-8e05-11ea-a438-5cf37097309a", "children": [{"source": "TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation", "value": 0.40594021400370056, "ngenes": 103, "max_val": 8.706, "rank": 1477.0, "id": "38f4efe6-8e05-11ea-9607-5cf37097309a", "children": [{"source": "MAP kinase activation", "value": 0.5180663835710579, "ngenes": 69, "max_val": 8.706, "rank": 1051.0, "id": "38f4efe7-8e05-11ea-a0ff-5cf37097309a", "children": [{"source": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "value": 2.317351857242661, "ngenes": 17, "max_val": 8.706, "rank": 96.0, "id": "38f4efe8-8e05-11ea-8441-5cf37097309a"}, {"source": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "value": 0.8904984852142677, "ngenes": 22, "max_val": 8.706, "rank": 607.0, "id": "38f4efe9-8e05-11ea-adb6-5cf37097309a"}, {"source": "MAPK targets/ Nuclear events mediated by MAP kinases", "value": 0.3908178161262853, "ngenes": 35, "max_val": 8.706, "rank": 1542.0, "id": "38f4efea-8e05-11ea-8b7b-5cf37097309a", "children": [{"source": "Activation of the AP-1 family of transcription factors", "value": 0.406467316447748, "ngenes": 10, "max_val": 8.706, "rank": 1467.0, "id": "38f4efeb-8e05-11ea-9106-5cf37097309a"}, {"source": "ERK/MAPK targets", "value": 0.5471840327551817, "ngenes": 26, "max_val": 8.706, "rank": 1002.0, "id": "38f4efec-8e05-11ea-9baf-5cf37097309a", "children": [{"source": "ERKs are inactivated", "value": 0.3849420497242914, "ngenes": 13, "max_val": 8.706, "rank": 1559.0, "id": "38f4efed-8e05-11ea-9a05-5cf37097309a"}]}, {"source": "CREB phosphorylation", "value": 0.3050811988978337, "ngenes": 8, "max_val": 8.706, "rank": 2033.0, "id": "38f4efee-8e05-11ea-9ce5-5cf37097309a"}]}, {"source": "activated TAK1 mediates p38 MAPK activation", "value": 0.37331638253090615, "ngenes": 23, "max_val": 8.706, "rank": 1608.0, "id": "38f4efef-8e05-11ea-ac33-5cf37097309a"}]}, {"source": "IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation", "value": 0.3984289558542966, "ngenes": 15, "max_val": 8.706, "rank": 1503.0, "id": "38f4eff0-8e05-11ea-b440-5cf37097309a"}, {"source": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "value": 0.38432146764772507, "ngenes": 39, "max_val": 8.706, "rank": 1576.0, "id": "38f4eff1-8e05-11ea-b2ba-5cf37097309a"}, {"source": "IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation", "value": 0.3483210271800589, "ngenes": 14, "max_val": 8.706, "rank": 1741.0, "id": "38f4eff2-8e05-11ea-8003-5cf37097309a"}]}, {"source": "TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling", "value": 0.37331638253090615, "ngenes": 15, "max_val": 8.706, "rank": 1609.0, "id": "38f4eff3-8e05-11ea-96cb-5cf37097309a"}]}]}, {"source": "Toll Like Receptor 10 (TLR10) Cascade", "value": 0.3592004814595621, "ngenes": 97, "max_val": 8.706, "rank": 1671.0, "id": "38f4eff4-8e05-11ea-a558-5cf37097309a", "children": [{"source": "MyD88 cascade initiated on plasma membrane", "value": 0.3592004814595621, "ngenes": 97, "max_val": 8.706, "rank": 1672.0, "id": "38f4eff5-8e05-11ea-8530-5cf37097309a", "children": [{"source": "MAP kinase activation", "value": 0.5180663835710579, "ngenes": 69, "max_val": 8.706, "rank": 1051.0, "id": "38f4eff6-8e05-11ea-b846-5cf37097309a", "children": [{"source": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "value": 2.317351857242661, "ngenes": 17, "max_val": 8.706, "rank": 96.0, "id": "38f4eff7-8e05-11ea-9de0-5cf37097309a"}, {"source": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "value": 0.8904984852142677, "ngenes": 22, "max_val": 8.706, "rank": 607.0, "id": "38f4eff8-8e05-11ea-b317-5cf37097309a"}, {"source": "MAPK targets/ Nuclear events mediated by MAP kinases", "value": 0.3908178161262853, "ngenes": 35, "max_val": 8.706, "rank": 1542.0, "id": "38f4eff9-8e05-11ea-b175-5cf37097309a", "children": [{"source": "Activation of the AP-1 family of transcription factors", "value": 0.406467316447748, "ngenes": 10, "max_val": 8.706, "rank": 1467.0, "id": "38f4effa-8e05-11ea-8ced-5cf37097309a"}, {"source": "ERK/MAPK targets", "value": 0.5471840327551817, "ngenes": 26, "max_val": 8.706, "rank": 1002.0, "id": "38f4effb-8e05-11ea-9082-5cf37097309a", "children": [{"source": "ERKs are inactivated", "value": 0.3849420497242914, "ngenes": 13, "max_val": 8.706, "rank": 1559.0, "id": "38f4effc-8e05-11ea-8d80-5cf37097309a"}]}, {"source": "CREB phosphorylation", "value": 0.3050811988978337, "ngenes": 8, "max_val": 8.706, "rank": 2033.0, "id": "38f4effd-8e05-11ea-844d-5cf37097309a"}]}, {"source": "activated TAK1 mediates p38 MAPK activation", "value": 0.37331638253090615, "ngenes": 23, "max_val": 8.706, "rank": 1608.0, "id": "38f4effe-8e05-11ea-8a51-5cf37097309a"}]}, {"source": "IRAK2 mediated activation of TAK1 complex", "value": 0.3962649391839888, "ngenes": 10, "max_val": 8.706, "rank": 1526.0, "id": "38f4efff-8e05-11ea-8763-5cf37097309a"}, {"source": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "value": 0.38432146764772507, "ngenes": 39, "max_val": 8.706, "rank": 1576.0, "id": "38f4f000-8e05-11ea-974f-5cf37097309a"}, {"source": "IRAK1 recruits IKK complex", "value": 0.3483210271800589, "ngenes": 14, "max_val": 8.706, "rank": 1743.0, "id": "38f4f001-8e05-11ea-8bf9-5cf37097309a"}]}]}, {"source": "Toll Like Receptor 3 (TLR3) Cascade", "value": 0.5084255126755077, "ngenes": 108, "max_val": 8.706, "rank": 1078.0, "id": "38f4f002-8e05-11ea-bd13-5cf37097309a", "children": [{"source": "MAP kinase activation", "value": 0.5180663835710579, "ngenes": 69, "max_val": 8.706, "rank": 1051.0, "id": "38f4f003-8e05-11ea-863a-5cf37097309a", "children": [{"source": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "value": 2.317351857242661, "ngenes": 17, "max_val": 8.706, "rank": 96.0, "id": "38f4f004-8e05-11ea-809f-5cf37097309a"}, {"source": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "value": 0.8904984852142677, "ngenes": 22, "max_val": 8.706, "rank": 607.0, "id": "38f4f005-8e05-11ea-b2a1-5cf37097309a"}, {"source": "MAPK targets/ Nuclear events mediated by MAP kinases", "value": 0.3908178161262853, "ngenes": 35, "max_val": 8.706, "rank": 1542.0, "id": "38f4f006-8e05-11ea-898e-5cf37097309a", "children": [{"source": "Activation of the AP-1 family of transcription factors", "value": 0.406467316447748, "ngenes": 10, "max_val": 8.706, "rank": 1467.0, "id": "38f4f007-8e05-11ea-9136-5cf37097309a"}, {"source": "ERK/MAPK targets", "value": 0.5471840327551817, "ngenes": 26, "max_val": 8.706, "rank": 1002.0, "id": "38f4f008-8e05-11ea-87d1-5cf37097309a", "children": [{"source": "ERKs are inactivated", "value": 0.3849420497242914, "ngenes": 13, "max_val": 8.706, "rank": 1559.0, "id": "38f4f009-8e05-11ea-9f2b-5cf37097309a"}]}, {"source": "CREB phosphorylation", "value": 0.3050811988978337, "ngenes": 8, "max_val": 8.706, "rank": 2033.0, "id": "38f4f00a-8e05-11ea-9756-5cf37097309a"}]}, {"source": "activated TAK1 mediates p38 MAPK activation", "value": 0.37331638253090615, "ngenes": 23, "max_val": 8.706, "rank": 1608.0, "id": "38f4f00b-8e05-11ea-a9c1-5cf37097309a"}]}, {"source": "TICAM1,TRAF6-dependent induction of TAK1 complex", "value": 0.7390898562975314, "ngenes": 11, "max_val": 8.706, "rank": 716.0, "id": "38f4f00c-8e05-11ea-b276-5cf37097309a"}, {"source": "TLR3-mediated TICAM1-dependent programmed cell death", "value": 0.721392241826102, "ngenes": 7, "max_val": 8.706, "rank": 742.0, "id": "38f4f00d-8e05-11ea-8e79-5cf37097309a"}, {"source": "TICAM1, RIP1-mediated IKK complex recruitment", "value": 0.5565507266078732, "ngenes": 20, "max_val": 8.706, "rank": 968.0, "id": "38f4f00e-8e05-11ea-857f-5cf37097309a"}, {"source": "TICAM1-dependent activation of IRF3/IRF7", "value": 0.4544000457004255, "ngenes": 13, "max_val": 8.706, "rank": 1266.0, "id": "38f4f00f-8e05-11ea-b6fd-5cf37097309a"}, {"source": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "value": 0.38432146764772507, "ngenes": 39, "max_val": 8.706, "rank": 1576.0, "id": "38f4f010-8e05-11ea-b268-5cf37097309a"}]}, {"source": "Toll Like Receptor 5 (TLR5) Cascade", "value": 0.3592004814595621, "ngenes": 97, "max_val": 8.706, "rank": 1669.0, "id": "38f4f011-8e05-11ea-9a5d-5cf37097309a", "children": [{"source": "MyD88 cascade initiated on plasma membrane", "value": 0.3592004814595621, "ngenes": 97, "max_val": 8.706, "rank": 1672.0, "id": "38f4f012-8e05-11ea-bcd4-5cf37097309a", "children": [{"source": "MAP kinase activation", "value": 0.5180663835710579, "ngenes": 69, "max_val": 8.706, "rank": 1051.0, "id": "38f4f013-8e05-11ea-8088-5cf37097309a", "children": [{"source": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "value": 2.317351857242661, "ngenes": 17, "max_val": 8.706, "rank": 96.0, "id": "38f4f014-8e05-11ea-9fd5-5cf37097309a"}, {"source": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "value": 0.8904984852142677, "ngenes": 22, "max_val": 8.706, "rank": 607.0, "id": "38f4f015-8e05-11ea-89bf-5cf37097309a"}, {"source": "MAPK targets/ Nuclear events mediated by MAP kinases", "value": 0.3908178161262853, "ngenes": 35, "max_val": 8.706, "rank": 1542.0, "id": "38f4f016-8e05-11ea-a6b5-5cf37097309a", "children": [{"source": "Activation of the AP-1 family of transcription factors", "value": 0.406467316447748, "ngenes": 10, "max_val": 8.706, "rank": 1467.0, "id": "38f51680-8e05-11ea-b3f8-5cf37097309a"}, {"source": "ERK/MAPK targets", "value": 0.5471840327551817, "ngenes": 26, "max_val": 8.706, "rank": 1002.0, "id": "38f51681-8e05-11ea-9cdc-5cf37097309a", "children": [{"source": "ERKs are inactivated", "value": 0.3849420497242914, "ngenes": 13, "max_val": 8.706, "rank": 1559.0, "id": "38f51682-8e05-11ea-a55a-5cf37097309a"}]}, {"source": "CREB phosphorylation", "value": 0.3050811988978337, "ngenes": 8, "max_val": 8.706, "rank": 2033.0, "id": "38f51683-8e05-11ea-9ede-5cf37097309a"}]}, {"source": "activated TAK1 mediates p38 MAPK activation", "value": 0.37331638253090615, "ngenes": 23, "max_val": 8.706, "rank": 1608.0, "id": "38f51684-8e05-11ea-92fe-5cf37097309a"}]}, {"source": "IRAK2 mediated activation of TAK1 complex", "value": 0.3962649391839888, "ngenes": 10, "max_val": 8.706, "rank": 1526.0, "id": "38f51685-8e05-11ea-a343-5cf37097309a"}, {"source": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "value": 0.38432146764772507, "ngenes": 39, "max_val": 8.706, "rank": 1576.0, "id": "38f51686-8e05-11ea-a16d-5cf37097309a"}, {"source": "IRAK1 recruits IKK complex", "value": 0.3483210271800589, "ngenes": 14, "max_val": 8.706, "rank": 1743.0, "id": "38f51687-8e05-11ea-9c50-5cf37097309a"}]}]}, {"source": "Toll Like Receptor 7/8 (TLR7/8) Cascade", "value": 0.4165866033279961, "ngenes": 105, "max_val": 8.706, "rank": 1429.0, "id": "38f51688-8e05-11ea-bc2a-5cf37097309a", "children": [{"source": "MyD88 dependent cascade initiated on endosome", "value": 0.4165800722910016, "ngenes": 105, "max_val": 8.706, "rank": 1436.0, "id": "38f51689-8e05-11ea-bd1c-5cf37097309a", "children": [{"source": "TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation", "value": 0.40594021400370056, "ngenes": 103, "max_val": 8.706, "rank": 1477.0, "id": "38f5168a-8e05-11ea-84a1-5cf37097309a", "children": [{"source": "MAP kinase activation", "value": 0.5180663835710579, "ngenes": 69, "max_val": 8.706, "rank": 1051.0, "id": "38f5168b-8e05-11ea-b18b-5cf37097309a", "children": [{"source": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "value": 2.317351857242661, "ngenes": 17, "max_val": 8.706, "rank": 96.0, "id": "38f5168c-8e05-11ea-bc25-5cf37097309a"}, {"source": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "value": 0.8904984852142677, "ngenes": 22, "max_val": 8.706, "rank": 607.0, "id": "38f5168d-8e05-11ea-861f-5cf37097309a"}, {"source": "MAPK targets/ Nuclear events mediated by MAP kinases", "value": 0.3908178161262853, "ngenes": 35, "max_val": 8.706, "rank": 1542.0, "id": "38f5168e-8e05-11ea-80bb-5cf37097309a", "children": [{"source": "Activation of the AP-1 family of transcription factors", "value": 0.406467316447748, "ngenes": 10, "max_val": 8.706, "rank": 1467.0, "id": "38f5168f-8e05-11ea-bf61-5cf37097309a"}, {"source": "ERK/MAPK targets", "value": 0.5471840327551817, "ngenes": 26, "max_val": 8.706, "rank": 1002.0, "id": "38f51690-8e05-11ea-8566-5cf37097309a", "children": [{"source": "ERKs are inactivated", "value": 0.3849420497242914, "ngenes": 13, "max_val": 8.706, "rank": 1559.0, "id": "38f51691-8e05-11ea-9e43-5cf37097309a"}]}, {"source": "CREB phosphorylation", "value": 0.3050811988978337, "ngenes": 8, "max_val": 8.706, "rank": 2033.0, "id": "38f51692-8e05-11ea-b38b-5cf37097309a"}]}, {"source": "activated TAK1 mediates p38 MAPK activation", "value": 0.37331638253090615, "ngenes": 23, "max_val": 8.706, "rank": 1608.0, "id": "38f51693-8e05-11ea-98ce-5cf37097309a"}]}, {"source": "IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation", "value": 0.3984289558542966, "ngenes": 15, "max_val": 8.706, "rank": 1503.0, "id": "38f51694-8e05-11ea-b609-5cf37097309a"}, {"source": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "value": 0.38432146764772507, "ngenes": 39, "max_val": 8.706, "rank": 1576.0, "id": "38f51695-8e05-11ea-ae37-5cf37097309a"}, {"source": "IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation", "value": 0.3483210271800589, "ngenes": 14, "max_val": 8.706, "rank": 1741.0, "id": "38f51696-8e05-11ea-b730-5cf37097309a"}]}, {"source": "TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling", "value": 0.37331638253090615, "ngenes": 15, "max_val": 8.706, "rank": 1609.0, "id": "38f51697-8e05-11ea-a58e-5cf37097309a"}]}]}, {"source": "Toll Like Receptor 2 (TLR2) Cascade", "value": 0.36097258849275415, "ngenes": 110, "max_val": 8.706, "rank": 1658.0, "id": "38f51698-8e05-11ea-919b-5cf37097309a", "children": [{"source": "Toll Like Receptor TLR1:TLR2 Cascade", "value": 0.3612419444430817, "ngenes": 110, "max_val": 8.706, "rank": 1653.0, "id": "38f51699-8e05-11ea-8b7d-5cf37097309a", "children": [{"source": "MyD88:MAL(TIRAP) cascade initiated on plasma membrane", "value": 0.3582908682862535, "ngenes": 107, "max_val": 8.706, "rank": 1686.0, "id": "38f5169a-8e05-11ea-a35c-5cf37097309a", "children": [{"source": "MAP kinase activation", "value": 0.5180663835710579, "ngenes": 69, "max_val": 8.706, "rank": 1051.0, "id": "38f5169b-8e05-11ea-8769-5cf37097309a", "children": [{"source": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "value": 2.317351857242661, "ngenes": 17, "max_val": 8.706, "rank": 96.0, "id": "38f5169c-8e05-11ea-aeb4-5cf37097309a"}, {"source": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "value": 0.8904984852142677, "ngenes": 22, "max_val": 8.706, "rank": 607.0, "id": "38f5169d-8e05-11ea-a183-5cf37097309a"}, {"source": "MAPK targets/ Nuclear events mediated by MAP kinases", "value": 0.3908178161262853, "ngenes": 35, "max_val": 8.706, "rank": 1542.0, "id": "38f5169e-8e05-11ea-8bd2-5cf37097309a", "children": [{"source": "Activation of the AP-1 family of transcription factors", "value": 0.406467316447748, "ngenes": 10, "max_val": 8.706, "rank": 1467.0, "id": "38f5169f-8e05-11ea-a412-5cf37097309a"}, {"source": "ERK/MAPK targets", "value": 0.5471840327551817, "ngenes": 26, "max_val": 8.706, "rank": 1002.0, "id": "38f516a0-8e05-11ea-a942-5cf37097309a", "children": [{"source": "ERKs are inactivated", "value": 0.3849420497242914, "ngenes": 13, "max_val": 8.706, "rank": 1559.0, "id": "38f516a1-8e05-11ea-9cda-5cf37097309a"}]}, {"source": "CREB phosphorylation", "value": 0.3050811988978337, "ngenes": 8, "max_val": 8.706, "rank": 2033.0, "id": "38f516a2-8e05-11ea-9e3c-5cf37097309a"}]}, {"source": "activated TAK1 mediates p38 MAPK activation", "value": 0.37331638253090615, "ngenes": 23, "max_val": 8.706, "rank": 1608.0, "id": "38f516a3-8e05-11ea-ba8d-5cf37097309a"}]}, {"source": "IRAK2 mediated activation of TAK1 complex", "value": 0.3962649391839888, "ngenes": 10, "max_val": 8.706, "rank": 1526.0, "id": "38f516a4-8e05-11ea-9d50-5cf37097309a"}, {"source": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "value": 0.38432146764772507, "ngenes": 39, "max_val": 8.706, "rank": 1576.0, "id": "38f516a5-8e05-11ea-9e4a-5cf37097309a"}, {"source": "IRAK1 recruits IKK complex", "value": 0.3483210271800589, "ngenes": 14, "max_val": 8.706, "rank": 1743.0, "id": "38f516a6-8e05-11ea-aea3-5cf37097309a"}]}]}, {"source": "Toll Like Receptor TLR6:TLR2 Cascade", "value": 0.3574248285523114, "ngenes": 107, "max_val": 8.706, "rank": 1694.0, "id": "38f516a7-8e05-11ea-8031-5cf37097309a", "children": [{"source": "MyD88:MAL(TIRAP) cascade initiated on plasma membrane", "value": 0.3582908682862535, "ngenes": 107, "max_val": 8.706, "rank": 1686.0, "id": "38f516a8-8e05-11ea-a91b-5cf37097309a", "children": [{"source": "MAP kinase activation", "value": 0.5180663835710579, "ngenes": 69, "max_val": 8.706, "rank": 1051.0, "id": "38f516a9-8e05-11ea-ac37-5cf37097309a", "children": [{"source": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "value": 2.317351857242661, "ngenes": 17, "max_val": 8.706, "rank": 96.0, "id": "38f516aa-8e05-11ea-b7fe-5cf37097309a"}, {"source": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "value": 0.8904984852142677, "ngenes": 22, "max_val": 8.706, "rank": 607.0, "id": "38f516ab-8e05-11ea-8373-5cf37097309a"}, {"source": "MAPK targets/ Nuclear events mediated by MAP kinases", "value": 0.3908178161262853, "ngenes": 35, "max_val": 8.706, "rank": 1542.0, "id": "38f516ac-8e05-11ea-8c8e-5cf37097309a", "children": [{"source": "Activation of the AP-1 family of transcription factors", "value": 0.406467316447748, "ngenes": 10, "max_val": 8.706, "rank": 1467.0, "id": "38f516ad-8e05-11ea-9374-5cf37097309a"}, {"source": "ERK/MAPK targets", "value": 0.5471840327551817, "ngenes": 26, "max_val": 8.706, "rank": 1002.0, "id": "38f516ae-8e05-11ea-9424-5cf37097309a", "children": [{"source": "ERKs are inactivated", "value": 0.3849420497242914, "ngenes": 13, "max_val": 8.706, "rank": 1559.0, "id": "38f516af-8e05-11ea-a1de-5cf37097309a"}]}, {"source": "CREB phosphorylation", "value": 0.3050811988978337, "ngenes": 8, "max_val": 8.706, "rank": 2033.0, "id": "38f516b0-8e05-11ea-92f7-5cf37097309a"}]}, {"source": "activated TAK1 mediates p38 MAPK activation", "value": 0.37331638253090615, "ngenes": 23, "max_val": 8.706, "rank": 1608.0, "id": "38f516b1-8e05-11ea-a863-5cf37097309a"}]}, {"source": "IRAK2 mediated activation of TAK1 complex", "value": 0.3962649391839888, "ngenes": 10, "max_val": 8.706, "rank": 1526.0, "id": "38f516b2-8e05-11ea-bea4-5cf37097309a"}, {"source": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "value": 0.38432146764772507, "ngenes": 39, "max_val": 8.706, "rank": 1576.0, "id": "38f516b3-8e05-11ea-b1ab-5cf37097309a"}, {"source": "IRAK1 recruits IKK complex", "value": 0.3483210271800589, "ngenes": 14, "max_val": 8.706, "rank": 1743.0, "id": "38f516b4-8e05-11ea-9745-5cf37097309a"}]}]}]}, {"source": "Regulation of TLR by endogenous ligand", "value": 0.7352076824464555, "ngenes": 19, "max_val": 8.706, "rank": 720.0, "id": "38f516b5-8e05-11ea-acc8-5cf37097309a"}, {"source": "Trafficking and processing of endosomal TLR", "value": 0.3054605019195545, "ngenes": 13, "max_val": 8.706, "rank": 2027.0, "id": "38f516b6-8e05-11ea-9f27-5cf37097309a"}]}, {"source": "Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways", "value": 1.2518070214032486, "ngenes": 65, "max_val": 8.706, "rank": 405.0, "id": "38f516b7-8e05-11ea-b516-5cf37097309a", "children": [{"source": "Inflammasomes", "value": 1.5496038549587865, "ngenes": 28, "max_val": 8.706, "rank": 288.0, "id": "38f516b8-8e05-11ea-b0b1-5cf37097309a", "children": [{"source": "The NLRP1 inflammasome", "value": 1.9486203325139888, "ngenes": 3, "max_val": 8.706, "rank": 155.0, "id": "38f516b9-8e05-11ea-9cb8-5cf37097309a"}, {"source": "The NLRP3 inflammasome", "value": 1.625041882317914, "ngenes": 19, "max_val": 8.706, "rank": 256.0, "id": "38f516ba-8e05-11ea-b642-5cf37097309a"}, {"source": "The AIM2 inflammasome", "value": 0.3750724859188269, "ngenes": 4, "max_val": 8.706, "rank": 1604.0, "id": "38f516bb-8e05-11ea-802f-5cf37097309a"}, {"source": "The IPAF inflammasome", "value": 0.3692901478169492, "ngenes": 3, "max_val": 8.706, "rank": 1625.0, "id": "38f516bc-8e05-11ea-a811-5cf37097309a"}]}, {"source": "NOD1/2 Signaling Pathway", "value": 0.4908093789985074, "ngenes": 38, "max_val": 8.706, "rank": 1112.0, "id": "38f516bd-8e05-11ea-a5d3-5cf37097309a"}]}, {"source": "C-type lectin receptors (CLRs)", "value": 0.4574762108357018, "ngenes": 172, "max_val": 8.706, "rank": 1256.0, "id": "38f516be-8e05-11ea-97b8-5cf37097309a", "children": [{"source": "CD209 (DC-SIGN) signaling", "value": 1.1798413414031954, "ngenes": 22, "max_val": 8.706, "rank": 449.0, "id": "38f516bf-8e05-11ea-88f6-5cf37097309a"}, {"source": "CLEC7A (Dectin-1) signaling", "value": 0.3135746486533741, "ngenes": 121, "max_val": 8.706, "rank": 1959.0, "id": "38f516c0-8e05-11ea-89ed-5cf37097309a", "children": [{"source": "Dectin-1 mediated noncanonical NF-kB signaling", "value": 0.5471840327551817, "ngenes": 80, "max_val": 8.706, "rank": 1017.0, "id": "38f516c1-8e05-11ea-b239-5cf37097309a"}, {"source": "CLEC7A/inflammasome pathway", "value": 0.4930534138479528, "ngenes": 6, "max_val": 8.706, "rank": 1109.0, "id": "38f516c2-8e05-11ea-a860-5cf37097309a"}, {"source": "CLEC7A (Dectin-1) induces NFAT activation", "value": 0.35647002589378085, "ngenes": 12, "max_val": 8.706, "rank": 1707.0, "id": "38f516c3-8e05-11ea-95ee-5cf37097309a"}]}, {"source": "Dectin-2 family", "value": 0.4649278207945483, "ngenes": 37, "max_val": 8.706, "rank": 1227.0, "id": "38f516c4-8e05-11ea-976f-5cf37097309a"}]}, {"source": "Fc epsilon receptor (FCERI) signaling", "value": 0.3624812178515287, "ngenes": 350, "max_val": 8.706, "rank": 1649.0, "id": "38f516c5-8e05-11ea-8e4c-5cf37097309a", "children": [{"source": "FCERI mediated MAPK activation", "value": 1.1541921907606865, "ngenes": 121, "max_val": 8.706, "rank": 460.0, "id": "38f516c6-8e05-11ea-b46c-5cf37097309a"}, {"source": "FCERI mediated Ca+2 mobilization", "value": 1.1433253465191442, "ngenes": 222, "max_val": 8.706, "rank": 465.0, "id": "38f516c7-8e05-11ea-891f-5cf37097309a"}, {"source": "Role of LAT2/NTAL/LAB on calcium mobilization", "value": 1.041853880978478, "ngenes": 196, "max_val": 8.706, "rank": 516.0, "id": "38f516c8-8e05-11ea-8c31-5cf37097309a"}, {"source": "FCERI mediated NF-kB activation", "value": 0.6420498749023168, "ngenes": 188, "max_val": 8.706, "rank": 844.0, "id": "38f516c9-8e05-11ea-a7cf-5cf37097309a"}]}, {"source": "Fcgamma receptor (FCGR) dependent phagocytosis", "value": 1.0652967967935014, "ngenes": 303, "max_val": 8.706, "rank": 492.0, "id": "38f516ca-8e05-11ea-aa8b-5cf37097309a", "children": [{"source": "Role of phospholipids in phagocytosis", "value": 1.0629234034971091, "ngenes": 115, "max_val": 8.706, "rank": 498.0, "id": "38f516cb-8e05-11ea-a274-5cf37097309a"}, {"source": "FCGR activation", "value": 1.041853880978478, "ngenes": 196, "max_val": 8.706, "rank": 515.0, "id": "38f516cc-8e05-11ea-967e-5cf37097309a"}, {"source": "Regulation of actin dynamics for phagocytic cup formation", "value": 0.9507977267366129, "ngenes": 182, "max_val": 8.706, "rank": 568.0, "id": "38f516cd-8e05-11ea-940d-5cf37097309a"}]}, {"source": "Complement cascade", "value": 1.0485791137354077, "ngenes": 165, "max_val": 8.706, "rank": 508.0, "id": "38f516ce-8e05-11ea-a01a-5cf37097309a", "children": [{"source": "Regulation of Complement cascade", "value": 1.0230929066990757, "ngenes": 153, "max_val": 8.706, "rank": 536.0, "id": "38f516cf-8e05-11ea-abb4-5cf37097309a"}, {"source": "Initial triggering of complement", "value": 0.8106789198145359, "ngenes": 129, "max_val": 8.706, "rank": 661.0, "id": "38f516d0-8e05-11ea-a831-5cf37097309a", "children": [{"source": "Creation of C4 and C2 activators", "value": 1.0230929066990757, "ngenes": 103, "max_val": 8.706, "rank": 538.0, "id": "38f516d1-8e05-11ea-b00f-5cf37097309a", "children": [{"source": "Classical antibody-mediated complement activation", "value": 0.97574506973835, "ngenes": 95, "max_val": 8.706, "rank": 556.0, "id": "38f516d2-8e05-11ea-9d8a-5cf37097309a"}, {"source": "Lectin pathway of complement activation", "value": 0.5104201517191181, "ngenes": 8, "max_val": 8.706, "rank": 1067.0, "id": "38f516d3-8e05-11ea-a4d4-5cf37097309a", "children": [{"source": "Ficolins bind to repetitive carbohydrate structures on the target cell surface", "value": 0.3135746486533741, "ngenes": 5, "max_val": 8.706, "rank": 1970.0, "id": "38f516d4-8e05-11ea-91c1-5cf37097309a"}]}]}, {"source": "Alternative complement activation", "value": 0.642979852847405, "ngenes": 11, "max_val": 8.706, "rank": 843.0, "id": "38f516d5-8e05-11ea-8136-5cf37097309a"}]}, {"source": "Terminal pathway of complement", "value": 0.6804467027155674, "ngenes": 8, "max_val": 8.706, "rank": 773.0, "id": "38f516d6-8e05-11ea-aac2-5cf37097309a"}, {"source": "Activation of C3 and C5", "value": 0.3040711199823073, "ngenes": 24, "max_val": 8.706, "rank": 2045.0, "id": "38f516d7-8e05-11ea-b79b-5cf37097309a"}]}, {"source": "Antimicrobial peptides", "value": 1.5458402962933917, "ngenes": 129, "max_val": 8.706, "rank": 295.0, "id": "38f516d8-8e05-11ea-beb1-5cf37097309a", "children": [{"source": "Metal sequestration by antimicrobial proteins", "value": 0.8199941346336901, "ngenes": 6, "max_val": 8.706, "rank": 649.0, "id": "38f516d9-8e05-11ea-b66f-5cf37097309a"}, {"source": "Ion influx/efflux at host-pathogen interface", "value": 0.6110274058194686, "ngenes": 4, "max_val": 8.706, "rank": 905.0, "id": "38f516da-8e05-11ea-9552-5cf37097309a"}, {"source": "Defensins", "value": 0.307809407982239, "ngenes": 79, "max_val": 8.706, "rank": 2015.0, "id": "38f516db-8e05-11ea-a506-5cf37097309a", "children": [{"source": "Alpha-defensins", "value": 0.44227409954858976, "ngenes": 16, "max_val": 8.706, "rank": 1320.0, "id": "38f516dc-8e05-11ea-a4ae-5cf37097309a"}, {"source": "Beta defensins", "value": 0.3559994417179559, "ngenes": 63, "max_val": 8.706, "rank": 1711.0, "id": "38f516dd-8e05-11ea-b0b0-5cf37097309a"}]}]}, {"source": "Cytosolic sensors of pathogen-associated DNA ", "value": 0.31211243572932124, "ngenes": 70, "max_val": 8.706, "rank": 1991.0, "id": "38f516de-8e05-11ea-a89f-5cf37097309a", "children": [{"source": "LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production", "value": 0.6541848875074258, "ngenes": 5, "max_val": 8.706, "rank": 823.0, "id": "38f516df-8e05-11ea-a38b-5cf37097309a"}, {"source": "ZBP1(DAI) mediated induction of type I IFNs", "value": 0.33871289172223634, "ngenes": 26, "max_val": 8.706, "rank": 1800.0, "id": "38f516e0-8e05-11ea-832a-5cf37097309a", "children": [{"source": "IRF3 mediated activation of type 1 IFN", "value": 0.4956021610862506, "ngenes": 8, "max_val": 8.706, "rank": 1106.0, "id": "38f516e1-8e05-11ea-adc2-5cf37097309a"}, {"source": "RIP-mediated NFkB activation via ZBP1", "value": 0.4165866033279961, "ngenes": 19, "max_val": 8.706, "rank": 1428.0, "id": "38f516e2-8e05-11ea-ac5b-5cf37097309a"}]}, {"source": "STING mediated induction of host immune responses", "value": 0.3608306486501528, "ngenes": 16, "max_val": 8.706, "rank": 1665.0, "id": "38f516e3-8e05-11ea-9496-5cf37097309a", "children": [{"source": "IRF3-mediated induction of type I IFN", "value": 0.3483210271800589, "ngenes": 13, "max_val": 8.706, "rank": 1748.0, "id": "38f516e4-8e05-11ea-b2bb-5cf37097309a"}, {"source": "STAT6-mediated induction of chemokines", "value": 0.32943830271672403, "ngenes": 3, "max_val": 8.706, "rank": 1855.0, "id": "38f516e5-8e05-11ea-8ea8-5cf37097309a"}]}, {"source": "Regulation of innate immune responses to cytosolic DNA", "value": 0.3483210271800589, "ngenes": 15, "max_val": 8.706, "rank": 1752.0, "id": "38f516e6-8e05-11ea-a3ee-5cf37097309a"}, {"source": "DEx/H-box helicases activate type I IFN and inflammatory cytokines production ", "value": 0.3088724561369422, "ngenes": 8, "max_val": 8.706, "rank": 2003.0, "id": "38f516e7-8e05-11ea-8485-5cf37097309a"}]}, {"source": "DAP12 interactions", "value": 0.5775136710074167, "ngenes": 89, "max_val": 8.706, "rank": 949.0, "id": "38f516e8-8e05-11ea-8f0b-5cf37097309a", "children": [{"source": "DAP12 signaling", "value": 0.6495994913559057, "ngenes": 53, "max_val": 8.706, "rank": 831.0, "id": "38f516e9-8e05-11ea-85b4-5cf37097309a"}]}, {"source": "DDX58/IFIH1-mediated induction of interferon-alpha/beta", "value": 0.6586332459534382, "ngenes": 95, "max_val": 8.706, "rank": 809.0, "id": "38f516ea-8e05-11ea-a06d-5cf37097309a", "children": [{"source": "Negative regulators of DDX58/IFIH1 signaling", "value": 0.5261868648768158, "ngenes": 40, "max_val": 8.706, "rank": 1038.0, "id": "38f516eb-8e05-11ea-b341-5cf37097309a"}, {"source": "TRAF6 mediated IRF7 activation", "value": 0.43722136432570896, "ngenes": 30, "max_val": 8.706, "rank": 1351.0, "id": "38f516ec-8e05-11ea-8b97-5cf37097309a"}, {"source": "TRAF6 mediated NF-kB activation", "value": 0.4052503345983252, "ngenes": 39, "max_val": 8.706, "rank": 1486.0, "id": "38f516ed-8e05-11ea-a59a-5cf37097309a"}, {"source": "NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10", "value": 0.3712048826224124, "ngenes": 12, "max_val": 8.706, "rank": 1618.0, "id": "38f516ee-8e05-11ea-9ab7-5cf37097309a"}, {"source": "TRAF3-dependent IRF activation pathway", "value": 0.3608306486501528, "ngenes": 15, "max_val": 8.706, "rank": 1666.0, "id": "38f516ef-8e05-11ea-b1ff-5cf37097309a"}]}, {"source": "ROS and RNS production in phagocytes", "value": 1.4762685268012885, "ngenes": 43, "max_val": 8.706, "rank": 321.0, "id": "38f516f0-8e05-11ea-a7d8-5cf37097309a", "children": [{"source": "Events associated with phagocytolytic activity of PMN cells", "value": 0.42910731206928376, "ngenes": 2, "max_val": 8.706, "rank": 1368.0, "id": "38f516f1-8e05-11ea-b4cd-5cf37097309a"}]}, {"source": "Alpha-protein kinase 1 signaling pathway", "value": 0.4083663025909468, "ngenes": 11, "max_val": 8.706, "rank": 1461.0, "id": "38f516f2-8e05-11ea-b1c6-5cf37097309a"}, {"source": "Neutrophil degranulation", "value": 0.3845554833325704, "ngenes": 570, "max_val": 8.706, "rank": 1573.0, "id": "38f516f3-8e05-11ea-a64c-5cf37097309a"}, {"source": "Advanced glycosylation endproduct receptor signaling", "value": 0.34217341397470546, "ngenes": 31, "max_val": 8.706, "rank": 1780.0, "id": "38f516f4-8e05-11ea-822c-5cf37097309a"}]}, {"source": "Adaptive Immune System", "value": 0.6287478209031482, "ngenes": 1413, "max_val": 8.706, "rank": 871.0, "id": "38f516f5-8e05-11ea-8c0e-5cf37097309a", "children": [{"source": "Signaling by the B Cell Receptor (BCR)", "value": 0.3962893504295674, "ngenes": 339, "max_val": 8.706, "rank": 1525.0, "id": "38f516f6-8e05-11ea-af4c-5cf37097309a", "children": [{"source": "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers", "value": 1.3172744012649678, "ngenes": 223, "max_val": 8.706, "rank": 381.0, "id": "38f516f7-8e05-11ea-a6cb-5cf37097309a"}, {"source": "CD22 mediated BCR regulation", "value": 1.1301479245255617, "ngenes": 91, "max_val": 8.706, "rank": 476.0, "id": "38f516f8-8e05-11ea-9716-5cf37097309a"}, {"source": "Downstream signaling events of B Cell Receptor (BCR)", "value": 0.6018304199040804, "ngenes": 116, "max_val": 8.706, "rank": 915.0, "id": "38f516f9-8e05-11ea-bd7f-5cf37097309a", "children": [{"source": "Activation of NF-kappaB in B cells", "value": 0.5202675432027881, "ngenes": 92, "max_val": 8.706, "rank": 1049.0, "id": "38f516fa-8e05-11ea-a26d-5cf37097309a"}, {"source": "Calcineurin activates NFAT", "value": 0.4237924916712859, "ngenes": 16, "max_val": 8.706, "rank": 1396.0, "id": "38f516fb-8e05-11ea-aa89-5cf37097309a"}, {"source": "Activation of RAS in B cells", "value": 0.33871289172223634, "ngenes": 8, "max_val": 8.706, "rank": 1802.0, "id": "38f516fc-8e05-11ea-84bc-5cf37097309a"}]}]}, {"source": "Rap1 signalling", "value": 1.1442183683022995, "ngenes": 16, "max_val": 8.706, "rank": 464.0, "id": "38f516fd-8e05-11ea-ba18-5cf37097309a"}, {"source": "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell", "value": 0.6348430454009657, "ngenes": 394, "max_val": 8.706, "rank": 857.0, "id": "38f516fe-8e05-11ea-bcbd-5cf37097309a"}, {"source": "MHC class II antigen presentation", "value": 0.6286195179544306, "ngenes": 196, "max_val": 8.706, "rank": 874.0, "id": "38f516ff-8e05-11ea-8859-5cf37097309a"}, {"source": "Class I MHC mediated antigen processing & presentation", "value": 0.44227409954858976, "ngenes": 576, "max_val": 8.706, "rank": 1299.0, "id": "38f51700-8e05-11ea-be20-5cf37097309a", "children": [{"source": "Antigen processing-Cross presentation", "value": 0.5565507266078732, "ngenes": 287, "max_val": 8.706, "rank": 973.0, "id": "38f51701-8e05-11ea-bb23-5cf37097309a", "children": [{"source": "Cross-presentation of soluble exogenous antigens (endosomes)", "value": 0.5789528125814773, "ngenes": 73, "max_val": 8.706, "rank": 948.0, "id": "38f51702-8e05-11ea-b104-5cf37097309a"}, {"source": "ER-Phagosome pathway", "value": 0.5471840327551817, "ngenes": 203, "max_val": 8.706, "rank": 1019.0, "id": "38f51703-8e05-11ea-9b68-5cf37097309a"}, {"source": "Cross-presentation of particulate exogenous antigens (phagosomes)", "value": 0.3416738873259401, "ngenes": 8, "max_val": 8.706, "rank": 1786.0, "id": "38f51704-8e05-11ea-a76b-5cf37097309a"}, {"source": "Endosomal/Vacuolar pathway", "value": 0.3226933204850961, "ngenes": 42, "max_val": 8.706, "rank": 1907.0, "id": "38f51705-8e05-11ea-b236-5cf37097309a"}]}, {"source": "Antigen Presentation: Folding, assembly and peptide loading of class I MHC", "value": 0.3105793227855824, "ngenes": 114, "max_val": 8.706, "rank": 1999.0, "id": "38f51706-8e05-11ea-90d4-5cf37097309a"}, {"source": "Antigen processing: Ubiquitination & Proteasome degradation", "value": 0.3071128122122555, "ngenes": 336, "max_val": 8.706, "rank": 2021.0, "id": "38f51707-8e05-11ea-b534-5cf37097309a"}]}, {"source": "TCR signaling", "value": 0.3054119582193906, "ngenes": 189, "max_val": 8.706, "rank": 2032.0, "id": "38f51708-8e05-11ea-9067-5cf37097309a", "children": [{"source": "Generation of second messenger molecules", "value": 0.5138735430859052, "ngenes": 84, "max_val": 8.706, "rank": 1055.0, "id": "38f51709-8e05-11ea-b73b-5cf37097309a"}, {"source": "Translocation of ZAP-70 to Immunological synapse", "value": 0.4646123127797776, "ngenes": 67, "max_val": 8.706, "rank": 1241.0, "id": "38f53d74-8e05-11ea-b37e-5cf37097309a"}, {"source": "Phosphorylation of CD3 and TCR zeta chains", "value": 0.44958607382897975, "ngenes": 71, "max_val": 8.706, "rank": 1275.0, "id": "38f53d75-8e05-11ea-9103-5cf37097309a"}, {"source": "Downstream TCR signaling", "value": 0.3894910406723921, "ngenes": 164, "max_val": 8.706, "rank": 1544.0, "id": "38f53d76-8e05-11ea-bdc4-5cf37097309a"}]}, {"source": "Costimulation by the CD28 family", "value": 0.47285193963944605, "ngenes": 123, "max_val": 8.706, "rank": 1191.0, "id": "38f53d77-8e05-11ea-a62e-5cf37097309a", "children": [{"source": "PD-1 signaling", "value": 0.4647304025875293, "ngenes": 72, "max_val": 8.706, "rank": 1230.0, "id": "38f53d78-8e05-11ea-80a2-5cf37097309a"}, {"source": "CD28 co-stimulation", "value": 0.3574248285523114, "ngenes": 34, "max_val": 8.706, "rank": 1693.0, "id": "38f53d79-8e05-11ea-86ff-5cf37097309a", "children": [{"source": "CD28 dependent PI3K/Akt signaling", "value": 0.4129012734621538, "ngenes": 23, "max_val": 8.706, "rank": 1449.0, "id": "38f53d7a-8e05-11ea-ac69-5cf37097309a"}, {"source": "CD28 dependent Vav1 pathway", "value": 0.3697835599897704, "ngenes": 12, "max_val": 8.706, "rank": 1623.0, "id": "38f53d7b-8e05-11ea-af7f-5cf37097309a"}]}, {"source": "CTLA4 inhibitory signaling", "value": 0.3229052919360341, "ngenes": 22, "max_val": 8.706, "rank": 1901.0, "id": "38f53d7c-8e05-11ea-9631-5cf37097309a"}]}, {"source": "Butyrophilin (BTN) family interactions", "value": 0.40211125538565895, "ngenes": 19, "max_val": 8.706, "rank": 1494.0, "id": "38f53d7d-8e05-11ea-9a97-5cf37097309a"}]}]}, {"source": "Programmed Cell Death", "value": 0.4731128235942158, "ngenes": 217, "max_val": 8.706, "rank": 1185.0, "id": "38f53d7e-8e05-11ea-bd64-5cf37097309a", "children": [{"source": "Apoptosis", "value": 0.5357846389649563, "ngenes": 209, "max_val": 8.706, "rank": 1031.0, "id": "38f53d7f-8e05-11ea-9be7-5cf37097309a", "children": [{"source": "Intrinsic Pathway for Apoptosis", "value": 0.5519775888320267, "ngenes": 64, "max_val": 8.706, "rank": 988.0, "id": "38f53d80-8e05-11ea-bf4b-5cf37097309a", "children": [{"source": "BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members", "value": 2.248959385177685, "ngenes": 9, "max_val": 8.706, "rank": 103.0, "id": "38f53d81-8e05-11ea-835c-5cf37097309a"}, {"source": "Apoptotic factor-mediated response", "value": 0.3618644575238823, "ngenes": 26, "max_val": 8.706, "rank": 1652.0, "id": "38f53d82-8e05-11ea-acd7-5cf37097309a", "children": [{"source": "Release of apoptotic factors from the mitochondria", "value": 0.6533504283858577, "ngenes": 6, "max_val": 8.706, "rank": 826.0, "id": "38f53d83-8e05-11ea-9893-5cf37097309a"}, {"source": "Cytochrome c-mediated apoptotic response", "value": 0.3107479865717629, "ngenes": 17, "max_val": 8.706, "rank": 1997.0, "id": "38f53d84-8e05-11ea-b256-5cf37097309a", "children": [{"source": "Formation of apoptosome", "value": 0.4096490938308899, "ngenes": 15, "max_val": 8.706, "rank": 1458.0, "id": "38f53d85-8e05-11ea-9089-5cf37097309a", "children": [{"source": "Regulation of the apoptosome activity", "value": 0.4107316574352216, "ngenes": 15, "max_val": 8.706, "rank": 1457.0, "id": "38f53d86-8e05-11ea-a0c9-5cf37097309a"}]}, {"source": "Activation of caspases through apoptosome-mediated cleavage", "value": 0.3592004814595621, "ngenes": 6, "max_val": 8.706, "rank": 1677.0, "id": "38f53d87-8e05-11ea-b645-5cf37097309a"}]}, {"source": "SMAC, XIAP-regulated apoptotic response", "value": 0.35647002589378085, "ngenes": 13, "max_val": 8.706, "rank": 1710.0, "id": "38f53d88-8e05-11ea-a50a-5cf37097309a", "children": [{"source": "SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ", "value": 0.33791596117958894, "ngenes": 11, "max_val": 8.706, "rank": 1809.0, "id": "38f53d89-8e05-11ea-ac4b-5cf37097309a"}, {"source": "SMAC (DIABLO) binds to IAPs ", "value": 0.33791596117958894, "ngenes": 11, "max_val": 8.706, "rank": 1810.0, "id": "38f53d8a-8e05-11ea-bcb8-5cf37097309a"}]}]}, {"source": "Activation, myristolyation of BID and translocation to mitochondria", "value": 0.4548063126614417, "ngenes": 4, "max_val": 8.706, "rank": 1264.0, "id": "38f53d8b-8e05-11ea-a281-5cf37097309a"}, {"source": "Activation of BH3-only proteins", "value": 0.3135746486533741, "ngenes": 33, "max_val": 8.706, "rank": 1965.0, "id": "38f53d8c-8e05-11ea-b312-5cf37097309a", "children": [{"source": "Activation of NOXA and translocation to mitochondria", "value": 0.44227409954858976, "ngenes": 5, "max_val": 8.706, "rank": 1297.0, "id": "38f53d8d-8e05-11ea-a5a5-5cf37097309a"}, {"source": "Activation of BMF and translocation to mitochondria", "value": 0.3329354557992007, "ngenes": 3, "max_val": 8.706, "rank": 1851.0, "id": "38f53d8e-8e05-11ea-bedb-5cf37097309a"}, {"source": "Activation of BAD and translocation to mitochondria ", "value": 0.31494787026486865, "ngenes": 18, "max_val": 8.706, "rank": 1945.0, "id": "38f53d8f-8e05-11ea-9b0c-5cf37097309a"}, {"source": "Activation of PUMA and translocation to mitochondria", "value": 0.3135746486533741, "ngenes": 9, "max_val": 8.706, "rank": 1973.0, "id": "38f53d90-8e05-11ea-8757-5cf37097309a"}, {"source": "Activation of BIM and translocation to mitochondria ", "value": 0.3033573189818823, "ngenes": 3, "max_val": 8.706, "rank": 2050.0, "id": "38f53d91-8e05-11ea-b28e-5cf37097309a"}]}, {"source": "Activation and oligomerization of BAK protein", "value": 0.44227409954858976, "ngenes": 2, "max_val": 8.706, "rank": 1310.0, "id": "38f53d92-8e05-11ea-8e31-5cf37097309a"}, {"source": "Activation, translocation and oligomerization of BAX", "value": 0.44227409954858976, "ngenes": 2, "max_val": 8.706, "rank": 1313.0, "id": "38f53d93-8e05-11ea-b374-5cf37097309a"}]}, {"source": "Apoptotic execution phase", "value": 0.6348039960955303, "ngenes": 56, "max_val": 8.706, "rank": 860.0, "id": "38f53d94-8e05-11ea-9cac-5cf37097309a", "children": [{"source": "Apoptosis induced DNA fragmentation", "value": 2.243535002065994, "ngenes": 13, "max_val": 8.706, "rank": 107.0, "id": "38f53d95-8e05-11ea-8e0a-5cf37097309a"}, {"source": "Stimulation of the cell death response by PAK-2p34", "value": 0.7523147664214483, "ngenes": 2, "max_val": 8.706, "rank": 702.0, "id": "38f53d96-8e05-11ea-9877-5cf37097309a"}, {"source": "Apoptotic cleavage of cellular proteins", "value": 0.5179043214991355, "ngenes": 41, "max_val": 8.706, "rank": 1052.0, "id": "38f53d97-8e05-11ea-adaa-5cf37097309a", "children": [{"source": "Apoptotic cleavage of cell adhesion  proteins", "value": 0.6511705749423734, "ngenes": 12, "max_val": 8.706, "rank": 829.0, "id": "38f53d98-8e05-11ea-b9fe-5cf37097309a"}, {"source": "Caspase-mediated cleavage of cytoskeletal proteins", "value": 0.4704952658544049, "ngenes": 14, "max_val": 8.706, "rank": 1205.0, "id": "38f53d99-8e05-11ea-8ac6-5cf37097309a"}, {"source": "Breakdown of the nuclear lamina", "value": 0.4646123127797776, "ngenes": 3, "max_val": 8.706, "rank": 1238.0, "id": "38f53d9a-8e05-11ea-a515-5cf37097309a"}]}]}, {"source": "Regulation of Apoptosis", "value": 0.7371511519580098, "ngenes": 71, "max_val": 8.706, "rank": 718.0, "id": "38f53d9b-8e05-11ea-b216-5cf37097309a", "children": [{"source": "Regulation of PAK-2p34 activity by PS-GAP/RHG10", "value": 1.746296790816183, "ngenes": 2, "max_val": 8.706, "rank": 205.0, "id": "38f53d9c-8e05-11ea-8aed-5cf37097309a"}, {"source": "Regulation of activated PAK-2p34 by proteasome mediated degradation", "value": 0.6698985380668772, "ngenes": 68, "max_val": 8.706, "rank": 787.0, "id": "38f53d9d-8e05-11ea-9b52-5cf37097309a"}]}, {"source": "Caspase activation via extrinsic apoptotic signalling pathway", "value": 0.3750724859188269, "ngenes": 27, "max_val": 8.706, "rank": 1602.0, "id": "38f53d9e-8e05-11ea-a9dd-5cf37097309a", "children": [{"source": "Caspase activation via Death Receptors in the presence of ligand", "value": 0.3203240162347684, "ngenes": 16, "max_val": 8.706, "rank": 1915.0, "id": "38f53d9f-8e05-11ea-8ca5-5cf37097309a", "children": [{"source": "Dimerization of procaspase-8", "value": 0.4978312627148301, "ngenes": 11, "max_val": 8.706, "rank": 1100.0, "id": "38f53da0-8e05-11ea-b7c4-5cf37097309a"}, {"source": "Regulation by c-FLIP", "value": 0.4959003104721595, "ngenes": 11, "max_val": 8.706, "rank": 1103.0, "id": "38f53da1-8e05-11ea-9880-5cf37097309a"}]}, {"source": "Caspase activation via Dependence Receptors in the absence of ligand", "value": 0.388754159245383, "ngenes": 11, "max_val": 8.706, "rank": 1546.0, "id": "38f53da2-8e05-11ea-8db1-5cf37097309a"}]}]}, {"source": "Regulated Necrosis", "value": 0.5471840327551817, "ngenes": 21, "max_val": 8.706, "rank": 998.0, "id": "38f53da3-8e05-11ea-8674-5cf37097309a", "children": [{"source": "RIPK1-mediated regulated necrosis", "value": 0.5471840327551817, "ngenes": 21, "max_val": 8.706, "rank": 1000.0, "id": "38f53da4-8e05-11ea-92e1-5cf37097309a", "children": [{"source": "Regulation of necroptotic cell death", "value": 0.4129012734621538, "ngenes": 18, "max_val": 8.706, "rank": 1453.0, "id": "38f53da5-8e05-11ea-978a-5cf37097309a", "children": [{"source": "CASP8 activity is inhibited", "value": 0.495930525210356, "ngenes": 11, "max_val": 8.706, "rank": 1102.0, "id": "38f53da6-8e05-11ea-884c-5cf37097309a"}]}]}]}]}, {"source": "Chromatin organization", "value": 1.0392836614911098, "ngenes": 358, "max_val": 8.706, "rank": 521.0, "id": "38f53da7-8e05-11ea-91f9-5cf37097309a", "children": [{"source": "Chromatin modifying enzymes", "value": 1.0392836614911098, "ngenes": 358, "max_val": 8.706, "rank": 518.0, "id": "38f53da8-8e05-11ea-9c56-5cf37097309a", "children": [{"source": "RMTs methylate histone arginines", "value": 1.9486203325139888, "ngenes": 81, "max_val": 8.706, "rank": 152.0, "id": "38f53da9-8e05-11ea-b818-5cf37097309a"}, {"source": "HATs acetylate histones", "value": 1.9486203325139888, "ngenes": 214, "max_val": 8.706, "rank": 156.0, "id": "38f53daa-8e05-11ea-91e4-5cf37097309a"}, {"source": "HDACs deacetylate histones", "value": 1.5452964802223617, "ngenes": 97, "max_val": 8.706, "rank": 296.0, "id": "38f53dab-8e05-11ea-aaa6-5cf37097309a"}, {"source": "HDMs demethylate histones", "value": 1.5411445750463468, "ngenes": 50, "max_val": 8.706, "rank": 300.0, "id": "38f53dac-8e05-11ea-93ac-5cf37097309a"}, {"source": "PKMTs methylate histone lysines", "value": 1.2346109249288977, "ngenes": 76, "max_val": 8.706, "rank": 413.0, "id": "38f53dad-8e05-11ea-9c24-5cf37097309a"}]}]}, {"source": "Metabolism of RNA", "value": 0.3727213414860511, "ngenes": 873, "max_val": 8.706, "rank": 1612.0, "id": "38f53dae-8e05-11ea-aedf-5cf37097309a", "children": [{"source": "tRNA processing", "value": 0.4165866033279961, "ngenes": 132, "max_val": 8.706, "rank": 1434.0, "id": "38f53daf-8e05-11ea-8271-5cf37097309a", "children": [{"source": "tRNA modification in the nucleus and cytosol", "value": 0.4788365094295219, "ngenes": 45, "max_val": 8.706, "rank": 1170.0, "id": "38f53db0-8e05-11ea-8983-5cf37097309a", "children": [{"source": "Synthesis of wybutosine at G37 of tRNA(Phe)", "value": 1.9033899703674428, "ngenes": 7, "max_val": 8.706, "rank": 173.0, "id": "38f53db1-8e05-11ea-87dd-5cf37097309a"}]}, {"source": "tRNA processing in the mitochondrion", "value": 1.7046865309937722, "ngenes": 7, "max_val": 8.706, "rank": 218.0, "id": "38f53db2-8e05-11ea-9c41-5cf37097309a"}, {"source": "tRNA processing in the nucleus", "value": 0.623727271487475, "ngenes": 76, "max_val": 8.706, "rank": 882.0, "id": "38f53db3-8e05-11ea-a793-5cf37097309a"}, {"source": "tRNA modification in the mitochondrion", "value": 0.3333488691934495, "ngenes": 9, "max_val": 8.706, "rank": 1850.0, "id": "38f53db4-8e05-11ea-b41d-5cf37097309a"}]}, {"source": "Regulation of mRNA stability by proteins that bind AU-rich elements", "value": 0.36097258849275415, "ngenes": 111, "max_val": 8.706, "rank": 1657.0, "id": "38f53db5-8e05-11ea-bf65-5cf37097309a", "children": [{"source": "Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA", "value": 1.7192109142232588, "ngenes": 17, "max_val": 8.706, "rank": 213.0, "id": "38f53db6-8e05-11ea-b69c-5cf37097309a"}, {"source": "KSRP (KHSRP) binds and destabilizes mRNA", "value": 1.3219502908065917, "ngenes": 19, "max_val": 8.706, "rank": 380.0, "id": "38f53db7-8e05-11ea-baaf-5cf37097309a"}, {"source": "Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA", "value": 0.8502266077186681, "ngenes": 17, "max_val": 8.706, "rank": 636.0, "id": "38f53db8-8e05-11ea-a164-5cf37097309a"}, {"source": "AUF1 (hnRNP D0) binds and destabilizes mRNA", "value": 0.6008310757219172, "ngenes": 77, "max_val": 8.706, "rank": 919.0, "id": "38f53db9-8e05-11ea-8b2e-5cf37097309a"}, {"source": "HuR (ELAVL1) binds and stabilizes mRNA", "value": 0.5346153580215802, "ngenes": 8, "max_val": 8.706, "rank": 1032.0, "id": "38f53dba-8e05-11ea-b1bb-5cf37097309a"}]}, {"source": "Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA", "value": 1.4520169349171257, "ngenes": 3, "max_val": 8.706, "rank": 333.0, "id": "38f53dbb-8e05-11ea-9ac5-5cf37097309a"}, {"source": "Processing of Capped Intronless Pre-mRNA", "value": 0.3586028553859912, "ngenes": 29, "max_val": 8.706, "rank": 1684.0, "id": "38f53dbc-8e05-11ea-a7c3-5cf37097309a", "children": [{"source": "SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs", "value": 1.0230929066990757, "ngenes": 11, "max_val": 8.706, "rank": 533.0, "id": "38f53dbd-8e05-11ea-8038-5cf37097309a"}, {"source": "SLBP independent Processing of Histone Pre-mRNAs", "value": 0.5098760850672088, "ngenes": 10, "max_val": 8.706, "rank": 1071.0, "id": "38f53dbe-8e05-11ea-8908-5cf37097309a"}, {"source": "Processing of Intronless Pre-mRNAs", "value": 0.3088724561369422, "ngenes": 20, "max_val": 8.706, "rank": 2004.0, "id": "38f53dbf-8e05-11ea-9a24-5cf37097309a"}]}, {"source": "Metabolism of non-coding RNA", "value": 0.9742568369533391, "ngenes": 58, "max_val": 8.706, "rank": 558.0, "id": "38f53dc0-8e05-11ea-b0fb-5cf37097309a", "children": [{"source": "snRNP Assembly", "value": 0.9742568369533391, "ngenes": 58, "max_val": 8.706, "rank": 557.0, "id": "38f53dc1-8e05-11ea-a6a3-5cf37097309a"}]}, {"source": "mRNA Capping", "value": 0.7840753180362913, "ngenes": 37, "max_val": 8.706, "rank": 676.0, "id": "38f53dc2-8e05-11ea-bbb8-5cf37097309a"}, {"source": "Processing of Capped Intron-Containing Pre-mRNA", "value": 0.7351803864773258, "ngenes": 269, "max_val": 8.706, "rank": 722.0, "id": "38f53dc3-8e05-11ea-9eb0-5cf37097309a", "children": [{"source": "Transport of Mature Transcript to Cytoplasm", "value": 0.6495994913559057, "ngenes": 92, "max_val": 8.706, "rank": 833.0, "id": "38f53dc4-8e05-11ea-ab0f-5cf37097309a", "children": [{"source": "Transport of Mature mRNA derived from an Intron-Containing Transcript", "value": 0.6647834081114088, "ngenes": 82, "max_val": 8.706, "rank": 798.0, "id": "38f53dc5-8e05-11ea-b20b-5cf37097309a"}, {"source": "Transport of Mature mRNAs Derived from Intronless Transcripts", "value": 0.3543975045465841, "ngenes": 45, "max_val": 8.706, "rank": 1721.0, "id": "38f53dc6-8e05-11ea-87e4-5cf37097309a", "children": [{"source": "Transport of the SLBP Dependant Mature mRNA", "value": 0.4294215496716524, "ngenes": 37, "max_val": 8.706, "rank": 1366.0, "id": "38f53dc7-8e05-11ea-afb9-5cf37097309a"}, {"source": "Transport of the SLBP independent Mature mRNA", "value": 0.35319786283332305, "ngenes": 36, "max_val": 8.706, "rank": 1727.0, "id": "38f53dc8-8e05-11ea-9f0e-5cf37097309a"}, {"source": "Transport of Mature mRNA Derived from an Intronless Transcript", "value": 0.3135746486533741, "ngenes": 44, "max_val": 8.706, "rank": 1968.0, "id": "38f53dc9-8e05-11ea-aba1-5cf37097309a"}]}]}, {"source": "mRNA Splicing", "value": 0.7072553038615724, "ngenes": 208, "max_val": 8.706, "rank": 756.0, "id": "38f53dca-8e05-11ea-998e-5cf37097309a", "children": [{"source": "mRNA Splicing - Major Pathway", "value": 0.6410788406347994, "ngenes": 200, "max_val": 8.706, "rank": 846.0, "id": "38f53dcb-8e05-11ea-af24-5cf37097309a"}, {"source": "mRNA Splicing - Minor Pathway", "value": 0.4266462015709692, "ngenes": 58, "max_val": 8.706, "rank": 1379.0, "id": "38f53dcc-8e05-11ea-a600-5cf37097309a"}]}, {"source": "mRNA 3'-end processing", "value": 0.3288714815669623, "ngenes": 64, "max_val": 8.706, "rank": 1866.0, "id": "38f53dcd-8e05-11ea-bc72-5cf37097309a"}]}, {"source": "rRNA processing", "value": 0.5565507266078732, "ngenes": 300, "max_val": 8.706, "rank": 980.0, "id": "38f53dce-8e05-11ea-be81-5cf37097309a", "children": [{"source": "rRNA processing in the nucleus and cytosol", "value": 0.7073571356562612, "ngenes": 287, "max_val": 8.706, "rank": 754.0, "id": "38f53dcf-8e05-11ea-9603-5cf37097309a", "children": [{"source": "Major pathway of rRNA processing in the nucleolus and cytosol", "value": 0.5502822871549383, "ngenes": 213, "max_val": 8.706, "rank": 991.0, "id": "38f53dd0-8e05-11ea-95f4-5cf37097309a"}, {"source": "rRNA modification in the nucleus and cytosol", "value": 0.3135746486533741, "ngenes": 76, "max_val": 8.706, "rank": 1952.0, "id": "38f53dd1-8e05-11ea-abe7-5cf37097309a"}]}, {"source": "rRNA processing in the mitochondrion", "value": 0.3040711199823073, "ngenes": 13, "max_val": 8.706, "rank": 2048.0, "id": "38f53dd2-8e05-11ea-8c09-5cf37097309a", "children": [{"source": "rRNA modification in the mitochondrion", "value": 0.3288714815669623, "ngenes": 9, "max_val": 8.706, "rank": 1858.0, "id": "38f53dd3-8e05-11ea-b6c2-5cf37097309a"}]}]}, {"source": "Deadenylation-dependent mRNA decay", "value": 0.4378764711343367, "ngenes": 90, "max_val": 8.706, "rank": 1350.0, "id": "38f53dd4-8e05-11ea-8d29-5cf37097309a", "children": [{"source": "mRNA decay by 5' to 3' exoribonuclease", "value": 0.3663505507769889, "ngenes": 34, "max_val": 8.706, "rank": 1639.0, "id": "38f53dd5-8e05-11ea-a94c-5cf37097309a"}, {"source": "Deadenylation of mRNA", "value": 0.35647002589378085, "ngenes": 35, "max_val": 8.706, "rank": 1709.0, "id": "38f53dd6-8e05-11ea-ad80-5cf37097309a"}, {"source": "mRNA decay by 3' to 5' exoribonuclease", "value": 0.3483210271800589, "ngenes": 21, "max_val": 8.706, "rank": 1759.0, "id": "38f53dd7-8e05-11ea-8066-5cf37097309a"}]}, {"source": "mRNA Editing", "value": 0.4788365094295219, "ngenes": 11, "max_val": 8.706, "rank": 1172.0, "id": "38f53dd8-8e05-11ea-8038-5cf37097309a", "children": [{"source": "mRNA Editing: A to I Conversion", "value": 0.3592004814595621, "ngenes": 2, "max_val": 8.706, "rank": 1674.0, "id": "38f53dd9-8e05-11ea-a0dd-5cf37097309a", "children": [{"source": "Formation of editosomes by ADAR proteins", "value": 0.3608306486501528, "ngenes": 2, "max_val": 8.706, "rank": 1662.0, "id": "38f53dda-8e05-11ea-bbda-5cf37097309a"}, {"source": "C6 deamination of adenosine", "value": 0.35997239791599234, "ngenes": 2, "max_val": 8.706, "rank": 1668.0, "id": "38f53ddb-8e05-11ea-87c2-5cf37097309a"}]}, {"source": "mRNA Editing: C to U Conversion", "value": 0.351317923462216, "ngenes": 9, "max_val": 8.706, "rank": 1731.0, "id": "38f53ddc-8e05-11ea-a0dd-5cf37097309a", "children": [{"source": "Formation of the Editosome", "value": 0.351317923462216, "ngenes": 9, "max_val": 8.706, "rank": 1732.0, "id": "38f53ddd-8e05-11ea-8ce0-5cf37097309a"}]}]}, {"source": "Nonsense-Mediated Decay (NMD)", "value": 0.33944594742321177, "ngenes": 132, "max_val": 8.706, "rank": 1798.0, "id": "38f53dde-8e05-11ea-abad-5cf37097309a", "children": [{"source": "Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)", "value": 0.3396703179276215, "ngenes": 132, "max_val": 8.706, "rank": 1797.0, "id": "38f53ddf-8e05-11ea-beb3-5cf37097309a"}, {"source": "Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)", "value": 0.3167912402659615, "ngenes": 112, "max_val": 8.706, "rank": 1940.0, "id": "38f53de0-8e05-11ea-bbd9-5cf37097309a"}]}]}, {"source": "Vesicle-mediated transport", "value": 0.3333488691934495, "ngenes": 836, "max_val": 8.706, "rank": 1847.0, "id": "38f53de1-8e05-11ea-856e-5cf37097309a", "children": [{"source": "Membrane Trafficking", "value": 0.4237924916712859, "ngenes": 692, "max_val": 8.706, "rank": 1388.0, "id": "38f53de2-8e05-11ea-a755-5cf37097309a", "children": [{"source": "Intra-Golgi and retrograde Golgi-to-ER traffic", "value": 0.3849420497242914, "ngenes": 216, "max_val": 8.706, "rank": 1557.0, "id": "38f53de3-8e05-11ea-b916-5cf37097309a", "children": [{"source": "Intra-Golgi traffic", "value": 1.7894309844534653, "ngenes": 46, "max_val": 8.706, "rank": 194.0, "id": "38f53de4-8e05-11ea-91fa-5cf37097309a"}, {"source": "Golgi-to-ER retrograde transport", "value": 0.33680443321456344, "ngenes": 140, "max_val": 8.706, "rank": 1822.0, "id": "38f53de5-8e05-11ea-9578-5cf37097309a", "children": [{"source": "COPI-dependent Golgi-to-ER retrograde traffic", "value": 1.0230929066990757, "ngenes": 106, "max_val": 8.706, "rank": 530.0, "id": "38f53de6-8e05-11ea-b49d-5cf37097309a"}, {"source": "COPI-independent Golgi-to-ER retrograde traffic", "value": 0.350933254566744, "ngenes": 53, "max_val": 8.706, "rank": 1738.0, "id": "38f53de7-8e05-11ea-b058-5cf37097309a"}]}, {"source": "Retrograde transport at the Trans-Golgi-Network", "value": 0.7332175660277244, "ngenes": 58, "max_val": 8.706, "rank": 723.0, "id": "38f53de8-8e05-11ea-b22f-5cf37097309a"}]}, {"source": "Gap junction trafficking and regulation", "value": 0.508641362139664, "ngenes": 76, "max_val": 8.706, "rank": 1074.0, "id": "38f53de9-8e05-11ea-a6c3-5cf37097309a", "children": [{"source": "Gap junction trafficking", "value": 0.5207794081994234, "ngenes": 71, "max_val": 8.706, "rank": 1046.0, "id": "38f53dea-8e05-11ea-b033-5cf37097309a", "children": [{"source": "Gap junction degradation", "value": 1.14305429974148, "ngenes": 12, "max_val": 8.706, "rank": 466.0, "id": "38f53deb-8e05-11ea-8383-5cf37097309a", "children": [{"source": "Formation of annular gap junctions", "value": 1.0508668608598393, "ngenes": 11, "max_val": 8.706, "rank": 506.0, "id": "38f53dec-8e05-11ea-888f-5cf37097309a"}]}, {"source": "Gap junction assembly", "value": 0.3333488691934495, "ngenes": 60, "max_val": 8.706, "rank": 1848.0, "id": "38f53ded-8e05-11ea-af93-5cf37097309a", "children": [{"source": "Transport of connexons to the plasma membrane", "value": 0.41963911371854973, "ngenes": 21, "max_val": 8.706, "rank": 1411.0, "id": "38f53dee-8e05-11ea-9f39-5cf37097309a", "children": [{"source": "Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane", "value": 0.3663505507769889, "ngenes": 20, "max_val": 8.706, "rank": 1634.0, "id": "38f53def-8e05-11ea-bec5-5cf37097309a"}]}, {"source": "Oligomerization of connexins into connexons", "value": 0.3120931528325873, "ngenes": 4, "max_val": 8.706, "rank": 1992.0, "id": "38f53df0-8e05-11ea-8331-5cf37097309a"}, {"source": "Transport of connexins along the secretory pathway", "value": 0.31196157368232824, "ngenes": 3, "max_val": 8.706, "rank": 1993.0, "id": "38f53df1-8e05-11ea-a98d-5cf37097309a"}]}]}, {"source": "Regulation of gap junction activity", "value": 0.39196759391578734, "ngenes": 7, "max_val": 8.706, "rank": 1532.0, "id": "38f53df2-8e05-11ea-9b64-5cf37097309a"}]}, {"source": "Endosomal Sorting Complex Required For Transport (ESCRT)", "value": 0.9776278004200736, "ngenes": 33, "max_val": 8.706, "rank": 555.0, "id": "38f53df3-8e05-11ea-8d86-5cf37097309a"}, {"source": "Clathrin-mediated endocytosis", "value": 0.5556109850639417, "ngenes": 146, "max_val": 8.706, "rank": 985.0, "id": "38f53df4-8e05-11ea-8bdc-5cf37097309a", "children": [{"source": "Cargo recognition for clathrin-mediated endocytosis", "value": 0.887377738737015, "ngenes": 106, "max_val": 8.706, "rank": 611.0, "id": "38f53df5-8e05-11ea-a1c8-5cf37097309a"}]}, {"source": "ER to Golgi Anterograde Transport", "value": 0.3135746486533741, "ngenes": 158, "max_val": 8.706, "rank": 1963.0, "id": "38f53df6-8e05-11ea-95d3-5cf37097309a", "children": [{"source": "Cargo concentration in the ER", "value": 0.86492840468403, "ngenes": 33, "max_val": 8.706, "rank": 626.0, "id": "38f53df7-8e05-11ea-ab99-5cf37097309a"}, {"source": "COPII-mediated vesicle transport", "value": 0.5479041359653877, "ngenes": 71, "max_val": 8.706, "rank": 996.0, "id": "38f53df8-8e05-11ea-875e-5cf37097309a"}, {"source": "COPI-mediated anterograde transport", "value": 0.3766009196519696, "ngenes": 104, "max_val": 8.706, "rank": 1595.0, "id": "38f53df9-8e05-11ea-82e4-5cf37097309a"}]}, {"source": "Rab regulation of trafficking", "value": 0.3766009196519696, "ngenes": 126, "max_val": 8.706, "rank": 1594.0, "id": "38f53dfa-8e05-11ea-b533-5cf37097309a", "children": [{"source": "RAB GEFs exchange GTP for GDP on RABs", "value": 0.4177733493359091, "ngenes": 94, "max_val": 8.706, "rank": 1414.0, "id": "38f53dfb-8e05-11ea-9d3e-5cf37097309a"}, {"source": "TBC/RABGAPs", "value": 0.35647002589378085, "ngenes": 44, "max_val": 8.706, "rank": 1699.0, "id": "38f53dfc-8e05-11ea-b2a8-5cf37097309a"}]}, {"source": "trans-Golgi Network Vesicle Budding", "value": 0.33832512665576203, "ngenes": 72, "max_val": 8.706, "rank": 1804.0, "id": "38f53dfd-8e05-11ea-a24d-5cf37097309a", "children": [{"source": "Lysosome Vesicle Biogenesis", "value": 0.32302352043803056, "ngenes": 35, "max_val": 8.706, "rank": 1900.0, "id": "38f53dfe-8e05-11ea-b9f0-5cf37097309a"}, {"source": "Golgi Associated Vesicle Biogenesis", "value": 0.3229052919360341, "ngenes": 56, "max_val": 8.706, "rank": 1904.0, "id": "38f53dff-8e05-11ea-be34-5cf37097309a"}]}, {"source": "Translocation of SLC2A4 (GLUT4) to the plasma membrane", "value": 0.3135746486533741, "ngenes": 73, "max_val": 8.706, "rank": 1969.0, "id": "38f5646e-8e05-11ea-9452-5cf37097309a"}]}, {"source": "Binding and Uptake of Ligands by Scavenger Receptors", "value": 1.1957209721612054, "ngenes": 145, "max_val": 8.706, "rank": 440.0, "id": "38f5646f-8e05-11ea-8923-5cf37097309a", "children": [{"source": "Scavenging by Class H Receptors", "value": 1.4954639650827157, "ngenes": 4, "max_val": 8.706, "rank": 317.0, "id": "38f56470-8e05-11ea-a653-5cf37097309a"}, {"source": "Scavenging of heme from plasma", "value": 1.0541204291117197, "ngenes": 99, "max_val": 8.706, "rank": 505.0, "id": "38f56471-8e05-11ea-828d-5cf37097309a"}, {"source": "Scavenging by Class F Receptors", "value": 0.44227409954858976, "ngenes": 16, "max_val": 8.706, "rank": 1323.0, "id": "38f56472-8e05-11ea-900f-5cf37097309a"}, {"source": "Scavenging by Class A Receptors", "value": 0.406467316447748, "ngenes": 27, "max_val": 8.706, "rank": 1466.0, "id": "38f56473-8e05-11ea-b8cf-5cf37097309a"}, {"source": "Scavenging by Class B Receptors", "value": 0.3513971844420395, "ngenes": 9, "max_val": 8.706, "rank": 1730.0, "id": "38f56474-8e05-11ea-98f7-5cf37097309a"}]}]}, {"source": "Reproduction", "value": 1.9591814189566623, "ngenes": 157, "max_val": 8.706, "rank": 148.0, "id": "38f56475-8e05-11ea-aa46-5cf37097309a", "children": [{"source": "Meiosis", "value": 1.9486203325139888, "ngenes": 127, "max_val": 8.706, "rank": 153.0, "id": "38f56476-8e05-11ea-aea3-5cf37097309a", "children": [{"source": "Meiotic recombination", "value": 1.7876299106393332, "ngenes": 94, "max_val": 8.706, "rank": 195.0, "id": "38f56477-8e05-11ea-a27a-5cf37097309a"}, {"source": "Meiotic synapsis", "value": 1.724270257946776, "ngenes": 82, "max_val": 8.706, "rank": 211.0, "id": "38f56478-8e05-11ea-adcb-5cf37097309a"}]}, {"source": "Fertilization", "value": 0.3483210271800589, "ngenes": 30, "max_val": 8.706, "rank": 1762.0, "id": "38f56479-8e05-11ea-9c08-5cf37097309a", "children": [{"source": "Interaction With Cumulus Cells And The Zona Pellucida", "value": 0.6617484213056293, "ngenes": 13, "max_val": 8.706, "rank": 804.0, "id": "38f5647a-8e05-11ea-8c60-5cf37097309a"}, {"source": "Acrosome Reaction and Sperm:Oocyte Membrane Binding", "value": 0.4129204759764161, "ngenes": 7, "max_val": 8.706, "rank": 1446.0, "id": "38f5647b-8e05-11ea-8220-5cf37097309a"}, {"source": "Sperm Motility And Taxes", "value": 0.3886713294759547, "ngenes": 10, "max_val": 8.706, "rank": 1547.0, "id": "38f5647c-8e05-11ea-b7f6-5cf37097309a"}]}]}, {"source": "DNA Replication", "value": 0.8443494087527166, "ngenes": 158, "max_val": 8.706, "rank": 639.0, "id": "38f5647d-8e05-11ea-b663-5cf37097309a", "children": [{"source": "Synthesis of DNA", "value": 0.9001944453660256, "ngenes": 148, "max_val": 8.706, "rank": 602.0, "id": "38f5647e-8e05-11ea-b183-5cf37097309a", "children": [{"source": "DNA replication initiation", "value": 1.6678919263086482, "ngenes": 8, "max_val": 8.706, "rank": 227.0, "id": "38f5647f-8e05-11ea-a6cf-5cf37097309a"}, {"source": "DNA strand elongation", "value": 1.1346340826365409, "ngenes": 36, "max_val": 8.706, "rank": 472.0, "id": "38f56480-8e05-11ea-bf8c-5cf37097309a", "children": [{"source": "Lagging Strand Synthesis", "value": 1.2809833691874195, "ngenes": 20, "max_val": 8.706, "rank": 393.0, "id": "38f56481-8e05-11ea-af37-5cf37097309a", "children": [{"source": "Processive synthesis on the lagging strand", "value": 1.2937793685933063, "ngenes": 15, "max_val": 8.706, "rank": 391.0, "id": "38f56482-8e05-11ea-a522-5cf37097309a", "children": [{"source": "Removal of the Flap Intermediate", "value": 1.5163013074021197, "ngenes": 14, "max_val": 8.706, "rank": 310.0, "id": "38f56483-8e05-11ea-b684-5cf37097309a"}]}, {"source": "Polymerase switching", "value": 0.8178691883509146, "ngenes": 14, "max_val": 8.706, "rank": 654.0, "id": "38f56484-8e05-11ea-a9ab-5cf37097309a"}]}, {"source": "Unwinding of DNA", "value": 0.9040451189857748, "ngenes": 16, "max_val": 8.706, "rank": 600.0, "id": "38f56485-8e05-11ea-9b98-5cf37097309a"}, {"source": "Leading Strand Synthesis", "value": 0.8178691883509146, "ngenes": 14, "max_val": 8.706, "rank": 653.0, "id": "38f56486-8e05-11ea-8968-5cf37097309a", "children": [{"source": "Polymerase switching", "value": 0.8178691883509146, "ngenes": 14, "max_val": 8.706, "rank": 654.0, "id": "38f56487-8e05-11ea-8da5-5cf37097309a"}]}]}, {"source": "Switching of origins to a post-replicative state", "value": 0.383122548138848, "ngenes": 108, "max_val": 8.706, "rank": 1578.0, "id": "38f56488-8e05-11ea-8822-5cf37097309a", "children": [{"source": "Orc1 removal from chromatin", "value": 0.3870089130792698, "ngenes": 89, "max_val": 8.706, "rank": 1553.0, "id": "38f56489-8e05-11ea-b6a5-5cf37097309a"}, {"source": "CDK-mediated phosphorylation and removal of Cdc6", "value": 0.3128507621405376, "ngenes": 90, "max_val": 8.706, "rank": 1979.0, "id": "38f5648a-8e05-11ea-8193-5cf37097309a"}]}]}, {"source": "DNA Replication Pre-Initiation", "value": 0.4780077744234615, "ngenes": 104, "max_val": 8.706, "rank": 1175.0, "id": "38f5648b-8e05-11ea-b055-5cf37097309a", "children": [{"source": "Activation of the pre-replicative complex", "value": 1.009028139243736, "ngenes": 33, "max_val": 8.706, "rank": 544.0, "id": "38f5648c-8e05-11ea-9b11-5cf37097309a"}, {"source": "Assembly of the pre-replicative complex", "value": 0.3846942455040212, "ngenes": 87, "max_val": 8.706, "rank": 1567.0, "id": "38f5648d-8e05-11ea-a84d-5cf37097309a", "children": [{"source": "CDT1 association with the CDC6:ORC:origin complex", "value": 0.4865631200748303, "ngenes": 77, "max_val": 8.706, "rank": 1134.0, "id": "38f5648e-8e05-11ea-afae-5cf37097309a"}, {"source": "Assembly of the ORC complex at the origin of replication", "value": 0.3967816616170723, "ngenes": 6, "max_val": 8.706, "rank": 1518.0, "id": "38f5648f-8e05-11ea-9cc6-5cf37097309a"}, {"source": "CDC6 association with the ORC:origin complex", "value": 0.3721247903393208, "ngenes": 12, "max_val": 8.706, "rank": 1617.0, "id": "38f56490-8e05-11ea-925e-5cf37097309a"}]}]}]}, {"source": "Extracellular matrix organization", "value": 1.657615261891164, "ngenes": 439, "max_val": 8.706, "rank": 235.0, "id": "38f56491-8e05-11ea-ab3e-5cf37097309a", "children": [{"source": "Invadopodia formation", "value": 1.657615261891164, "ngenes": 4, "max_val": 8.706, "rank": 234.0, "id": "38f56492-8e05-11ea-97d4-5cf37097309a"}, {"source": "Laminin interactions", "value": 1.6285898565172368, "ngenes": 55, "max_val": 8.706, "rank": 252.0, "id": "38f56493-8e05-11ea-a406-5cf37097309a"}, {"source": "Elastic fibre formation", "value": 1.5452964802223617, "ngenes": 59, "max_val": 8.706, "rank": 298.0, "id": "38f56494-8e05-11ea-82e2-5cf37097309a", "children": [{"source": "Molecules associated with elastic fibres", "value": 1.434200512371639, "ngenes": 52, "max_val": 8.706, "rank": 345.0, "id": "38f56495-8e05-11ea-a7f9-5cf37097309a"}]}, {"source": "Collagen formation", "value": 1.311998569350695, "ngenes": 95, "max_val": 8.706, "rank": 386.0, "id": "38f56496-8e05-11ea-a679-5cf37097309a", "children": [{"source": "Assembly of collagen fibrils and other multimeric structures", "value": 0.8947115305057501, "ngenes": 65, "max_val": 8.706, "rank": 603.0, "id": "38f56497-8e05-11ea-9c82-5cf37097309a", "children": [{"source": "Anchoring fibril formation", "value": 1.2297852930649709, "ngenes": 15, "max_val": 8.706, "rank": 414.0, "id": "38f56498-8e05-11ea-ad61-5cf37097309a"}, {"source": "Crosslinking of collagen fibrils", "value": 0.7699143358175191, "ngenes": 18, "max_val": 8.706, "rank": 685.0, "id": "38f56499-8e05-11ea-8bb9-5cf37097309a"}]}, {"source": "Collagen biosynthesis and modifying enzymes", "value": 1.163640992394798, "ngenes": 72, "max_val": 8.706, "rank": 456.0, "id": "38f5649a-8e05-11ea-8c4e-5cf37097309a", "children": [{"source": "Collagen chain trimerization", "value": 0.7633075525804415, "ngenes": 48, "max_val": 8.706, "rank": 689.0, "id": "38f5649b-8e05-11ea-bb60-5cf37097309a"}]}]}, {"source": "Integrin cell surface interactions", "value": 0.8844612820472848, "ngenes": 109, "max_val": 8.706, "rank": 616.0, "id": "38f5649c-8e05-11ea-b0a0-5cf37097309a"}, {"source": "ECM proteoglycans", "value": 0.8794052508761692, "ngenes": 92, "max_val": 8.706, "rank": 617.0, "id": "38f5649d-8e05-11ea-95f8-5cf37097309a"}, {"source": "Degradation of the extracellular matrix", "value": 0.9954651226027226, "ngenes": 201, "max_val": 8.706, "rank": 547.0, "id": "38f5649e-8e05-11ea-b2e8-5cf37097309a", "children": [{"source": "Collagen degradation", "value": 0.660018151722631, "ngenes": 100, "max_val": 8.706, "rank": 808.0, "id": "38f5649f-8e05-11ea-80c9-5cf37097309a"}, {"source": "Activation of Matrix Metalloproteinases", "value": 0.5565507266078732, "ngenes": 37, "max_val": 8.706, "rank": 981.0, "id": "38f564a0-8e05-11ea-acdc-5cf37097309a"}]}, {"source": "Non-integrin membrane-ECM interactions", "value": 0.913589610544886, "ngenes": 82, "max_val": 8.706, "rank": 587.0, "id": "38f564a1-8e05-11ea-b027-5cf37097309a", "children": [{"source": "Syndecan interactions", "value": 0.3911487587762643, "ngenes": 35, "max_val": 8.706, "rank": 1541.0, "id": "38f564a2-8e05-11ea-9e93-5cf37097309a"}]}, {"source": "Fibronectin matrix formation", "value": 0.3727213414860511, "ngenes": 6, "max_val": 8.706, "rank": 1611.0, "id": "38f564a3-8e05-11ea-b2b6-5cf37097309a"}]}, {"source": "Organelle biogenesis and maintenance", "value": 0.3849420497242914, "ngenes": 350, "max_val": 8.706, "rank": 1561.0, "id": "38f564a4-8e05-11ea-bed5-5cf37097309a", "children": [{"source": "Mitochondrial biogenesis", "value": 1.1728491614139245, "ngenes": 104, "max_val": 8.706, "rank": 453.0, "id": "38f564a5-8e05-11ea-8294-5cf37097309a", "children": [{"source": "Cristae formation", "value": 1.5698885367185134, "ngenes": 31, "max_val": 8.706, "rank": 282.0, "id": "38f564a6-8e05-11ea-9839-5cf37097309a"}, {"source": "Activation of PPARGC1A (PGC-1alpha) by phosphorylation", "value": 1.2135544825273883, "ngenes": 10, "max_val": 8.706, "rank": 420.0, "id": "38f564a7-8e05-11ea-abdf-5cf37097309a"}, {"source": "Transcriptional activation of mitochondrial biogenesis", "value": 0.8053336674550169, "ngenes": 64, "max_val": 8.706, "rank": 664.0, "id": "38f564a8-8e05-11ea-9a6e-5cf37097309a"}]}, {"source": "Cilium Assembly", "value": 0.3492120791603117, "ngenes": 246, "max_val": 8.706, "rank": 1740.0, "id": "38f564a9-8e05-11ea-bd58-5cf37097309a", "children": [{"source": "Cargo trafficking to the periciliary membrane", "value": 0.4717863154195249, "ngenes": 60, "max_val": 8.706, "rank": 1195.0, "id": "38f564aa-8e05-11ea-9134-5cf37097309a", "children": [{"source": "ARL13B-mediated ciliary trafficking of INPP5E", "value": 0.4898322962446102, "ngenes": 3, "max_val": 8.706, "rank": 1115.0, "id": "38f564ab-8e05-11ea-b831-5cf37097309a"}, {"source": "Trafficking of myristoylated proteins to the cilium", "value": 0.4660324748675502, "ngenes": 5, "max_val": 8.706, "rank": 1222.0, "id": "38f564ac-8e05-11ea-8d5e-5cf37097309a"}, {"source": "BBSome-mediated cargo-targeting to cilium", "value": 0.4246279586318637, "ngenes": 23, "max_val": 8.706, "rank": 1384.0, "id": "38f564ad-8e05-11ea-85e6-5cf37097309a"}, {"source": "VxPx cargo-targeting to cilium", "value": 0.3582908682862535, "ngenes": 30, "max_val": 8.706, "rank": 1689.0, "id": "38f564ae-8e05-11ea-b5ec-5cf37097309a"}]}, {"source": "Anchoring of the basal body to the plasma membrane", "value": 0.43490941393839655, "ngenes": 108, "max_val": 8.706, "rank": 1357.0, "id": "38f564af-8e05-11ea-a145-5cf37097309a"}, {"source": "Intraflagellar transport", "value": 0.3988171647970603, "ngenes": 72, "max_val": 8.706, "rank": 1498.0, "id": "38f564b0-8e05-11ea-aae0-5cf37097309a"}]}]}, {"source": "Autophagy", "value": 0.3084182102447057, "ngenes": 217, "max_val": 8.706, "rank": 2009.0, "id": "38f564b1-8e05-11ea-a022-5cf37097309a", "children": [{"source": "Macroautophagy", "value": 0.40594021400370056, "ngenes": 191, "max_val": 8.706, "rank": 1483.0, "id": "38f564b2-8e05-11ea-bf23-5cf37097309a", "children": [{"source": "Selective autophagy", "value": 0.4762659212904118, "ngenes": 123, "max_val": 8.706, "rank": 1179.0, "id": "38f564b3-8e05-11ea-a66d-5cf37097309a", "children": [{"source": "Aggrephagy", "value": 0.6783032359193764, "ngenes": 84, "max_val": 8.706, "rank": 775.0, "id": "38f564b4-8e05-11ea-8b7f-5cf37097309a"}, {"source": "Mitophagy", "value": 0.4689265375340588, "ngenes": 35, "max_val": 8.706, "rank": 1217.0, "id": "38f564b5-8e05-11ea-b444-5cf37097309a", "children": [{"source": "Pink/Parkin Mediated Mitophagy", "value": 0.6580731317637653, "ngenes": 22, "max_val": 8.706, "rank": 810.0, "id": "38f564b6-8e05-11ea-aa78-5cf37097309a"}, {"source": "Receptor Mediated Mitophagy", "value": 0.3663505507769889, "ngenes": 17, "max_val": 8.706, "rank": 1636.0, "id": "38f564b7-8e05-11ea-876b-5cf37097309a"}]}, {"source": "Lipophagy", "value": 0.3058941684179461, "ngenes": 9, "max_val": 8.706, "rank": 2025.0, "id": "38f564b8-8e05-11ea-9d7b-5cf37097309a"}]}]}, {"source": "Chaperone Mediated Autophagy", "value": 0.3483210271800589, "ngenes": 22, "max_val": 8.706, "rank": 1746.0, "id": "38f564b9-8e05-11ea-b52f-5cf37097309a"}, {"source": "Late endosomal microautophagy", "value": 0.3272772875640805, "ngenes": 36, "max_val": 8.706, "rank": 1880.0, "id": "38f564ba-8e05-11ea-b060-5cf37097309a"}]}, {"source": "Digestion and absorption", "value": 0.6690947057056273, "ngenes": 29, "max_val": 8.706, "rank": 789.0, "id": "38f564bb-8e05-11ea-a608-5cf37097309a", "children": [{"source": "Digestion", "value": 0.5565507266078732, "ngenes": 23, "max_val": 8.706, "rank": 979.0, "id": "38f564bc-8e05-11ea-8c84-5cf37097309a", "children": [{"source": "Digestion of dietary carbohydrate", "value": 0.4882341197091889, "ngenes": 11, "max_val": 8.706, "rank": 1118.0, "id": "38f564bd-8e05-11ea-b92a-5cf37097309a"}, {"source": "Digestion of dietary lipid", "value": 0.3333488691934495, "ngenes": 7, "max_val": 8.706, "rank": 1836.0, "id": "38f564be-8e05-11ea-956a-5cf37097309a"}]}, {"source": "Intestinal absorption", "value": 0.8594586706257212, "ngenes": 6, "max_val": 8.706, "rank": 633.0, "id": "38f564bf-8e05-11ea-ad4c-5cf37097309a", "children": [{"source": "Intestinal hexose absorption", "value": 0.3592004814595621, "ngenes": 4, "max_val": 8.706, "rank": 1675.0, "id": "38f564c0-8e05-11ea-82de-5cf37097309a"}]}]}, {"source": "Circadian Clock", "value": 0.6156480966272587, "ngenes": 99, "max_val": 8.706, "rank": 893.0, "id": "38f564c1-8e05-11ea-acde-5cf37097309a", "children": [{"source": "RORA activates gene expression", "value": 0.4788365094295219, "ngenes": 22, "max_val": 8.706, "rank": 1167.0, "id": "38f564c2-8e05-11ea-b5aa-5cf37097309a"}, {"source": "BMAL1:CLOCK,NPAS2 activates circadian gene expression", "value": 0.4646123127797776, "ngenes": 32, "max_val": 8.706, "rank": 1243.0, "id": "38f564c3-8e05-11ea-9c60-5cf37097309a"}, {"source": "NR1D1 (REV-ERBA) represses gene expression", "value": 0.3121787816127303, "ngenes": 4, "max_val": 8.706, "rank": 1987.0, "id": "38f564c4-8e05-11ea-b9ef-5cf37097309a"}]}]}